<SEC-DOCUMENT>0001193125-15-162509.txt : 20150430
<SEC-HEADER>0001193125-15-162509.hdr.sgml : 20150430
<ACCEPTANCE-DATETIME>20150430170122
ACCESSION NUMBER:		0001193125-15-162509
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		8
CONFORMED PERIOD OF REPORT:	20150616
FILED AS OF DATE:		20150430
DATE AS OF CHANGE:		20150430
EFFECTIVENESS DATE:		20150430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NEKTAR THERAPEUTICS
		CENTRAL INDEX KEY:			0000906709
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				943134940
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-24006
		FILM NUMBER:		15819929

	BUSINESS ADDRESS:	
		STREET 1:		455 MISSION BAY BOULEVARD SOUTH
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94158
		BUSINESS PHONE:		4154825300

	MAIL ADDRESS:	
		STREET 1:		455 MISSION BAY BOULEVARD SOUTH
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94158

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INHALE THERAPEUTIC SYSTEMS INC
		DATE OF NAME CHANGE:	19980723

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INHALE THERAPEUTIC SYSTEMS
		DATE OF NAME CHANGE:	19940303
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d913905ddef14a.htm
<DESCRIPTION>DEFINITIVE PROXY STATEMENT
<TEXT>
<HTML><HEAD>
<TITLE>Definitive Proxy Statement</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed by a
Party other than the Registrant&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="97%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">Preliminary Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><B>Confidential, for Use of the Commission Only (as permitted by Rule&nbsp;14a-6(e)(2))</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">Definitive Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">Definitive Additional Materials</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">Soliciting Material Pursuant to &#167;240.14a-12</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>Nektar Therapeutics </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">No fee required.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of each class of securities to which transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aggregate number of securities to which transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proposed maximum aggregate value of transaction:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">(5)</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total fee paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">Fee paid previously with preliminary materials.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amount Previously Paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Form, Schedule or Registration Statement No.:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing Party:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date Filed:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g913905g36i66.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:2px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">NEKTAR THERAPEUTICS </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">455 Mission Bay Boulevard South </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">San Francisco, California 94158 </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">TO BE HELD ON JUNE 16, 2015 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">AT 2:00 P.M. PACIFIC TIME </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Dear Stockholder: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You are cordially invited to attend the 2015 Annual Meeting of
Stockholders of Nektar Therapeutics, a Delaware corporation. The 2015 Annual Meeting will be held on Tuesday, June&nbsp;16, 2015, at 2:00 p.m. local time at Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, California 94158, for
the following purposes: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To elect three directors with terms to expire at the 2018 Annual Meeting of Stockholders. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To approve an amendment to our 2012 Performance Incentive Plan to increase the aggregate number of shares of common stock available for issuance under the plan by
7,000,000 shares. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To ratify the selection of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2015.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To approve a non-binding advisory resolution regarding our executive compensation (a &#147;say-on-pay&#148; vote). </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To conduct any other business properly brought before the 2015 Annual Meeting. </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">These items of business are more fully described in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. The record date for the 2015 Annual Meeting is April&nbsp;20, 2015. Only
stockholders of record at the close of business on that date are entitled to notice of, and to vote at, the 2015 Annual Meeting or any adjournment thereof. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Your vote is very important. Whether or not you attend the 2015 Annual Meeting in person, it is important that your shares be represented. You may vote your proxy on the Internet, by phone or by mail in
accordance with the instructions in the Notice of Availability of Proxy Materials. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On behalf of the Board of Directors, thank
you for your participation in this important annual process. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Gil M. Labrucherie </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Senior Vice President, General Counsel
and </I></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Secretary </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">San Francisco, California </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">May&nbsp;7, 2015 </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Y<SMALL>OU</SMALL> <SMALL>ARE</SMALL> <SMALL>CORDIALLY</SMALL> <SMALL>INVITED</SMALL> <SMALL>TO</SMALL> <SMALL>ATTEND</SMALL>
<SMALL>THE</SMALL> A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL> <SMALL>IN</SMALL> <SMALL>PERSON</SMALL>. W<SMALL>HETHER</SMALL> <SMALL>OR</SMALL> <SMALL>NOT</SMALL> <SMALL>YOU</SMALL> <SMALL>EXPECT</SMALL> <SMALL>TO</SMALL> <SMALL>ATTEND</SMALL>
<SMALL>THE</SMALL> A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL>, <SMALL>PLEASE</SMALL> <SMALL>VOTE</SMALL> <SMALL>ON</SMALL> <SMALL>THE</SMALL> <SMALL>INTERNET</SMALL>, <SMALL>BY</SMALL> <SMALL>PHONE</SMALL> <SMALL>OR</SMALL> <SMALL>BY</SMALL>
<SMALL>MAIL</SMALL> <SMALL>AS</SMALL> <SMALL>INSTRUCTED</SMALL> <SMALL>IN</SMALL> <SMALL>THE</SMALL> N<SMALL>OTICE</SMALL> <SMALL>OF</SMALL> A<SMALL>VAILABILITY</SMALL> <SMALL>OF</SMALL> P<SMALL>ROXY</SMALL> M<SMALL>ATERIALS</SMALL>,
<SMALL>AS</SMALL> <SMALL>PROMPTLY</SMALL> <SMALL>AS</SMALL> <SMALL>POSSIBLE</SMALL> <SMALL>IN</SMALL> <SMALL>ORDER</SMALL> <SMALL>TO</SMALL> <SMALL>ENSURE</SMALL> <SMALL>YOUR</SMALL> <SMALL>REPRESENTATION</SMALL> <SMALL>AT</SMALL> <SMALL>THE</SMALL>
<SMALL>MEETING</SMALL>. E<SMALL>VEN</SMALL> <SMALL>IF</SMALL> <SMALL>YOU</SMALL> <SMALL>HAVE</SMALL> <SMALL>VOTED</SMALL> <SMALL>BY</SMALL> <SMALL>PROXY</SMALL>, <SMALL>YOU</SMALL> <SMALL>MAY</SMALL> <SMALL>STILL</SMALL> <SMALL>VOTE</SMALL>
<SMALL>IN</SMALL> <SMALL>PERSON</SMALL> <SMALL>IF</SMALL> <SMALL>YOU</SMALL> <SMALL>ATTEND</SMALL> <SMALL>THE</SMALL> A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL>. P<SMALL>LEASE</SMALL> <SMALL>NOTE</SMALL>, <SMALL>HOWEVER</SMALL>,
<SMALL>THAT</SMALL> <SMALL>IF</SMALL> <SMALL>YOUR</SMALL> <SMALL>SHARES</SMALL> <SMALL>ARE</SMALL> <SMALL>HELD</SMALL> <SMALL>OF</SMALL> <SMALL>RECORD</SMALL> <SMALL>BY</SMALL> <SMALL>A</SMALL> <SMALL>BROKER</SMALL>, <SMALL>BANK</SMALL>
<SMALL>OR</SMALL> <SMALL>OTHER</SMALL> <SMALL>NOMINEE</SMALL> <SMALL>AND</SMALL> <SMALL>YOU</SMALL> <SMALL>WISH</SMALL> <SMALL>TO</SMALL> <SMALL>VOTE</SMALL> <SMALL>AT</SMALL> <SMALL>THE</SMALL> A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL>,
<SMALL>YOU</SMALL> <SMALL>MUST</SMALL> <SMALL>OBTAIN</SMALL> <SMALL>A</SMALL> <SMALL>PROXY</SMALL> <SMALL>ISSUED</SMALL> <SMALL>IN</SMALL> <SMALL>YOUR</SMALL> <SMALL>NAME</SMALL> <SMALL>FROM</SMALL> <SMALL>THAT</SMALL> <SMALL>RECORD</SMALL>
<SMALL>HOLDER</SMALL>. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="96%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_1">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING PROCEDURES</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_2">PROPOSAL 1: ELECTION OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_3">PROPOSAL 2: APPROVAL OF AN AMENDMENT TO OUR 2012 PERFORMANCE INCENTIVE PLAN</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_4">PROPOSAL 3: RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></FONT></P></TD>

<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_5">PROPOSAL 4: ADVISORY VOTE ON EXECUTIVE COMPENSATION</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_6">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_7">SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_8">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_9">INFORMATION ABOUT THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_10">THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_11">DIRECTORS CONTINUING IN OFFICE UNTIL THE 2016 ANNUAL MEETING</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_12">DIRECTORS CONTINUING IN OFFICE UNTIL THE 2017 ANNUAL MEETING</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_13">CURRENT DIRECTORS NOMINATED FOR REELECTION TO SERVE UNTIL THE 2018 ANNUAL MEETING</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_14">MEETINGS OF THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_15">CORPORATE GOVERNANCE</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_16">BOARD LEADERSHIP STRUCTURE</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_17">RISK OVERSIGHT</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_18">INDEPENDENCE OF THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_19">INFORMATION REGARDING THE COMMITTEES OF THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_20">STOCKHOLDER COMMUNICATIONS WITH THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_21">CODE OF BUSINESS CONDUCT AND ETHICS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_22">ORGANIZATION AND COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_23">DIRECTOR COMPENSATION TABLE</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_24">COMPENSATION DISCUSSION AND ANALYSIS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">37</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_25">COMPENSATION COMMITTEE REPORT</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_26">SUMMARY COMPENSATION TABLE&#151;FISCAL 2012-2014</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">56</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_27">DESCRIPTION OF EMPLOYMENT AGREEMENTS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">57</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_28">GRANTS OF PLAN BASED AWARDS IN 2014</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">58</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_29">OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END FOR 2014</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">61</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_30">OPTION EXERCISES AND STOCK VESTED IN 2014</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">63</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_31">POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE OF CONTROL</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">63</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_32">INFORMATION ABOUT OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">67</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_33">PRE-APPROVAL POLICIES AND PROCEDURES</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">67</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_34">REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">67</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_35">OTHER MATTERS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc913905_36">ADDITIONAL INFORMATION</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g913905g36i66.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:2px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">NEKTAR THERAPEUTICS </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">455 Mission Bay Boulevard South </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">San Francisco, California 94158 </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">TO BE HELD ON JUNE 16, 2015 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">AT 2:00 P.M. PACIFIC TIME </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_1"></A>QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING PROCEDURES </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HY</SMALL> <SMALL>AM</SMALL> I <SMALL>RECEIVING</SMALL> <SMALL>THESE</SMALL> <SMALL>MATERIALS</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We sent you a Notice of Availability of Proxy Materials (the &#147;Notice&#148;) because the board of directors of Nektar Therapeutics (&#147;Nektar,&#148; the &#147;Company,&#148; &#147;we&#148; or
&#147;us&#148;) is soliciting your proxy to vote at our 2015 annual meeting of stockholders (the &#147;Annual Meeting&#148;) to be held on June&nbsp;16, 2015 at 2:00 p.m. local time at Nektar Therapeutics, 455 Mission Bay Boulevard South, San
Francisco, California 94158. We invite you to attend the Annual Meeting to vote on the proposals described in this proxy statement. However, you do not need to attend the meeting to vote your shares. Instead, you may vote by proxy over the Internet
or by phone by following the instructions provided in the Notice or, if you request printed copies of the proxy materials by mail, you may vote by mail. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Notice was first sent or made available on or about May&nbsp;4, 2015 to all stockholders of record entitled to vote at the Annual Meeting. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HO</SMALL> <SMALL>CAN</SMALL> <SMALL>VOTE</SMALL> <SMALL>AT</SMALL> <SMALL>THE</SMALL> <SMALL>ANNUAL</SMALL> <SMALL>MEETING</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Only stockholders of record at the close of business on April&nbsp;20, 2015 will be entitled to vote at the Annual Meeting. On this record
date, there were 131,492,350 shares of common stock outstanding and entitled to vote. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stockholder of Record: Shares
Registered in Your Name </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If, on April&nbsp;20, 2015, your shares were registered directly in your name with our transfer
agent, Computershare Investor Services, LLC, then you are a stockholder of record. The Notice will be sent to you by mail directly by us. As a stockholder of record, you may vote in person at the Annual Meeting or vote by proxy. Whether or not you
plan to attend the Annual Meeting, we urge you to vote on the Internet or by phone as instructed in the Notice or by proxy by mail by requesting a paper copy of the proxy materials as instructed in the Notice to ensure your vote is counted.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Other Agent </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If, on April&nbsp;20, 2015, your shares were held in an account at a brokerage firm, bank or other agent, then you are the beneficial
owner of shares held in &#147;street name&#148; and the Notice is being forwarded to you by that organization. The organization holding your account is considered the stockholder of record for purposes of voting at the Annual Meeting. As a
beneficial owner, you have the right to direct your broker, bank or other agent on how to vote the shares in your account. Your brokerage firm, bank or other agent will not be able to vote in the election of directors unless they have your voting
instructions, so it is very important that you indicate your voting instructions to the institution holding your shares. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You are also invited to attend the Annual Meeting. However, since you are not the
stockholder of record, you may not vote your shares in person at the Annual Meeting unless you request and obtain a valid proxy from your broker, bank or other agent. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HAT</SMALL> <SMALL>AM</SMALL> <SMALL>I</SMALL> <SMALL>VOTING</SMALL> <SMALL>ON</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">There are four matters scheduled for a vote: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 1: To elect three directors with terms to expire at the 2018 Annual Meeting of Stockholders. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 2: To approve an amendment to our 2012 Performance Incentive Plan to increase the aggregate number of shares of common stock available for
issuance under the plan by 7,000,000 shares. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 3: To ratify the selection of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for our fiscal year ending
December&nbsp;31, 2015. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 4: To approve a non-binding advisory resolution regarding our executive compensation (a &#147;say-on-pay&#148; vote).
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>H<SMALL>OW</SMALL> <SMALL>ARE</SMALL> <SMALL>PROXY</SMALL> <SMALL>MATERIALS</SMALL> <SMALL>DISTRIBUTED</SMALL>?
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under rules adopted by the Securities and Exchange Commission (&#147;SEC&#148;), we are sending the Notice to our
stockholders of record and beneficial owners as of April&nbsp;20, 2015. Stockholders will have the ability to access the proxy materials, including this proxy statement and our Annual Report on Form 10-K for the fiscal year ended December&nbsp;31,
2014, on the Internet at <I><U>www.nektar.com</U></I> or to request a printed or electronic set of the proxy materials at no charge. Instructions on how to access the proxy materials over the Internet and how to request a printed copy may be found
on the Notice. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, any stockholder may request to receive proxy materials in printed form by mail or electronically
by email on an ongoing basis. Choosing to receive future proxy materials by email will save us the cost of printing and mailing documents to stockholders and will reduce the impact of annual meetings on the environment. A stockholder who chooses to
receive future proxy materials by email will receive an email prior to next year&#146;s annual meeting with instructions containing a link to those materials and a link to the proxy voting website. A stockholder&#146;s election to receive proxy
materials by email will remain in effect until the stockholder terminates it. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>H<SMALL>OW</SMALL> <SMALL>DO</SMALL> I <SMALL>VOTE</SMALL>?
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may either vote &#147;For&#148; or &#147;Against&#148; or abstain from voting with respect to each nominee to the
board of directors. For each of the other matters to be voted on, you may vote &#147;For&#148; or &#147;Against&#148; or abstain from voting. The procedures for voting are: </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Stockholder of Record: Shares Registered in Your Name </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a
stockholder of record as of April&nbsp;20, 2015, you may vote in person at the Annual Meeting, vote by proxy over the Internet or by phone by following the instructions provided in the Notice or, if you request printed copies of the proxy materials
by mail, you may vote by mail. If your proxy is properly executed in time to be voted at the Annual Meeting, the shares represented by the proxy will be voted in accordance with the instructions you provide. Whether or not you plan to attend the
Annual Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the Annual Meeting and vote in person if you have already voted by proxy. </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote in person, come to the Annual Meeting and we will give you a ballot when you arrive. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote on the Internet, go to www.proxyvote.com to complete an electronic proxy card. You will be asked to provide the 12-digit control number from the Notice and
follow the instructions. Your vote must be received by 11:59 p.m. Eastern Time on June&nbsp;15, 2015 to be counted. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote by phone, request a paper or email copy of the proxy materials by following the instructions on the Notice and call the number provided with the proxy materials
to transmit your voting instructions. Your vote must be received by 11:59 p.m. Eastern Time on June&nbsp;15, 2015 to be counted. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote by mail, request a paper copy of the proxy materials by following the instructions on the Notice and complete, sign and date the proxy card enclosed with the
paper copy of the proxy materials and return it promptly in the envelope provided. If you return your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Other Agent </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, you should have received a Notice and
voting instructions from that organization rather than from us. Simply follow the instructions to ensure that your vote is counted. To vote in person at the Annual Meeting, you must obtain a valid proxy from your broker, bank or other agent. Follow
the instructions from your broker, bank or other agent included with the Notice, or contact your broker, bank or other agent. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We provide Internet proxy voting to allow you to vote your shares on-line, with procedures designed to ensure the authenticity and
correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your Internet access, such as usage charges from Internet access providers and telephone companies. </B></FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>H<SMALL>OW</SMALL> <SMALL>MANY</SMALL> <SMALL>VOTES</SMALL> <SMALL>DO</SMALL> I <SMALL>HAVE</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On each matter to be voted upon, you have one vote for each share of common stock you owned as of April&nbsp;20, 2015. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HAT</SMALL> <SMALL>IS</SMALL> <SMALL>THE</SMALL> <SMALL>QUORUM</SMALL> <SMALL>REQUIREMENT</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A quorum of stockholders is necessary to take any action at the meeting (other than to adjourn the meeting). The presence, in person or by
proxy duly authorized, of the holders of a majority of the outstanding shares of stock entitled to vote will constitute a quorum. On April&nbsp;20, 2015, there were 131,492,350&nbsp;shares outstanding and entitled to vote. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Your shares will be counted towards the quorum only if you submit a valid proxy or vote in person at the Annual Meeting. Even if your
valid proxy card indicates that you abstain from voting or if a broker indicates on a proxy that it lacks discretionary authority to vote your shares on a particular matter, commonly referred to as &#147;broker non-votes,&#148; your shares will
still be counted for purposes of determining the presence of a quorum at the Annual Meeting. If there is no quorum, the chairman of the Annual Meeting or a majority of the votes present at the Annual Meeting may adjourn the Annual Meeting to another
date. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HAT</SMALL> <SMALL>IF</SMALL> I <SMALL>RETURN</SMALL> <SMALL>A</SMALL> <SMALL>PROXY</SMALL> <SMALL>CARD</SMALL>
<SMALL>BUT</SMALL> <SMALL>DO</SMALL> <SMALL>NOT</SMALL> <SMALL>MAKE</SMALL> <SMALL>SPECIFIC</SMALL> <SMALL>CHOICES</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a stockholder of record and you return a proxy card without marking any voting selections, your shares will be voted:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 1: &#147;For&#148; election of all three nominees for director. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 2: &#147;For&#148; the increase to the aggregate number of shares of common stock authorized for issuance under the 2012 Performance Incentive Plan.
</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 3: &#147;For&#148; the ratification of the audit committee&#146;s selection of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm
for our fiscal year ending December&nbsp;31, 2015. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 4: &#147;For&#148; the approval of the resolution regarding executive compensation. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If any other matter is properly presented at the meeting, your proxy (one of the individuals named on your proxy card) will vote your
shares using his best judgment. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a beneficial owner of shares registered in the name of your broker, bank or other
agent, your shares are held by your broker, bank or other agent as your nominee (that is, in &#147;street name&#148;) and you will need to obtain a proxy form from the organization that holds your shares and follow the instructions included on that
form regarding how to instruct the organization to vote your shares. If you do not give instructions to your broker, bank or other agent, it can vote your shares with respect to &#147;discretionary&#148; items but not with respect to &#147;non-
discretionary&#148; items. Discretionary items are proposals considered routine under the rules of various national securities exchanges, and, in the absence of your voting instructions, your broker, bank or other agent may vote your shares held in
street name on such proposals. Non-discretionary items are proposals considered non-routine under the rules of various national securities exchanges, and, in the absence of your voting instructions, your broker, bank or other agent may not vote your
shares held in street name on such proposals and the shares will be treated as broker non-votes. Proposals 1, 2, and 4 are matters considered non-routine under the applicable rules. If you do not give your broker specific instructions, the broker
will not vote your shares on Proposals 1, 2, and 4 and your shares will constitute broker non-votes which will be counted for purposes of determining whether a quorum exists but will not affect the outcome of these proposals. Proposal 3 involves a
matter we believe to be routine and thus if you do not give instructions to your broker, the broker may vote your shares in its discretion on Proposal 3 and therefore no broker non-votes are expected to exist in connection with Proposal 3.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>H<SMALL>OW</SMALL> <SMALL>ARE</SMALL> <SMALL>VOTES</SMALL> <SMALL>COUNTED</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Votes will be counted by the inspector of election appointed for the Annual Meeting, who will count, with respect to Proposals 1, 2, 3,
and 4 &#147;For&#148; votes, &#147;Against&#148; votes and abstentions, and with respect to Proposals 1, 2, and 4, broker non-votes. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HO</SMALL> <SMALL>WILL</SMALL> <SMALL>SERVE</SMALL> <SMALL>AS</SMALL> <SMALL>INSPECTOR</SMALL> <SMALL>OF</SMALL> <SMALL>ELECTIONS</SMALL>?
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A representative of Broadridge Financial Solutions, Inc. will serve as the inspector of elections. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>H<SMALL>OW</SMALL> <SMALL>MANY</SMALL> <SMALL>VOTES</SMALL> <SMALL>ARE</SMALL> <SMALL>NEEDED</SMALL> <SMALL>TO</SMALL> <SMALL>APPROVE</SMALL>
<SMALL>EACH</SMALL> <SMALL>PROPOSAL</SMALL>? </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Proposal 1 electing three members of the board of directors, each director must receive a &#147;For&#148; vote from a majority of the shares
present and entitled to vote and cast in person or by proxy at the Annual Meeting on the election of the director. A majority of the shares cast shall mean that the number of shares voted &#147;For&#148; a director&#146;s election exceeds fifty
percent (50%)&nbsp;of the number of the shares cast with respect to that director&#146;s election, with shares cast including shares voted &#147;Against&#148; in each case and excluding abstentions and broker non-votes with respect to that
director&#146;s election. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Proposal 2 approving an amendment to our 2012 Performance Incentive Plan to increase the aggregate number of shares of common stock authorized for
issuance under the plan, the proposal must receive a &#147;For&#148; vote from a majority of the shares present and entitled to vote and cast either in person or by proxy at the Annual Meeting. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Proposal 3 ratifying the audit committee&#146;s selection of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for
our fiscal year ending December&nbsp;31, 2015, the proposal must receive a &#147;For&#148; vote from a majority of the shares present and entitled to vote and cast either in person or by proxy at the Annual Meeting. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Proposal 4 approving the resolution regarding executive compensation, the proposal must receive a &#147;For&#148; vote from a majority of the
shares present and entitled to vote and cast either in person or by proxy at the Annual Meeting. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HO</SMALL>
<SMALL>IS</SMALL> <SMALL>PAYING</SMALL> <SMALL>FOR</SMALL> <SMALL>THIS</SMALL> <SMALL>PROXY</SMALL> <SMALL>SOLICITATION</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We will pay for the entire cost of soliciting proxies. In addition to the Notice and the proxy materials, our directors and employees may also solicit proxies in person, by telephone or by other means of
communication. We will not pay our directors and employees any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other agents for the cost of forwarding the Notice and any other proxy materials to
beneficial owners. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HAT</SMALL> <SMALL>DOES</SMALL> <SMALL>IT</SMALL> <SMALL>MEAN</SMALL> <SMALL>IF</SMALL> I
<SMALL>RECEIVE</SMALL> <SMALL>MORE</SMALL> <SMALL>THAN</SMALL> <SMALL>ONE</SMALL> N<SMALL>OTICE</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you receive
more than one Notice, your shares are registered in more than one name or are registered in different accounts. Please vote by proxy according to each Notice to ensure that all of your shares are voted. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>C<SMALL>AN</SMALL> I <SMALL>CHANGE</SMALL> <SMALL>MY</SMALL> <SMALL>VOTE</SMALL> <SMALL>AFTER</SMALL> <SMALL>SUBMITTING</SMALL> <SMALL>MY</SMALL>
<SMALL>PROXY</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yes, you can revoke your proxy at any time before the final vote at the Annual Meeting. If you are a
stockholder of record, you may revoke your proxy in any one of three ways: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A duly executed proxy card with a later date or time than the previously submitted proxy; </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A written notice that you are revoking your proxy to our Secretary, care of Nektar Therapeutics, at 455 Mission Bay Boulevard South, San Francisco, California 94158; or
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A later-dated vote on the Internet or by phone or a ballot cast in person at the Annual Meeting (simply attending the Annual Meeting will not, by itself, revoke your
proxy). </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a beneficial owner, you may revoke your proxy by submitting new instructions to your broker,
bank or other agent, or if you have received a proxy from your broker, bank or other agent giving you the right to vote your shares at the Annual Meeting, by attending the meeting and voting in person. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HEN</SMALL> <SMALL>ARE</SMALL> <SMALL>STOCKHOLDER</SMALL> <SMALL>PROPOSALS</SMALL> <SMALL>DUE</SMALL> <SMALL>FOR</SMALL> <SMALL>NEXT</SMALL>
<SMALL>YEAR</SMALL>&#146;<SMALL>S</SMALL> A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to Rule 14a-8 under the
Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), some stockholder proposals may be eligible for inclusion in our 2016 proxy statement. Any such proposal must be submitted in writing by January&nbsp;8, 2016, to our
Secretary, care of Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, California 94158. If we change the date of our 2016 annual meeting by more than 30 days from the date of the previous year&#146;s annual meeting, the deadline
shall be a reasonable time before we begin to print and send our proxy materials. Stockholders interested in submitting such a proposal are advised to contact knowledgeable counsel with regard to the detailed requirements of the applicable
securities laws and our bylaws. The submission of a stockholder proposal does not guarantee that it will be included in our proxy statement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Alternatively, under our bylaws, if you wish to submit a proposal that is not to be included in next year&#146;s proxy statement or nominate a director, you must provide specific information to us no
earlier than March&nbsp;18, 2016 and no later than the close of business on April&nbsp;18, 2016. If we change the date of our 2016 annual meeting by more than 30 days from the date of the previous year&#146;s annual meeting, the deadline shall be
changed to not later than the sixtieth day prior to such annual meeting and no earlier than the close of business on the ninetieth day prior to such annual meeting. In the event we provide less than 70 days&#146; notice or prior public disclosure of
the date of the annual meeting, the stockholder proposal or nomination must be received not later than the tenth </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
day following the day on which such notice of the date of the annual meeting was mailed or such public disclosure was made. The public announcement of an adjournment or postponement of the 2016
annual meeting does not commence a new time period (or extend any time period) for the giving of a stockholder&#146;s notice as described in this proxy statement. You are advised to review our bylaws, which contain additional requirements with
respect to advance notice of stockholder proposals and director nominees. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A stockholder&#146;s submission must include
certain specific information concerning the proposal or nominee, as the case may be, and information as to the stockholder&#146;s ownership of our common stock. Proposals or nominations not meeting these requirements will not be entertained at any
annual meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In relation to stockholder proposals and nominations, in certain instances we may exercise discretionary
voting authority under proxies held by the board of directors. For instance, if we do not receive a stockholder proposal by April&nbsp;18, 2016, we may exercise discretionary voting authority under proxies held by the board of directors on such
stockholder proposal. If we change the date of our 2016 annual meeting by more than 30 days from the date of the previous year&#146;s annual meeting, the deadline will change to a reasonable time before we begin to print and send our proxy
materials. In addition, even if we are notified of a stockholder proposal within the time requirements discussed above, if the stockholder does not comply with certain requirements of the Exchange Act, we may exercise discretionary voting authority
under proxies held by the board of directors on such stockholder proposal if we include advice in our proxy statement on the nature of the matter and how we intend to exercise our discretion to vote on the matter. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HAT</SMALL> <SMALL>IS</SMALL> &#147;<SMALL>HOUSEHOLDING</SMALL>&#148; <SMALL>AND</SMALL> <SMALL>HOW</SMALL> <SMALL>DOES</SMALL>
<SMALL>IT</SMALL> <SMALL>AFFECT</SMALL> <SMALL>ME</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have adopted a procedure approved by the SEC called
&#147;householding.&#148; Under this procedure, stockholders who have the same address may receive only one copy of the Notice, unless one or more of these stockholders notifies us that they wish to receive individual copies of the Notice and, if
requested, other proxy materials. This process potentially means extra convenience for stockholders and cost savings for companies. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If you are a beneficial owner of our common stock, once you receive notice from your broker, bank or other agent that they will be householding communications to your address, householding will continue
until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in householding and would prefer to receive separate Notices or other proxy materials, please notify your broker, bank or other
agent, direct your written request to Nektar Therapeutics, Secretary, 455 Mission Bay Boulevard South, San Francisco, California 94158 or contact our Secretary at (415)&nbsp;482-5300. Stockholders who currently receive multiple copies of the Notice
or other proxy materials at their address and would like to request householding of their communications should contact their broker, bank or other agent. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>H<SMALL>OW</SMALL> <SMALL>CAN</SMALL> I <SMALL>FIND</SMALL> <SMALL>OUT</SMALL> <SMALL>THE</SMALL> <SMALL>RESULTS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> <SMALL>VOTING</SMALL> <SMALL>AT</SMALL>
<SMALL>THE</SMALL> <SMALL>ANNUAL</SMALL> <SMALL>MEETING</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preliminary voting results will be announced at the
Annual Meeting. Final voting results will be published in a Current Report on Form 8-K filed with the SEC within four business days following the Annual Meeting. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL 1 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_2"></A>ELECTION OF DIRECTORS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our board of directors is
presently comprised of nine (9)&nbsp;directors and is divided into three (3)&nbsp;classes. Each class consists of one third of the total number of directors, and each class has a three (3)&nbsp;year term. There are three (3)&nbsp;current directors
in Class II, whose term of office expires in 2015: Robert B. Chess, Susan Wang and Roy A. Whitfield. Each of the current directors in Class II has been nominated for reelection at the Annual Meeting. Messrs. Chess and Whitfield and Ms.&nbsp;Wang
were all previously elected by the stockholders. Vacancies on the board, including vacancies created by an increase in the number of directors, are filled only by persons elected by a majority of the remaining directors. A director elected by the
board to fill a vacancy in a class serves until the earlier of the remainder of the full term of that class, that director&#146;s successor is elected and qualified or their death, resignation or removal. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Directors are elected by a majority of the votes cast at the Annual Meeting on the election of directors. A majority of votes cast shall
mean that the number of shares voted &#147;For&#148; a director&#146;s election exceeds fifty percent (50%)&nbsp;of the number of votes cast with respect to that director&#146;s election, with votes cast including votes &#147;Against&#148; in each
case but excluding abstentions and broker non-votes with respect to that director&#146;s election. Shares represented by executed proxies by stockholders of record will be voted for the election of the three&nbsp;nominees named below, unless the
&#147;Against&#148; or &#147;Abstain&#148; voting selection has been marked on the proxy card. Neither abstentions nor broker non-votes will have an effect on the outcome of the vote. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If any nominee becomes unavailable for election as a result of an unexpected occurrence, shares that would otherwise be voted for such
nominee will be voted for the election of a substitute nominee proposed by the nominating and corporate governance committee and nominated by the board of directors. Each person nominated for election has agreed to serve if elected. Our management
has no reason to believe that any nominee will be unable to serve. If elected at the Annual Meeting, each of the nominees will serve until the earliest of the 2018 annual meeting of our stockholders, his or her successor is elected and qualified or
his or her death, resignation or removal. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following is a brief biography of each nominee. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Robert B. Chess </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Robert B. Chess</I>, age 58, is the Chairman of our board of directors and has served as a director since May 1992. From March 2006 until January 2007, Mr.&nbsp;Chess served as our Acting President and
Chief Executive Officer, and from April 1999 to January 2007, served as Executive Chairman.&nbsp;He also served as our Co-Chief Executive Officer from August 1998 to April 2000, as President from December 1991 to August 1998, and as Chief Executive
Officer from May 1992 to August 1998. Mr.&nbsp;Chess was previously the co-founder and President of Penederm, Inc., a publicly-traded dermatological pharmaceutical company that was sold to Mylan Laboratories. He has held management positions at
Intel Corporation and Metaphor Computer Systems (now part of IBM), and was a member of the first President Bush&#146;s White House staff as a White House Fellow and Associate Director of the White House Office of Economic and Domestic
Policy.&nbsp;From 1997 until his retirement in 2009, Mr.&nbsp;Chess served on the board of directors of the Biotechnology Industry Organization (BIO).&nbsp;Mr. Chess served as Chairman of BIO&#146;s Emerging Companies Section&nbsp;and Co-Chairman of
BIO&#146;s Intellectual Property Committee. Mr.&nbsp;Chess was the initial Chairman of Bio Ventures for Global Health and continues to serve on its board.&nbsp;He also serves on the Board of Trustees of the California Institute of Technology where
he chairs the Technology Transfer Committee. Mr.&nbsp;Chess is currently the Chairman of OPX Biotechnologies, a private company in the renewable fuels and chemicals field, the co-founder and Chairman of Biota Technologies, a private company
developing industrial applications of the analysis of microbial communities, and also serves as a director of each of Pelvalon, Inc., a private medical device company and Twist Biosciences, a private company in the synthetic DNA production field. He
is currently a member of the faculty of the Stanford Graduate School </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
of Business, where he teaches courses in the MBA program on starting technology-based businesses and the healthcare industry.&nbsp;Mr. Chess received his B.S. degree in Engineering with honors
from the California Institute of Technology and an M.B.A. from Harvard University. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Susan Wang </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Susan Wang</I>, age 64, has served as our director since December 2003. Ms.&nbsp;Wang, who retired from Solectron Corporation in May
2002, served in various management positions there from 1984 to June 2002. Her final position at Solectron, an electronics manufacturing services and supply chain solutions company, was Executive Vice President for Corporate Development and Chief
Financial Officer, a position she held from September 2001 to June 2002. Prior to joining Solectron, Ms.&nbsp;Wang held financial and managerial positions with Xerox Corporation and Westvaco Corporation. She began her career with Price
Waterhouse&nbsp;&amp; Co. in New York and was a certified public accountant. Ms.&nbsp;Wang is also a director of Cirrus Logic, Inc. (NASDAQ: CRUS), an analog chip company, and Premier, Inc. (NASDAQ: PINC), a healthcare information technology and
hospital supply chain company. She serves as Chair of the audit committees of both Cirrus Logic, Inc. and Premier, Inc. Ms.&nbsp;Wang has been nominated for election as a director of Veeco Instruments Inc.(NASDAQ: VECO), a company that designs,
manufactures and markets thin film equipment, at its annual meeting of stockholders to be held on May&nbsp;13, 2015. In addition, Ms.&nbsp;Wang served as a director of Suntech Power Holdings Co., Ltd., a solar energy company, from 2009 to August
2013, a director of Altera Corporation, a programmable semiconductor company from 2002 to May 2013, a director of Calpine Corporation, an independent power generation company, from 2003 to 2009, a director of Avanex Corporation, a telecommunications
component and sub-systems provider, from 2002 to 2009, and a director of Rae Systems Inc., a developer of sensory technology for hazardous materials from 2009 to 2011. Ms.&nbsp;Wang holds an M.B.A. from the University of Connecticut and a B.S. in
accounting from the University of Texas. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Roy A. Whitfield </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Roy A. Whitfield</I>, age 61, has served as our director since August 2000. Mr.&nbsp;Whitfield is the former Chairman of the Board and
Chief Executive Officer of Incyte Corporation, a drug discovery and development company he co-founded in 1991. From January 1993 to November 2001, Mr.&nbsp;Whitfield served as its Chief Executive Officer and from November 2001 until June 2003 as its
Chairman. He also served as a director of Incyte from 1991 to January 2014. From 1984 to 1989, Mr.&nbsp;Whitfield held senior operating and business development positions with Technicon Instruments Corporation, a medical instrumentation company, and
its predecessor company, Cooper Biomedical, Inc., a biotechnology and medical diagnostics company. Prior to his work at Technicon, Mr.&nbsp;Whitfield spent seven years with the Boston Consulting Group&#146;s international consulting practice. He
currently serves as a director of Illumina, Inc., a developer, manufacturer and marketer of integrated systems for analysis of genetic variations and biological functions, and Station X, Inc. a private company. Since February 2008, he has also
served as Executive Chairman of the board of directors of Bioseek. Mr.&nbsp;Whitfield received a B.S. in mathematics from Oxford University and an M.B.A. from Stanford University. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; THE ELECTION OF EACH NAMED NOMINEE. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL 2 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_3"></A>APPROVAL OF AN AMENDMENT TO OUR 2012 PERFORMANCE INCENTIVE PLAN </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In April 2012, our board of directors adopted the Nektar Therapeutics 2012 Performance Incentive Plan (the &#147;2012 Plan&#148;), and on June&nbsp;28, 2012, the stockholders approved the 2012 Plan. On
April&nbsp;3, 2015, subject to stockholder approval, our board of directors amended the 2012 Plan to increase the number of shares of common stock available for issuance under the 2012 Plan by an additional 7,000,000 shares. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Prior to the adoption of the 2012 Plan, the company maintained the Nektar Therapeutics 2008 Equity Incentive Plan, as amended (the
&#147;2008 Plan&#148;), the Nektar Therapeutics 2000 Equity Incentive Plan, as amended (the &#147;2000 Plan&#148;), and the Nektar Therapeutics 2000 Non-Officer Equity Incentive Plan, as amended (the &#147;2000 Non-Officer Plan&#148;, and together
with the 2008 Plan and 2000 Plan, the &#147;Prior Plans&#148;). Following stockholder approval of the 2012 Plan, no further awards were made under the Prior Plans. As of March&nbsp;31, 2015, 10,807,852 shares were subject to stock options under the
2012 Plan and 1,263,329 shares remained available for future grants. In addition, under the terms of the 2012 Plan, the reserve pool under the 2012 Plan may be increased by shares subject to stock options granted under the Prior Plans that were
outstanding as of December&nbsp;31, 2011 in the event that such stock options expire, or for any reason are cancelled or terminated, without being exercised. As of March&nbsp;31, 2015, 11,273,386 shares remained subject to outstanding stock options
granted under the Prior Plans. If stockholders approve the amendment to the 2012 Plan, as of March&nbsp;31, 2015, the number of shares available for future awards under the 2012 Plan will increase by 7,000,000 shares from 1,263,329 shares to
8,263,329 shares. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Given the limited number of shares that currently remain available under the 2012 Plan, our board of
directors and management believe it is important that this amendment be approved in order to maintain the Company&#146;s ability to retain employees and continue to provide them with strong incentives to contribute to the Company&#146;s future
success. The Company believes that incentives and stock-based awards focus employees on the objective of creating stockholder value and promoting the success of the Company, and that incentive compensation plans like the 2012 Plan are an important
attraction, retention and motivation tool for participants in the plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Approval of the Amendment will also constitute
re-approval, for purposes of Section&nbsp;162(m) of the Internal Revenue Code, as amended, of the material terms of the performance measures contained in the 2012 Plan (described below) that are to be used in connection with awards under the 2012
Plan that are intended to qualify as &#147;performance-based&#148; compensation for purposes of Section&nbsp;162(m). One of the conditions for compensation to be considered &#147;performance-based&#148; under Section&nbsp;162(m) is that the material
terms under which such compensation will be paid (the class of eligible employees, performance criteria and the per-person maximums) be disclosed to and approved by stockholders every five years. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">All members of the board of directors and all of the Company&#146;s executive officers are eligible for awards under the 2012 Plan and
thus have a personal interest in the approval of the amendment to the 2012 Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholders are requested in this Proposal
2 to approve the amendment to the 2012 Plan. Approval of the amendment to the 2012 Plan requires the affirmative vote of a majority of the common stock present, in person or by proxy, and entitled to vote at the Annual Meeting. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE IN FAVOR OF PROPOSAL 2. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The essential features of the 2012 Plan, as proposed to be amended, are outlined below: </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Summary Description of the 2012 Performance Incentive Plan (As Proposed to Be Amended) </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The principal terms of the 2012 Plan, as proposed to be amended, are summarized below. The following summary is qualified in its entirety
by the full text of the 2012 Plan, in its current form, which appears as Exhibit 1 to this proxy statement. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Purpose</I></B>. The purpose of the 2012 Plan is to promote the success of the Company and the interests of our stockholders by
providing an additional means for us to attract, motivate, retain and reward directors, officers, employees and other eligible persons through the grant of awards. Equity-based awards are also intended to further align the interests of award
recipients and our stockholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Administration</I></B><B>.</B> Our board of directors or one or more committees
appointed by our board of directors administers the 2012 Plan. Our board of directors has delegated general administrative authority for the 2012 Plan to the organization and compensation committee. The organization and compensation committee may
delegate some or all of its authority with respect to the 2012 Plan to another committee of directors, and certain limited authority to grant awards to employees may be delegated to one or more officers of the Company. (The appropriate acting body,
be it the board of directors, a committee within its delegated authority, or an officer within his or her delegated authority, is referred to in this proposal as the &#147;Administrator&#148;). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Administrator has broad authority under the 2012 Plan with respect to award grants including, without limitation, the authority:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">to select participants and determine the type(s) of award(s) that they are to receive; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">to determine the number of shares that are to be subject to awards and the terms and conditions of awards, including the price (if any) to be paid for
the shares or the award; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">to cancel, modify, or waive the Company&#146;s rights with respect to, or modify, discontinue, suspend, or terminate any or all outstanding awards,
subject to any required consents; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">to accelerate or extend the vesting or exercisability or extend the term of any or all outstanding awards; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">subject to the other provisions of the 2012 Plan, to make certain adjustments to an outstanding award and to authorize the termination, conversion,
succession or substitution of an award; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">to allow the purchase price of an award or shares of the Company&#146;s common stock to be paid in the form of cash, check, or electronic funds
transfer, by the delivery of already-owned shares of the Company&#146;s common stock or by a reduction of the number of shares deliverable pursuant to the award, by services rendered by the recipient of the award, by notice and third party payment
or cashless exercise on such terms as the Administrator may authorize, or any other form permitted by law. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>No Repricing.</I></B> In no case (except due to an adjustment to reflect a stock split or other event referred to under
&#147;Adjustments&#148; below, or any repricing that may be approved by stockholders) will the Administrator (1)&nbsp;amend an outstanding stock option or stock appreciation right to reduce the exercise price or base price of the award,
(2)&nbsp;cancel, exchange, or surrender an outstanding stock option or stock appreciation right in exchange for cash or other awards for the purpose of repricing the award, or (3)&nbsp;cancel, exchange, or surrender an outstanding stock option or
stock appreciation right in exchange for an option or stock appreciation right with an exercise or base price that is less than the exercise or base price of the original award. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Eligibility.</I></B> Persons eligible to receive awards under the 2012 Plan include officers or employees of the Company or any of
its subsidiaries, directors of the Company or any of its subsidiaries, and certain consultants and advisors to the Company or any of its subsidiaries. Currently, approximately 440 officers and employees of the Company and its subsidiaries, including
all of the Company&#146;s named executed officers (&#147;NEOs&#148;), and each of the Company&#146;s eight non-employee directors, are considered eligible under the 2012 Plan. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Authorized Shares; Limits on Awards</I></B><B>.</B> The maximum number of shares of
the Company&#146;s common stock that may be issued or transferred pursuant to outstanding or future awards under the 2012 Plan is: (1)&nbsp;19,936,433, less (2)&nbsp;the number of any shares subject to awards granted under the Prior Plans after
December&nbsp;31, 2011 and on or before the date of stockholder approval of the 2012 Plan (June 28, 2012); plus (3)&nbsp;the number of any shares subject to stock options granted under the Prior Plans and outstanding as of December&nbsp;31, 2011
which expire, or for any reason are cancelled or terminated, after December&nbsp;31, 2011 without being exercised; plus (4)&nbsp;the number of any shares subject to restricted stock and restricted stock unit awards granted under the Prior Plans that
were outstanding and unvested on December&nbsp;31, 2011 that are forfeited, terminated, cancelled or otherwise reacquired by the Company without having become vested. For these purposes, shares subject to awards granted under the Prior Plans that
are &#147;full-value awards&#148; (as described below) will be taken into account based on the full-value award ratio described below. As of March&nbsp;31, 2015, no shares were subject to &#147;full-value awards&#148; then outstanding under the
Prior Plans. No additional awards may be granted under the Prior Plans. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shares issued in respect of any &#147;full-value
award&#148; granted under the 2012 Plan will be counted against the share limit described in the preceding paragraph as 1.50 shares for every one share actually issued in connection with the award. For example, if the Company granted 100 shares of
its common stock under the 2012 Plan, 150 shares would be charged against the share limit with respect to that award. For this purpose, a &#147;full-value award&#148; generally means any award granted under the plan other than a stock option or
stock appreciation right. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following other limits are also contained in the 2012 Plan: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The maximum number of shares that may be delivered pursuant to options qualified as incentive stock options granted under the plan is 9,500,000.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The maximum number of shares subject to options and stock appreciation rights that are granted during any calendar year to any individual under the
plan is 3,000,000 shares. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;Performance-Based Awards&#148; under Section&nbsp;5.2 of the 2012 Plan granted to a participant in any one calendar year will not provide for
payment of more than (1)&nbsp;in the case of awards payable only in cash and not related to shares, $5,000,000, and (2)&nbsp;in the case of awards related to shares (and in addition to options and stock appreciation rights which are subject to the
limit referred to above), 3,000,000 shares. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Except as described in the next sentence, shares that are
subject to or underlie awards which expire or for any reason are cancelled or terminated, are forfeited, fail to vest, or for any other reason are not paid or delivered under the 2012 Plan will again be available for subsequent awards under the 2012
Plan (with any such shares subject to full-value awards increasing the plan&#146;s share limit based on the full-value award ratio described above). Shares that are exchanged by a participant or withheld by the Company to pay the exercise price of
an award granted under the 2012 Plan, as well as any shares exchanged or withheld to satisfy the tax withholding obligations related to any award, will not be available for subsequent awards under the 2012 Plan. To the extent that an award is
settled in cash or a form other than shares, the shares that would have been delivered had there been no such cash or other settlement will again be available for subsequent awards under the 2012 Plan (with any such shares subject to full-value
awards increasing the plan&#146;s share limit based on the full-value award ratio described above). In the event that shares are delivered in respect of a dividend equivalent right, the actual number of shares delivered with respect to the award
shall be counted against the share limits of the 2012 Plan. (For purposes of clarity, if 1,000 dividend equivalent rights are granted and outstanding when the Company pays a dividend, and 50 shares are delivered in payment of those rights with
respect to that dividend, 75 shares (after adjustment for the full-value award share counting ratio described above) shall be counted against the share limits of the plan.) To the extent that shares are delivered pursuant to the exercise of a stock
appreciation right or stock option, the number of underlying shares as to which the exercise related shall be counted against the applicable share limits, as opposed to only counting the shares actually issued. (For purposes of clarity, if a stock
appreciation right relates to 100,000 shares and is exercised at a time when the payment due to the participant is 15,000 shares, 100,000 shares shall be charged against the applicable share limits with respect to such exercise.) In addition, the
2012 Plan generally provides that shares issued in connection with awards that are granted by or </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
become obligations of the Company through the assumption of awards (or in substitution for awards) in connection with an acquisition of another company will not count against the shares available
for issuance under the 2012 Plan. The Company may not increase the applicable share limits of the 2012 Plan by repurchasing shares of common stock on the market (by using cash received through the exercise of stock options or otherwise). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Types of Awards</I></B><B>.</B> The 2012 Plan authorizes stock options, stock appreciation rights, stock bonuses, restricted stock,
performance stock, stock units, phantom stock or similar rights to purchase or acquire shares, whether at a fixed or variable price or ratio related to the common stock, upon the passage of time, the occurrence of one or more events or the
satisfaction of performance criteria or other conditions, awards of any similar securities with a value derived from the value of or related to the common stock and/or returns thereon, or cash awards. The 2012 Plan retains flexibility to offer
competitive incentives and to tailor benefits to specific needs and circumstances. Awards granted under the plan will be subject to such terms and conditions as established by the Administrator and set forth in the underlying award agreement,
including terms relating to the treatment of an award upon a termination of employment. Any award may be paid or settled in cash. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">A stock option is the right to purchase shares of the Company&#146;s common stock at a future date at a specified price per share (the &#147;exercise price&#148;). The per share exercise price of an
option may not be less than the fair market value of a share of the Company&#146;s common stock on the date of grant. The maximum term of an option is eight years from the date of grant. An option may either be an incentive stock option or a
nonqualified stock option. Incentive stock option benefits are taxed differently from nonqualified stock options, as described under &#147;Federal Income Tax Consequences of Awards Under the 2012 Plan&#148; below. Incentive stock options are also
subject to more restrictive terms and are limited in amount by the U.S. Internal Revenue Code and the 2012 Plan. Incentive stock options may only be granted to employees of the Company or a subsidiary. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A stock appreciation right is the right to receive payment of an amount equal to the excess of the fair market value of share of the
Company&#146;s common stock on the date of exercise of the stock appreciation right over the base price of the stock appreciation right. The base price will be established by the Administrator at the time of grant of the stock appreciation right and
may not be less than the fair market value of a share of the Company&#146;s common stock on the date of grant. Stock appreciation rights may be granted in connection with other awards or independently. The maximum term of a stock appreciation right
is eight years from the date of grant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Performance-Based Awards</I></B><B>.</B> The Administrator may grant awards that
are intended to be performance-based awards within the meaning of Section&nbsp;162(m) of the U.S. Internal Revenue Code (&#147;Performance-Based Awards&#148;). Performance-Based Awards are in addition to any of the other types of awards that may be
granted under the 2012 Plan (including options and stock appreciation rights which may also qualify as performance-based awards for Section&nbsp;162(m) purposes). Performance-Based Awards may be in the form of restricted stock, performance stock,
stock units, other rights, or cash bonus opportunities. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The vesting or payment of Performance-Based Awards (other than
options or stock appreciation rights) will depend on the absolute or relative performance of the Company on a consolidated, subsidiary, segment, division, or business unit basis. The Administrator will establish the criterion or criteria and
target(s) on which performance will be measured. The Administrator must establish criteria and targets in advance of applicable deadlines under the U.S. Internal Revenue Code and while the attainment of the performance targets remains substantially
uncertain. The criteria that the Administrator may use for this purpose will include one or more of the following: earnings per share, cash flow (which means cash and cash equivalents derived from either net cash flow from operations or net cash
flow from operations, financing and investing activities), working capital, stock price, total stockholder return, gross revenue, revenue growth, gross profit, operating income (before or after taxes), net earnings (before or after interest, taxes,
depreciation and/or amortization), gross margin, operating margin, net margin, return on equity or on assets or on net investment, cost containment or reduction, regulatory submissions or approvals, manufacturing production, completion of strategic
partnerships, research milestones or any combination thereof. The performance measurement period with respect to an award may range from three </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
months to ten years. The terms of any Performance-Based Award may specify the manner, if any, in which performance targets will be adjusted to mitigate the unbudgeted impact of material, unusual
or nonrecurring gains and losses, accounting changes or other extraordinary events not foreseen at the time the targets were set unless the Administrator provides otherwise at the time of establishing the targets. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Performance-Based Awards may be paid in stock or in cash (in either case, subject to the limits described under the heading
&#147;Authorized Shares; Limits on Awards&#148; above). Before any Performance-Based Award (other than an option or stock appreciation right) is paid, the Administrator must certify that the performance target or targets have been satisfied. The
Administrator has discretion to determine the performance target or targets and any other restrictions or other limitations of Performance-Based Awards and may reserve discretion to reduce payments below maximum award limits. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Dividend Equivalents; Deferrals</I></B><B>.</B>&nbsp;The Administrator may provide for the deferred payment of awards, and may
determine the other terms applicable to deferrals.&nbsp;The Administrator may provide that awards under the 2012 Plan (other than options or stock appreciation rights), and/or deferrals, earn dividends or dividend equivalents based on the amount of
dividends paid on outstanding shares of Common Stock, provided that as to any dividend equivalent rights granted in connection with an award granted under the 2012 Plan that is subject to performance-based vesting requirements, no dividend
equivalent payment will be made unless the related performance-based vesting conditions of the award are satisfied (or, in the case of a restricted stock or similar award where the dividend must be paid as a matter of law, the dividend payment will
be subject to forfeiture or repayment, as the case may be, if the related performance-based vesting conditions are not satisfied). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Assumption and Termination of Awards</I></B><B>.</B> Generally, and subject to limited exceptions set forth in the 2012 Plan, if the Company dissolves or undergoes certain corporate transactions
such as a merger, business combination, or other reorganization, or a sale of substantially all of its assets, the Administrator may provide for the cash payment in settlement of, or for the termination, assumption, substitution or exchange of any
or all outstanding awards granted under the 2012 Plan. To the extent the administrator does not provide for the assumption, substitution or other continuation of the awards, then all awards then-outstanding under the 2012 Plan will become fully
vested or paid, as applicable, and will terminate or be terminated in such circumstances. The Administrator also has the discretion to establish other change in control provisions with respect to awards granted under the 2012 Plan. For example, the
Administrator could provide for the acceleration of vesting or payment of an award in connection with a corporate event that is not described above and provide that any such acceleration shall be automatic upon the occurrence of any such event,
including a termination of employment within a limited period of time following a corporate transaction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Transfer
Restrictions</I></B><B>.</B> Subject to certain exceptions contained in Section&nbsp;5.7 of the 2012 Plan, awards under the 2012 Plan generally are not transferable by the recipient other than by will or the laws of descent and distribution and are
generally exercisable, during the recipient&#146;s lifetime, only by the recipient. Any amounts payable or shares issuable pursuant to an award generally will be paid only to the recipient or the recipient&#146;s beneficiary or representative. The
Administrator has discretion, however, to establish written conditions and procedures for the transfer of awards to other persons or entities, provided that such transfers comply with applicable federal and state securities laws and are not made for
value (other than nominal consideration, settlement of marital property rights, or for interests in an entity in which more than 50% of the voting securities are held by the award recipient or by the recipient&#146;s family members). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Adjustments</I></B><B>.</B> As is customary in incentive plans of this nature, each share limit and the number and kind of shares
available under the 2012 Plan and any outstanding awards, as well as the exercise or purchase prices of awards, and performance targets under certain types of performance-based awards, are subject to adjustment in the event of certain
reorganizations, mergers, combinations, recapitalizations, stock splits, stock dividends, or other similar events that change the number or kind of shares outstanding, and extraordinary dividends or distributions of property to the stockholders.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>No Limit on Other Authority</I></B><B>.</B> The 2012 Plan does not limit the authority
of the board of directors or any committee to grant awards or authorize any other compensation, with or without reference to the Company&#146;s common stock, under any other plan or authority. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Termination of or Changes to the 2012 Plan</I></B><B>.</B> The board of directors may amend or terminate the 2012 Plan at any time
and in any manner. Stockholder approval for an amendment will be required only to the extent then required by applicable law or any applicable listing agency or required under Sections 162, 422 or 424 of the U.S. Internal Revenue Code to preserve
the intended tax consequences of the plan. For example, stockholder approval will be required for any amendment that proposes to increase the maximum number of shares that may be delivered with respect to awards granted under the 2012 Plan.
(Adjustments as a result of stock splits or similar events will not, however, be considered an amendment requiring stockholder approval.) Unless terminated earlier by the board of directors, the authority to grant new awards under the 2012 Plan will
terminate on April&nbsp;3, 2022. Outstanding awards, as well as the Administrator&#146;s authority with respect thereto, generally will continue following the expiration or termination of the plan. Generally speaking, outstanding awards may be
amended by the Administrator (except for a repricing), but the consent of the award holder is required if the amendment (or any plan amendment) materially and adversely affects the holder. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Clawback Policy. </I></B>The awards under the 2012 Plan are subject to the terms of the Company&#146;s clawback policy as it may be
in effect from time to time. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Federal Income Tax Consequences of Awards under the 2012 Plan </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The U.S. federal income tax consequences of the 2012 Plan under current federal law, which is subject to change, are summarized in the
following discussion of the general tax principles applicable to the 2012 Plan. This summary is not intended to be exhaustive and, among other considerations, does not describe the deferred compensation provisions of Section&nbsp;409A of the U.S.
Internal Revenue Code to the extent an award is subject to and does not satisfy those rules, nor does it describe state, local, or international tax consequences. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">With respect to nonqualified stock options, the Company is generally entitled to deduct and the participant recognizes taxable income in an amount equal to the difference between the option exercise price
and the fair market value of the shares at the time of exercise. With respect to incentive stock options, the Company is generally not entitled to a deduction nor does the participant recognize income at the time of exercise, although the
participant may be subject to the U.S. federal alternative minimum tax. If the shares acquired by exercise of an incentive stock option are held for at least two years from the date the option was granted and one year from the date it was exercised,
any gain or loss arising from a subsequent disposition of those shares will be taxed as long-term capital gain or loss, and we will not be entitled to any deduction. If, however, such shares are disposed of within the above-described period, then in
the year of that disposition the participant will recognize compensation taxable as ordinary income equal to the excess of the lesser of (i)&nbsp;the amount realized upon that disposition and (ii)&nbsp;the excess of the fair market value of those
shares on the date of exercise over the purchase price, and we will be entitled to a corresponding deduction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The current
federal income tax consequences of other awards authorized under the 2012 Plan generally follow certain basic patterns: nontransferable restricted stock subject to a substantial risk of forfeiture results in income recognition equal to the excess of
the fair market value over the price paid (if any) only at the time the restrictions lapse (unless the recipient elects to accelerate recognition as of the date of grant); bonuses, restricted stock units, stock appreciation rights, cash and
stock-based performance awards, dividend equivalents, stock units, and other types of awards are generally subject to tax at the time of payment; and compensation otherwise effectively deferred is taxed when paid. In each of the foregoing cases, the
Company will generally have a corresponding deduction at the time the participant recognizes income. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If an award is
accelerated under the 2012 Plan in connection with a &#147;change in control&#148; (as this term is used under the U.S. Internal Revenue Code), the Company may not be permitted to deduct the portion of the compensation attributable to the
acceleration (&#147;parachute payments&#148;) if it exceeds certain threshold limits under </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
the U.S. Internal Revenue Code (and certain related excise taxes may be triggered). Furthermore, the aggregate compensation in excess of $1,000,000 attributable to awards that are not
&#147;performance-based&#148; within the meaning of Section&nbsp;162(m) of the U.S. Internal Revenue Code may not be permitted to be deducted by the Company in certain circumstances. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Specific Benefits under the 2012 Performance Incentive Plan </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company
has not approved any awards that are conditioned upon stockholder approval of the amendment to the 2012 Plan. The Company is not currently considering any other specific award grants under the 2012 Plan. If the amendment to the 2012 Plan had been in
existence in fiscal 2014, the Company expects that its award grants for fiscal 2014 would not have been substantially different from those actually made in that year under the 2012 Plan. For information regarding stock-based awards granted to the
NEOs during fiscal 2014, see the material under the heading &#147;Executive Compensation&#148; below. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table
sets forth the number of stock options granted over the lifetime of the 2012 Plan to the following individuals and groups: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="88%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Position</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock&nbsp;Options</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,350,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and Chief Executive Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Nicholson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">535,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President and Chief Financial Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen K. Doberstein, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President and Chief Scientific Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ivan P. Gergel, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">650,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President and Chief Medical Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">495,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President and General Counsel</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All executive officers (7 persons)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,890,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All non-executive directors (8 persons other than Mr.&nbsp;Robin)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,000,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All employees (other than current executive officers) (approximately 490 persons)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,156,420</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">*&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of April&nbsp;20, 2015 </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
closing market price for a share of the Company&#146;s common stock as of April&nbsp;20, 2015 was $10.96 per share. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE
BOARD OF DIRECTORS RECOMMENDS A VOTE IN FAVOR OF PROPOSAL 2. </B></FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>EQUITY COMPENSATION PLAN INFORMATION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company currently maintains five equity compensation plans: the 2008 Plan, the 2000 Non-Officer Plan, the 2000 Plan, the 2012 Plan
and the Employee Stock Purchase Plan, as amended and restated (the &#147;Purchase Plan&#148;). With the exception of the 2000 Non-Officer Plan, these plans have each been approved by the Company&#146;s stockholders. Stockholders are being asked to
approve an amendment to the 2012 Plan, as described above. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth, for each of the Company&#146;s equity compensation plans,
the number of shares of common stock subject to outstanding awards, the weighted-average exercise price of outstanding options, and the number of shares remaining available for future award grants as of December&nbsp;31, 2014. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:46pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Plan category</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;shares&nbsp;of<BR>Common&nbsp;Stock&nbsp;to&nbsp;be<BR>issued&nbsp;upon&nbsp;
exercise&nbsp;of<BR>outstanding options</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B><FONT STYLE="white-space:nowrap">Weighted-average</FONT><BR>exercise price
of<BR>outstanding&nbsp;options</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;shares&nbsp;of<BR>Common&nbsp;Stock&nbsp;remaining<BR>available&nbsp;for&nbsp;
future&nbsp;issuance<BR>under equity compensation<BR>plans (excluding shares<BR>reflected&nbsp;in&nbsp;the&nbsp;first&nbsp;column)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity compensation plans approved by stockholders</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,601,352</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.68</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,811,730</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity compensation plans not approved by stockholders(3)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,393,483</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.52</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21,994,835</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,811,730</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">1</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Of these shares, 10,525,682 shares were subject to options then outstanding under the 2012 Plan, and 0 shares were subject to restricted stock unit
awards then outstanding under the 2012 Plan. 2,937,391 shares were subject to options then outstanding under the 2008 Plan, and 0 shares were subject to restricted stock unit awards then outstanding under the 2008 Plan. In addition, 5,138,279 shares
were subject to options then outstanding under the 2000 Plan and 0 shares were subject to stock unit awards then outstanding under the 2000 Plan. The Company&#146;s authority to grant new awards under the 2000 Plan terminated on February&nbsp;9,
2010, and the Company&#146;s authority to grant new awards under the 2008 Plan terminated on June&nbsp;28, 2012. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">2</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">This number of shares is presented after giving effect to the 64,212 shares purchased under the Purchase Plan for the purchase period that ended
November&nbsp;30, 2014. Of the aggregate number of shares that remained available for future issuance, 1,550,531 shares were available under the 2012 Plan, 0 shares were available under the 2008 Plan and 1,261,199 shares were available under the
Purchase Plan. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">3</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">This row reflects information for the 2000 Non-Officer Plan. The 2000 Non-Officer Plan was adopted by our board of directors on August&nbsp;18, 1998,
and was amended and restated in its entirety on June&nbsp;6, 2000. The purpose of the 2000 Non-Officer Plan is to attract and retain qualified personnel, to provide additional incentives to employees and consultants and to promote the success of our
business. Pursuant to the 2000 Non-Officer Plan, we may grant or issue non-qualified stock options, rights to acquire restricted stock and stock bonuses to employees and consultants who are neither officers nor directors of the Company. The maximum
term of a stock option under the 2000 Non-Officer Plan is eight years. The exercise price of stock options granted under the 2000 Non-Officer Plan is determined by our board of directors by reference to the closing price of our common stock on the
Nasdaq Global Select Market on the date of grant. The Company&#146;s authority to grant new awards under the 2000 Non-Officer Plan terminated on June&nbsp;28, 2012. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">4</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Of these shares, 3,393,483 were subject to options then outstanding under the 2000 Non-Officer Plan, and 0 were subject to restricted stock units then
outstanding under the 2000 Non-Officer Plan. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">16 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL 3 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_4"></A>RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The audit committee of the board of directors has selected Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2015, and has
further directed that management submit the selection of our independent registered public accounting firm for ratification by the stockholders at the Annual Meeting. Ernst&nbsp;&amp; Young LLP has audited our consolidated financial statements since
our inception in 1990. Representatives of Ernst&nbsp;&amp; Young LLP are expected to be present at the Annual Meeting. They will have an opportunity to make a statement if they so desire and will be available to respond to appropriate questions.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Neither our bylaws nor other governing documents or law require stockholder ratification of the selection of Ernst&nbsp;&amp;
Young LLP as our independent registered public accounting firm. However, the audit committee is submitting the selection of Ernst&nbsp;&amp; Young LLP to the stockholders for ratification as a matter of good corporate practice. If the stockholders
fail to ratify the selection, the audit committee will reconsider whether or not to retain Ernst&nbsp;&amp; Young LLP. Even if the selection is ratified, the audit committee, in its discretion, may direct the appointment of a different independent
registered public accounting firm at any time during the year if the committee determines that such a change would be in our best interests and our stockholders&#146; best interest. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The affirmative vote of the holders of a majority of the shares of our common stock present in person or represented by proxy at the
Annual Meeting and cast on this proposal will be required to ratify the selection of Ernst&nbsp;&amp; Young LLP for our fiscal year ending December&nbsp;31, 2015. Abstentions are treated as shares represented in person or by proxy and entitled to
vote at the Annual Meeting and, therefore, will have the effect of a vote against the ratification of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm. No broker non-votes are expected to exist in connection with this
proposal. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE IN FAVOR OF PROPOSAL 3. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">17 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_5"></A>PROPOSAL 4 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ADVISORY VOTE ON EXECUTIVE COMPENSATION </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The board of directors is committed to excellence in governance and is aware of the significant interest in executive compensation matters by investors and the general public. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have designed our executive compensation program to attract, motivate, reward and retain the senior management talent required to
achieve our corporate objectives and increase stockholder value. We believe that our compensation policies and procedures are centered on pay-for-performance principles and are strongly aligned with the long-term interests of our stockholders.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We urge you to carefully review the Compensation Discussion and Analysis section of this proxy statement for details on our
executive compensation, including our compensation philosophy and objectives and the 2014 compensation of the NEOs described in &#147;Information About the Executive Officers&#151;Compensation Discussion and Analysis&#151;Introduction.&#148;
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are presenting this proposal, which gives you as a stockholder the opportunity to endorse or not endorse our compensation
program for the NEOs by voting for or against the following resolution (a &#147;say-on-pay&#148; vote), as required pursuant to Section&nbsp;14A of the Exchange Act: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&#147;RESOLVED, that the compensation paid to the Company&#146;s NEOs, as disclosed pursuant to Item&nbsp;402 of Regulation S-K promulgated by the SEC, including the Compensation Discussion and Analysis,
compensation tables and related narrative discussion contained in the proxy statement for the Company&#146;s 2015 Annual Meeting is hereby APPROVED.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">While the vote on the resolution is advisory in nature and therefore will not bind us to take any particular action, our board of directors and our organization and compensation committee intend to
carefully consider the stockholder vote resulting from the proposal in making future decisions regarding our compensation program. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Based on the results of voting at our 2011 annual meeting of stockholders, we have determined to hold a non-binding advisory vote on the compensation of NEOs every year, until the next non-binding
advisory vote on the frequency of future advisory votes on the compensation of our NEOs. Accordingly, we expect that our next say-on-pay vote will be held at the 2016 annual meeting of stockholders. An advisory vote on the frequency of future
advisory votes on the compensation paid to our NEOs is required to be held at least once every six years. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The affirmative
vote of a majority of the votes cast by holders of the shares of common stock present in person or represented by proxy at the Annual Meeting is required (on a non-binding advisory basis) for approval of this proposal. Abstentions are treated as
shares represented in person or by proxy and entitled to vote at the Annual Meeting and, therefore, will have the effect of a vote against this proposal. Broker non-votes will have no effect on the outcome of the vote. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE IN FAVOR OF PROPOSAL 4. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">18 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_6"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth certain information regarding the ownership of our common stock as of April&nbsp;15, 2015,
by: (i)&nbsp;each director and nominee for director; (ii)&nbsp;each of our NEOs; (iii)&nbsp;all of our executive officers and directors as a group; and (iv)&nbsp;all those known by us to be beneficial owners of more than five percent of our common
stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unless otherwise noted below, the address of each beneficial owner listed in the table is c/o Nektar Therapeutics, 455
Mission Bay Boulevard South, San Francisco, California 94158. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Beneficial&nbsp;Ownership&nbsp;**</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:59pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Beneficial&nbsp;Owner</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of<BR>Shares</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percent&nbsp;of<BR>Total</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">OppenheimerFunds, Inc. and related entities(1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24,200,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">PRIMECAP Management Company(2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,225,786</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13.86</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">BlackRock, Inc. and certain subsidiaries(3)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,643,319</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.57</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Vanguard Group(4)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,304,449</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert B. Chess(5)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">475,623</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">R. Scott Greer(6)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">253,333</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Joseph J. Krivulka(7)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">235,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher A. Kuebler(8)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">220,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lutz Lingnau(9)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">253,950</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin(10)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,859,367</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Susan Wang(11)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">250,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roy A. Whitfield(12)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">235,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dennis Winger(13)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">220,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen K. Doberstein, Ph.D.(14)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">781,246</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ivan P. Gergel, M.D.(15)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">143,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie(16)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">964,354</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Nicholson(17)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,133,517</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All executive officers and directors as a group (15 persons)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,889,651</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.76</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Denotes ownership percentage less than 1%. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">**</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">This table is based upon information supplied by officers, directors and principal stockholders and Schedules 13G filed with the SEC. Unless otherwise indicated in the
footnotes to this table, and subject to community property laws where applicable, we believe that each of the stockholders named in the table has sole voting and investment power with respect to the shares indicated as beneficially owned. Applicable
percentages are based on 131,485,838 shares outstanding on April&nbsp;15, 2015, adjusted as required by rules promulgated by the SEC. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based solely on the Schedule 13G/A (Amendment No.&nbsp;17) filed with the SEC on February&nbsp;6, 2015 by OppenheimerFunds, Inc., a registered investment adviser under
Section&nbsp;203 of the Investment Advisers Act of 1940, and Oppenheimer Global Opportunities Fund, an investment company registered under Section&nbsp;8 of the Investment Company Act of 1940. Oppenheimer Global Opportunities Fund has sole voting
and shared dispositive power with respect to 24,200,000 shares of our common stock. OppenheimerFunds, Inc. has shared voting and dispositive power with respect to the 24,200,000 shares of our common stock beneficially owned by Oppenheimer Global
Opportunities Fund. OppenheimerFunds, Inc. disclaims beneficial ownership as an investment adviser pursuant to Rule 13d-4 of the Exchange Act. The address of OppenheimerFunds, Inc. is Two World Financial Center, 225 Liberty Street, New York, NY
10281. The address of Oppenheimer Global Opportunities Fund is 6803 S. Tucson Way, Centennial, CO 80112. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based solely on the Schedule 13G/A (Amendment No.&nbsp;5) filed with the SEC on February&nbsp;13, 2015 by PRIMECAP Management Company, a registered
investment adviser under Section&nbsp;203 of the Investment Advisers Act of 1940. PRIMECAP Management Company has the sole voting power with respect to </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">19 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
15,991,886 shares of our common stock and sole dispositive power with respect to 18,225,786 shares of our common stock. The address of PRIMECAP Management Company is 225 South Lake Ave., #400,
Pasadena, CA 91101. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based solely on the Schedule 13G/A (Amendment No.&nbsp;5) filed with the SEC on January&nbsp;29, 2015 by BlackRock, Inc., a parent holding company or control person in
accordance with Rule 13d-1(b)(1)(ii)(G). BlackRock, Inc. has the sole voting power with respect to 8,355,497 shares of our common stock and the sole dispositive power with respect to 8,643,319 shares of our common stock. The address of BlackRock,
Inc. is 55 East 52nd Street, New York, NY 10022. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based solely on the Schedule 13G/A (Amendment No.&nbsp;2) filed with the SEC on February&nbsp;10, 2015 by The Vanguard Group, a registered investment adviser under
Section&nbsp;203 of the Investment Advisers Act of 1940. The Vanguard Group has the sole voting power with respect to 174,624 shares of our common stock, sole dispositive power with respect to 8,139,925 shares of our common stock and shared
dispositive power with respect to 164,524 shares of our common stock. Vanguard Fiduciary Trust Company, a wholly-owned subsidiary of The Vanguard Group, Inc., is the beneficial owner of 164,524 shares as a result of its serving as investment manager
of collective trust accounts. Vanguard Investments Australia, Ltd., a wholly-owned subsidiary of The Vanguard Group, Inc., is the beneficial owner of 10,100 shares as a result of its serving as investment manager of Australian investment offerings.
The address of The Vanguard Group, Inc. is 100 Vanguard Blvd., Malvern, PA 19355. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;215,000 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2015, and (ii)&nbsp;4,914 shares issued pursuant to our
401(k) Retirement Plan. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 202,500 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2015. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 215,000 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2015. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 200,000 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2015. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 237,500 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2015. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;2,848,957 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2015 and (ii)&nbsp;410 shares owned by
Mr.&nbsp;Robin&#146;s wife. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(11)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 230,000 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2015. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(12)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;215,000 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2015 and (ii)&nbsp;20,000 shares held in trust for
Mr.&nbsp;Whitfield&#146;s children under which Mr.&nbsp;Whitfield is the sole trustee. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(13)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 203,750 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2015 and (ii)&nbsp;5,000 shares held in his revocable living
trust. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(14)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 781,246 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2015. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(15)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 143,750 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2015. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(16)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;960,103 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2015, (ii)&nbsp;997 shares issued pursuant to our 401(k)
Retirement Plan, and (iii)&nbsp;750 shares issued pursuant to our Employee Stock Purchase Plan. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(17)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 1,123,517 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2015. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_7"></A>S<SMALL>ECTION</SMALL>&nbsp;16(<SMALL>A</SMALL>) B<SMALL>ENEFICIAL</SMALL> O<SMALL>WNERSHIP</SMALL> R<SMALL>EPORTING</SMALL>
C<SMALL>OMPLIANCE</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section&nbsp;16(a) of the Exchange Act requires our directors and executive officers, and
persons who beneficially own more than ten percent of a registered class of our equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of our common stock and other equity securities. Officers,
directors and greater than ten percent beneficial owners are required by SEC regulations to furnish us with copies of all Section&nbsp;16(a) forms they file. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">To our knowledge, based solely on our review of Forms 3, 4 and 5, and any amendments thereto, furnished to us or written representations that no Form 5 was required, we believe that during the fiscal year
ended December&nbsp;31, 2014, all filing requirements applicable to our executive officers and directors under the Exchange Act were met in a timely manner except that Joseph J. Krivulka filed a late Form 4 on September&nbsp;26, 2014 reporting the
grant of a stock option by the Company to him on September&nbsp;23, 2014. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_8"></A>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We review all relationships and transactions between us and (i)&nbsp;any of our directors or executive officers,
(ii)&nbsp;any nominee for election as a director, (iii)&nbsp;any security holder who is known to us to own beneficially or of record more than five percent of our common stock or (iv)&nbsp;any member of the immediate family of any of the foregoing.
Our legal staff is primarily responsible for the development and implementation of processes and controls to obtain information with respect to related person transactions and for then determining, based on the facts and circumstances, whether the
Company or a related person has a direct or indirect material interest in the transaction. In addition, the audit committee reviews and approves or ratifies any related person transaction that is required to be disclosed. In the course of its review
and approval or ratification of a disclosable related party transaction, the committee considers: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the nature of the related person&#146;s interest in the transaction; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the material terms of the transaction, including, without limitation, the dollar amount and type of transaction; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the importance of the transaction to the related person; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the importance of the transaction to the Company; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">whether the transaction would impair the judgment of a director or executive officer to act in the best interest of the Company; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any other matters the committee deems appropriate. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Any member of the audit committee who is a related person with respect to a transaction under review may not participate in the deliberations or vote respecting approval or ratification of the
transaction; however, such director may be counted in determining the presence of a quorum at a meeting where the audit committee reviews the transaction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As required under SEC rules, related party transactions that are determined to be directly or indirectly material to us or the related party are disclosed in our proxy statement. Historically, we have not
entered into transactions with related parties. Michael Robin, the son of Howard W. Robin, our President and Chief Executive Officer, is employed by the Company in a non-executive officer capacity as a manager in our project management
group.&nbsp;During 2014, Michael Robin&#146;s total compensation was approximately $267,000 including base salary, target bonus, stock options (based on grant date fair value), and benefits. His compensation for 2014 included an annual equity awards
in both February 2014 and December 2014 as we changed our annual compensation in 2014 bringing it forward to the December of the annual performance period rather than the February following the annual performance period. Michael Robin&#146;s
compensation was established by the Company in accordance with its compensation practices applicable to employees with equivalent qualifications and responsibilities and holding similar positions, without the direct involvement of Howard W. Robin.
During the 2014 fiscal year, there were no other relationships or transactions between us and any related party for which disclosure is required under the rules of the SEC. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">21 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_9"></A>INFORMATION ABOUT THE BOARD OF DIRECTORS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following is a brief biography of each current director, including each nominee for reelection at the Annual Meeting to a new term of
office and each director whose current term of office continues through the Annual Meeting. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_10"></A>THE BOARD OF
DIRECTORS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_11"></A>D<SMALL>IRECTORS</SMALL> C<SMALL>ONTINUING</SMALL> <SMALL>IN</SMALL> O<SMALL>FFICE</SMALL>
U<SMALL>NTIL</SMALL> <SMALL>THE</SMALL> 2016 A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>R. Scott Greer
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>R. Scott Greer, </I>age 56, has served as our director since February 2010. Mr.&nbsp;Greer currently serves as Managing
Director of Numenor Ventures, LLC, a venture capital firm. In 1996, Mr.&nbsp;Greer co-founded Abgenix, Inc., a company that specialized in the discovery, development and manufacture of human therapeutic antibodies, and from June 1996 through May
2002, he served as its Chief Executive Officer. He also served as a director of Abgenix from 1996 and Chairman of the board of directors from 2000 until the acquisition of Abgenix by Amgen, Inc. in April 2006. Prior to Abgenix&#146;s formation,
Mr.&nbsp;Greer held senior management positions at Cell Genesys, Inc., a biotechnology company, initially as Chief Financial Officer and Vice President of Corporate Development and later as Senior Vice President of Corporate Development, and various
positions at Genetics Institute, Inc., a biotechnology research and development company. Mr.&nbsp;Greer served as a member of the board of directors of Sirna Therapeutics, Inc., a biotechnology company, from 2003, and as its Chairman of the board of
directors from 2005, through the closing of the acquisition of Sirna by Merck&nbsp;&amp; Co., Inc. in December 2006. From 2001 to 2005, Mr.&nbsp;Greer served as a member of the board of directors of Illumina, Inc., a provider of integrated systems
for the analysis of genetic variation and biological function, and from 2001 to 2004, he served as member of the board of directors of CV Therapeutics, Inc., a biotechnology company. He currently serves as a member of the board of directors of
Auspex Pharmaceuticals, Inc., a biopharmaceutical company developing drugs for patients with movement disorders and other rare diseases, Sientra, Inc. a medical aesthetics company, StemCells, Inc., a biopharmaceutical company focused on stem cell
therapeutics, and Versartis, Inc., an endocrine focused biopharmaceutical company. Mr.&nbsp;Greer received a B.A. in Economics from Whitman College and an M.B.A. degree from Harvard University. He also was a certified public accountant. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Christopher A. Kuebler </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B></B><I>Christopher A. Kuebler</I><B></B>, age 61, has served as our director since December 2001. Mr.&nbsp;Kuebler also currently serves on the board of directors of Waters Corporation, an analytical
technologies products and services company. From January 1997 to December 2005, Mr.&nbsp;Kuebler served as Chairman of the Board of Covance Inc., a drug development services company, and from November 1994 to December 2004, served as its Chief
Executive Officer. From March 1993 through November 1994, he was the Corporate Vice President, European Operations for Abbott Laboratories, a diversified health care company. From January 1986 until March 1993, Mr.&nbsp;Kuebler served in various
commercial positions for Abbott Laboratories&#146; Pharmaceutical Division and was that Division&#146;s Vice President, Sales and Marketing prior to taking the position of Corporate Vice President, European Operations. Before that, he held positions
at Squibb Inc. and Monsanto Health Care. Mr.&nbsp;Kuebler holds a B.S. in Biological Science from Florida State University.<B> </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Lutz Lingnau </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Lutz Lingnau</I>, age 72, has served as our director since
August 2007. Mr.&nbsp;Lingnau retired from Schering AG Group, Germany, in December 2005 as a member of Schering AG&#146;s Executive Board and as Vice Chairman, President and Chief Executive Officer of Schering Berlin, Inc., a United States
subsidiary. Prior to his retirement, Mr.&nbsp;Lingnau was responsible for Schering AG&#146;s worldwide specialized therapeutics and dermatology businesses. He joined Schering AG&#146;s business trainee program in 1966. Throughout his career at
Schering AG, he served in various capacities and in a number of subsidiaries in South America and the United States, including his roles as </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">22 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
President of Berlex Laboratories, Inc., from 1983 to 1985, as the Head of Worldwide Sales and Marketing in the Pharmaceutical Division of Schering AG, from 1985 to 1989, and as Chairman of Berlex
Laboratories, Inc. from 1985 to 2005. Mr.&nbsp;Lingnau was a member of the Supervisory Board of LANXESS AG, a specialty chemicals company listed on the Frankfurt Stock Exchange from 2005 to May 2010. From December 2006 through September 2009, he
served as Chairman of the board of directors of Micropharma Limited, a private biotechnology company, and was a member of was a member of the board of directors of Sirna Therapeutics, Inc., a biotechnology company, from February 2006 through the
closing of the acquisition of Sirna by Merck&nbsp;&amp; Co., Inc. in December 2006. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_12"></A>D<SMALL>IRECTORS</SMALL>
C<SMALL>ONTINUING</SMALL> <SMALL>IN</SMALL> O<SMALL>FFICE</SMALL> U<SMALL>NTIL</SMALL> <SMALL>THE</SMALL> 2017 A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Joseph J. Krivulka </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Joseph J. Krivulka, </I>age 63, has served as our
director since March 2005. Mr.&nbsp;Krivulka is the founder and current Chairman of Akrimax Pharmaceuticals, LLC, an emerging branded pharmaceutical company, and has served in that capacity since its inception in February 2007.&nbsp;He is also the
founder and chairman of Rouses Point Pharmaceuticals LLC, a generic pharmaceutical products company, as well as the founder and chairman of MIST Pharmaceuticals, LLC, a cardiovascular pharmaceutical products company. Mr.&nbsp;Krivulka was the
founder and President of Triax Pharmaceuticals, a dermatology products company, a position he held from November 2004 through the sale of the company to PreCision Dermatology in April 2012. Mr.&nbsp;Krivulka was a co-founder and President of Reliant
Pharmaceuticals, LLC, a company that markets pharmaceutical products, from 1999 until 2004. Mr.&nbsp;Krivulka was formerly Chief Executive Officer of Bertek, Inc., a generic pharmaceutical products company that is a subsidiary of Mylan Inc., and
Corporate Vice President of Mylan Inc., a generic pharmaceutical products company. He holds a B.S. from West Virginia Wesleyan College. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Howard W. Robin </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Howard W. Robin</I>, age 62, has served as our
President and Chief Executive Officer since January 2007 and has served as a member of our board of directors since February 2007. Mr.&nbsp;Robin served as Chief Executive Officer, President and a director of Sirna Therapeutics, Inc., a
biotechnology company, from July 2001 to November 2006 and from January 2001 to June 2001, served as their Chief Operating Officer, President and as director. From 1991 to 2001, Mr.&nbsp;Robin was Corporate Vice President and General Manager at
Berlex Laboratories, Inc., a pharmaceutical products company that is a subsidiary of Schering, AG, and from 1987 to 1991 he served as Vice President of Finance and Business Development and Chief Financial Officer. From 1984 to 1987, Mr.&nbsp;Robin
was Director of Business Planning and Development at Berlex. He was a Senior Associate with Arthur Andersen&nbsp;&amp; Co. prior to joining Berlex. He received his B.S. in Accounting and Finance from Fairleigh Dickinson University and serves as a
member of its Board of Trustees. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dennis L. Winger </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Dennis L. Winger</I>, age 67, has served as our director since December 2009. Mr.&nbsp;Winger was Senior Vice President and Chief
Financial Officer of Applera Corporation, a life sciences company, from 1997 through December 2008. From 1989 to 1997, Mr.&nbsp;Winger served as Senior Vice President, Finance and Administration, and Chief Financial Officer of Chiron Corporation.
From 1982 to 1989, Mr.&nbsp;Winger was with The Cooper Companies, Inc., where he held positions of increasing responsibility, including that of Chief Financial Officer. Mr.&nbsp;Winger currently serves on the board of directors of Accuray
Incorporated (NASDAQ: ARAY), a radiosurgery company. Mr.&nbsp;Winger recently served on the board of directors of each of Vertex Pharmaceuticals Incorporated, a pharmaceutical company, until May 2012, Cephalon, Inc. a pharmaceutical company, until
its merger with Teva Pharmaceuticals Industry Limited in October 2011 and Cell Genesys, Inc. until its merger with BioSante Pharmaceuticals in October 2009. Mr.&nbsp;Winger received a B.A. from Siena College and an M.B.A. from the Columbia
University Graduate School of Business. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">23 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_13"></A>C<SMALL>URRENT</SMALL> D<SMALL>IRECTORS</SMALL> N<SMALL>OMINATED</SMALL>
F<SMALL>OR</SMALL> R<SMALL>EELECTION</SMALL> <SMALL>TO</SMALL> S<SMALL>ERVE</SMALL> U<SMALL>NTIL</SMALL> <SMALL>THE</SMALL> 2018 A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Robert B. Chess </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Robert B. Chess</I>, age 58, is the Chairman of our board of directors and has served as a director since May 1992. From March 2006 until January 2007, Mr.&nbsp;Chess served as our Acting President and
Chief Executive Officer, and from April 1999 to January 2007, served as Executive Chairman.&nbsp;He also served as our Co-Chief Executive Officer from August 1998 to April 2000, as President from December 1991 to August 1998, and as Chief Executive
Officer from May 1992 to August 1998. Mr.&nbsp;Chess was previously the co-founder and President of Penederm, Inc., a publicly-traded dermatological pharmaceutical company that was sold to Mylan Laboratories. He has held management positions at
Intel Corporation and Metaphor Computer Systems (now part of IBM), and was a member of the first President Bush&#146;s White House staff as a White House Fellow and Associate Director of the White House Office of Economic and Domestic
Policy.&nbsp;From 1997 until his retirement in 2009, Mr.&nbsp;Chess served on the board of directors of the Biotechnology Industry Organization (BIO).&nbsp;Mr. Chess served as Chairman of BIO&#146;s Emerging Companies Section&nbsp;and Co-Chairman of
BIO&#146;s Intellectual Property Committee. Mr.&nbsp;Chess was the initial Chairman of Bio Ventures for Global Health and continues to serve on its board.&nbsp;He also serves on the Board of Trustees of the California Institute of Technology where
he chairs the Technology Transfer Committee. Mr.&nbsp;Chess is currently the Chairman of OPX Biotechnologies, a private company in the renewable fuels and chemicals field, the co-founder and Chairman of Biota Technologies, a private company
developing industrial applications of the analysis of microbial communities, and also serves as a director of each of Pelvalon, Inc., a private medical device company and Twist Biosciences, a private company in the synthetic DNA production field. He
is currently a member of the faculty of the Stanford Graduate School of Business, where he teaches courses in the MBA program on starting technology-based businesses and the healthcare industry.&nbsp;Mr. Chess received his B.S. degree in Engineering
with honors from the California Institute of Technology and an M.B.A. from Harvard University. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Susan Wang </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Susan Wang</I>, age 64, has served as our director since December 2003. Ms.&nbsp;Wang, who retired from Solectron Corporation in May
2002, served in various management positions there from 1984 to June 2002. Her final position at Solectron, an electronics manufacturing services and supply chain solutions company, was Executive Vice President for Corporate Development and Chief
Financial Officer, a position she held from September 2001 to June 2002. Prior to joining Solectron, Ms.&nbsp;Wang held financial and managerial positions with Xerox Corporation and Westvaco Corporation. She began her career with Price
Waterhouse&nbsp;&amp; Co. in New York and was a certified public accountant. Ms.&nbsp;Wang is also a director of Cirrus Logic, Inc. (NASDAQ: CRUS), an analog chip company, and Premier, Inc. (NASDAQ: PINC), a healthcare information technology and
hospital supply chain company. She serves as Chair of the audit committees of both Cirrus Logic, Inc. and Premier, Inc. Ms.&nbsp;Wang has been nominated for election as a director of Veeco Instruments Inc.(NASDAQ: VECO), a company that designs,
manufactures and markets thin film equipment, at its annual meeting of stockholders to be held on May&nbsp;13, 2015. In addition, Ms.&nbsp;Wang served as a director of Suntech Power Holdings Co., Ltd., a solar energy company, from 2009 to August
2013, a director of Altera Corporation, a programmable semiconductor company from 2002 to May 2013, a director of Calpine Corporation, an independent power generation company, from 2003 to 2009, a direct of Avanex Corporation, a telecommunications
component and sub-systems provider, from 2002 to 2009, and a director of Rae Systems Inc., a developer of sensory technology for hazardous materials from 2009 to 2011. Ms.&nbsp;Wang holds an M.B.A. from the University of Connecticut and a B.S. in
accounting from the University of Texas. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Roy A. Whitfield </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Roy A. Whitfield</I>, age 61, has served as our director since August 2000. Mr.&nbsp;Whitfield is the former Chairman of the Board and
Chief Executive Officer of Incyte Corporation, a drug discovery and development company he co-founded in 1991. From January 1993 to November 2001, Mr.&nbsp;Whitfield served as its Chief Executive Officer and from November 2001 until June 2003 as its
Chairman. He also served as a director of </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">24 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Incyte from 1991 to January 2014. From 1984 to 1989, Mr.&nbsp;Whitfield held senior operating and business development positions with Technicon Instruments Corporation, a medical instrumentation
company, and its predecessor company, Cooper Biomedical, Inc., a biotechnology and medical diagnostics company. Prior to his work at Technicon, Mr.&nbsp;Whitfield spent seven years with the Boston Consulting Group&#146;s international consulting
practice. He currently serves as a director of Illumina, Inc., a developer, manufacturer and marketer of integrated systems for analysis of genetic variations and biological functions, and Station X, Inc. a private company. Since February 2008, he
has also served as Executive Chairman of the board of directors of Bioseek. Mr.&nbsp;Whitfield received a B.S. in mathematics from Oxford University and an M.B.A. from Stanford University. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_14"></A>M<SMALL>EETINGS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The board of directors met eleven (11)&nbsp;times during 2014. Each board member attended 75% or more of the aggregate of the meetings of
the board and of the committees on which he or she served held during the period of the 2014 fiscal year for which he or she was a director or committee member, as applicable. All of our directors on our board attended our 2014 annual meeting of
stockholders. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_15"></A>C<SMALL>ORPORATE</SMALL> G<SMALL>OVERNANCE</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The board of directors has documented our governance practices in our Corporate Governance Policy Statement to assure that the board will
have the necessary authority and practices in place to review and evaluate our business operations as needed and to make decisions that are independent of our management. The guidelines are also intended to align the interests of directors and
management with those of our stockholders. The Corporate Governance Policy Statement sets forth certain practices the board will follow with respect to board composition, board committees, board nomination, director qualifications and evaluation of
the board and committees. The Corporate Governance Policy Statement, as well as the charters for each committee of the board, may be viewed at <I><U>www.nektar.com</U></I>. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_16"></A>B<SMALL>OARD</SMALL> L<SMALL>EADERSHIP</SMALL> S<SMALL>TRUCTURE</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The positions of Chief Executive Officer and Chairman of the board of directors are currently held by Howard W. Robin and Robert B. Chess, respectively. The board of directors believes at this time having
a separate chairman provides a more effective channel for the board of directors to express its views on management, by enhancing the board&#146;s oversight of, and independence from, management, and allows the Chief Executive Officer to focus more
on the strategy and operations of the Company. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_17"></A>R<SMALL>ISK</SMALL> O<SMALL>VERSIGHT</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The board of directors monitors and assesses key business risks directly through deliberations of the board of directors and also by way
of delegation of certain risk oversight functions to be performed by committees of the board of directors.&nbsp;The board of directors regularly reviews and assesses, among other matters, the following important areas that present both opportunities
and risk to the Company&#146;s business: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Review and approval of the Company&#146;s annual operating and capital spending plan and review of management&#146;s updates as to the progress against
plan and any related risks and uncertainties. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Periodic consideration of the balance of risk and opportunities presented by the Company&#146;s medium to long-term strategic plan and the potential
implications of success and failure in one or more of the Company&#146;s key drug development programs. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Regular consideration of the risks and uncertainties presented by alternative clinical development strategies. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Regular review of the progress and results of the Company&#146;s clinical development programs and early research efforts including but not limited to
the strengths, weaknesses, opportunities and threats for these programs. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">25 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Periodic review and oversight of material outstanding litigation or threatened litigation. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Review and approval of material collaboration partnerships for the further development and commercial exploitation of the Company&#146;s proprietary
drug development programs and technologies. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Regular review and approval of the annual corporate goals and an assessment of the Company&#146;s level of achievement against these established goals.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Regular review of the Company&#146;s financial position relative to the risk and opportunities for the Company&#146;s business.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Periodic review of the Company&#146;s intellectual property estate. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Periodic&nbsp;review and assessment of CEO succession planning. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Periodic&nbsp;review of the Company&#146;s compensation programs. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The discussion above of risk oversight matters reviewed by the board of directors is intended to be illustrative only and not a complete
list of all important matters reviewed and considered by the board of directors in providing oversight and direction for the Company&#146;s senior management and business. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The risk oversight function of the board of directors is also administered through various board committees.&nbsp;The audit committee oversees the management of financial, accounting, internal controls,
disclosure controls and the engagement arrangement and regular oversight of the independent auditors.&nbsp;The audit committee also periodically reviews the Company&#146;s investment policy for its cash reserves, corporate insurance policies,
information technology infrastructure and general fraud monitoring practices and procedures, including the maintenance and monitoring of a whistleblower hotline and the segregation of duties and access controls across various functions.&nbsp;To
assist the audit committee in its risk management oversight function, the internal auditor has a direct reporting relationship to the audit committee.&nbsp;The Company&#146;s internal audit function is focused on internal control monitoring and
activities in support of the audit committee&#146;s risk oversight function. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The organization and compensation committee is
responsible for the design and oversight of the Company&#146;s compensation programs as well as succession planning for the chief executive officer position and other key executive positions. The organization and compensation committee regularly
considers whether the Company&#146;s compensation policies and practices create risks that could have a material adverse impact on the Company and has concluded that they do not based on several design features of our compensation program that we
believe reduces the likelihood of excessive risk-taking, including the following: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The compensation plan design provides a mix of base salary, short-term incentive compensation opportunity and equity compensation earned over
multiple-year periods. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The determination of the corporate performance rating under the annual bonus plan is based on our achievement of a diversified mix of development,
research, organizational and financial objectives. Thus, the achievement of any single corporate objective does not have a disproportionate impact on the aggregate annual bonus awarded. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each employee&#146;s annual cash bonus is determined by a combination of the corporate performance rating and a subjective determination of individual
performance. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The maximum payout levels for annual incentive bonuses are capped at 200% of each employee&#146;s annual target bonus. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">A substantial portion of each executive&#146;s compensation opportunity is in the form of long-term equity incentives, which help to further align the
long-term interests of our executives with those of our stockholders. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">All employees are subject to our security trading policy which prohibits trading in derivative securities (i.e. puts or calls), short selling, and any
trading in the Company&#146;s securities on margin. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">26 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each executive officer is subject to our clawback policy which provides that any compensation received by an executive officer based upon the
achievement of financial results that are subsequently revised is subject to cancellation or a reimbursement obligation. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The nominating and corporate governance committee periodically reviews the Company&#146;s corporate governance practices, including certain risks that those practices are intended to address.&nbsp;This
committee periodically reviews the composition of the board of directors to help ensure that a diversity of skills and experiences is represented by the members of the board of directors taking into account the stage of growth of the Company and its
strategic direction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In carrying out their risk oversight functions, the board of directors and its committees routinely
request and review management updates, reports from the independent auditors and legal and regulatory advice from outside experts, as appropriate, to assist in discerning and managing important risks that may be faced by the Company.&nbsp;The board
of directors is committed to continuing to ensure and evolve its risk oversight practices as appropriate given the stage of the Company&#146;s evolution as a drug development company and the fast-paced changes in the biopharmaceutical industry. In
that regard, in 2013 the Company maintained a risk management committee composed of senior managers in charge of important functional areas that regularly reported to the board of directors or one of its designated committees. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_18"></A>I<SMALL>NDEPENDENCE</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL>
D<SMALL>IRECTORS</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As required under the NASDAQ Global Select Market listing standards, a majority of the members of
a listed company&#146;s board of directors must qualify as &#147;independent,&#148; as affirmatively determined by the board of directors. Our board consults with counsel to ensure that its determinations are consistent with all relevant securities
and other laws and regulations regarding the definition of &#147;independent,&#148; including those set forth in pertinent NASDAQ listing standards, as in effect from time to time. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consistent with these standards, after review of all relevant transactions (if any) or relationships between each director, or any of his
or her family members, and us, our senior management and our independent registered public accounting firm, the board has affirmatively determined that all of our directors are independent directors within the meaning of the applicable NASDAQ
listing standards, except for Mr.&nbsp;Robin, our President and Chief Executive Officer. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As required under applicable NASDAQ
listing standards, in the 2014 fiscal year, our independent directors met at least four times in regularly scheduled executive sessions at which only independent directors were present.&nbsp;The independent directors regularly rotate responsibility
for presiding over the executive sessions such that no single independent director presides over more than one executive session per year. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">27 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_19"></A>I<SMALL>NFORMATION</SMALL> R<SMALL>EGARDING</SMALL> <SMALL>THE</SMALL>
C<SMALL>OMMITTEES</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The board of directors has three regularly constituted committees: an audit committee, an organization and compensation committee, and a nominating and corporate governance committee. The following table
provides membership and meeting information as of December&nbsp;31, 2014, for each of the board committees: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Audit</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Organization&nbsp;
and</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Compensation</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Nominating</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>and</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Corporate</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Governance</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert B. Chess</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">R. Scott Greer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Joseph J. Krivulka</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher A. Kuebler</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lutz Lingnau</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Susan Wang</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roy A. Whitfield</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dennis L. Winger</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Total meetings in the 2014 fiscal year</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Committee Chairperson. </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Below
is a description of each committee of the board of directors. The board of directors has determined that each member of each committee meets the applicable rules and regulations regarding &#147;independence&#148; and that each member is free of any
relationship that would interfere with his or her individual exercise of independent judgment with regard to us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>A<SMALL>UDIT</SMALL>
C<SMALL>OMMITTEE</SMALL> </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The audit committee of the board of directors oversees our corporate accounting and financial
reporting process. For this purpose, the audit committee performs several functions. The audit committee: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">evaluates the performance of and assesses the qualifications of our independent registered public accounting firm; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">determines whether to retain or terminate our independent registered public accounting firm or to appoint and engage a new independent registered
public accounting firm; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and determines the engagement of the independent auditors, including the overall scope and plans for their respective audits, the adequacy of
staffing and compensation, and negotiates and executes, on behalf of the Company, engagement letters with the independent auditors; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">establishes guidelines and procedures with respect to the rotation of the lead or coordinating audit partners having primary responsibility for the
audit and the audit partner responsible for reviewing the audit; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and approves the retention of the independent registered public accounting firm for any permissible non-audit services and, at least annually,
discusses with our independent registered public accounting firm, and reviews, that firm&#146;s independence; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">obtains and reviews, at least annually, a formal written statement prepared by the independent registered public accounting firm delineating all
relationships between the independent registered public accounting firm and the Company and discusses with the independent registered public accounting firm, and reviews, its independence from management and the Company;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews with the independent registered public accounting firm any management or internal control letter issued or, to the extent practicable, proposed
to be issued by the independent registered public accounting firm and management&#146;s response; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">28 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews with management and the independent registered public accounting firm the scope, adequacy and effectiveness of our financial reporting
controls; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and discusses with management, the Company&#146;s risk management committee, the internal auditor and the independent registered public
accounting firm, as appropriate, the Company&#146;s major financial risks, the Company&#146;s policies for assessment and management of such risks, and the steps to be taken to control such risks; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">establishes and maintains procedures for the receipt, retention and treatment of complaints regarding accounting, internal accounting controls or
auditing matters, including procedures for the confidential and anonymous submission by employees of concerns regarding questionable accounting or auditing matters; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">investigates and resolves any disagreements between our management and the independent registered public accounting firm regarding our financial
reporting, accounting practices or accounting policies and reviews with the independent registered public accounting firm any other problems or difficulties it may have encountered during the course of the audit work; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">meets with senior management and the independent registered public accounting firm in separate executive sessions; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews the consolidated financial statements to be included in our quarterly reports on Form 10-Q and our annual reports on Form 10-K;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">discusses with management and the independent registered public accounting firm the results of the independent registered public accounting firm&#146;s
review of our quarterly consolidated financial statements and the results of our annual audit and the disclosures contained under the caption &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; in
our periodic reports; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and discusses with management and the independent registered public accounting firm any material financial arrangements of the Company which do
not appear on the financial statements of the Company and any significant transactions or courses of dealing with parties related to the Company; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews with management and the independent registered public accounting firm significant issues that arise regarding accounting principles and
financial statement presentation; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">oversees the Company&#146;s internal audit function; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">discusses with management and the independent registered public accounting firm any correspondence from or with regulators or governmental agencies,
any employee complaints or any published reports that raise material issues regarding the Company&#146;s consolidated financial statements, financial reporting process or accounting policies; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">oversees the preparation of the audit committee report to be included in the Company&#146;s annual report or proxy statement; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews the Company&#146;s investment policy for its cash reserves, corporate insurance policies, information technology infrastructure and general
fraud monitoring practices and procedures, including the maintenance and monitoring of a whistleblower hotline and the segregation of duties and access controls across various functions. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The audit committee has the authority to retain special legal, accounting or other professional advisors to advise the committee as it
deems necessary, at our expense, to carry out its duties and to determine the compensation of any such advisors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Four
directors comprised the audit committee at the end of the 2014 fiscal year: Ms.&nbsp;Wang, who chairs the committee, and Messrs. Greer, Krivulka, and Winger. The board of directors annually reviews the NASDAQ listing standards definition of
independence for audit committee members and has determined that all members </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">29 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
of our audit committee are independent. The board of directors has determined that Ms.&nbsp;Wang and Mr.&nbsp;Winger each qualify as an &#147;audit committee financial expert&#148; as defined in
applicable SEC rules. The board of directors made a qualitative assessment of Ms.&nbsp;Wang&#146;s level of knowledge and experience based on a number of factors, including her formal education and experience as a Chief Financial Officer of a public
reporting company. In addition to our audit committee, Ms.&nbsp;Wang also serves on the audit committees of Cirrus Logic, Inc. (NASDAQ: CRUS) and Premier, Inc. (NASDAQ: PINC). The board of directors does not believe that such simultaneous service
impairs Ms.&nbsp;Wang&#146;s ability to effectively serve on our audit committee and as the chairwoman of such committee. The board of directors made a qualitative assessment of Mr.&nbsp;Winger&#146;s level of knowledge and experience based on a
number of factors, including his formal education and experience as a Chief Financial Officer of a public reporting company. In addition to our audit committee, Mr.&nbsp;Winger also serves on the audit committee of Accuray Incorporated (NASDAQ:
ARAY). The board of directors does not believe that such simultaneous service impairs Mr.&nbsp;Winger&#146;s ability to effectively serve on our audit committee. The audit committee has adopted a written audit committee charter that is available on
our corporate website at <I>www.nektar.com</I>. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>O<SMALL>RGANIZATION</SMALL> <SMALL>AND</SMALL> C<SMALL>OMPENSATION</SMALL>
C<SMALL>OMMITTEE</SMALL> </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The organization and compensation committee of the board of directors administers the
variable compensation programs and reviews management&#146;s recommendations for organization structure and development of the Company. Additionally, the organization and compensation committee reviews and in some cases approves the type and level
of cash and equity-based compensation for officers, employees and consultants of the Company, and recommends certain compensation actions to the board of directors for review and approval. The organization and compensation committee: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and approves the structure and guidelines for various incentive compensation and benefit plans; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">grants equity awards under the various equity incentive compensation and benefit plans; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">approves the compensation for the executive officers of the Company, including the President and Chief Executive Officer, and those vice-president
level employees that report directly to the President and Chief Executive Officer, including, but not limited to, annual salary, bonus, equity compensation and other&nbsp;benefits; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">recommends the compensation levels for the members of the board of directors who are not employed by us or our subsidiaries (&#147;non-employee
directors&#148;) for approval by the independent members of the board of directors; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews the operation of the Company&#146;s executive compensation programs to determine whether they remain supportive of the Company&#146;s business
objectives and are competitive relative to comparable companies and establishes and periodically reviews policies for the administration of executive compensation programs; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews the Company&#146;s executive compensation arrangements to evaluate whether incentive and other forms of compensation do not encourage
inappropriate or excessive risk taking and reviews and discusses, at least annually, the relationship between risk management policies and practices, corporate strategy and the Company&#146;s executive compensation arrangements;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and discusses with management and the Company&#146;s risk management committee, as appropriate, the Company&#146;s major risks relating to the
purview of the organization and compensation committee, the Company&#146;s policies for assessment and management of such risks, and the steps to be taken to control such risks; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">oversees the preparation of the organization and compensation committee report to be included in the Company&#146;s annual proxy statement;
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">30 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews management recommendations on organization structure and development, including succession planning; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews performance of the executive officers and vice-president level employees that report directly to the Chief Executive Officer.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The organization and compensation committee takes into account our President and Chief Executive
Officer&#146;s recommendations regarding the compensatory arrangements for our executive officers, although our President and Chief Executive Officer does not participate in the deliberations or determinations of his own compensation. In particular,
the organization and compensation committee considered our President and Chief Executive Officer&#146;s recommendations for 2014 regarding the increase in annual base compensation, award of annual performance-based bonus compensation and the number
of stock options granted to our executive officers excluding himself. While the organization and compensation committee considers and appreciates the input and expertise of management in making its decisions, it does ensure that an executive session
where no management is present is included in the agenda for every committee meeting.&nbsp;The organization and compensation committee&#146;s charter gives the committee the sole authority to retain independent counsel, compensation and benefits
consultants or other outside experts or advisors that it believes to be necessary or appropriate. During 2014, the organization and compensation committee retained Frederic W. Cook&nbsp;&amp; Co. (&#147;FW Cook&#148;), a nationally recognized
executive compensation consulting firm that performs compensation benchmarking, analysis and design services.&nbsp;FW Cook was engaged in 2014 to provide regulatory, legislative updates and market trend analysis, to provide analysis on our
compensation programs, to provide recommendations and advice on the structure, elements and amounts of compensation provided to our non-employee directors, to review the Compensation Discussion and Analysis, and to provide executive compensation
analysis as needed.&nbsp;FW Cook does not provide any other services to us other than the executive and director compensation services it performs at the request of the organization and compensation committee, and after consideration of such
services and other factors prescribed by the SEC for purposes of assessing the independence of compensation consultants, we have determined that no conflicts of interest exist between the Company and FW Cook (or any individuals providing such
services to the committee on FW Cook&#146;s behalf). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The organization and compensation committee may delegate to its
subcommittees such authority as it deems appropriate, except for the authority the committee is required to exercise by applicable law or regulation. The organization and compensation committee has delegated certain limited authority to grant stock
option awards under our stock incentive plan to a committee comprised of management representatives, and with respect to certain limited authority to grant restricted stock unit awards, to a committee of the board of directors, with Mr.&nbsp;Robin
serving as the sole member of that committee. These committees may not approve award grants to anyone serving as an executive officer or director of the Company. Other than the authority delegated to these committees, the organization and
compensation committee has no current intention to delegate any of its authority to any other committee or subcommittee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Four
directors comprised the organization and compensation committee at the end of the 2014 fiscal year: Mr.&nbsp;Lingnau, who chaired the committee, and Messrs. Greer, Krivulka and Kuebler. The board of directors annually reviews the NASDAQ listing
standards definition of independence for organization and compensation committee members and has determined that all members of our organization and compensation committee are independent. The organization and compensation committee charter can be
found on our corporate website at <I>www.nektar.com</I>. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>N<SMALL>OMINATING</SMALL> <SMALL>AND</SMALL> C<SMALL>ORPORATE</SMALL>
G<SMALL>OVERNANCE</SMALL> C<SMALL>OMMITTEE</SMALL> </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The nominating and corporate governance committee: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">establishes criteria for board membership, including standards for independence, and considers and assess the independence of the directors;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">evaluates board composition and performance; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">31 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">identifies, reviews and recommends the board&#146;s selected candidates to serve as directors; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">considers stockholder recommendations for director nominations and other proposals submitted by stockholders; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews the adequacy of and compliance with our Code of Business Conduct and Ethics; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">administers and oversees all aspects of our corporate governance functions on behalf of the board; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">monitors regulatory and legislative developments in corporate governance, as well as trends in corporate governance practices, and makes
recommendations to the board regarding the same; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and discusses with management and the Company&#146;s risk management committee, as appropriate, the Company&#146;s major risks relating to the
purview of the nominating and corporate government committee, the Company&#146;s policies for assessment and management of such risks, and the steps to be taken to control such risks; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">establishes and oversees procedures for the receipt, retention and treatment of complaints received by the Company with respect to legal and regulatory
compliance (except for compliance relating to accounting, internal accounting controls, auditing matters and financial disclosure and reporting); and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">provides recommendations to the board of directors to establish such special committees as may be desirable or necessary from time to time in order to
address ethical, legal, business or other matters that may arise. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The nominating and corporate governance
committee believes that candidates for director should possess the highest personal and professional ethics, integrity and values, be committed to represent our long-term interests and those of our stockholders, possess diverse experience at
policy-making levels in business, science and technology, possess key personal characteristics such as strategic thinking, objectivity, independent judgment, intellect and the courage to speak out and actively participate in meetings, as well as
have sufficient time to carry out the duties and responsibilities of a board member effectively. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Three directors comprised
the nominating and corporate governance committee at the end of the 2014 fiscal year: Mr.&nbsp;Whitfield, who chairs the committee, and Messrs. Kuebler and Winger. The board of directors annually reviews the NASDAQ listing standards definition of
independence for the nominating and corporate governance committee and has determined that all members of our nominating and corporate governance committee are independent. The nominating and corporate governance committee charter can be found on
our corporate website at <I>www.nektar.com</I>. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The current members of our board of directors represent a desirable mix of
backgrounds, skills and experiences, and are all believed to share the key personal characteristics described above.&nbsp;Below are some of the specific experiences and skills of our directors. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Robert B. Chess </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Chess is our Chairman and former President and Chief Executive Officer and has a deep understanding of our business. Having founded and led private and public companies, Mr.&nbsp;Chess has strong
experience leading growing companies in our industry. Due to his long association with the Company as a co-founder, director and senior executive leader at various times, he possesses significant knowledge and perspective on the history and
development of the Company. Mr.&nbsp;Chess is a prominent participant in our industry, was a long-time member of the board of our industry association, and is on the board of trustees and faculty of leading academic institutions. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Susan Wang </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Wang has a strong financial and business background as a senior executive of Solectron Corporation, an electronics manufacturing services and supply chain solutions company. She is an audit
committee financial </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">32 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
expert as a result of her prior experience as Chief Financial Officer of Solectron, has extensive experience on the audit committees of other U.S. public companies, and was a certified public
accountant.&nbsp;Ms. Wang has extensive corporate governance experience through service on other public company boards. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Roy A. Whitfield </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Whitfield has a strong strategy development and leadership background in the biotechnology and medical industries. He is a former strategy consultant from a major consulting firm, was the founder
and chief executive officer of a public biotechnology company, and has held executive positions in various segments of the health care industry. He has extensive corporate governance experience through his service on other public company boards in
the pharmaceutical and life sciences industries. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Joseph J. Krivulka </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Krivulka has a strong operational and leadership record in the pharmaceutical industry with strong expertise in product
evaluation, development, and marketing.&nbsp;Mr. Krivulka has founded and served as chief executive officer of several successful pharmaceutical companies and is currently the Chairman of Akrimax Pharmaceuticals. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Howard W. Robin </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Robin is our President and Chief Executive Officer. Mr.&nbsp;Robin has over 25 years of experience in the pharmaceutical and biotechnology industries in a variety of roles of increasing
responsibility and, prior to becoming our chief executive officer, was the chief executive officer and president and a director of Sirna Therapeutics, a development stage biotechnology company. The board of directors has determined that
Mr.&nbsp;Robin&#146;s position as president and chief executive officer provides him with important insight into the Company&#146;s opportunities, risks, strengths and weaknesses, as well as its organizational and operational capabilities, which is
valuable to the board of directors in making strategic decisions and performing its oversight responsibilities. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dennis L.
Winger </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Winger has a strong operational and finance background with over 20 years of experience as a financial and
administrative senior executive in the life sciences and pharmaceutical industries. Most recently, he was Chief Financial Officer of Applera Corporation, a life sciences company, and prior to that was a senior financial and administrative executive
at Chiron Corporation, a biotechnology company, for eight years. Mr.&nbsp;Winger has corporate governance and audit committee experience through service on other public company boards in the pharmaceutical and life sciences industries. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>R. Scott Greer </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Greer has a proven track record as an entrepreneur and senior executive with extensive experience in the biotechnology industry, most recently with Abgenix, Inc., until its acquisition by Amgen,
Inc. in 2006. Mr.&nbsp;Greer has held senior executive and finance positions at other companies in our industry and currently serves as a director of several other companies in the biopharmaceutical and medical device industries. He possesses strong
expertise in biotech industry strategy, business models, and finance and has served on compensation and audit committees. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Christopher A. Kuebler </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Kuebler is a former chief executive officer of Covance Inc., a drug development services company. Prior to that, he had diverse management experience in positions of increasing responsibility
with Abbott Laboratories and other large health care companies. As a result of his experiences, Mr.&nbsp;Kuebler possesses valuable knowledge and insight regarding both the development and commercial aspects of the biopharmaceutical industry as well
as leadership experience in running a significant public company. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">33 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Lutz Lingnau </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Lingnau has a strong management background in the pharmaceutical industry as a senior executive and member of the executive board of Schering AG Group. He has international sales and operations
experience as former head of worldwide sales and marketing in the pharmaceutical division of Schering, and in operational roles in South America and the U.S., and also as a member of the supervisory board of a German specialty chemicals company.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Candidates for director nominees are reviewed in the context of the current composition of the board, our operating
requirements and the long-term interests of stockholders. In conducting this assessment, the committee considers diversity, age, skills and such other factors as it deems appropriate given our current needs and those of our board to maintain a
balance of knowledge, experience and capability. The nominating and corporate governance committee also periodically reviews the overall effectiveness of the board, including board attendance, level of participation, quality of performance,
self-assessment reviews and any relationships or transactions that might impair director independence. In the case of new director candidates, the nominating and corporate governance committee also determines whether the nominee must be independent
for NASDAQ purposes, which determination is based upon applicable NASDAQ listing standards, applicable SEC rules and regulations and the advice of counsel, if necessary. The committee then uses its network of contacts to compile a list of potential
candidates, but may also engage, if it deems appropriate, a professional search firm. The committee conducts any appropriate and necessary inquiries into the backgrounds and qualifications of possible candidates after considering the function and
needs of the board. The nominating and corporate governance committee meets to discuss and consider such candidates&#146; qualifications and then selects a nominee for recommendation to the board by majority vote. We have paid fees to third party
search firms in the past to assist in our process of identifying or evaluating director candidates. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The nominating and
corporate governance committee of our board of directors will consider for nomination any qualified director candidates recommended by our stockholders. Any stockholder who wishes to recommend a director candidate is directed to submit in writing
the candidate&#146;s name, biographical information, relevant qualifications and other information required by our bylaws to our Secretary at our principal executive offices before the deadline set forth in our bylaws. All written submissions
received from our stockholders will be reviewed by the nominating and corporate governance committee at the next appropriate meeting. The nominating and corporate governance committee will evaluate any suggested director candidates received from our
stockholders in the same manner as recommendations received from management, committee members or members of our board. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_20">
</A>S<SMALL>TOCKHOLDER</SMALL> C<SMALL>OMMUNICATIONS</SMALL> <SMALL>WITH</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The board of directors will consider any written or electronic communication from our stockholders to the board, a committee of the board or any individual director. Any stockholder who wishes to
communicate to the board of directors, a committee of the board or any individual director should submit written or electronic communications to our Secretary at our principal executive offices, which shall include contact information for such
stockholder. All communications from stockholders received will be forwarded by our Secretary to the board of directors, a committee of the board or an individual director, as appropriate, on a periodic basis, but in any event no later than the
board of director&#146;s next scheduled meeting. The board of directors, a committee of the board, or individual directors, as appropriate, will consider and review carefully any communications from stockholders forwarded by our Secretary.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_21"></A>C<SMALL>ODE</SMALL> <SMALL>OF</SMALL> B<SMALL>USINESS</SMALL> C<SMALL>ONDUCT</SMALL> <SMALL>AND</SMALL>
E<SMALL>THICS</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have adopted a code of business conduct and ethics that applies to all employees, including our
principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. The code of business conduct and ethics is available on our website at <I><U>www.nektar.com</U></I>.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">34 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Amendments to, and waivers from, the code of business conduct and ethics that apply to any director, executive officer or persons performing similar functions will be disclosed at the website
address provided above and, to the extent required by applicable regulations, on a Current Report on Form 8-K filed with the SEC. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_22">
</A>O<SMALL>RGANIZATION</SMALL> <SMALL>AND</SMALL> C<SMALL>OMPENSATION</SMALL> C<SMALL>OMMITTEE</SMALL> I<SMALL>NTERLOCKS</SMALL> <SMALL>AND</SMALL> I<SMALL>NSIDER</SMALL> P<SMALL>ARTICIPATION</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The organization and compensation committee consisted of four independent directors at the end of 2014: Messrs. Greer, Krivulka, Kuebler
and Lingnau. No director who served on the organization and compensation committee in 2014 was, or has been, an officer or employee of us, nor has any director had any relationships requiring disclosure under the SEC rules regarding certain
relationships and related-party transactions. None of our executive officers served on the board of directors or the organization and compensation committee (or other board committee performing equivalent functions) of another entity, one of whose
executive officers served on our board of directors or organization and compensation committee. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_23"></A>D<SMALL>IRECTOR</SMALL> C<SMALL>OMPENSATION</SMALL> T<SMALL>ABLE</SMALL>&#151;F<SMALL>ISCAL</SMALL> 2014
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each of our non-employee directors participates in our Amended and Restated Compensation Plan for Non-Employee Directors
(the &#147;Director Plan&#148;). Only our non-employee directors are eligible to participate in the Director Plan. The following table shows compensation awarded or paid to our non-employee directors for the fiscal year ended December&nbsp;31, 2014.
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="58%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name(1)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:29pt"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fees&nbsp;Earned<BR>or&nbsp;Paid&nbsp;in<BR>Cash&nbsp;($)<BR>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock<BR>Awards<BR>($)<BR>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Awards<BR>($)(2)<BR>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total&nbsp;($)<BR>(f)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Robert B. Chess</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">110,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">266,963</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">377,713</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>R. Scott Greer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">80,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">266,963</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">346,963</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Joseph J. Krivulka</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">68,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">266,963</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">334,963</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Christopher A. Kuebler</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">69,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">266,963</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">336,213</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Lutz Lingnau</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">81,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">266,963</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">347,963</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Susan Wang</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">82,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">266,963</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">349,213</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Roy A. Whitfield</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">80,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">266,963</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">347,713</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dennis L. Winger</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">78,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">266,963</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">345,213</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Robin, our President and Chief Executive Officer, is not included in this table as he was an employee of us in 2014 and received no additional compensation for
his services in his capacity as a director. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts reported represent the aggregate grant date fair value of awards computed in accordance with Financial Accounting Standards Board Accounting Standards
Codification Topic 718, Compensation&#151;Stock Compensation (&#147;FASB ASC Topic 718&#148;), which excludes the effects of estimated forfeitures. For a complete description of the assumptions made in determining the valuation, please refer to Note
11 (Stock-Based Compensation) to our audited financial statements in our annual report on Form 10-K for the fiscal year ended December&nbsp;31, 2014.&nbsp;Each of our non-employee directors received 45,000 options for their annual stock option grant
on September&nbsp;23, 2014. The grant date fair value of the stock options awarded to each of our non-employee directors for their annual stock option grant in 2014 was $266,963. As of December&nbsp;31, 2014, each of our non-employee directors had
the following number of outstanding stock options: Robert B. Chess: 230,000; R. Scott Greer: 217,500; Joseph J. Krivulka: 230,000; Christopher A. Kuebler: 230,000; Lutz Lingnau: 252,500; Susan Wang: 245,000; Roy A. Whitfield: 230,000; and Dennis L.
Winger: 218,750. </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Director Plan, each non-employee director is eligible to receive an annual retainer
of $30,000 for serving on the board of directors, an additional annual retainer of $50,000 for serving as the chair or lead director of the board of directors, an additional annual retainer of $20,000 for serving as chair of the audit committee, an
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">35 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
additional annual retainer of $15,000 for serving as chair of the organization and compensation committee, an additional annual retainer of $10,000 for serving as chair of the nominating and
corporate governance committee, and an additional annual retainer of $5,000 for serving as chair of any other committee. In addition, each non-employee director is entitled to $2,000 for each in-person or telephonic board meeting he or she attends
and $1,000 for each in-person board meeting he or she attends by telephone. Each non-employee director is also entitled to $1,750 for each in-person or telephonic committee meeting he or she attends and $875 for each in-person committee meeting he
or she attends by telephone. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In September of each year, each non-employee director is eligible to receive an equity award
consisting of either all stock options or a combination of stock options and restricted stock units, as determined by the board of directors. These equity awards vest over a period of one year and will have a total value or cover a number of shares
as determined annually by the board of directors. Upon initial appointment to the board of directors, each non-employee director is eligible to receive an equity award consisting of either all stock options or a combination of stock options and
restricted stock units. These initial equity awards vest over a period of three years from the date of appointment and will be at a level based on 150% of the most recent annual equity compensation grant to non-employee directors, as determined
annually by the board of directors. Non-employee directors are also eligible to receive discretionary equity-based awards under our stock incentive plans from time to time as determined by the board of directors. The exercise price of stock options
granted is equal to the closing price of the Company&#146;s common stock on the grant date<B>.</B> Following completion of a non-employee director&#146;s service on the board of directors, his or her stock options will remain exercisable for a
period of eighteen months (or, if earlier, the end of the maximum term of the option). The term of stock options granted to non-employee directors is eight years. In the event of a change of control, the vesting of each option or restricted stock
unit award held by each non-employee director will accelerate in full as of the closing of such transaction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Director
Plan includes ownership guidelines for non-employee directors, stating that each non-employee director should own shares of our common stock equal to at least three times the value of the annual board cash retainer. The minimum stock ownership level
was to be achieved by each non-employee director by January&nbsp;1, 2015 or within five years of the date of his or her first appointment to the board of directors. Each non-employee director currently meets the minimum stock ownership guidelines.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">36 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>INFORMATION ABOUT THE EXECUTIVE OFFICERS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_24"></A>C<SMALL>OMPENSATION</SMALL> D<SMALL>ISCUSSION</SMALL> <SMALL>AND</SMALL> A<SMALL>NALYSIS</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Introduction </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Compensation Discussion and Analysis is designed to provide our stockholders with an understanding of our executive compensation philosophy and decision making process. It discusses the principles underlying the structure of the compensation
arrangements for our Chief Executive Officer, our Chief Financial Officer, and our other three most highly compensated executive officers who were serving as executive officers on December&nbsp;31, 2014, our NEOs. Unless noted otherwise, any
reference within the Compensation Discussion and Analysis to decisions made by the board of directors refers to the decisions made by the independent members of the board of directors only. This Compensation Discussion and Analysis primarily focuses
on the compensation of our NEOs for 2014 that are identified in the table below. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="43%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Title</B></FONT></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and Chief Executive Officer</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Nicholson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President and Chief Financial Officer</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen&nbsp;K.&nbsp;Doberstein,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior&nbsp;Vice&nbsp;President&nbsp;and&nbsp;Chief&nbsp;Scientific&nbsp;Officer</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ivan P. Gergel, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President and Chief Medical Officer</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President and General Counsel</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our current compensation programs for the NEOs are determined and approved by the organization and
compensation committee of our board of directors. As described in more detail above under the caption &#147;Information About the Board of Directors-Information Regarding the Committees of the Board of Directors&#151;Organization and Compensation
Committee,&#148; the organization and compensation committee takes into account Mr.&nbsp;Robin&#146;s recommendations regarding the compensatory arrangements for our executive officers, although Mr.&nbsp;Robin does not participate in the
deliberations or determinations of his own compensation. For example, during 2014, the organization and compensation committee considered Mr.&nbsp;Robin&#146;s recommendations regarding the increase in annual base compensation, award of annual
performance-based bonus compensation, and the number of stock options to be granted to our executive officers other than himself. The other NEOs did not have any role in determining or recommending the form or amount of compensation paid to any of
our executive officers. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Company Performance Highlights </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In assessing the appropriate level of compensation for our executive officers, in particular the short-term incentive compensation to be awarded for a particular year, we take into account the overall
performance of the Company against the specific annual corporate objectives established by the board of directors at the beginning of that year. The biotechnology industry is characterized by high stock price volatility and, as a result, our focus
on pay-for-performance is based on an assessment of the level of the Company&#146;s achievement against those specific objectives rather than the stock price at any given point in time. Some of the significant accomplishments achieved by the Company
in 2014 are summarized below. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">On June&nbsp;12, 2014, the members of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) of the United States Food and Drug
Administration (FDA) voted that the FDA should not require cardiovascular outcomes trials for the peripherally-acting mu-opioid receptor antagonist (PAMORA) class of drugs, which included MOVANTIK&#153; (formerly known as naloxegol and NKTR-118).
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The FDA approved MOVANTIK&#153; for the treatment of opioid-induced constipation in adult patients with chronic, non-cancer pain. As a result of the
approval, we received an additional $35 million milestone payment from AstraZeneca AB (AstraZeneca) in September 2014 pursuant to the license agreement between AstraZeneca and us, as amended. The FDA approval also extinguished our
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">37 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2">
contingent obligation to repay $70 million previously paid by AstraZeneca to us under the license agreement. In addition, we received a $100 million payment from AstraZeneca in March 2015
triggered by the first commercial sale of MOVANTIK&#153; by AstraZeneca in the United States following the FDA approval. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The European Commission granted a Marketing Authorisation to MOVENTIG<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> (the naloxegol brand name in the European Union) as the first once-daily oral PAMORA approved in the European Union for the treatment of opioid-induced constipation
in adult patients who have had an inadequate response to laxative(s). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our collaboration partner, Baxter Healthcare, reported positive top-line results from its Phase 3 study of BAX 855, a longer-acting (PEGylated) form of
a full-length recombinant factor VIII (rFVIII) protein, in patients with hemophilia. Based on this data, Baxter submitted a biologics license application (BLA) to the FDA for BAX 855. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We completed the design of the first Phase 3 efficacy trial for NKTR-181 and related discussions with the FDA that enabled us to enroll the first
patient in the SUMMIT-07 Phase 3 clinical trial for NKTR-181 on February&nbsp;24, 2015. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We reported positive clinical data from an investigator sponsored Phase 2 study of etirinotecan pegol (NKTR-102) in patients with Avastin<FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> refractory high-grade glioma that was conducted by Stanford University. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We presented data on target-specific biomarkers from circulating tumor cell sub-study of Phase 3 BEACON study of etirinotecan pegol (NKTR-102) in
patients with advanced breast cancer. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We reported positive clinical data from a Phase 1 study of etirinotecan pegol (NKTR-102) in combination with 5- fluorouracil/leucovorin in patients
with refractory solid tumor cancers. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We presented positive pre-clinical data for etirinotecan pegol (NKTR-102) in combination with a PARP inhibitor in BRCA1-deficient cancer model.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We continued to advance our earlier stage pipeline including the Phase 1 program for NKTR-171, the completion of significant preclinical work for
NKTR-214, and the advancement of our research projects including a presentation of data for an oral, peripherally-acting kappa agonist molecule. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In addition to considering the Company&#146;s accomplishments and progress each year, we also think it is important in making compensation decisions to take into account the long-term performance of the
executive leadership team. We believe that the skills, creativity and dedication of executive leadership have led to numerous significant accomplishments including the following: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Over the past eight years, our business has been transformed from a drug delivery service provider to a drug development company which included a
significant change in the mix of senior leadership and the skills and experience of personnel in key functional areas, a reprioritization of resource allocation, and building a more efficient and productive organization.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In August 2013, we negotiated an amendment to our worldwide naloxegol license agreement entered into in September 2009 with AstraZeneca to provide for
a risk-benefit sharing arrangement that resulted in a commitment by AstraZeneca to submit a New Drug Application (&#147;NDA&#148;) with the FDA and a Market Authorisation Application (&#147;MAA&#148;) with the European Medicines Agency
(&#147;EMA&#148;). We received from AstraZeneca a total payment of $95 million in milestones in the fourth quarter of 2013 after these filings were accepted by these governmental health authorities and an additional $35 million payment in September
2014 upon receipt of the FDA approval of MOVANTIK&#153;. In addition, under the license agreement, as amended, we are eligible to receive up to $140 million in commercial launch milestones, of which $100 million was received in April 2015 as a
result of the first commercial sale of MOVANTIK&#153; in the United States, and up to $375 million in additional sales milestones. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">38 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In July 2012, we closed a $125 million secured debt financing that was a very unique transaction (and on very attractive terms, in our view) for a
development stage biotechnology company such as Nektar. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In February 2012, we successfully completed the sale of the Company&#146;s CIMZIA<B><I><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></I></B> and MIRCERA<B><I><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></I></B> royalty rights for $124 million.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In September 2009, we entered into a license agreement with AstraZeneca for MOVANTIK&#153; (formerly known as naloxegol and NKTR-118) and naloxegol
fixed-dose combination products (formerly known as NKTR-119). AstraZeneca paid us an up-front payment of $125 million and assumed all future development costs for MOVANTIK&#153; and the naloxegol fixed-dose combination products under the license
agreement.&nbsp;AstraZeneca announced positive Phase 3 clinical trial results for naloxegol in November 2012 and February 2013. In relation to the naloxegol fixed-dose combination products, for each of the first two initial fixed-dose combination
products, we are eligible to receive for each of such products up to $75 million in development milestones and up to $310 million in additional sales milestones.&nbsp;For both MOVANTIK&#153; and the naloxegol fixed-dose combination products, we are
also eligible to receive significant and escalating royalty payments. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The above accomplishments, together
with accomplishments achieved by the Company since 2007, directly resulted in the Company (1)&nbsp;building and advancing a significant drug candidate pipeline; (2)&nbsp;building an organization and infrastructure designed to execute on our mission
of being a leading drug development company; (3)&nbsp;receiving over $800 million in capital from transactions that did not involve the issuance of equity securities; (4)&nbsp;avoiding significant future financial commitments in certain cases; and
(5)&nbsp;establishing collaboration and proprietary product opportunities that have significant future economic potential based on milestone payments, royalties and sales. We believe that the compensation programs and awards to our NEOs should be
evaluated within the context of these significant accomplishments and performance over a sustained period of time. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Compensation Program
Objectives and Philosophy </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In order to continue the execution and growth of our business as described above, we believe
that it is vital that we continue to retain and attract highly experienced and skilled senior leadership by offering competitive base compensation and benefits, significant performance-based incentives, and the potential for long-term equity
compensation. Our goal is to structure a meaningful portion of executive compensation such that it will only have value if the senior leadership is successful in building significant long-term value for us and our stockholders. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our current executive compensation programs are intended to achieve the following four fundamental goals and objectives: (1)&nbsp;to
incent and reward sustained long-term performance by aligning significant elements of executive compensation with our stockholders&#146; interests, (2)&nbsp;to attract and retain an experienced, highly qualified and motivated executive management
team to lead our business, (3)&nbsp;to provide economic rewards for achieving high levels of our performance and individual contribution, and (4)&nbsp;to pay compensation that is competitive, taking into account the experience, skills and
performance of the executives required to build and maintain the organization necessary to support our mission to be a leading drug development company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">When structuring our executive compensation programs to achieve our goals and objectives, we are guided by the following philosophies: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Alignment with Stockholders&#146; Interests</I>. Our compensation model should be designed to align the economic interests of our executives with
those of our stockholders. In 2012, we established a performance-based stock option award program for our executive officers. Under this program, 50% of the annual stock options granted to our executive officers since inception were made in the form
of performance-based stock option awards that vest based on the standard four-year monthly vesting schedule plus a separate performance condition that must also be achieved before the executive officer is permitted to exercise the stock option. The
performance condition is met only if, within five years from the grant date, the Company or one of its collaboration partners files an NDA or BLA with the </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">39 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2">
FDA (or the equivalent new drug registration with the EMA) for any &#147;Proprietary Company Program&#148; which is defined to include any drug candidate that is wholly-owned by the Company (e.g.
NKTR-118, NKTR-102, NKTR-061 or BAX-855) or where the Company is entitled to an average royalty interest equal to or greater than 7.5%. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Pay for Performance</I>. Our compensation model should deliver compensation above industry median for exceptional performance and deliver
compensation below the median for years in which the Company does not perform well. In 2014, a study performed by the organization and compensation committee&#146;s independent compensation consultant showed that the value of total direct target
compensation for our NEOs, including our CEO, was below the median for similarly situated executives of our peer group. As used in this discussion, &#147;total direct compensation&#148; includes base salary, annual bonus and the grant date fair
value of equity awards granted to the executive. In addition, to the extent that a peer company&#146;s market capitalization is higher or lower than that of the Company, this difference was taken into account as one factor in evaluating the size of
equity awards. In 2012, 2013, and 2014, we also tied 50% of each NEOs&#146; equity award to the achievement of a rigorous and objective performance milestone in addition to standard time-based vesting requirements as described above. Further, all of
the time- and performance-based equity awards are granted as stock options, which we believe are also inherently performance based as they only provide value to the executive if stockholders realize a positive return on their investment.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Total Rewards Program.</I> The total compensation program must balance pay for performance elements with selected static non-performance based
elements in order to create a total rewards program that is competitive and will help us attract and retain highly qualified and motivated executives. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Flexible Approach</I>. The level of compensation provided to executives must take into account each executive&#146;s role, experience, tenure,
performance and expected contributions to our future success. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Focus on Achievement of Fundamental Business Goals.</I> The compensation program should be structured so that executives are appropriately
incentivized to achieve our short- and long-term goals that are viewed as fundamental to driving value in our business. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We believe that each element of our executive compensation program helps us to achieve one or more of our compensation goals and objectives. For example, we believe that performance-based short-term cash
incentive opportunities in combination with equity incentive awards that are earned over time and increase in value only if the Company becomes more valuable is the best way to align our executives&#146; interests with those of our stockholders and
pay for performance. We believe that the long-term vesting schedules applicable to equity awards also serve as a significant retention incentive as well as a focus on building long-term stockholder value. Providing base salaries and certain
severance protections helps us ensure that we are providing a competitive compensation package that will permit us to attract and retain qualified, experienced and highly skilled executives. We believe that we have created a total compensation
program that combines short- and long-term components, cash and equity, and fixed and contingent payments, in proportions that are appropriate to achieve each of our fundamental goals and objectives as described above. We also believe that the
structure of our compensation program provides appropriate incentives to reward our executives for achieving our long-term goals and objectives, some of the most important of which are building and advancing a robust drug candidate pipeline,
entering into new collaboration partnerships and executing on our current collaborations, increasing the skill level and efficiency of our organization and improving our financial performance. We believe that our compensation program has helped us
both recruit and retain superior executive talent to continue to build an organization capable of executing on our mission to become a leading drug development company. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Timing of Annual Equity Incentive Grants. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company moved the
timing of its annual equity grant from February to December in 2014. The effect of the one-time change in grant timing is that two annual grants were awarded in fiscal 2014. The Company views the two annual grants in 2014 as discrete annual grants
relating to two separate annual performance periods in 2013 and 2014, rather than as a combined basket of equity compensation for 2014. We expect that the 2014 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">40 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
transition year will be a one-time event and the anticipated future grant schedule for annual equity awards will be December of each year with the next annual compensation cycle occurring in
December 2015. The purpose of the change is to align the year in which the equity compensation is attributed for SEC reporting purposes with the annual performance period that we used as a basis for our equity compensation decisions. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The organization and compensation committee has historically reviewed and approved annual compensation, including equity awards to our
NEOs within a few weeks before or after February&nbsp;1 of each year which has been the effective date for our annual compensation decisions. The decisions in February depended primarily on our assessment of performance for the year that had just
ended. Accordingly, our annual compensation review and approval decisions for the calendar 2013 performance period took place in February 2014. SEC reporting rules required disclosure of the February grant in the year of grant, rather than the year
for which we assessed performance that was the basis of our equity compensation determination. The Company determined that reporting a grant as compensation in a different year than the performance period that played the primary role in determining
the size of the grant made it difficult and confusing for stockholders to assess the alignment of pay and performance. In 2014, the organization and compensation committee decided to migrate to a calendar year compensation cycle with our
compensation review and approval determinations completed no later than December of the calendar year performance period. We made this change in our practice in part to align our performance review and compensation decisions with our calendar year
business planning cycle including the approval of the corporate goals and operating plan for the following calendar year. Further, since equity awards are the largest component of our NEOs&#146; total annual compensation, making equity award
determinations toward the end of each calendar year also allows us to more timely consider and respond to the outcome of that year&#146;s stockholder advisory &#147;say-on-pay&#148; vote as well as feedback we receive from our stockholders as one
component of our compensation decision-making process. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We changed the annual compensation cycle in December 2014 and intend
to stay on this annual cycle in the future (i.e., the next annual compensation cycle is expected to occur in December 2015). As a result of the timing transition, the &#147;Summary Compensation Table&#148; (on page 56) includes not only the value of
equity awards granted for the 2013 performance period which were granted in February 2014, but also the value of equity awards for the 2014 performance period which we granted in December 2014. The 2014 timing transition resulted in two years of
annual equity grants being included in one calendar year even though the equity grants were made ten months apart and reflect compensation awarded based on performance in different years. The February 2014 grant was made in recognition of 2013
performance, while the December 2014 grant was made based on our assessment of 2014 performance. The table below graphically illustrates the timing impact for the 2014 transition year with respect to our CEO. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g913905g31b98.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Relationship between Company Performance and Executive Pay </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The biotechnology industry is generally thought to be characterized by a higher risk profile and by more potentially binary business
outcomes than more established industries which historically has led to high stock volatility for biotechnology companies. The Company ended 2014 with a closing stock price of $15.50 which represented a five-year company annual stockholder return of
10.7%, a two year compound stockholder annual return of 44.6%, and a one year annual return of 36.6%. Mr.&nbsp;Robin&#146;s total compensation, as reported below in the </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">41 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Summary Compensation Table, increased by 125% from 2013 to 2014. The large perceived increase in his 2014 total compensation was a result of changing our compensation review cycle starting in
December 2014 as described above. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we include just one of the 2014 stock option grants in order to present the data
comparatively to the prior annual periods on the graph, the increase in compensation would have been 31% if considering just the February 2014 stock option grant or 50% if considering just the December 2014 stock option grant. A 50% increase follows
the stock price increasing by 37% over the same period and the clinical milestones listed in the section titled &#147;Company Performance Highlights.&#148; The graph below demonstrates that even with high levels of volatility in stock price, the
total direct compensation for Mr.&nbsp;Robin has been generally aligned with our stock price performance since he joined the Company as our Chief Executive Officer in 2007. We believe this alignment is due in large part to our commitment to pay
based on performance and our consideration of capitalization adjusted peer company data rather than relying simply on grant date fair value to determine the size of annual equity grants. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g913905g45u09.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Robin&#146;s total compensation for 2014 includes two annual stock option grants, one made in February 2014 based on 2013 performance and one
made in December 2014 based on 2014 performance, as a result of our transition this year to a calendar year compensation cycle. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In 2012, 2013 and 2014, stock option awards made to Mr.&nbsp;Robin accounted for 47%, 58% and 75%, respectively, of his total direct compensation (For 2014, stock option awards would have accounted for
57% of his total direct compensation if we included only his February 2014 grant and 62% of his total direct compensation if we included only his December 2014 award). Our objective in providing a substantial portion of Mr.&nbsp;Robin&#146;s
compensation in the form of stock options is to ensure that substantial compensation value is made available to him only if the stock price increases after the grant date and over the applicable vesting period. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, one-half of Mr.&nbsp;Robin&#146;s stock options awarded in 2012, 2013, and 2014 also include performance-based vesting and
have value only if a NDA or MAA approval filing was made for a significant drug development program in the Company&#146;s pipeline. This performance hurdle is in addition time-based vesting requirements which also apply to his stock option awards.
We believe these performance-based stock option grants served to further align Mr.&nbsp;Robin&#146;s interests with those of our stockholders and create appropriate additional incentives to achieve performance objectives that we consider critical to
the long-term growth and </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">42 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
value of the Company. The business milestone that we have established for this performance-based equity program has been met only twice in the history of the Company with FDA new drug
applications filed for MOVANTIK&#153; in September 2014 and BAX 855 in January 2015, both of which represent significant programs in the Company&#146;s pipeline. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Executive Compensation Practices </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Below we provide a summary of our
executive compensation practices, including both the practices that we follow and those that we do not follow, in each case based on whether we believe they serve the long-term interests of our stockholders. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Core Compensation Principles and Practices </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Pay-for-Performance</I>. A substantial majority of the compensation awarded to our NEOs is either tied to specific company-wide and individual performance objectives
or has been made in the form of stock option awards that will only have value if the price of our stock increases after the grant date. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Performance-Based Equity Grants</I>. In 2012, 2013 and 2014, we awarded 50% of each executive officer&#146;s equity compensation in the form of performance-based
stock options that only vest and become exercisable upon the achievement of specified significant accomplishments in addition to satisfying our typical 4-year time-based vesting requirement. We continued this performance-based equity program for
executive officers in 2014 for both annual grants. We believe this program is important in that it even more tightly aligns the economic interests of our senior leadership team with those of our stockholders. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Regular Peer Group Review</I>. The organization and compensation committee regularly reviews the Company&#146;s compensation peer group. This review occurred most
recently in September 2014 where the compensation peer group was prospectively adjusted for the 2015 annual compensation cycle to include five additional companies with market capitalizations more in line with that of the Company and exclude certain
companies that have evolved to much larger market capitalizations after we selected them as peers. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Double Trigger</I>. Our change of control severance benefit plan (CIC Plan) only provides our executive officers with acceleration of unvested equity awards held by
them if they are terminated (without cause or constructively) in connection with a change of control transaction or within 12 months following a change of control transaction. We do not provide accelerated vesting of equity awards on a change in
control alone. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Modest Perquisites</I>. We provide only modest perquisites and nearly all of those perquisites are in the form of insurance benefits that we believe are in line with
industry practice for executive compensation. We do not provide perquisites such as personal travel reimbursement, tax services or financial planning. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Reasonable Post-Employment and Change of Control Severance Arrangements</I>. We believe that our severance arrangements with our executive officers are reasonable
and in line with industry practice. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Review Tally Sheets</I>. We review tally sheets for our NEOs prior to making annual executive compensation decisions. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Compensation Claw-Back Policy</I>. We have implemented a claw-back policy which permits us to require reimbursement or cancellation of all or a portion of any
performance-based cash awards or equity incentive payments to the extent based on financial results that are subsequently revised. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Regular Review of Share Utilization for Equity Compensation</I>. We regularly evaluate equity incentive plan share reserve pool utilization by reviewing overhang
levels (the dilutive impact of equity compensation on stockholders) and annual run rates (the aggregate shares awarded as a percentage of total outstanding shares). </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">43 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Mitigate Undue Risk</I>. We have designed our executive compensation program to mitigate undue risk associated with compensation by implementing the following:
multiple performance targets and caps on potential payments of short-term incentive compensation (i.e. annual bonuses), awarding a substantial portion of executive compensation in the form of long-term compensation (i.e. stock options with
multi-year vesting requirements), and compensation claw-back provisions. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Utilize Independent Compensation Consulting Firm</I>. The organization and compensation committee regularly consults with an independent compensation consulting firm
which provides no other services to the Company. For more information on our independent compensation consultant, please see &#147;Organization and Compensation Committee&#148; under &#147;Information About Our Board of Directors&#148; above.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Shareholder Outreach</I>. We regularly meet with our shareholders to get feedback and discuss items of concern to them, including executive compensation. We describe
shareholder outreach efforts on executive compensation in more detail below in the section titled &#147;Role of Stockholder Say-on-Pay Votes.&#148; </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Stock Option Repricing</I>. Our equity incentive plans prohibit us from repricing, exchanging or otherwise providing value for underwater stock options.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Elimination of Excise Tax Gross-Ups on Change of Control Payments</I>. On April&nbsp;5, 2011, we amended our CIC Plan to eliminate any &#147;gross up&#148; payments
for any excise taxes imposed on participants who became eligible to participate in the plan after January&nbsp;1, 2010. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Full Value Equity Awards</I>. We have not awarded &#147;full value&#148; restricted stock units to our NEOs during the last seven years. Stock options are our
preferred form of long-term incentive compensation because we believe they are more performance based than other equity vehicles, with value delivered only if the stock price of our common shares appreciates following the stock option grant date.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Accelerated Vesting of Equity Awards on Termination</I>. Whether one of our NEOs is terminated by the Company without cause or resigns for a good reason, our
severance arrangements do not provide for accelerated vesting of outstanding equity awards (other than a qualifying termination after a change in control as provided in the CIC Plan). </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Inclusion of the Value of Equity Awards in Severance Calculations.</I> Our post-termination and change of control severance arrangements do not include the value
of equity awards in annual compensation for purposes of determining cash severance amounts. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Fixed Employment Terms</I>. We do not have employment contracts with our executive officers that provide for a guaranteed term of employment.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Funded Pension or Retirement Plans</I>. We do not provide any guaranteed or funded retirement plan benefits other than a matching contribution up to $3,000 for
401(k) plan participation that we make available to all employees. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Hedging Transactions, Share Pledging, or Short Sales by Employees or Directors</I>. Our security trading policy prohibits any employee or director from engaging
in hedging transactions, short sales or trading in any derivative security of the Company. This policy also prohibits pledging our shares on margin. </FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Role of Stockholder Say-on-Pay Votes </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We provide our stockholders
with the opportunity to cast an annual advisory vote on our executive compensation program (referred to as a &#147;say-on-pay vote&#148;). At our annual meeting of stockholders held in June 2014, approximately 99% of the votes cast on the say-on-pay
proposal were voted in favor of the proposal. Over the past two years, we have solicited feedback on our executive compensation program from a substantial majority of our major stockholders. In these discussions, management has reviewed peer group
design, the performance-based equity standards, and our practice of taking into account capitalization adjusted peer company data. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">44 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The stockholders have provided consistent feedback supporting our executive pay program and
this support was affirmed in 2014 with 99% approval of the management say-on-pay proposal in 2014. After considering the 2014 say-on-pay vote, the organization and compensation committee reaffirmed the design and elements of our executive
compensation program and did not make any changes to our executive compensation program in response to the 2014 say-on-pay vote. The board of directors and organization and compensation committee will continue to consider the outcome of our
say-on-pay proposals and direct stockholder feedback when making future compensation decisions for the NEOs. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Design and Elements of Our
Compensation Program </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The material elements of our current executive compensation programs for NEOs consist primarily
of the following: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Base Salary.</I> Each NEO earned an annual base salary during 2014. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Short-Term Incentive Compensation.</I> Each NEO was eligible to earn an incentive cash compensation payment for the 2014 performance period based on a combination of
the Company&#146;s achievement of corporate performance objectives and their individual performance. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Long-Term Incentive Compensation.</I> Each NEO was awarded stock option grants during 2014 (two annual equity grants due to the grant timing transition in 2014),
with 50% of each grant being subject to a rigorous and objective performance-based vesting condition as well as a time-based vesting schedule. </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">While we review peer group company data regarding the mix of current and long-term incentive compensation and between cash and non-cash compensation, we have not adopted any formal policies or guidelines
for allocations among these various compensation elements. However, consistent with our pay for performance philosophy, we believe that a greater component of overall direct compensation for the NEOs relative to other employees should be
performance-based; therefore, the table below shows the percentage of total direct compensation of the NEOs tied to Company and individual performance objectives or linked to the value of our stock price. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Impact of Transition</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Performance-<BR>Based Pay</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2014 Full Year (Transition with Two Annual Grants)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">77%&nbsp;-&nbsp;91%</FONT></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2014 with February Grants Only</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65%&nbsp;-&nbsp;81%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2014 with December Grants Only</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">68%&nbsp;-&nbsp;91%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">45 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As illustrated in the accompanying charts, in 2014, approximately 89% of total direct
compensation to Mr.&nbsp;Robin was performance-based and not guaranteed (approximately 81% or 84% if only February or December grants are taken into consideration, respectively). </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g913905g60i22.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">50% of the stock options granted to Mr.&nbsp;Robin in 2014 were contingent upon achievement of a
performance-based milestone. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Use of Peer Company Data </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We regularly review the compensation practices of our peer group companies identified below in response to the fast moving nature of the biotechnology industry, including merger and acquisition activity,
and changes in product pipeline and business stage.&nbsp;In determining the appropriate peer companies, we consider the following factors: business model, business stage and complexity, therapeutic area similarity, status of the drug candidate
pipeline, manufacturing activity (if any), technology platform, product focus and company size based on the number of employees, revenue and market capitalization. As a result of the Company having a combination of multiple drug candidates in
diverse therapeutic areas (and, in the case of Amikacin Inhale and Cipro DPI, drug candidates based on different technologies), a mix of wholly-owned and partnered drug candidates, a technology platform with the potential to enable multiple drug
candidates in future years, and a significant legacy proprietary manufacturing operation, it is very challenging to identify truly comparable companies. In September 2013, our organization and compensation committee reviewed the composition of our
peer group, with the assistance of its outside compensation consultant, with the objective of more closely aligning the Company&#146;s market capitalization and business model with that of the peer group. As a result of this review, Affymetrix,
Inc., BioMarin Pharmaceutical, Inc., and Onyx Pharmaceuticals, Inc. were removed from the peer group. We also determined that we would replace them with the following companies that were generally smaller than the peers they were replacing: Arena
Pharmaceuticals, Inc., ImmunoGen, Inc., Ironwood Pharmaceuticals, Inc., NPS </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">46 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Pharmaceuticals, Inc. and Questcor Pharmaceuticals, Inc. The peer group of companies considered when determining 2014 compensation decisions consisted of the following companies: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="49%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Acorda Therapeutics, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Alkermes, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Arena Pharmaceuticals, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Auxilium Pharmaceuticals</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Cubist Pharmaceutical Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exelixis, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">ImmunoGen, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ironwood Pharmaceuticals, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Incyte Corporation</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Isis Pharmaceuticals,&nbsp;Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jazz Pharmaceuticals, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">NPS Pharmaceuticals, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Questcor Pharmaceuticals, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Seattle Genetics</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Theravance</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">United
Therapeutics Corp.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Viropharma, Inc.</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In September 2014, the organization and compensation committee also undertook a review of peers, with the
objective of further aligning the Company&#146;s market capitalization and business model with that of the peer group to be used for the 2015 annual compensation decisions scheduled to be made in December 2015. This revised peer group was not used
as part of the December 2014 compensation decisions. As a result of this review, the organization and compensation committee (i)&nbsp;removed Jazz Pharmaceuticals, Inc., United Therapeutics Corp., Exelexis Inc., and Theravance and (ii)&nbsp;added
Ariad Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., Clovis Oncology, Inc., Halozyme Therapeutics, Inc., Infinity Pharmaceuticals, Inc., Medivation, Inc., Puma Biotechnology, Inc., Spectrum Pharmaceuticals, Inc., and Thereavance Biopharma,
Inc. to the peer group. Viropharma and Auxilium Pharmaceuticals were also removed because they were acquired in 2014. The updated peer group of companies that we currently intend to use for 2015 compensation decisions consists of the following
companies: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="49%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Acorda Therapeutics, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Alkermes, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Alnylam Pharmaceuticals, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Arena Pharmaceuticals, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Ariad Pharmaceuticals, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Clovis Oncology, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cubist Pharmaceutical Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Halozyme Therapeutics, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">ImmunoGen, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Incyte Corporation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Infinity Pharmaceuticals, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Ironwood Pharmaceuticals, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Isis Pharmaceuticals,&nbsp;Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Medivation, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">NPS Pharmaceuticals, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Puma Biotechnology, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Questcor Pharmaceuticals, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Seattle Genetics</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Spectrum Pharmaceuticals, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Theravance Biopharma, Inc.</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Given that certain of our peer group companies have larger market capitalizations than the Company, we
also review equity and total direct compensation data for our executives against the compensation for similarly situated executives with the peer companies with the data adjusted for differences in capitalization to help further inform our
decision-making process. Although we reviewed and discussed the compensation data for the peer group companies to help inform executive compensation decisions, we do not set compensation at any specific level or percentile based solely on the peer
group data. The peer group data is used by us as only one reference point taken into account in making compensation decisions. We do not use peer group or industry survey data as a standalone tool for setting compensation due to the unique aspects
of our business and the need to attract and retain particular expert managers with unique experience, skills and other individual facts and circumstances. However, we generally believe that reviewing and analyzing this information is an important
component of our executive compensation decision-making process. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Base Salary </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Base salary is the initial building block of compensation for the NEOs because it provides the executives with a specified minimum level
of cash compensation which we believe is important to attract and retain executives. We determine base salary by considering competitive pay practices, cost of labor and compensation trends, individual performance and promotions, level and scope of
responsibility, experience and internal pay </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">47 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
equity. However, we do not use a formula or assign a particular weight to any one factor. Rather, the determination of base salary levels is subjective, and we set base salaries that we believe
are reasonably competitive. In February 2014, we reviewed the base salaries of the NEOs and increased them by 3.5% to 4.5%. We considered a number of factors in determining Dr.&nbsp;Gergel&#146;s initial base salary as part of his new hire
compensation package, including peer group company data for similar executive roles, the compensation he received at his prior employer, internal pay equity, as well as our evaluation of his relevant skills and experience and the competitive nature
of the market for such skills and experience. The base salary earned by each NEO during 2014 is reported below in the Summary Compensation Table. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Short-Term Incentive Compensation </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Incentive Compensation
Policy.</I> We believe that our short-term incentive compensation program (&#147;Incentive Compensation Policy&#148;) for the NEOs rewards the achievement of important short-term objectives that advance us toward our long-term strategic objectives.
Our Incentive Compensation Policy applies to all employees and all executive officers other than Mr.&nbsp;Robin, who is subject to his own separate annual performance-based bonus compensation arrangement with a combination of corporate and personal
objectives established and evaluated by the organization and compensation committee. However, Mr.&nbsp;Robin&#146;s bonus arrangement for 2014 was based on substantially the same corporate objectives that we established under the Incentive
Compensation Policy. Consistent with our compensation philosophy of paying for performance and maintaining a flexible approach, we use the Incentive Compensation Policy to incent the NEOs to achieve important corporate goals while at the same time
encouraging and rewarding excellent individual performance by recognizing and rewarding differences in performance between individual executives. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Plan Design.</I> The board of directors establishes a small number of important annual corporate goals each year that include clinical development, research, manufacturing, organizational and financial
goals which we believe are essential to building long-term stockholder value and are used to assess annual corporate performance. The relative weightings of these corporate goals are based upon our assessment of the importance of each goal in
creating long-term value for the Company and our stockholders. If we achieve the target level of performance for all of the stated goals, the overall corporate performance rating should be approximately 100%. We endeavor to select corporate goals
that, if met by management, represent significant levels of annual achievement, although we believe the long-term nature of our drug development business does not lend itself to over-weighting the importance of annual goals. Following the conclusion
of the annual performance period, the level of achievement for each corporate goal is assessed by the board of directors. The board determines whether each corporate goal has been met, exceeded, or not satisfied. In addition, in assessing corporate
performance, the determination of corporate performance may be adjusted upward or down-ward as deemed appropriate to factor in other significant corporate events, either negative or positive, that occurred during the performance period. After taking
into account the level of attainment of each corporate goal and such other corporate performance factors as the board may determine appropriate in reviewing performance for a particular year, the board of directors assigns an overall corporate
performance rating for the year, which may range from 0% to 200%. The organization and compensation committee then confirms the corporate performance rating for purposes of the Incentive Compensation Policy. The total available bonus pool under the
Incentive Compensation Policy is determined by multiplying the corporate performance rating by the aggregate target bonus of all eligible participants which includes nearly all of the Company&#146;s full-time employees. The aggregate of all
individual bonuses awarded under the policy cannot exceed the total available bonus pool so that the total cost of bonuses ultimately reflects our assessment of overall performance and is not inflated by the sum of individual performance ratings.
Mr.&nbsp;Robin does not participate in the final selection of the corporate goals or determining the corporate performance rating. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">After the corporate performance rating is determined, the individual performance of each NEO is reviewed by the organization and compensation committee in consultation with Mr.&nbsp;Robin (other than his
own performance) in order to determine the appropriate individual performance percentage rating to be assigned to the executive for the performance period. Mr.&nbsp;Robin&#146;s individual performance is separately reviewed by the
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">48 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
organization and compensation committee. Each NEO&#146;s actual annual bonus is based on a combination of the corporate performance rating and his or her individual performance. The Incentive
Compensation Policy does not provide for a specific allocation or weighting of between corporate and individual performance.&nbsp;The actual annual bonus awarded for each NEO is determined by us in our sole discretion, and the maximum payout for
each NEO, including Mr.&nbsp;Robin, could be up to 200% of his or her annual performance-based compensation target (or, by the same token, an individual executive&#146;s award could be reduced to 0% based on individual performance regardless of the
corporate performance rating). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Target Annual Short-Term Incentive Compensation for 2014.</I> The NEOs were each assigned a
target annual incentive for 2014 ranging from 50% to 75% of base salary, which remained unchanged from the levels established in 2013 for our continuing NEOs. We considered a number of factors in determining Dr.&nbsp;Gergel&#146;s initial target
annual incentive as part of his new hire compensation package, including peer group company data for similar executive roles, the compensation he received at his prior employer, internal pay equity, as well as our evaluation of his relevant skills
and experience and the competitive nature of the market for such skills and experience. The table below shows the target annual incentive assigned by us to each NEO for 2014 both as a dollar amount and as a percentage of base salary. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="67%"></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Annual</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Incentive&nbsp;for</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Annual</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Incentive&nbsp;for</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(%&nbsp;of&nbsp;Base</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Salary)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">646,826</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Nicholson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">272,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen K. Doberstein, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">239,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ivan P. Gergel, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">175,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">264,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Gergel&#146;s 2014 target annual incentive was pro-rated based on his employment start date of May&nbsp;19, 2014. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Company Performance Objectives.</I> The 2014 corporate objectives and relative weightings assigned to each objective were as follows:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">A regulatory objective of achieving FDA approval of MOVANTIK<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&#153;</SUP></FONT> (naloxegol) with certain minimum labeling requirements (25%). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A clinical development objective related to the Phase 3 BEACON (NKTR-102) etirinotecan pegol study (15%). </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A clinical development objective related to the NKTR-181 Phase 3 clinical study design (15%). </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A clinical development objective related to NKTR-171 (10%). </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A research objective related to advancing investigational new drug (&#147;IND&#148;) enabling work (toxicology studies) for certain pre-specified pain drug candidates
(5%). </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A research objective to advance multiple molecules into development candidate status (5%). </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A manufacturing and supply objective related to the Phase 3 clinical studies for BAY41-6551 (Inhaled Amikacin Solution formally known as NKTR-061) (5%).
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A manufacturing objective related to CMC regulatory goals for NKTR-102 (5%). </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A business development objective to complete a new transaction meeting certain strategic criteria (5%). </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A financial objective for year-end cash position of $225 million (10%). </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">49 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">These performance objectives served as the corporate performance objectives under the
Company&#146;s Incentive Compensation Policy and were also used as one data point for purposes of the organization and compensation committee determining Mr.&nbsp;Robin&#146;s 2014 cash bonus. The 2014 corporate objectives were weighted at 100%
allocated as follows: 75% to research and development, 10% to manufacturing, and 15% to financial objectives. This weighting of objectives is a reflection of our long-term focus as a drug development company with the goal of building a broad, robust
and diverse pipeline of proprietary drug candidates.&nbsp;We believe this mix of corporate goals was not only an appropriate measure of achievement in 2014, but also represents objectives important to building the long-term foundation of our
business. A corporate performance rating in excess of 100% can only be achieved if the board of directors determines that the goal achievement for one or many of the goals substantially and qualitatively exceeded the target metrics, or the board
uses its discretion to factor in other significantly positive corporate events that occurred during the performance period. The maximum potential corporate performance rating is 200%. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Actual Annual Incentives Earned for 2014 </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Management prepared a report on status of achievement of the 2014 corporate objectives that was reviewed by the board of directors. The board of directors determined that seven of the corporate goals
identified above were met (including the financial objective), one goal was not met, one was partially met, and one was exceeded resulting in a 95% aggregate quantitative achievement. The board of directors also recognized certain accomplishments
directly related to management efforts including the positive FDA advisory committee vote for MOVANTIK&#153; that resulted in a $35 million milestone bonus and extinguishment of a $70 million contingent liability and the FDA and EC approval of
naloxegol which is the first oral pegylated small molecule medicine to be approved by health authorities. In recognition of these accomplishments, the board concluded a discretionary upward adjustment of 18% was warranted resulting in a corporate
performance rating of 112% for 2014. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The organization and compensation committee, in consultation with Mr.&nbsp;Robin,
determined an individual performance rating for each of the NEOs excluding Mr.&nbsp;Robin, whose performance is determined independently by the organization and compensation committee without his participation. Consistent with standards used to
determine annual incentive awards for all employees and our objective to tie pay to performance, the NEOs are eligible to earn annual bonus awards that exceed the corporate performance rating if their rating is &#147;exceptional&#148; and
&#147;exceeds expectations.&#148; Employees with ratings of &#147;solid performer&#148;, &#147;needs improvement&#148; and &#147;does not meet expectations&#148; received awards below the corporate performance rating level, and in some cases they
received bonuses significantly below that level or no bonus award at all. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We considered a number of performance factors in
determining each executive&#146;s performance rating and associated annual incentive awards, including specific accomplishments of each NEO, the effectiveness of leadership within the NEO&#146;s functional area, the level of his contributions to the
achievement of the corporate objectives, the achievement of certain outcomes that were not corporate objectives but nonetheless important projects at the Company, and the ability to effectively work with other members of the management team.
Although the NEO bonus awards were higher than the 112% corporate performance rating, these bonus awards were substantially consistent with the bonus awards made to participants in the Incentive Compensation Policy who achieved a similar individual
performance rating. The table below includes the actual 2014 bonuses, as a percentage of the target bonus, that we awarded the NEOs for 2014. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="80%"></TD>
<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Actual&nbsp;Bonus</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>as a</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percentage&nbsp;of</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Target&nbsp;Bonus<BR>for&nbsp;Entire<BR>2014&nbsp;Year</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(%)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">175</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Nicholson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen K. Doberstein, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">130</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ivan P. Gergel, M.D.(1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">130</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">50 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Gergel&#146;s 2014 target annual incentive was pro-rated based on his employment start date of May&nbsp;19, 2014. The percentage shown is a percentage of the
pro-rated target bonus (75.8% of the full-year target bonus). </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts of each NEO&#146;s bonuses for the
2014 fiscal year are reported in the Summary Compensation Table. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Long-Term Incentive Compensation: Equity Awards </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Overview.</I> In accordance with our objective of aligning executive compensation with our stockholders&#146; interests, our current
long-term incentive program for the NEOs generally consists of one annual award of equity compensation that is typically subject to a multi-year vesting schedule. We believe that equity compensation is a very effective tool to align the interests of
our NEOs, who have significant responsibility for driving our success, with the interests of our stockholders. Stock options are our preferred form of long-term incentive compensation because we believe they are inherently performance-based with
value delivered only if the price of our common shares appreciates following the grant. As discussed above, in 2014, we transitioned from a February annual grant schedule to a December annual grant schedule. Under the SEC executive compensation
disclosure rules, the February annual grant and the December annual grant are both reported as 2014 compensation even though the February 2014 grant was viewed by the organization and compensation as compensation for 2013 performance and the
December 2014 grant was viewed as compensation for 2014 performance. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Performance-Based Equity Compensation Program</I>. In
2012, we established a performance-based stock option award program for our executive officers. Under this program, 50% of the annual merit stock options granted to our executive officers each year have been made in the form of performance-based
stock option awards that vest based on the standard four-year monthly vesting schedule plus a separate performance condition that must also be achieved before the executive officer is permitted to exercise the performance-based stock option. The
performance condition will be met only if, within five years from the grant date, the Company or one of its collaboration partners files a new drug application or biologics license application with the FDA (or the equivalent new drug registration
with the European Medicines Agency) for any &#147;Proprietary Company Program&#148; which includes any drug candidate that is wholly-owned by the Company (e.g. NKTR-102 or NKTR-181) or where the Company is entitled to an average royalty interest
equal to or greater than 7.5% of net sales. In setting this performance hurdle, the organization and compensation committee believed it would be challenging to achieve and, if achieved, would help create long-term stockholder value. For example,
this performance condition has only been achieved three times in the history of the Company. The remaining 50% of the stock option grants awarded to our executive officers in each year are subject to our standard time-based vesting requirements. At
this point in the Company&#146;s evolution as a drug development company, we believe that the advancement of the late stage drug candidate pipeline remains critical to potential future stockholder value creation. As such, the performance condition
for our 2014 performance-based stock option awards is also based on a future regulatory approval filing with the FDA or EMA for a Proprietary Company Program. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Actual Long-Term Incentives Awarded</I>. The NEOs received an annual equity award in February 2014 in connection
with the 2013 annual performance review. Our view is that the equity awards granted in February 2014 primarily represent compensation earned for performance during the preceding year, even though SEC proxy rules require that the grant date fair
value be included as compensation in the annual period in which the equity grant is awarded (i.e. 2014 instead of 2013 which is differs from the way annual cash bonus awards are categorized even though both compensation awards are made on the same
day). Our independent compensation consultant provided data that indicated that the grant date value of the stock options granted to Mr.&nbsp;Robin in February 2014 were approximately at the
24</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile against the unadjusted median for chief
executive officers of our peer group and slightly below the median of our peer group after adjusting for market capitalization as described below. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In June 2014, the organization and compensation committee determined to make the annual merit date effective January&nbsp;1 to make the process consistent with the fiscal and other planning cycles, and to
enable </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">51 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">
management to start the year with clear focus on objectives and initiate goal setting in January rather than the end of the first quarter. Further, since equity compensation is the largest part
of our NEOs&#146; annual compensation, granting awards at the end of the year allowed more timely consideration of stockholders&#146; &#147;say-on-pay&#148; feedback and by changing the timing of equity award grants to near the end of the fiscal
year, the equity award amounts are more closely aligned with performance for the fiscal year in which the awards are granted and with the feedback provided by stockholders through the advisory vote. As a result, the organization and compensation
committee moved up the compensation recommendations related to the 2014 year, including equity grants, to December 2014 (i.e., before fiscal year-end) so that the awards would correspond more closely with our year-end performance review process.
Therefore, a second annual grant was made in December 2014 relating to the 2014 annual performance review process. Our independent compensation consultant provided data that indicated that the grant date value of the stock options granted to
Mr.&nbsp;Robin in December 2014 approximated the 45</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
percentile of the unadjusted median for chief executive officers of our peer group and were slightly below median of our peer group after adjusting for capitalization as described above. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In determining the grant levels for these awards, we consider a number of factors including an assessment of individual performance,
competitive market practices, the number of unvested stock options held by the executive and average exercise price (i.e. the retention value) of these options, the individual&#146;s overall contributions, and stockholder dilution. However, we do
not use a formula or assign a particular weight to any one factor in determining equity award levels. Rather, the determination of equity grant levels is subjective, and the organization and compensation committee awards equity grants at levels it
believes in its judgment are reasonably competitive and consistent with our philosophy that a substantial portion of our executives&#146; compensation should be performance-based and help to further link the interests of our executives with those of
our stockholders. These annual stock option awards vest monthly over a period of four years and thus provide a retention incentive for the executive as well as an additional incentive to help create value for our stockholders. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We also granted a stock option award to Dr.&nbsp;Gergel in connection with his hiring in May 2014. We determined the size of
Dr.&nbsp;Gergel&#146;s stock option grant during the process of negotiating his overall compensation package and creating a sufficient long-term incentive package to secure his skills and experience in building and managing development
organizations. Consistent with market practice, the size of the new hire stock option grant is larger than the anticipated annual award levels. This initial new hire stock option grant vests over four years with 25% of the stock option vesting on
the one year anniversary of Dr.&nbsp;Gergel&#146;s employment start date and the remainder vesting monthly over the following three years. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The number of shares of common stock subject to stock options granted to each NEO during 2014 and the grant-date fair value of these equity awards is presented in the Grants of Plan Based Awards in 2014
table below. A description of the material terms of the 2014 stock option awards is presented in the narrative section following that table. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Severance and Change of Control Benefits </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If the employment of an NEO is terminated by us without cause or by the executive for a designated good reason outside of the context of a change of control transaction, the executive would be entitled to
severance benefits under the executive&#146;s agreements with the Company. These severance benefits include a cash severance payment based on the executive&#146;s then current base salary and the amount of his or her target annual incentive bonus,
payment of COBRA premiums for one year, and an additional 12 month period to exercise vested options (an 18 month period for Mr.&nbsp;Robin).&nbsp;In order to attract and retain these NEOs in a competitive environment for highly skilled senior
executive talent in the biotechnology and pharmaceutical industry and to provide an incentive to obtain a broad release of claims in favor of the Company, we determined it was necessary to offer each of them severance benefits in the case of a
termination without cause or constructive termination outside the context of a change of control transaction. Many of our peer companies provide severance benefits for similar types of terminations of employment, and we believe that it is important
for us to offer these severance benefits in order to continue to provide a competitive total compensation program. These NEOs would also be entitled to certain termination benefits upon a termination of employment because of death or disability.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">52 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We also maintain a Change of Control Severance Benefit Plan (the &#147;CIC Plan&#148;) that
provides the NEOs with certain severance benefits if their employment is terminated in connection with a change of control. The CIC Plan was originally established in 2006, and no amendments have been made to the plan since that time that would
increase the severance benefits available under the CIC Plan. Severance benefits under the CIC Plan are structured on a &#147;double-trigger&#148; basis, meaning that the executive must experience a termination without cause or resign for a
specifically defined good reason in connection with the change of control in order for severance benefits to become payable under the CIC Plan. Like the severance benefits under the letter agreements, we believe that these change of control
severance benefits are an important element of a competitive total compensation program. Additionally, we believe that providing change of control benefits should eliminate, or at least reduce, any reluctance of our NEOs and other key employees
covered by the CIC Plan to diligently consider and pursue potential change of control opportunities that may be in the best interests of our stockholders. At the same time, by providing change of control benefits only upon the occurrence of an
additional triggering event occurring in connection with the change of control transaction resulting in a job loss, we believe that this CIC Plan helps preserve the value of our key personnel for any potential acquiring company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the CIC Plan, the executive would be entitled to accelerated equity award vesting upon a termination described above. The other
severance benefits under the CIC Plan are generally similar to the severance benefits described above; however Mr.&nbsp;Robin&#146;s cash severance would cover the two-year period following termination and Company-paid COBRA coverage would be
eighteen months. Outplacement services received within twelve months following separation, up to a maximum of $5,000, are provided to all participants. In addition, each of the NEOs would be entitled to full equity vesting and, except for
Drs.&nbsp;Doberstein and Gergel, a &#147;gross up&#148; payment for any excise taxes imposed under Section&nbsp;4999 of the Internal Revenue Code once a 10% cutback threshold is exceeded. The excise tax gross-up was included in the CIC Plan as
originally adopted in 2006 to make the participants whole for any adverse tax consequences to which they may become subject under Section&nbsp;4999 of the Internal Revenue Code and to avoid unintended differences in net severance based on individual
factors like the date of hire and past option exercise decisions, which preserves the level of change of control severance protections that we have determined to be appropriate.&nbsp;At the time the CIC Plan was established, we believed this excise
tax gross-up protection was a reasonable part of a competitive total compensation package and generally consistent with industry practice at the time. On April&nbsp;5, 2011, the board of directors amended the CIC Plan to eliminate any &#147;gross
up&#148; payments for any excise taxes imposed under Section&nbsp;4999 of the Internal Revenue Code for participants who became eligible to participate in the CIC Plan on or after January&nbsp;1, 2010. The board of directors decided to eliminate
this tax gross-up provision under the plan for new participants based on its review of current industry practices. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
&#147;Potential Payments Upon Termination or Change of Control&#148; section below describes and quantifies the severance and other benefits potentially payable to the NEOs. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Other Benefits </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe that establishing competitive benefit
packages for employees is an important factor in attracting and retaining highly-qualified personnel, including the NEOs. The NEOs are eligible to participate in all of our employee benefit plans, such as medical, dental, vision, group life,
disability insurance, commuting benefits, employee stock purchase plan and the 401(k) plan, in each case generally on the same basis as other employees. We do not offer a tax-qualified defined-benefit pension plan or any non-qualified defined
benefit retirement plans, nor do we provide material perquisites to our executives. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Section&nbsp;162(m) Policy </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section&nbsp;162(m) of the U.S. Internal Revenue Code limits our deduction for federal income tax purposes to $1 million of compensation
paid to certain NEOs in a taxable year. Compensation above $1 million may be deducted if it is &#147;performance-based compensation&#148; within the meaning of Section&nbsp;162(m). While we consider
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">53 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
the compensation limits of Section&nbsp;162(m) when designing our executive compensation programs, we reserve discretion to grant compensation that may not be deductible under the
Section&nbsp;162(m) limits in situations where we have determined the compensation to be appropriate to satisfy our compensation and other objectives. We intend to continue to evaluate the effects of the compensation limits of Section&nbsp;162(m)
and to grant compensation awards in the future in a manner we believe is consistent with the best interests of our Company and stockholders. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">54 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_25"></A>C<SMALL>OMPENSATION</SMALL> C<SMALL>OMMITTEE</SMALL>
R<SMALL>EPORT</SMALL> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>The material in this report is being furnished and shall not be deemed &#147;filed&#148; with
the SEC for purposes of Section&nbsp;18 of the Exchange Act or otherwise subject to the liability of that section, nor shall the material in this section be deemed to be &#147;soliciting material&#148; or incorporated by reference in any
registration statement or other document filed with the SEC under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), or the Exchange Act, except as otherwise expressly stated in such filing. </I></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The organization and compensation committee has reviewed the Compensation Discussion and Analysis and discussed it with management. Based
on its review and discussions with management, the committee recommended to our board of directors that the Compensation Discussion and Analysis be included in our annual report on Form 10-K for the fiscal year ended December&nbsp;31, 2014 and in
our 2014 proxy statement. This report is provided by the following independent directors, who currently comprise the committee: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lutz
Lingnau&#151;Chairman </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">R. Scott Greer </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Joseph J. Krivulka </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher A. Kuebler
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">55 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_26"></A>S<SMALL>UMMARY</SMALL> C<SMALL>OMPENSATION</SMALL>
T<SMALL>ABLE</SMALL>&#151;F<SMALL>ISCAL</SMALL> 2012-2014 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table shows, for the fiscal year ended
December&nbsp;31, 2014, compensation awarded to or earned by our Chief Executive Officer, our Chief Financial Officer and our other three most highly compensated executive officers who were serving as executive officers on December&nbsp;31, 2014
(the &#147;NEOs&#148;). To the extent any NEOs were also named executive officers for the fiscal years ended December&nbsp;31, 2013 or December&nbsp;31, 2012, compensation information for our 2013 and 2012 fiscal years is also presented for such
executives. As discussed above, in 2014 the Company moved the timing of its annual equity grant from February to December. The effect of this one-time change in grant timing is that two annual grants were awarded in fiscal 2014. The Company views
the two annual grants in 2014 as discrete annual grants relating to two separate annual performance periods in 2013 and 2014, rather than as a combined basket of equity compensation for 2014. If only the value of the February 2014 stock option grant
were included, Mr.&nbsp;Robin&#146;s total compensation would have been $4,692,587, and if only the value of his December 2014 stock option grant were included, Mr.&nbsp;Robin&#146;s total compensation would have been $5,350,622. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Principal Position</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:97pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year<BR>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary<BR>($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Bonus<BR>($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards<BR>($)</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Awards<BR>($)(1)(2)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(f)</B></FONT>
</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Non-Equity<BR>Incentive Plan<BR>Compensation<BR>($)(3)</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(g)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All
Other<BR>Compensation<BR>($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(i)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total ($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(j)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Howard W. Robin</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>860,004</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6,022,755</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,131,945</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>18,279</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(4)&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8,032,982</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>President and Chief<BR></B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Executive Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2013</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>831,247</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,067,165</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>656,200</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>15,039</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3,569,652</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2012</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>807,196</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>500</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,510,160</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>910,125</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>14,351</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3,242,332</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>John Nicholson</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>542,458</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,342,183</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>408,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>12,854</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(5)&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3,305,495</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Senior Vice President and<BR></B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Chief Financial Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2013</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>524,264</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>849,835</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>276,000</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>12,112</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,662,210</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2012</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>509,529</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>500</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>377,540</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>357,000</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>12,225</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,256,794</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Stephen K. Doberstein</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>477,583</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,338,390</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>311,350</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>11,804</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(6)&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,139,128</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Senior Vice President and<BR></B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Chief Scientific Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2013</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>459,722</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>459,370</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>231,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>9,513</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,159,605</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2012</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>433,605</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>377,540</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>260,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>9,613</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,080,758</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Ivan P. Gergel(7)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>372,728</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3,610,890</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>227,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,133</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(8)&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4,213,251</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Senior Vice President and<BR></B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Chief Medical Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Gil M. Labrucherie</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>526,125</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,312,379</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>396,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8,354</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(9)&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3,242,858</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Senior Vice President and<BR></B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>General Counsel</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2013</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>504,195</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>689,055</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>278,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7,238</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,478,488</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2012</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>488,270</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>566,310</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>330,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6,503</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,391,083</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts reported represent the aggregate grant date fair value of awards granted in the applicable year computed in accordance with FASB ASC Topic 718, which excludes
the effects of estimated forfeitures. For a complete description of the assumptions made in determining the valuation, please refer to (i)&nbsp;Note 11 (Stock-Based Compensation) to our audited financial statements in our annual report on Form 10-K
for the fiscal year ended December&nbsp;31, 2014 and (ii)&nbsp;similar footnotes to our audited financial statements in our annual reports on Form 10-K for prior years when the awards were granted. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">As noted in the Compensation Discussion and Analysis above, certain options granted to the NEOs in 2012, 2013 and 2014 were performance-based and vest only to the
extent a specified performance-based vesting condition is satisfied during the performance period. If the performance-based vesting condition is satisfied, then the performance-based stock options also remain subject to time-based vesting
requirements. The amounts reported in the &#147;Option Awards&#148; column of the table for 2012, 2013 and 2014 above include the grant date fair value of these performance-based stock options based on the probable outcome (determined as of the
grant date in accordance with applicable accounting rules) of the performance-based conditions applicable to the awards. The probable grant date fair value for these awards was determined assuming that the underlying performance-based vesting
condition would be achieved. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">56 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts reported for 2014 include grants related to the 2013 performance year awarded in February 2014 for Messrs. Robin, Nicholson, Doberstein and Labrucherie; grants
related to the 2014 performance year awarded in December 2014 for all NEOs; and new-hire grants awarded in May 2014 to Dr.&nbsp;Gergel. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts reported for 2012, 2013 and 2014 represent amounts earned under the Incentive Compensation Policy for that year or, for Mr.&nbsp;Robin, under his amended and
restated offer letter effective as of December&nbsp;1, 2008. As noted in the &#147;Compensation Discussion and Analysis&#148; above, Mr.&nbsp;Robin&#146;s annual bonus opportunity for 2014 was similar in structure to the bonus opportunities for the
other NEOs under the Incentive Compensation Policy. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;life insurance premiums of $13,851, (ii)&nbsp;a $3,000 contribution to the Company&#146;s 401(k) plan, and (iii)&nbsp;$1,428 for parking.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;life insurance premiums of $9,854, and (ii)&nbsp;a $3,000 contribution to the Company&#146;s 401(k) plan. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;life insurance premiums of $6,042, (ii)&nbsp;a $3,000 contribution to the Company&#146;s 401(k), (iii)&nbsp;$2,462 for parking and $50 for a tax gross
up on parking, and (iv)&nbsp;a $250 public transit match. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Gergel&#146;s first day of employment with the Company was May&nbsp;19, 2014. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes life insurance premiums of $2,133. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;life insurance premiums of $1,590, (ii)&nbsp;a $3,000 contribution to the Company&#146;s 401(k), (iii)&nbsp;$2,885 for parking and $114 for a tax
gross up on parking, (iv)&nbsp;a $600 public transit match, and (v)&nbsp;
a $165 public transit pass. </FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_27"></A>Description of Employment Agreements </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each of the NEOs has entered into our standard form of employment agreement and an offer letter or letter agreement. The form of
employment agreement provides for protective covenants with respect to confidential information, intellectual property and assignment of inventions and also sets forth other standard terms and conditions of employment. The offer letter entered into
by Messrs. Robin, Nicholson, and Drs.&nbsp;Doberstein and Gergel provide for a minimum base salary and target annual short-term incentive compensation amounts, as well as other additional terms and conditions of employment. Each of these letters
specifies an initial base salary that may be increased in our discretion, but which may not be decreased. The base salary level as of 31&nbsp;December, 2014 for Mr.&nbsp;Robin was $862,434, for Mr.&nbsp;Nicholson was $544,000 and for
Dr.&nbsp;Doberstein was $479,000 and for Dr.&nbsp;Gergel was $600,000. Under the offer letter agreements, Mr.&nbsp;Robin&#146;s annual target bonus is 65%, but has since been increased to 75% of his base salary, and the minimum target bonus levels
for Mr.&nbsp;Nicholson and Drs.&nbsp;Doberstein and Gergel is 50% of the executive&#146;s base salary. The offer letter agreements do not provide for any minimum or guaranteed term of employment. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The letter agreements entered into by each of the NEOs establish the compensation arrangements following separation from us under certain
circumstances. Please see &#147;Potential Payments upon Termination or Change in Control&#148; below for more information on these separation arrangements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">57 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_28"></A>GRANTS OF PLAN BASED AWARDS IN 2014 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table shows, for the fiscal year ended December&nbsp;31, 2014, certain information regarding grants of plan-based awards to
the NEOs. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="78%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:20pt"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant<BR>Date<BR>(b)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" STYLE="border-bottom:1px solid #000000"> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated Possible Payouts<BR>Under Non-Equity<BR>Incentive Plan Awards(1)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated Future Payouts<BR>Under Equity<BR>Incentive Plan Awards(2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All&nbsp;Other<BR>Stock<BR>Awards:<BR>Number<BR>of&nbsp;Shares<BR>of Stock<BR>or
Units<BR>(#)<BR>(i)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All&nbsp;Other<BR>Option<BR>Awards:<BR>Number
of<BR>Securities<BR>Underlying<BR>Options<BR>(#)(3)<BR>(j)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise<BR>or&nbsp;Base<BR>Price&nbsp;of<BR>Option<BR>Awards<BR>($/sh)<BR>(k)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant&nbsp;Date<BR>Fair Value<BR>of
Stock<BR>and&nbsp;Option<BR>Awards<BR>($)(4)<BR>(l)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Threshold<BR>($)<BR>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target<BR>($)<BR>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Maximum<BR>($)<BR>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Threshold<BR>(#)<BR>(f)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target<BR>(#)<BR>(g)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Maximum<BR>(#)<BR>(h)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Howard W. Robin</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual Incentive Award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>646,826</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1,293,652</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2/5/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>225,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12.43</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1,341,180</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2/5/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>225,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12.43</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1,341,180</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/9/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>225,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>16.305</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1,670,198</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/9/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>225,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>16.305</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1,670,198</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>John Nicholson</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual Incentive Award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>272,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>544,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2/5/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>87,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12.43</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>521,570</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2/5/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>87,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12.43</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>521,570</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/9/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>87,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>16.305</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>649,521</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/9/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>87,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>16.305</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>649,521</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stephen K. Doberstein, Ph.D.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual Incentive Award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>239,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>479,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2/5/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>50,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12.43</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>298,040</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2/5/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>50,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12.43</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>298,040</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/9/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>50,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>16.305</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>371,155</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/9/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>50,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>16.305</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>371,155</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Ivan P. Gergel, M.D.(5)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual Incentive Award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>175,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>350,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>5/19/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>36,248</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>11.035</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>189,055</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>5/19/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>513,752</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>11.035</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2,679,525</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/9/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>50,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>16.305</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>371,155</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/9/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>50,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>16.305</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>371,155</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Gil M. Labrucherie</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual Incentive Award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>264,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>528,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2/5/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>85,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12.43</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>506,668</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2/5/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>85,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12.43</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>506,668</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/9/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>87,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>16.305</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>649,521</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/9/2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>87,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>16.305</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>649,521</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Amounts reported represent the potential short-term incentive compensation amounts payable for our 2014 fiscal year under our Incentive Compensation Policy (or for
Mr.&nbsp;Robin, the potential amounts payable under his offer letter). The amounts reported represent each NEO&#146;s target and maximum possible payments for the entire 2014 calendar year Because actual payments to the NEOs could range from 0% to
200% of their target bonus, no threshold payment amount has been established for the NEOs. The actual short-term incentive bonus amount earned by each NEO for 2014 is reported in Column (g)&nbsp;(Non-Equity Incentive Plan Compensation) of the
Summary Compensation Table above. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">These grants are subject to both a 4-year time-based vesting requirement and the achievement of specified performance criteria. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">These grants are subject to a 4-year time-based vesting requirement. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Refer to Note 11 (Stock-Based Compensation) to our audited financial statements in our annual report on Form 10-K for the fiscal year ended December&nbsp;31, 2014 for
the relevant assumptions used to determine the grant date fair value of the stock options granted during 2014. The amounts reflected in this column for stock options granted during 2014 that are subject to performance-based vesting conditions
represent the grant date fair value of these awards based on the probable outcome (determined as of the grant date in accordance with applicable accounting rules) of the performance-based conditions applicable to the awards.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Dr.&nbsp;Gergel&#146;s Target Annual Incentive Award opportunity for 2014 of $300,000 was pro-rated based on his employment start date of May&nbsp;19, 2014.
</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">58 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Description of Plan-Based Awards </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stock Options.</I> Each stock option granted to the NEOs during 2014 may be exercised to purchase the designated number of shares of
our common stock at an exercise price equal to the closing price of the underlying common stock on the grant date. During 2014, the NEOs were granted only non-qualified stock options, except for a portion of Dr.&nbsp;Gergel&#146;s new hire grant
which was incentive stock options. Each NEO&#146;s stock option award granted in 2014 has a maximum term of eight years and is subject to a vesting schedule that requires the executive&#146;s continued service through the vesting date. For the stock
option awards granted to NEOs in February 2014 as part of the annual performance and compensation review for 2013, and in December 2014 as part of the annual performance and compensation review process for 2014, 50% of the options granted will vest
and become exercisable on a monthly pro-rata basis over a four-year period following the grant date, and 50% of the options granted will vest and become exercisable after achievement of specified performance criteria described further below as well
as also being subject to vesting on a monthly pro-rata basis over a four-year period following the grant date. Stock option awards granted to Dr.&nbsp;Gergel during 2014 in connection with his hire also generally vest and become exercisable on a
monthly pro-rata basis over a four-year period; however the first 25% of the shares subject to the stock option &#147;cliff vests&#148; on the first anniversary of the grant date and the remaining shares subject to the stock option vests in
substantially equal monthly installments over the following three years. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under our performance-based stock option award
program for our executive officers, 50% of the stock options granted to our executive officers in February 2014 and December 2014 were made in the form of performance-based stock option awards that vest based on the standard four-year monthly
time-based vesting plus a separate performance condition that must also be achieved before the executive officer is permitted to exercise the performance-based stock option. The performance condition will be met only if within five years from the
grant date, the Company or one of its collaboration partners files a new drug application or biologics license application with the FDA (or the equivalent new drug registration with the EMA) for any &#147;Proprietary Company Program&#148; which is
defined to include any drug candidate that is wholly-owned by the Company (e.g. NKTR-102 or NKTR-181) or where the Company is entitled to an average royalty interest equal to or greater than 7.5% of net sales. In January 2015, the FDA accepted the
BLA for Baxter&#146;s BAX855. This regulatory filing acceptance met the performance condition for the 2014 performance equity grants, which are now only subject to the standard four-year monthly vesting schedule from the date of grant. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Any stock options that are unvested upon an NEO&#146;s termination of continuous employment or services will be forfeited without any
value, unless the termination of continuous service is a result of death, in which event, subject to any restrictions in the stock option agreement or equity incentive plan, the option would become fully vested and exercisable as of the date of
termination. For Messrs. Robin, Nicholson and Drs.&nbsp;Doberstein and Gergel, in accordance with their letter agreements if any stock options that are unvested upon a termination of continuous employment as a result of a disability, 50% of the
unvested options would become fully vested and exercisable as of the date of termination. In accordance with the letter agreements for the NEOs described above, any stock options that are vested upon termination of continuous service by us without
cause or by the executive for a good reason resignation (as defined in the CIC Plan) will generally remain outstanding and exercisable for 12 months following termination (18 months for Mr.&nbsp;Robin). This exercise period is also 12 months if the
termination of employment or continuous services is because of disability and is 18 months if the termination is a result of death. We also have the discretion to extend the applicable exercise period in connection with other terminations of
employment. Any vested options that are not exercised within the applicable post-termination of employment exercise period will terminate. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Under the terms of the 2012 Equity Incentive Plan, if there is a change in control of the Company, outstanding awards granted under the plan will generally become fully vested and, in the case of options,
exercisable, unless the organization and compensation committee provides for the substitution, assumption, exchange or other continuation of the outstanding awards. Any options that become vested in connection with a change in control generally must
be exercised prior to the change in control, or they will be cancelled in exchange for the right to receive a cash payment in connection with the change in control transaction. In addition, </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">59 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
outstanding awards held by our NEOs may vest, upon certain terminations of the NEO&#146;s employment without cause or for a good reason resignation in connection with a change of control and in
connection with terminations of employment resulting from disability or death. Please see the &#147;Potential Payments Upon Termination or Change of Control&#148; section below for a description of the vesting that may occur in such circumstances.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each NEO&#146;s stock option award was granted under, and is subject to the terms of, the 2012 Equity Incentive Plan. The
plans are administered by the organization and compensation committee, and this committee has the ability to interpret and make all required determinations under the plans. This authority includes making required proportionate adjustments to
outstanding stock options to reflect certain corporate transactions and making provision to ensure that participants satisfy any required withholding taxes. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The NEOs are not entitled to any dividend equivalent rights on their stock option awards, and stock option awards are generally only transferable to a beneficiary of an NEO upon his death. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Short-Term Incentive Compensation.</I> All of the NEOs were eligible to earn a short-term incentive compensation payment under the
Incentive Compensation Policy or, for Mr.&nbsp;Robin, under an arrangement that mirrors the Incentive Compensation Policy. These opportunities are reflected in the &#147;Estimated Possible Payouts Under Non-Equity Incentive Plan Awards&#148; columns
of the table above. Please see &#147;Compensation Discussion and Analysis&#151;Current Executive Compensation Program Elements&#151;Short-Term Incentive Compensation&#148; for a description of the material terms of the Incentive Compensation Policy
and Mr.&nbsp;Robin&#146;s related short-term incentive compensation arrangement. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">60 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_29"></A>OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END FOR 2014
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table includes certain information with respect to the value of all unexercised options previously awarded
to the NEOs as of December&nbsp;31, 2014. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant<BR>Date</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(b)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Exercisable<BR>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Unexercisable<BR>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number
of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Unearned<BR>Options<BR>(#)(1)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(e)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Exercise<BR>Price<BR>($)</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(f)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Expiration<BR>Date</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(2)</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(g)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Howard W. Robin</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/21/2007</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">350,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.98</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/20/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/25/2008</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">400,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.46</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/24/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">525,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4.65</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/22/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/1/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">500,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11.34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/31/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">287,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10.69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">141,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">58,334</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">141,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">58,334</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">103,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">121,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">103,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">121,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">46,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">178,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/4/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">225,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/4/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/9/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">225,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16.305</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/8/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/9/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">225,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16.305</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/8/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>John Nicholson</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/2/2007</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">45,092</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.87</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/1/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/2/2007</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">154,908</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.87</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/1/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/21/2007</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.98</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/20/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/25/2008</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">85,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.46</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/24/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">120,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4.65</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/22/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/10/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/9/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11/18/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9.24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11/17/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/1/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">120,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11.34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/1/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">60,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10.69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">35,416</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14,584</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">35,416</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14,584</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">42,395</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,105</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">42,395</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,105</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">18,229</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">69,271</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/4/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">87,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/4/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/9/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">87,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16.305</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/8/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/9/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">87,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16.305</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/8/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stephen K. Doberstein, Ph.D.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/6/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">540,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9.53</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/5/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">57,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10.69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">35,416</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14,584</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">35,416</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14,584</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">22,916</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">27,084</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">22,916</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">27,084</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,416</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">39,584</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/4/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/4/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/9/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16.305</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/8/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/9/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16.305</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/8/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Ivan P. Gergel, M.D.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5/19/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">36,248</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11.035</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5/18/22</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5/19/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">513,752</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11.035</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5/18/22</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/9/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16.305</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/8/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/9/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16.305</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/8/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">61 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant<BR>Date</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(b)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Exercisable<BR>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Unexercisable<BR>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number
of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Unearned<BR>Options<BR>(#)(1)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(e)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Exercise<BR>Price<BR>($)</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(f)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Expiration<BR>Date</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(2)</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(g)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Gil M. Labrucherie</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/21/2007</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">200,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.98</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/20/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/25/2008</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.46</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/24/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/10/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">175,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/9/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11/18/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9.24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11/17/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/1/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">120,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11.34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/31/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">86,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10.69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">53,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">21,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">53,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">21,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">34,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">40,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">34,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">40,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">17,708</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">67,292</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/4/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">85,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/4/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/9/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">87,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16.305</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/8/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/9/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">87,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16.305</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/8/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Options subject to achievement of specified performance criteria. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">For all NEOs, the expiration date shown is the normal expiration date occurring on the eighth anniversary of the grant date, which is the latest date that the options
may be exercised. Options may terminate earlier in certain circumstances, such as in connection with a NEO&#146;s termination of employment or in connection with certain corporate transactions, including a change of control.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Options vest over a four year period, with the first 25% of the options vesting one year from the date of grant and the remaining portion of the options vesting
pro-rata on a monthly basis over the following three years. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Options vest pro-rata on a monthly basis over a period of four years from the date of grant. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Options vest upon achievement of specified performance criteria, and additionally once the applicable performance goal has been achieved, will vest pro-rata on a
monthly basis over a period of four years from the date of grant. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">62 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_30"></A>OPTION EXERCISES AND STOCK VESTED IN 2014 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table includes certain information with respect to the exercise of stock options by the NEOs during the fiscal year ended
December&nbsp;31, 2014. None of our NEOs acquired any shares during 2014 upon the vesting of any stock awards held by the NEOs. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="42%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:20pt"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of<BR>Shares<BR>Acquired<BR>on&nbsp;Exercise&nbsp;(#)<BR>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value&nbsp;Realized<BR>on&nbsp;Exercise&nbsp;($)<BR>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of<BR>Shares<BR>Acquired&nbsp;on<BR>Vesting (#)<BR>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value&nbsp;Realized<BR>on&nbsp;Vesting ($)<BR>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Howard W. Robin</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">950,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,944,999</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>John Nicholson</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Stephen K. Doberstein, Ph.D.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Ivan P. Gergel, M.D.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Gil M. Labrucherie</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">140,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,528,605</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_31"></A>POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE OF CONTROL </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following section describes the benefits that may become payable to the NEOs in connection with their termination of employment with
us or in connection with a change of control. Please see &#147;Compensation Discussion and Analysis&#151;Severance and Change of Control Benefits&#148; for a discussion of how the payments and benefits presented below were determined. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Severance Benefits&#151;No Change of Control </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Each of the NEOs is a party to certain letter agreements and our standard form executive employment agreement, and these agreements include provisions for severance benefits upon certain terminations of
employment that are not related to a change of control. Upon a termination of employment by us without cause or by the executive for a good reason resignation (as defined in the CIC Plan and described below), the executive would be entitled to the
following severance benefits: (i)&nbsp;a cash severance payment equal to his or her total annual cash compensation target (including base salary and the target value of his or her annual incentive bonus, as such bonus target may be adjusted downward
to take into account our performance through the fiscal quarter preceding termination), (ii)&nbsp;an extension of the exercise period for the vested and unexercised portion of all outstanding stock options held by him or her for up to 12 months (18
months for Mr.&nbsp;Robin) following termination and (iii)&nbsp;payment of all applicable COBRA premiums for the executive for up to one year following the termination date. In order to receive the severance benefits described above, each executive
must first execute an effective waiver and release of claims in favor of us. Each executive&#146;s cash severance payment would ordinarily be paid in a lump-sum within 60 days following the executive&#146;s separation from service, although payment
will be delayed to the extent required to comply with Section&nbsp;409A of the Internal Revenue Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If a NEO&#146;s
employment with us terminates due to death, the executive&#146;s outstanding unvested stock options will become fully vested and will be exercisable for up to 18 months following termination pursuant to the terms of the Company&#146;s equity
incentive compensation plans. In addition, in the case of Messrs. Robin, Nicholson and Drs.&nbsp;Doberstein and Gergel, the executive&#146;s estate would be entitled to a pro-rata portion of the target annual incentive bonus for the year in which
his death occurred. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If a NEO terminates employment with us as a result of disability, vested options will be exercisable for
up to twelve months following termination pursuant to the terms of the Company&#146;s stock option agreement. Each NEO is entitled to have 100% of his stock options become fully vested upon disability for all outstanding stock options other than
those under the 2012 Plan. For Messrs. Robin, Nicholson and Drs.&nbsp;Doberstein and Gergel, they are each also entitled to have 50% of outstanding unvested stock options become fully vested upon disability for
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">63 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
stock options under the 2012 Plan in accordance with the terms and conditions of their letter agreements. In addition, pursuant to their offer letter agreements, Messrs. Robin, Nicholson and
Drs.&nbsp;Doberstein and Gergel would each be entitled to receive a pro-rata portion of the executive&#146;s target annual incentive bonus for the year of termination in the event of a disability. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to our standard form employment agreement, following a termination of employment, each NEO will be subject to an indefinite
restriction on the disclosure of our confidential information and a one-year non-solicitation restriction covering our customers and employees. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following table lists the estimated amounts that would become payable to each of the NEOs under the circumstances described above, assuming that the applicable triggering event occurred on
December&nbsp;31, 2014. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="53%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Executive &amp;</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:58pt"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Triggering Event</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value&nbsp;of&nbsp;Cash<BR>Severance<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value&nbsp;of<BR>COBRA<BR>Benefits<BR>($)(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value of<BR>Vesting<BR>Acceleration<BR>($)(2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value of<BR>Pro-Rata<BR>Bonus<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Total<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Howard W. Robin</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Without Cause or Good Reason</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,509,260</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>30,693</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,539,953</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Disability</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,457,637</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>646,826</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3,104,463</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Death</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3,887,971</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>646,826</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4,534,797</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>John Nicholson</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Without Cause or Good Reason</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>816,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>24,501</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>840,501</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Disability</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,108,553</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>272,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,380,553</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Death</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,684,900</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>272,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,956,900</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Stephen K. Doberstein, Ph. D.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Without Cause or Good Reason</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>718,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>21,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>740,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Disability</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,020,462</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>239,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,259,962</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Death</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,339,436</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>239,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,578,936</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Ivan P. Gergel, M.D.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Without Cause or Good Reason</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>900,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>34,915</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>934,915</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Disability</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,343,774</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>175,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,518,774</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Death</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,687,548</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>175,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,862,548</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Gil M. Labrucherie</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Without Cause or Good Reason</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>792,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>30,693</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>822,693</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Disability</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>380,725</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>380,725</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Death</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,392,636</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,392,636</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The value of COBRA benefits are based upon actual rates that were in place effective as of December 2014. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">For purposes of this table, we have assumed that (i)&nbsp;the price per share of our common stock is equal to the closing price per share on the last trading day of the
fiscal year ended December&nbsp;31, 2014 ($15.50), and (ii)&nbsp;the value of any stock options that may be accelerated is equal to the full value of such awards on that date (i.e., the full &#147;spread&#148; value for stock options). No value is
attributed to any stock options with an exercise price greater than or equal to $15.50. </FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Severance Benefits&#151;Change of
Control </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each of the NEOs is covered under the CIC Plan. The CIC Plan provides for certain severance benefits to these
executives and our other employees covered by the plan upon certain terminations of employment occurring in connection with a change of control of us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If a change of control of the Company occurs, each NEO will be entitled to severance benefits under the CIC Plan if the executive&#146;s employment is terminated by us or a successor company without cause
or by the </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">64 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
executive for a good reason resignation, in each case within a period generally beginning on the date the agreement providing for a change of control is executed and ending twelve months
following the change of control. Severance benefits under the CIC Plan include: (i)&nbsp;a cash severance payment equal to 12 months of base salary (24 months for Mr.&nbsp;Robin) and the target value of the executive&#146;s annual incentive bonus,
(ii)&nbsp;payment by us of the same portion of the executive&#146;s COBRA premiums as we pay for active employees&#146; group health coverage for up to 12 months (18 months for Mr.&nbsp;Robin) following termination, (iii)&nbsp;provision of up to
$5,000 for outplacement services received within 12 months following termination, (iv)&nbsp;accelerated vesting of all outstanding stock options and other outstanding equity awards; and (v)&nbsp;other than in the case of Drs.&nbsp;Doberstein and
Gergel, a &#147;gross up&#148; payment to compensate the executive for excise taxes (if any) on payments that are considered &#147;parachute payments&#148; under Section&nbsp;280G of the Internal Revenue Code (the &#147;Code&#148;) and therefore
subject to an excise tax imposed under Section&nbsp;4999 of the Code, but only to the extent the excise tax cannot be avoided by reducing the severance benefits by an amount not exceeding 10% such that the executive receives a greater-after tax
amount as a result of the &#147;cut-back&#148; in benefits. In April 2011, the board of directors amended the CIC Plan so that this &#147;gross up&#148; benefit is not available for new hires following January&nbsp;1, 2010 but is grandfathered for
employees who joined the CIC Plan before that date so long as they are not promoted to a position such that he or she would be entitled to additional benefits under the plan. Accordingly, Drs.&nbsp;Doberstein and Gergel are not entitled to this
&#147;gross up&#148; benefit as they joined the CIC Plan after January&nbsp;1, 2010. In order to receive the severance benefits described above, each executive must first execute an effective waiver and release of claims in favor of us pursuant to a
separation and release agreement. Each executive&#146;s cash severance payment will ordinarily be paid in a lump-sum within 60 days following the executive&#146;s separation from service, although payment will be delayed to the extent required to
comply with Section&nbsp;409A of the Internal Revenue Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the purposes of the CIC Plan, a good reason resignation means
a resignation upon the occurrence of one or more of the following events: (i)&nbsp;assignment of any authority, duties or responsibilities that results in a material diminution in the executive&#146;s authority, duties or responsibilities as in
effect immediately prior to the change of control, (ii)&nbsp;assignment to a work location more than 50 miles from the executive&#146;s immediately previous work location, unless such reassignment of work location decreases the executive&#146;s
commuting distance from his or her residence to the executive&#146;s assigned work location, (iii)&nbsp;a material diminution in the executive&#146;s monthly base salary as in effect on the date of the change of control or as increased thereafter,
(iv)&nbsp;notice to the executive by us or the successor company during the 12-month period following the change of control that the executive&#146;s employment will be terminated under circumstances that would trigger severance benefits under the
CIC Plan but for the designation of a date for termination that is greater than 12 months following the change of control and (v)&nbsp;for Mr.&nbsp;Robin, if he does not serve in his same position in the successor company or is not appointed to the
board of directors of the successor company. In order for a good reason resignation to occur, the executive must first give us timely written notice of the grounds for good reason resignation, and we must have failed to cure such condition after a
period of 30 days. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the CIC Plan, the separation and release agreement that each of the NEOs will be required to
execute to receive severance benefits under the plan will also require each executive to agree to continue to be subject to the restrictions on the disclosure of our confidential information in his or her employment agreement, to non-solicitation
restrictions and to non-disparagement obligations. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">65 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Had a change of control occurred during the 2014 fiscal year and had the employment of each
of the NEOs terminated on December&nbsp;31, 2014 under one of the qualifying circumstances described above, each executive would have been entitled to receive the estimated benefits set forth in the table below. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="border-bottom:1px solid #000000;width:29pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name(1)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value of</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Cash</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Severance&nbsp;($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value of</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>COBRA and</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Outplacement</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Benefits ($)(1)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value of</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Vesting</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Acceleration<BR>($)(2)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated&nbsp;Value&nbsp;of</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Excise Tax</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Gross-Up ($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Total ($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Howard&nbsp;W.&nbsp;Robin</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3,018,519</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>51,039</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3,887,971</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;0</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6,957,529</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>John Nicholson</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>816,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>29,501</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,684,900</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;0</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,530,401</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Stephen K. Doberstein, Ph.D.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>718,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>26,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,339,436</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,084,437</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Ivan P. Gergel, M.D.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>900,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>39,915</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,687,548</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3,627,463</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Gil M. Labrucherie</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>792,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>35,693</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,392,636</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;0</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,220,329</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">This amount includes estimated COBRA premiums based upon actual rates as of December 2014 and up to $5,000 for outplacement services. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the terms of our equity compensation plans, these NEOs would also have been entitled to this same full equity acceleration (i)&nbsp;if a corporate
transaction (as defined in the applicable plan) occurred and the surviving or acquiring corporation refused to assume outstanding equity awards or substitute similar replacement awards for outstanding equity awards or (ii)&nbsp;upon the acquisition
by any person of beneficial ownership of 50% or more of the combined voting power of our shares in a transaction that is not a corporate transaction as defined in the applicable plan. See note (2)&nbsp;to the table above for the calculation of these
amounts. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">66 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_32"></A>INFORMATION ABOUT OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>I<SMALL>NDEPENDENT</SMALL> R<SMALL>EGISTERED</SMALL> P<SMALL>UBLIC</SMALL> A<SMALL>CCOUNTING</SMALL>
F<SMALL>IRM</SMALL> F<SMALL>EES</SMALL> <SMALL>AND</SMALL> S<SMALL>ERVICES</SMALL> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table represents
aggregate fees billed to us for fiscal years ended December&nbsp;31, 2014 and December&nbsp;31, 2013 by Ernst&nbsp;&amp; Young LLP, our independent registered public accounting firm. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fiscal Year Ended</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,208,426</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">930,584</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit Related Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Tax Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,236</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,452</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All Other Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,215,662</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">942,036</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Audit Fees</I>. This category consists of fees related to the audit of our annual consolidated
financial statements and our internal control over financial reporting, review of interim condensed consolidated financial statements included in our quarterly reports on Form&nbsp;10-Q, and services that are normally provided by the independent
registered public accounting firm in connection with statutory audit, registration statements and other regulatory filings. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Tax Fees.</I> This category consists of fees related to services provided for international tax compliance and tax consultation
services. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The audit committee approved all fees described above. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_33"></A>P<SMALL>RE</SMALL>-A<SMALL>PPROVAL</SMALL> P<SMALL>OLICIES</SMALL> <SMALL>AND</SMALL> P<SMALL>ROCEDURES</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The audit committee has adopted policies and procedures for the pre-approval of audit and non-audit services rendered by our independent
registered public accounting firm, Ernst&nbsp;&amp; Young LLP. The policy generally requires pre-approval for specified services in the defined categories of audit services, audit-related services and tax services up to specified amounts.
Pre-approval may also be given as part of the audit committee&#146;s approval of the scope of the engagement of the independent registered public accounting firm or on an individual explicit case-by-case basis before the independent registered
public accounting firm is engaged to provide each service. The pre-approval of services may be delegated to one or more of the audit committee&#146;s members, but the decision must be reported to the full audit committee at its next scheduled
meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Prior to Ernst&nbsp;&amp; Young LLP rendering services other than audit services, the audit committee would review
and approve such non-audit services only if such services were compatible with maintaining Ernst&nbsp;&amp; Young LLP&#146;s status as our independent registered public accounting firm. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_34"></A>R<SMALL>EPORT</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> A<SMALL>UDIT</SMALL> C<SMALL>OMMITTEE</SMALL>
<SMALL>OF</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>The material in
this report is being furnished and shall not be deemed &#147;filed&#148; with the SEC for purposes of Section&nbsp;18 of the Exchange Act or otherwise subject to the liability of that section, nor shall the material in this section be deemed to be
&#147;soliciting material&#148; or incorporated by reference in any registration statement or other document filed with the SEC under the Securities Act or the Exchange Act, except as otherwise expressly stated in such filing. </I></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">67 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The audit committee is currently comprised of four non-employee directors, Susan Wang, who
chairs the committee, and R. Scott Greer, Joseph J. Krivulka, and Dennis L. Winger. Our board of directors has determined that Ms.&nbsp;Wang and Messrs. Greer. Krivulka, and Winger meet the independence requirements set forth in Rule 10A-3(b)(1)
under the Exchange Act and in the applicable NASDAQ rules. In addition, the board of directors has determined that Ms.&nbsp;Wang and Mr.&nbsp;Winger each qualify as audit committee financial experts as defined by SEC rules. The audit committee has
the responsibility and authority described in the Nektar Therapeutics Audit Committee Charter, which has been approved by the board of directors. A copy of the Audit Committee Charter is available on our website at <I><U>www.nektar.com</U></I>.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The audit committee is responsible for assessing the information provided by management and our independent registered public
accounting firm in accordance with its business judgment. Management is responsible for the preparation, presentation and integrity of our financial statements and for the appropriateness of the accounting principles and reporting policies that are
used. Management is also responsible for testing the system of internal controls and reports to the audit committee on any deficiencies found. Our independent registered public accounting firm, Ernst&nbsp;&amp; Young LLP, is responsible for auditing
the annual financial statements and for reviewing the unaudited interim financial statements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In fulfilling its oversight
responsibilities, the audit committee has reviewed and discussed the audited financial statements in the annual report on Form 10-K for the year ended December&nbsp;31, 2014 with both management and our independent registered public accounting firm.
The audit committee&#146;s review included a discussion of the quality and integrity of the accounting principles, the reasonableness of significant estimates and judgments and the clarity of disclosures in the financial statements. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The audit committee reviewed with our independent registered public accounting firm the overall scope and plan of the audit. In addition,
it met with our independent registered public accounting firm, with and without management present, to discuss the results of our independent registered public accounting firm&#146;s examination, the evaluation of our system of internal controls,
the overall quality of our financial reporting and such other matters as are required to be discussed under generally accepted accounting standards in the United States. The audit committee has also received from, and discussed with, our independent
registered public accounting firm the matters required to be discussed by Auditing Standard No.&nbsp;16, &#147;<I>Communications with Audit Committees&#148;</I> issued by the Public Company Accounting Oversight Board (PCAOB). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The audit committee has discussed with Ernst&nbsp;&amp; Young LLP that firm&#146;s independence from management and our Company,
including the matters in the written disclosures and the letter regarding independence from Ernst&nbsp;&amp; Young LLP required by applicable requirements of the PCAOB. The audit committee has also considered the compatibility of audit related and
tax services with the auditors&#146; independence. Based on its evaluation, the audit committee has selected Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2015.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In reliance on the reviews and discussions referred to above, the audit committee recommended to the board of directors, and
the board of directors approved, the inclusion of the audited financial statements and management&#146;s assessment of the effectiveness of our internal controls over financial reporting in the annual report on Form 10-K for the year ended
December&nbsp;31, 2014 filed with the SEC. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Audit Committee </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Susan Wang&#151;Chairwoman </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">R. Scott Greer </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Joseph J. Krivulka </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dennis L. Winger </FONT></P>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">68 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_35"></A>OTHER MATTERS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The board of directors knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are
properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc913905_36"></A>ADDITIONAL INFORMATION </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our website address is
<I>http://www.nektar.com</I>. The information in, or that can be accessed through, our website is not deemed to be incorporated by reference into this proxy statement. Our annual reports on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K,</FONT>
quarterly reports on Form 10-Q and current reports on Form 8-K and amendments to those reports are available, free of charge, on or through our website as soon as reasonably practicable after we electronically file such material with, or furnish it
to, the SEC. The public may read and copy any materials we file with the SEC at the SEC&#146;s Public Reference Room at 100 F Street, NE, Washington, D.C. 20549. Information on the operation of the Public Reference Room can be obtained by calling
1-800-SEC-0330. The SEC maintains an internet site that contains reports, proxy and information statements and other information regarding our filings at <I>www.sec.gov</I>. In addition, a copy of our Annual Report on Form 10-K for the fiscal year
ended December&nbsp;31, 2014 filed with the SEC is available without charge upon written request to: Secretary, Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, California 94158. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Gil M. Labrucherie </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Senior Vice President, General Counsel
and</I> </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Secretary</I> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">May&nbsp;7, 2015 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">69 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exhibit 1 </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>N<SMALL>EKTAR</SMALL> T<SMALL>HERAPEUTICS</SMALL> </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2012
P<SMALL>ERFORMANCE</SMALL> I<SMALL>NCENTIVE</SMALL> P<SMALL>LAN</SMALL> </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>P<SMALL>URPOSE</SMALL> <SMALL>OF</SMALL> P<SMALL>LAN</SMALL> </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The purpose of this Nektar Therapeutics 2012 Performance Incentive Plan (this &#147;<B>Plan</B>&#148;) of Nektar Therapeutics, a Delaware corporation (the &#147;<B>Corporation</B>&#148;), is to promote
the success of the Corporation and to increase stockholder value by providing an additional means through the grant of awards to attract, motivate, retain and reward selected employees and other eligible persons. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>E<SMALL>LIGIBILITY</SMALL> </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Administrator (as such term is defined in Section&nbsp;3.1) may grant awards under this Plan only to those persons that the
Administrator determines to be Eligible Persons. An &#147;<B>Eligible Person</B>&#148; is any person who is either: (a)&nbsp;an officer (whether or not a director) or employee of the Corporation or one of its Subsidiaries; (b)&nbsp;a director of the
Corporation or one of its Subsidiaries; or (c)&nbsp;an individual consultant or advisor who renders or has rendered bona fide services (other than services in connection with the offering or sale of securities of the Corporation or one of its
Subsidiaries in a capital-raising transaction or as a market maker or promoter of securities of the Corporation or one of its Subsidiaries) to the Corporation or one of its Subsidiaries and who is selected to participate in this Plan by the
Administrator; provided, however, that a person who is otherwise an Eligible Person under clause (c)&nbsp;above may participate in this Plan only if such participation would not adversely affect either the Corporation&#146;s eligibility to use Form
S-8 to register under the Securities Act of 1933, as amended (the &#147;<B>Securities Act</B>&#148;), the offering and sale of shares issuable under this Plan by the Corporation or the Corporation&#146;s compliance with any other applicable laws. An
Eligible Person who has been granted an award (a &#147;participant&#148;) may, if otherwise eligible, be granted additional awards if the Administrator shall so determine. As used herein, &#147;<B>Subsidiary</B>&#148; means any corporation or other
entity a majority of whose outstanding voting stock or voting power is beneficially owned directly or indirectly by the Corporation; and &#147;<B>Board</B>&#148; means the Board of Directors of the Corporation. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>P<SMALL>LAN</SMALL> A<SMALL>DMINISTRATION</SMALL> </B></FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.1</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>The Administrator</I></B>. This Plan shall be administered by and all awards under this Plan shall be authorized by the Administrator. The
&#147;<B>Administrator</B>&#148; means the Board or one or more committees appointed by the Board or another committee (within its delegated authority) to administer all or certain aspects of this Plan. Any such committee shall be comprised solely
of one or more directors or such number of directors as may be required under applicable law. A committee may delegate some or all of its authority to another committee so constituted. The Board or a committee comprised solely of directors may also
delegate, to the extent permitted by Section&nbsp;157(c) of the Delaware General Corporation Law and any other applicable law, to one or more officers of the Corporation, its powers under this Plan (a)&nbsp;to designate the officers and employees of
the Corporation and its Subsidiaries who will receive grants of awards under this Plan, and (b)&nbsp;to determine the number of shares subject to, and the other terms and conditions of, such awards. The Board may delegate different levels of
authority to different committees with administrative and grant authority under this Plan. Unless otherwise provided in the Bylaws of the Corporation or the applicable charter of any Administrator: (a)&nbsp;a majority of the members of the acting
Administrator shall constitute a quorum, and (b)&nbsp;the vote of a majority of the members present assuming the presence of a quorum or the unanimous written consent of the members of the Administrator shall constitute action by the acting
Administrator. </FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">With respect to awards intended to satisfy the requirements for performance-based compensation
under Section&nbsp;162(m) of the Internal Revenue Code of 1986, as amended (the &#147;<B>Code</B>&#148;), this Plan shall be administered by a committee consisting solely of two or more outside directors (as this requirement is applied under
Section&nbsp;162(m) of the Code); provided, however, that the failure to satisfy such requirement shall not affect the validity of the action of any committee otherwise duly authorized and </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">
acting in the matter. Award grants, and transactions in or involving awards, intended to be exempt under Rule 16b-3 under the Securities Exchange Act of 1934, as amended (the &#147;<B>Exchange
Act</B>&#148;), must be duly and timely authorized by the Board or a committee consisting solely of two or more non-employee directors (as this requirement is applied under Rule 16b-3 promulgated under the Exchange Act). To the extent required by
any applicable listing agency, this Plan shall be administered by a committee composed entirely of independent directors (within the meaning of the applicable listing agency). </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.2</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Powers of the Administrator</I></B>. Subject to the express provisions of this Plan, the Administrator is authorized and empowered to do all things
necessary or desirable in connection with the authorization of awards and the administration of this Plan (in the case of a committee or delegation to one or more officers, within the authority delegated to that committee or person(s)), including,
without limitation, the authority to: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">determine eligibility and, from among those persons determined to be eligible, the particular Eligible Persons who will receive an award under this Plan;
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">grant awards to Eligible Persons, determine the price at which securities will be offered or awarded and the number of securities to be offered or awarded to any of
such persons, determine the other specific terms and conditions of such awards consistent with the express limits of this Plan, establish the installments (if any) in which such awards shall become exercisable or shall vest (which may include,
without limitation, performance and/or time-based schedules), or determine that no delayed exercisability or vesting is required, establish any applicable performance targets, and establish the events of termination or reversion of such awards;
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(c)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">approve the forms of award agreements (which need not be identical either as to type of award or among participants); </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(d)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">construe and interpret this Plan and any agreements defining the rights and obligations of the Corporation, its Subsidiaries, and participants under this Plan, further
define the terms used in this Plan, and prescribe, amend and rescind rules and regulations relating to the administration of this Plan or the awards granted under this Plan; </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(e)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">cancel, modify, or waive the Corporation&#146;s rights with respect to, or modify, discontinue, suspend, or terminate any or all outstanding awards, subject to any
required consent under Section&nbsp;8.6.5; </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(f)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">accelerate or extend the vesting or exercisability or extend the term of any or all such outstanding awards (in the case of options or stock appreciation rights, within
the maximum ten-year term of such awards) in such circumstances as the Administrator may deem appropriate (including, without limitation, in connection with a termination of employment or services or other events of a personal nature) subject to any
required consent under Section&nbsp;8.6.5; </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(g)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">adjust the number of shares of Common Stock subject to any award, adjust the price of any or all outstanding awards or otherwise change previously imposed terms and
conditions, in such circumstances as the Administrator may deem appropriate, in each case subject to Sections 4 and 8.6 (and subject to the no repricing provision below); </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(h)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">determine the date of grant of an award, which may be a designated date after but not before the date of the Administrator&#146;s action (unless otherwise designated by
the Administrator, the date of grant of an award shall be the date upon which the Administrator took the action granting an award); </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(i)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">determine whether, and the extent to which, adjustments are required pursuant to Section&nbsp;7 hereof and authorize the termination, conversion, substitution or
succession of awards upon the occurrence of an event of the type described in Section&nbsp;7; </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(j)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">acquire or settle (subject to Sections 7 and 8.6) rights under awards in cash, stock of equivalent value, or other consideration (subject to the no repricing provision
below); and </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(k)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">determine the fair market value of the Common Stock or awards under this Plan from time to time and/or the manner in which such value will be determined.
</FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Notwithstanding the foregoing and except for an adjustment pursuant to Section&nbsp;7.1 or a repricing approved
by stockholders, in no case may the Administrator (1)&nbsp;amend an outstanding stock option or SAR to reduce the exercise price or base price of the award, (2)&nbsp;cancel, exchange, or surrender an outstanding stock option or SAR in exchange for
cash or other awards for the purpose of repricing the award, or (3)&nbsp;cancel, exchange, or surrender an outstanding stock option or SAR in exchange for an option or SAR with an exercise or base price that is less than the exercise or base price
of the original award. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.3</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Binding Determinations</I></B>. Any action taken by, or inaction of, the Corporation, any Subsidiary, or the Administrator relating or pursuant to this
Plan and within its authority hereunder or under applicable law shall be within the absolute discretion of that entity or body and shall be conclusive and binding upon all persons. Neither the Board nor any Board committee, nor any member thereof or
person acting at the direction thereof, shall be liable for any act, omission, interpretation, construction or determination made in good faith in connection with this Plan (or any award made under this Plan), and all such persons shall be entitled
to indemnification and reimbursement by the Corporation in respect of any claim, loss, damage or expense (including, without limitation, attorneys&#146; fees) arising or resulting therefrom to the fullest extent permitted by law and/or under any
directors and officers liability insurance coverage that may be in effect from time to time. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.4</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Reliance on Experts</I></B>. In making any determination or in taking or not taking any action under this Plan, the Administrator may obtain and may rely
upon the advice of experts, including employees and professional advisors to the Corporation. No director, officer or agent of the Corporation or any of its Subsidiaries shall be liable for any such action or determination taken or made or omitted
in good faith. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.5</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Delegation</I></B>. The Administrator may delegate ministerial, non-discretionary functions to individuals who are officers or employees of the Corporation
or any of its Subsidiaries or to third parties. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>S<SMALL>HARES</SMALL> <SMALL>OF</SMALL> C<SMALL>OMMON</SMALL> S<SMALL>TOCK</SMALL> S<SMALL>UBJECT</SMALL> <SMALL>TO</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>;
S<SMALL>HARE</SMALL> L<SMALL>IMITS</SMALL> </B></FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4.1</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Shares Available</I></B>. Subject to the provisions of Section&nbsp;7.1, the capital stock that may be delivered under this Plan shall be shares of the
Corporation&#146;s authorized but unissued Common Stock and any shares of its Common Stock held as treasury shares. For purposes of this Plan, &#147;<B>Common Stock</B>&#148; shall mean the common stock of the Corporation and such other securities
or property as may become the subject of awards under this Plan, or may become subject to such awards, pursuant to an adjustment made under Section&nbsp;7.1. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4.2</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Share Limits</I></B>. The maximum number of shares of Common Stock that may be delivered pursuant to awards granted to Eligible Persons under this Plan
(the &#147;<B>Share Limit</B>&#148;) is equal to: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,936,433 shares of Common Stock, less </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">the number of any shares subject to awards granted under the Corporation&#146;s 2008 Equity Incentive Plan, as amended (the &#147;<B>2008 Plan</B>&#148;), and the
Corporation&#146;s 2000 Non-Officer Equity Incentive Plan, as amended and restated (the &#147;<B>2000 Non-Officer Plan</B>&#148;), after December&nbsp;31, 2011 and on or before the date of stockholder approval of this Plan (with any shares subject
to such awards that are &#147;Full-Value Awards&#148; being counted against the Share Limit based on the Full-Value Award Ratio specified below), plus </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">the number of any shares subject to stock options granted under the 2008 Plan, the 2000 Non-Officer Plan, or the Corporation&#146;s 2000 Equity Incentive Plan, as
amended and restated (collectively, the &#147;Prior Plans&#148;) and outstanding as of December&nbsp;31, 2011 which expire, or for any reason are cancelled or terminated, after December&nbsp;31, 2011 without being exercised, plus
</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">the number of any shares subject to restricted stock and restricted stock unit awards granted under the Prior Plans that are outstanding and unvested on
December&nbsp;31, 2011 that are forfeited, terminated, cancelled or otherwise reacquired by the Corporation without having become vested (with any such shares increasing the Share Limit based on the Full Value Award Ratio specified below).
</FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">provided that in no event shall the Share Limit exceed 37,186,624 shares (which is the sum of (1)&nbsp;the
19,936,433 shares set forth above, plus (2)&nbsp;the aggregate number of shares subject to stock options previously granted and outstanding under the Prior Plans as of December&nbsp;31, 2011, plus (3)&nbsp;1.5 (the Full-Value Award Ratio) times the
aggregate number of shares subject to restricted stock and restricted stock units previously granted and outstanding under the Prior Plans as of December&nbsp;31, 2011). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Shares issued in respect of any &#147;Full-Value Award&#148; granted under this Plan shall be counted against the foregoing Share Limit as 1.5 shares for every one share issued in connection with such
award (the &#147;<B>Full-Value Award Ratio</B>&#148;). (For example, if a stock bonus of 100 shares of Common Stock is granted under this Plan, 150 shares shall be charged against the Share Limit in connection with that award.) For this purpose, a
&#147;<B>Full-Value Award</B>&#148; means any award under this Plan that is <U>not</U> a stock option grant or a stock appreciation right grant. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following limits also apply with respect to awards granted under this Plan: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The maximum number of shares of Common Stock that may be delivered pursuant to options qualified as incentive stock options granted under this Plan is 9,500,000 shares.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The maximum number of shares of Common Stock subject to options and stock appreciation rights that are granted during any calendar year to any individual under this
Plan is 3,000,000 shares. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(c)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Additional limits with respect to Performance-Based Awards are set forth in Section&nbsp;5.2.3. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each of the foregoing numerical limits is subject to adjustment as contemplated by Section&nbsp;4.3, Section&nbsp;7.1, and
Section&nbsp;8.10. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4.3</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Awards Settled in Cash, Reissue of Awards and Shares</I></B>. Except as provided in the next sentence, shares that are subject to or
underlie awards granted under this Plan which expire or for any reason are cancelled or terminated, are forfeited, fail to vest, or for any other reason are not paid or delivered under this Plan shall again be available for subsequent awards under
this Plan (with any such shares increasing the Share Limit based on the Full-Value Award Ratio specified in Section&nbsp;4.2). Shares that are exchanged by a participant or withheld by the Corporation as full or partial payment in connection with
any award under this Plan, as well as any shares exchanged by a participant or withheld by the Corporation or one of its Subsidiaries to satisfy the tax withholding obligations related to any award, shall not be available for subsequent awards under
this Plan. To the extent that an award granted under this Plan is settled in cash or a form other than shares of Common Stock, the shares that would have been delivered had there been no such cash or other settlement shall again be available for
subsequent awards under this Plan (with any such shares increasing the Share Limit based on the Full-Value Award Ratio specified in Section&nbsp;4.2). In the event that shares of Common Stock are delivered in respect of a dividend equivalent right
granted under this Plan, the number of shares delivered with respect to the award shall be counted against the share limits of this Plan (including, for purposes of clarity, the limits of Section&nbsp;4.2 of this Plan). (For purposes of clarity, if
1,000 dividend equivalent rights are granted and outstanding when the Corporation pays a dividend, and 50 shares are delivered in payment of those rights with respect to that dividend, 75 shares (after giving effect to the Full-Value Award premium
counting rules) shall be counted against the share limits of this Plan). To the extent that shares of Common Stock are delivered pursuant to the exercise of a stock appreciation right or stock option granted under this Plan, the number of underlying
shares as to which the exercise related shall be counted against the applicable share limits under Section&nbsp;4.2, as opposed to only counting the shares issued. (For purposes of clarity, if a stock appreciation right relates to 100,000 shares and
is </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
exercised at a time when the payment due to the participant is 15,000 shares, 100,000 shares shall be charged against the applicable share limits under Section&nbsp;4.2 with respect to such
exercise.) Refer to Section&nbsp;8.10 for application of the foregoing share limits with respect to assumed awards. The foregoing adjustments to the share limits of this Plan are subject to any applicable limitations under Section&nbsp;162(m) of the
Code with respect to awards intended as performance-based compensation thereunder. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4.4</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Reservation of Shares; No Fractional Shares; Minimum Issue</I></B>. The Corporation shall at all times reserve a number of shares of Common Stock
sufficient to cover the Corporation&#146;s obligations and contingent obligations to deliver shares with respect to awards then outstanding under this Plan (exclusive of any dividend equivalent obligations to the extent the Corporation has the right
to settle such rights in cash). No fractional shares shall be delivered under this Plan. The Administrator may pay cash in lieu of any fractional shares in settlements of awards under this Plan. The Administrator may from time to time impose a limit
(of not greater than 100 shares) on the minimum number of shares that may be purchased or exercised as to awards granted under this Plan unless (as to any particular award) the total number purchased or exercised is the total number at the time
available for purchase or exercise under the award. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>WARDS</SMALL> </B></FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.1</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Type and Form of Awards</I></B>. The Administrator shall determine the type or types of award(s) to be made to each selected Eligible Person. Awards may be
granted singly, in combination or in tandem. Awards also may be made in combination or in tandem with, in replacement of, as alternatives to, or as the payment form for grants or rights under any other employee or compensation plan of the
Corporation or one of its Subsidiaries. The types of awards that may be granted under this Plan are (subject, in each case, to the no repricing provisions of Section&nbsp;3.2): </FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.1.1 </B><B><I>Stock Options</I></B>. A stock option is the grant of a right to purchase a specified number of shares of Common Stock
during a specified period as determined by the Administrator. An option may be intended as an incentive stock option within the meaning of Section&nbsp;422 of the Code (an &#147;<B>ISO</B>&#148;) or a nonqualified stock option (an option not
intended to be an ISO). The award agreement for an option will indicate if the option is intended as an ISO; otherwise it will be deemed to be a nonqualified stock option. The maximum term of each option (ISO or nonqualified) shall be eight
(8)&nbsp;years. The per share exercise price for each option shall be not less than 100% of the fair market value of a share of Common Stock on the date of grant of the option. When an option is exercised, the exercise price for the shares to be
purchased shall be paid in full in cash or such other method permitted by the Administrator consistent with Section&nbsp;5.5. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.1.2 </B><B><I>Additional Rules Applicable to ISOs</I></B>. To the extent that the aggregate fair market value (determined at the time
of grant of the applicable option) of stock with respect to which ISOs first become exercisable by a participant in any calendar year exceeds $100,000, taking into account both Common Stock subject to ISOs under this Plan and stock subject to ISOs
under all other plans of the Corporation or one of its Subsidiaries (or any parent or predecessor corporation to the extent required by and within the meaning of Section&nbsp;422 of the Code and the regulations promulgated thereunder), such options
shall be treated as nonqualified stock options. In reducing the number of options treated as ISOs to meet the $100,000 limit, the most recently granted options shall be reduced first. To the extent a reduction of simultaneously granted options is
necessary to meet the $100,000 limit, the Administrator may, in the manner and to the extent permitted by law, designate which shares of Common Stock are to be treated as shares acquired pursuant to the exercise of an ISO. ISOs may only be granted
to employees of the Corporation or one of its subsidiaries (for this purpose, the term &#147;subsidiary&#148; is used as defined in Section&nbsp;424(f) of the Code, which generally requires an unbroken chain of ownership of at least 50% of the total
combined voting power of all classes of stock of each subsidiary in the chain beginning with the Corporation and ending with the subsidiary in question). There shall be imposed in any award agreement relating to ISOs such other terms and conditions
as from time to time are required in order that the option be an &#147;incentive stock option&#148; as that term is </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">
defined in Section&nbsp;422 of the Code. No ISO may be granted to any person who, at the time the option is granted, owns (or is deemed to own under Section&nbsp;424(d) of the Code) shares of
outstanding Common Stock possessing more than 10% of the total combined voting power of all classes of stock of the Corporation, unless the exercise price of such option is at least 110% of the fair market value of the stock subject to the option
and such option by its terms is not exercisable after the expiration of five years from the date such option is granted. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.1.3 </B><B><I>Stock Appreciation Rights</I></B>. A stock appreciation right or &#147;<B>SAR</B>&#148; is a right to receive a
payment, in cash and/or Common Stock, equal to the excess of the fair market value of a specified number of shares of Common Stock on the date the SAR is exercised over the &#147;<B>base price</B>&#148; of the award, which base price shall be set
forth in the applicable award agreement and shall be not less than 100% of the fair market value of a share of Common Stock on the date of grant of the SAR. The maximum term of a SAR shall be eight (8) years. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.1.4 </B><B><I>Other Awards; Dividend Equivalent Rights</I></B>. The other types of awards that may be granted under this Plan
include: (a)&nbsp;stock bonuses, restricted stock, performance stock, stock units, phantom stock or similar rights to purchase or acquire shares, whether at a fixed or variable price or ratio related to the Common Stock, upon the passage of time,
the occurrence of one or more events, or the satisfaction of performance criteria or other conditions, or any combination thereof; (b)&nbsp;any similar securities with a value derived from the value of or related to the Common Stock and/or returns
thereon; or (c)&nbsp;cash awards. Dividend equivalent rights may be granted as a separate award or in connection with another award under this Plan; provided, however, that dividend equivalent rights may not be granted in connection with a stock
option or SAR granted under this Plan. In addition, any dividends and/or dividend equivalents as to the unvested portion of a restricted stock award that is subject to performance-based vesting requirements or the unvested portion of a stock unit
award that is subject to performance-based vesting requirements will be subject to termination and forfeiture to the same extent as the corresponding portion of the award to which they relate. </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.2</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Section&nbsp;162(m) Performance-Based Awards</I></B><B>.</B> Without limiting the generality of the foregoing, any of the types of awards listed in
Section&nbsp;5.1.4 above may be, and options and SARs granted to officers and employees (&#147;<B>Qualifying Options</B>&#148; and &#147;<B>Qualifying SARS</B>,&#148; respectively) typically will be, granted as awards intended to satisfy the
requirements for &#147;performance-based compensation&#148; within the meaning of Section&nbsp;162(m) of the Code (&#147;<B>Performance-Based Awards</B><I>&#148;</I>). The grant, vesting, exercisability or payment of Performance-Based Awards may
depend (or, in the case of Qualifying Options or Qualifying SARs, may also depend) on the degree of achievement of one or more performance goals relative to a pre-established targeted level or levels using one or more of the Business Criteria set
forth below (on an absolute or relative (including, without limitation, relative to the performance of other companies or upon comparisons of any of the indicators of performance relative to other companies) basis) for the Corporation on a
consolidated basis or for one or more of the Corporation&#146;s subsidiaries, segments, divisions or business units, or any combination of the foregoing. Any Qualifying Option or Qualifying SAR shall be subject only to the requirements of
Section&nbsp;5.2.1 and 5.2.3 in order for such award to satisfy the requirements for &#147;performance-based compensation&#148; under Section&nbsp;162(m) of the Code. Any other Performance-Based Award shall be subject to all of the following
provisions of this Section&nbsp;5.2. </FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.2.1 </B><B><I>Class; Administrator</I></B><B>. </B>The eligible class
of persons for Performance-Based Awards under this Section&nbsp;5.2 shall be officers and employees of the Corporation or one of its Subsidiaries. The Administrator approving Performance-Based Awards or making any certification required pursuant to
Section&nbsp;5.2.4 must be constituted as provided in Section&nbsp;3.1 for awards that are intended as performance-based compensation under Section&nbsp;162(m) of the Code. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>5.2.2 </B><B><I>Performance Goals</I></B><B>. </B>The specific performance goals for Performance-Based Awards (other than Qualifying Options and Qualifying SARs) shall be, on an absolute or relative
basis, established based on one or more of the following business criteria (&#147;<B>Business Criteria</B>&#148;) as selected by the </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Administrator in its sole discretion: earnings per share, cash flow (which means cash and cash equivalents derived from either net cash flow from operations or net cash flow from operations,
financing and investing activities), working capital, stock price, total stockholder return, gross revenue, revenue growth, gross profit, operating income (before or after taxes), net earnings (before or after interest, taxes, depreciation and/or
amortization), gross margin, operating margin, net margin, return on equity or on assets or on net investment, cost containment or reduction, regulatory submissions or approvals, manufacturing production, completion of strategic partnerships,
research milestones, or any combination thereof. As applicable, these terms are used as applied under generally accepted accounting principles or in the financial reporting of the Corporation or of its Subsidiaries. To qualify awards as
performance-based under Section&nbsp;162(m), the applicable Business Criterion (or Business Criteria, as the case may be) and specific performance goal or goals (&#147;targets&#148;) must be established and approved by the Administrator during the
first 90 days of the performance period (and, in the case of performance periods of less than one year, in no event after 25% or more of the performance period has elapsed) and while performance relating to such target(s) remains substantially
uncertain within the meaning of Section&nbsp;162(m) of the Code. The terms of the Performance-Based Awards may specify the manner, if any, in which performance targets shall be adjusted to mitigate the unbudgeted impact of material, unusual or
nonrecurring gains and losses, accounting changes or other extraordinary events not foreseen at the time the targets were set unless the Administrator provides otherwise at the time of establishing the targets. The applicable performance measurement
period may not be less than three months nor more than 10 years. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.2.3 </B><B><I>Form of Payment; Maximum Performance-Based
Award</I></B><B>.</B> Grants or awards under this Section&nbsp;5.2 may be paid in cash or shares of Common Stock or any combination thereof. Grants of Qualifying Options and Qualifying SARs to any one participant in any one calendar year shall be
subject to the limit set forth in Section&nbsp;4.2(b). The maximum number of shares of Common Stock which may be subject to Performance-Based Awards (including Performance-Based Awards payable in shares of Common Stock and Performance-Based Awards
payable in cash where the amount of cash payable upon or following vesting of the award is determined with reference to the fair market value of a share of Common Stock at such time) that are granted to any one participant in any one calendar year
shall not exceed 3,000,000 shares, either individually or in the aggregate, subject to adjustment as provided in Section&nbsp;7.1; provided that this limit shall not apply to Qualifying Options and Qualifying SARs (which are covered by the limit of
Section&nbsp;4.2(b)). The aggregate amount of compensation to be paid to any one participant in respect of all Performance-Based Awards payable only in cash (excluding cash awards covered by the preceding sentence where the cash payment is
determined with reference to the fair market value of a share of Common Stock upon or following the vesting of the award) and granted to that participant in any one calendar year shall not exceed $5,000,000. Awards that are cancelled during the year
shall be counted against these limits to the extent required by Section&nbsp;162(m) of the Code. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.2.4
</B><B><I>Certification of Payment</I></B><B>. </B>Before any Performance-Based Award under this Section&nbsp;5.2 (other than Qualifying Options and Qualifying SARs) is paid and to the extent required to qualify the award as performance-based
compensation within the meaning of Section&nbsp;162(m) of the Code, the Administrator must certify in writing that the performance target(s) and any other material terms of the Performance-Based Award were in fact timely satisfied. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.2.5 </B><B><I>Reservation of Discretion</I></B><B>. </B>The Administrator will have the discretion to determine the restrictions or
other limitations of the individual awards granted under this Section&nbsp;5.2 including the authority to reduce awards, payouts or vesting or to pay no awards, in its sole discretion, if the Administrator preserves such authority at the time of
grant by language to this effect in its authorizing resolutions or otherwise. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.2.6 </B><B><I>Expiration of Grant
Authority</I></B><B>. </B>As required pursuant to Section&nbsp;162(m) of the Code and the regulations promulgated thereunder, the Administrator&#146;s authority to grant new awards that are intended to qualify as performance-based compensation
within the meaning of Section&nbsp;162(m) of the </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Code (other than Qualifying Options and Qualifying SARs) shall terminate upon the first meeting of the Corporation&#146;s stockholders that occurs in the fifth year following the year in which
the Corporation&#146;s stockholders first approve this Plan, subject to any subsequent extension that may be approved by stockholders. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.3</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Award Agreements</I></B>. Each award shall be evidenced by either (1)&nbsp;a written award agreement in a form approved by the Administrator and executed
by the Corporation by an officer duly authorized to act on its behalf, or (2)&nbsp;an electronic notice of award grant in a form approved by the Administrator and recorded by the Corporation (or its designee) in an electronic recordkeeping system
used for the purpose of tracking award grants under this Plan generally (in each case, an &#147;award agreement&#148;), as the Administrator may provide and, in each case and if required by the Administrator, executed or otherwise electronically
accepted by the recipient of the award in such form and manner as the Administrator may require. The Administrator may authorize any officer of the Corporation (other than the particular award recipient) to execute any or all award agreements on
behalf of the Corporation. The award agreement shall set forth the material terms and conditions of the award as established by the Administrator consistent with the express limitations of this Plan. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.4</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Deferrals and Settlements</I></B>. Payment of awards may be in the form of cash, Common Stock, other awards or combinations thereof as the Administrator
shall determine, and with such restrictions as it may impose. The Administrator may also require or permit participants to elect to defer the issuance of shares or the settlement of awards in cash under such rules and procedures as it may establish
under this Plan. The Administrator may also provide that deferred settlements include the payment or crediting of interest or other earnings on the deferral amounts, or the payment or crediting of dividend equivalents where the deferred amounts are
denominated in shares. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.5</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Consideration for Common Stock or Awards</I></B>. The purchase price for any award granted under this Plan or the Common Stock to be delivered pursuant to
an award, as applicable, may be paid by means of any lawful consideration as determined by the Administrator, including, without limitation, one or a combination of the following methods: </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">services rendered by the recipient of such award; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">cash, check payable to the order of the Corporation, or electronic funds transfer; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">notice and third party payment in such manner as may be authorized by the Administrator; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the delivery of previously owned shares of Common Stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">by a reduction in the number of shares otherwise deliverable pursuant to the award; or </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">subject to such procedures as the Administrator may adopt, pursuant to a &#147;cashless exercise&#148; with a third party who provides financing for
the purposes of (or who otherwise facilitates) the purchase or exercise of awards. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In no event shall any
shares newly-issued by the Corporation be issued for less than the minimum lawful consideration for such shares or for consideration other than consideration permitted by applicable state law. Shares of Common Stock used to satisfy the exercise
price of an option shall be valued at their fair market value on the date of exercise. The Corporation will not be obligated to deliver any shares unless and until it receives full payment of the exercise or purchase price therefor and any related
withholding obligations under Section&nbsp;8.5 and any other conditions to exercise or purchase have been satisfied. Unless otherwise expressly provided in the applicable award agreement, the Administrator may at any time eliminate or limit a
participant&#146;s ability to pay the purchase or exercise price of any award or shares by any method other than cash payment to the Corporation. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.6</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Definition of Fair Market Value</I></B>. For purposes of this Plan, &#147;fair market value&#148; shall mean, unless otherwise determined
or provided by the Administrator in the circumstances, the closing price (in regular trading) for a share of Common Stock on the NASDAQ Stock Market (the &#147;<B>Market</B>&#148;) for the
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
date in question or, if no sales of Common Stock were reported on the Market on that date, the closing price (in regular trading) for a share of Common Stock on the Market for the next preceding
day on which sales of Common Stock were reported on the Market. The Administrator may, however, provide with respect to one or more awards that the fair market value shall equal the closing price (in regular trading) for a share of Common Stock on
the Market on the last trading day preceding the date in question or the average of the high and low trading prices of a share of Common Stock on the Market for the date in question or the most recent trading day. If the Common Stock is no longer
listed or is no longer actively traded on the Market as of the applicable date, the fair market value of the Common Stock shall be the value as reasonably determined by the Administrator for purposes of the award in the circumstances. The
Administrator also may adopt a different methodology for determining fair market value with respect to one or more awards if a different methodology is necessary or advisable to secure any intended favorable tax, legal or other treatment for the
particular award(s) (for example, and without limitation, the Administrator may provide that fair market value for purposes of one or more awards will be based on an average of closing prices (or the average of high and low daily trading prices) for
a specified period preceding the relevant date). </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.7</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Transfer Restrictions</I></B>.<B><I></I></B> </FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>5.7.1 </B><B><I>Limitations on Exercise and Transfer</I></B>. Unless otherwise expressly provided in (or pursuant to) this Section&nbsp;5.7 or required by applicable law: (a)&nbsp;all awards are
non-transferable and shall not be subject in any manner to sale, transfer, anticipation, alienation, assignment, pledge, encumbrance or charge; (b)&nbsp;awards shall be exercised only by the participant; and (c)&nbsp;amounts payable or shares
issuable pursuant to any award shall be delivered only to (or for the account of) the participant. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.7.2
</B><B><I>Exceptions</I></B>. The Administrator may permit awards to be exercised by and paid to, or otherwise transferred to, other persons or entities pursuant to such conditions and procedures, including limitations on subsequent transfers, as
the Administrator may, in its sole discretion, establish in writing. Any permitted transfer shall be subject to compliance with applicable federal and state securities laws and shall not be for value (other than nominal consideration, settlement of
marital property rights, or for interests in an entity in which more than 50% of the voting interests are held by the Eligible Person or by the Eligible Person&#146;s family members). </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.7.3 </B><B><I>Further Exceptions to Limits on Transfer</I></B>. The exercise and transfer restrictions in Section&nbsp;5.7.1 shall
not apply to: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">transfers to the Corporation (for example, in connection with the expiration or termination of the award), </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">the designation of a beneficiary to receive benefits in the event of the participant&#146;s death or, if the participant has died, transfers to or exercise by the
participant&#146;s beneficiary, or, in the absence of a validly designated beneficiary, transfers by will or the laws of descent and distribution, </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(c)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">subject to any applicable limitations on ISOs, transfers to a family member (or former family member) pursuant to a domestic relations order if approved or ratified by
the Administrator, </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(d)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">if the participant has suffered a disability, permitted transfers or exercises on behalf of the participant by his or her legal representative, or
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(e)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">the authorization by the Administrator of &#147;cashless exercise&#148; procedures with third parties who provide financing for the purpose of (or who otherwise
facilitate) the exercise of awards consistent with applicable laws and the express authorization of the Administrator. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.8</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>International Awards</I></B>. One or more awards may be granted to Eligible Persons who provide services to the Corporation or one of its Subsidiaries
outside of the United States. Any awards granted to such persons may be granted pursuant to the terms and conditions of any applicable sub-plans, if any, appended to this Plan and approved by the Administrator. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>E<SMALL>FFECT</SMALL> <SMALL>OF</SMALL> T<SMALL>ERMINATION</SMALL> <SMALL>OF</SMALL> E<SMALL>MPLOYMENT</SMALL> <SMALL>OR</SMALL> S<SMALL>ERVICE</SMALL>
<SMALL>ON</SMALL> A<SMALL>WARDS</SMALL> </B></FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6.1</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>General</I></B>. The Administrator shall establish the effect of a termination of employment or service on the rights and benefits under each award under
this Plan and in so doing may make distinctions based upon, inter alia, the cause of termination and type of award. If the participant is not an employee of the Corporation or one of its Subsidiaries and provides other services to the Corporation or
one of its Subsidiaries, the Administrator shall be the sole judge for purposes of this Plan (unless a contract or the award otherwise provides) of whether the participant continues to render services to the Corporation or one of its Subsidiaries
and the date, if any, upon which such services shall be deemed to have terminated. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6.2</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Events Not Deemed Terminations of Service</I></B>. Unless the express policy of the Corporation or one of its Subsidiaries, or the Administrator, otherwise
provides, the employment relationship shall not be considered terminated in the case of (a)&nbsp;sick leave, (b)&nbsp;military leave, or (c)&nbsp;any other leave of absence authorized by the Corporation or one of its Subsidiaries, or the
Administrator; provided that, unless reemployment upon the expiration of such leave is guaranteed by contract or law or the Administrator otherwise provides, such leave is for a period of not more than three months. In the case of any employee of
the Corporation or one of its Subsidiaries on an approved leave of absence, continued vesting of the award while on leave from the employ of the Corporation or one of its Subsidiaries may be suspended until the employee returns to service, unless
the Administrator otherwise provides or applicable law otherwise requires. In no event shall an award be exercised after the expiration of the term set forth in the applicable award agreement. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6.3</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Effect of Change of Subsidiary Status</I></B>. For purposes of this Plan and any award, if an entity ceases to be a Subsidiary of the Corporation a
termination of employment or service shall be deemed to have occurred with respect to each Eligible Person in respect of such Subsidiary who does not continue as an Eligible Person in respect of the Corporation or another Subsidiary that continues
as such after giving effect to the transaction or other event giving rise to the change in status unless the Subsidiary that is sold, spun-off or otherwise divested (or its successor or a direct or indirect parent of such Subsidiary or successor)
assumes the Eligible Person&#146;s award(s) in connection with such transaction. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>DJUSTMENTS</SMALL>; A<SMALL>CCELERATION</SMALL> </B></FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.1</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Adjustments</I></B>. Subject to Section&nbsp;7.2, upon (or, as may be necessary to effect the adjustment, immediately prior to): any reclassification,
recapitalization, stock split (including a stock split in the form of a stock dividend) or reverse stock split; any merger, combination, consolidation, or other reorganization; any spin-off, split-up, or similar extraordinary dividend distribution
in respect of the Common Stock; or any exchange of Common Stock or other securities of the Corporation, or any similar, unusual or extraordinary corporate transaction in respect of the Common Stock; then the Administrator shall equitably and
proportionately adjust (1)&nbsp;the number and type of shares of Common Stock (or other securities) that thereafter may be made the subject of awards (including the specific share limits, maximums and numbers of shares set forth elsewhere in this
Plan), (2)&nbsp;the number, amount and type of shares of Common Stock (or other securities or property) subject to any outstanding awards, (3)&nbsp;the grant, purchase, or exercise price (which term includes the base price of any SAR or similar
right) of any outstanding awards, and/or (4)&nbsp;the securities, cash or other property deliverable upon exercise or payment of any outstanding awards, in each case to the extent necessary to preserve (but not increase) the level of incentives
intended by this Plan and the then-outstanding awards. </FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unless otherwise expressly provided in the applicable
award agreement, upon (or, as may be necessary to effect the adjustment, immediately prior to) any event or transaction described in the preceding paragraph or a sale of all or substantially all of the business or assets of the Corporation as an
entirety, the Administrator shall equitably and proportionately adjust the performance standards applicable to any then-outstanding performance-based awards to the extent necessary to preserve (but not increase) the level of incentives intended by
this Plan and the then-outstanding performance-based awards. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">It is intended that, if possible, any adjustments contemplated by the preceding two
paragraphs be made in a manner that satisfies applicable U.S. legal, tax (including, without limitation and as applicable in the circumstances, Section&nbsp;424 of the Code, Section&nbsp;409A of the Code and Section&nbsp;162(m) of the Code) and
accounting (so as to not trigger any charge to earnings with respect to such adjustment) requirements. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Without limiting the
generality of Section&nbsp;3.3, any good faith determination by the Administrator as to whether an adjustment is required in the circumstances pursuant to this Section&nbsp;7.1, and the extent and nature of any such adjustment, shall be conclusive
and binding on all persons. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.2</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Corporate Transactions&#151;Assumption and Termination of Awards</I></B>. Upon the occurrence of any of the following: any merger, combination,
consolidation, or other reorganization in connection with which the Corporation does not survive (or does not survive as a public company in respect of its Common Stock); any exchange of Common Stock or other securities of the Corporation in
connection with which the Corporation does not survive (or does not survive as a public company in respect of its Common Stock); a sale of all or substantially all the business, stock or assets of the Corporation in connection with which the
Corporation does not survive (or does not survive as a public company in respect of its Common Stock); a dissolution of the Corporation; or any other event in which the Corporation does not survive (or does not survive as a public company in respect
of its Common Stock); then the Administrator may make provision for a cash payment in settlement of, or for the termination, assumption, substitution or exchange of any or all outstanding share-based awards or the cash, securities or property
deliverable to the holder of any or all outstanding share-based awards, based upon, to the extent relevant under the circumstances, the distribution or consideration payable to holders of the Common Stock upon or in respect of such event. Upon the
occurrence of any event described in the preceding sentence, then, unless the Administrator has made a provision for the substitution, assumption, exchange or other continuation or settlement of the award or (unless the Administrator has provided
for the termination of the award) the award would otherwise continue in accordance with its terms in the circumstances: (1)&nbsp;unless otherwise provided in the applicable award agreement, each then-outstanding option and SAR shall become fully
vested, all shares of restricted stock then outstanding shall fully vest free of restrictions, and each other award granted under this Plan that is then outstanding shall become payable to the holder of such award; and (2)&nbsp;each award shall
terminate upon the related event; provided that the holder of an option or SAR shall be given reasonable advance notice of the impending termination and a reasonable opportunity to exercise his or her outstanding vested options and SARs (after
giving effect to any accelerated vesting required in the circumstances) in accordance with their terms before the termination of such awards (except that in no case shall more than ten days&#146; notice of the impending termination be required and
any acceleration of vesting and any exercise of any portion of an award that is so accelerated may be made contingent upon the actual occurrence of the event). </FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Administrator may adopt such valuation methodologies for outstanding awards as it deems reasonable in the event of a cash or property settlement and, in the case of options, SARs or similar rights,
but without limitation on other methodologies, may base such settlement solely upon the excess if any of the per share amount payable upon or in respect of such event over the exercise or base price of the award. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In any of the events referred to in this Section&nbsp;7.2, the Administrator may take such action contemplated by this Section&nbsp;7.2
prior to such event (as opposed to on the occurrence of such event) to the extent that the Administrator deems the action necessary to permit the participant to realize the benefits intended to be conveyed with respect to the underlying shares.
Without limiting the generality of the foregoing, the Administrator may deem an acceleration to occur immediately prior to the applicable event and, in such circumstances, will reinstate the original terms of the award if an event giving rise to an
acceleration does not occur. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Without limiting the generality of Section&nbsp;3.3, any good faith determination by the
Administrator pursuant to its authority under this Section&nbsp;7.2 shall be conclusive and binding on all persons. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.3</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Other Acceleration Rules</I></B>. The Administrator may override the provisions of Section&nbsp;7.2 by express provision in the award agreement and may
accord any Eligible Person a right to refuse any acceleration, whether pursuant to the award agreement or otherwise, in such circumstances as the Administrator may approve. The portion of any ISO accelerated in connection with an event referred to
in Section&nbsp;7.2 (or such other circumstances as may trigger accelerated vesting of the award) shall remain exercisable as an ISO only to the extent the applicable $100,000 limitation on ISOs is not exceeded. To the extent exceeded, the
accelerated portion of the option shall be exercisable as a nonqualified stock option under the Code. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.4</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Definition of Change in Control</I></B>. With respect to a particular award granted under this Plan, a &#147;Change in Control&#148; shall be deemed to
have occurred as of the first day, after the date of grant of the particular award, that any one or more of the following conditions shall have been satisfied: </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The acquisition by any individual, entity or group (within the meaning of Section&nbsp;13(d)(3) or 14(d)(2) of the Exchange Act (a &#147;<B>Person</B>&#148;)) of
beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of more than 30% of either (1)&nbsp;the then-outstanding shares of common stock of the Corporation (the &#147;<B>Outstanding Company Common Stock</B>&#148;)
or (2)&nbsp;the combined voting power of the then-outstanding voting securities of the Corporation entitled to vote generally in the election of directors (the &#147;<B>Outstanding Company Voting Securities</B>&#148;); provided, however, that, for
purposes of this clause (a), the following acquisitions shall not constitute a Change in Control Event; (A)&nbsp;any acquisition directly from the Corporation, (B)&nbsp;any acquisition by the Corporation, (C)&nbsp;any acquisition by any employee
benefit plan (or related trust) sponsored or maintained by the Corporation or any affiliate of the Corporation or a successor, or (D)&nbsp;any acquisition by any entity pursuant to a transaction that complies with Sections (c)(1), (2)&nbsp;and (3)
below; </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Individuals who, as of the Effective Date, constitute the Board (the &#147;<B>Incumbent Board</B>&#148;) cease for any reason to constitute at least a majority of the
Board; provided, however, that any individual becoming a director subsequent to the Effective Date whose election, or nomination for election by the Corporation&#146;s stockholders, was approved by a vote of at least two-thirds of the directors then
comprising the Incumbent Board (including for these purposes, the new members whose election or nomination was so approved, without counting the member and his predecessor twice) shall be considered as though such individual were a member of the
Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or
threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(c)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consummation of a reorganization, merger, statutory share exchange or consolidation or similar corporate transaction involving the Corporation or any
of its Subsidiaries, a sale or other disposition of all or substantially all of the assets of the Corporation, or the acquisition of assets or stock of another entity by the Corporation or any of its Subsidiaries (each, a &#147;<B>Business
Combination</B>&#148;), in each case unless, following such Business Combination, (1)&nbsp;all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding Company Common Stock and the Outstanding Company
Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock and the combined voting power of the then-outstanding voting securities entitled
to vote generally in the election of directors, as the case may be, of the entity resulting from such Business Combination (including, without limitation, an entity that, as a result of such transaction, owns the Corporation or all or substantially
all of the Corporation&#146;s assets directly or through one or more subsidiaries (a &#147;<B>Parent</B>&#148;)) in substantially the same </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="13%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
proportions as their ownership immediately prior to such Business Combination of the Outstanding Company Common Stock and the Outstanding Company Voting Securities, as the case may be,
(2)&nbsp;no Person (excluding any entity resulting from such Business Combination or a Parent or any employee benefit plan (or related trust) of the Corporation or such entity resulting from such Business Combination or Parent) beneficially owns,
directly or indirectly, more than 30% of, respectively, the then-outstanding shares of common stock of the entity resulting from such Business Combination or the combined voting power of the then-outstanding voting securities of such entity, except
to the extent that the ownership in excess of 30% existed prior to the Business Combination, and (3)&nbsp;at least a majority of the members of the board of directors or trustees of the entity resulting from such Business Combination or a Parent
were members of the Incumbent Board at the time of the execution of the initial agreement or of the action of the Board providing for such Business Combination; or </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(d)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Approval by the stockholders of the Corporation of a complete liquidation or dissolution of the Corporation other than in the context of a transaction that does not
constitute a Change in Control under clause (c)&nbsp;above. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>O<SMALL>THER</SMALL> P<SMALL>ROVISIONS</SMALL> </B></FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.1</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Compliance with Laws</I></B>. This Plan, the granting and vesting of awards under this Plan, the offer, issuance and delivery of shares of Common Stock,
and/or the payment of money under this Plan or under awards are subject to compliance with all applicable federal and state laws, rules and regulations (including but not limited to state and federal securities law and federal margin requirements)
and to such approvals by any listing, regulatory or governmental authority as may, in the opinion of counsel for the Corporation, be necessary or advisable in connection therewith. The person acquiring any securities under this Plan will, if
requested by the Corporation or one of its Subsidiaries, provide such assurances and representations to the Corporation or one of its Subsidiaries as the Administrator may deem necessary or desirable to assure compliance with all applicable legal
and accounting requirements. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.2</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>No Rights to Award</I></B>. No person shall have any claim or rights to be granted an award (or additional awards, as the case may be) under this Plan,
subject to any express contractual rights (set forth in a document other than this Plan) to the contrary. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.3</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>No Employment/Service Contract</I></B>. Nothing contained in this Plan (or in any other documents under this Plan or in any award) shall confer upon any
Eligible Person or other participant any right to continue in the employ or other service of the Corporation or one of its Subsidiaries, constitute any contract or agreement of employment or other service or affect an employee&#146;s status as an
employee at will, nor shall interfere in any way with the right of the Corporation or one of its Subsidiaries to change a person&#146;s compensation or other benefits, or to terminate his or her employment or other service, with or without cause.
Nothing in this Section&nbsp;8.3, however, is intended to adversely affect any express independent right of such person under a separate employment or service contract other than an award agreement. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.4</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Plan Not Funded</I></B>. Awards payable under this Plan shall be payable in shares or from the general assets of the Corporation, and no special or
separate reserve, fund or deposit shall be made to assure payment of such awards. No participant, beneficiary or other person shall have any right, title or interest in any fund or in any specific asset (including shares of Common Stock, except as
expressly otherwise provided) of the Corporation or one of its Subsidiaries by reason of any award hereunder. Neither the provisions of this Plan (or of any related documents), nor the creation or adoption of this Plan, nor any action taken pursuant
to the provisions of this Plan shall create, or be construed to create, a trust of any kind or a fiduciary relationship between the Corporation or one of its Subsidiaries and any participant, beneficiary or other person. To the extent that a
participant, beneficiary or other person acquires a right to receive payment pursuant to any award hereunder, such right shall be no greater than the right of any unsecured general creditor of the Corporation. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.5</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Tax Withholding</I></B>. Upon any exercise, vesting, or payment of any award, or upon the disposition of shares of Common Stock acquired pursuant to the
exercise of an ISO prior to satisfaction of the holding period requirements of Section&nbsp;422 of the Code, or upon any other tax withholding event with respect to any award, the Corporation or one of its Subsidiaries shall have the right at its
option to: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">require the participant (or the participant&#146;s personal representative or beneficiary, as the case may be) to pay or provide for payment of at least the minimum
amount of any taxes which the Corporation or one of its Subsidiaries may be required to withhold with respect to such award event or payment; or </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">deduct from any amount otherwise payable in cash (whether related to the award or otherwise) to the participant (or the participant&#146;s personal representative or
beneficiary, as the case may be) the minimum amount of any taxes which the Corporation or one of its Subsidiaries may be required to withhold with respect to such award event or payment. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In any case where a tax is required to be withheld in connection with the delivery of shares of Common Stock under this Plan, the
Administrator may in its sole discretion (subject to Section&nbsp;8.1) require or grant (either at the time of the award or thereafter) to the participant the right to elect, pursuant to such rules and subject to such conditions as the Administrator
may establish, that the Corporation reduce the number of shares to be delivered by (or otherwise reacquire) the appropriate number of shares, valued in a consistent manner at their fair market value or at the sales price in accordance with
authorized procedures for cashless exercises, necessary to satisfy the minimum applicable withholding obligation on exercise, vesting or payment. In no event shall the shares withheld exceed the minimum whole number of shares required for tax
withholding under applicable law. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.6</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B></B><B><I>Effective Date, Termination and Suspension, Amendments</I></B><B></B><B>.</B><B></B> </FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.6.1 </B><B><I>Effective Date</I></B>.<B><I> </I></B>This Plan is effective as of April&nbsp;4, 2012, the date of its approval by the
Board<B><I> </I></B>(the<B><I> &#147;</I></B><B>Effective Date</B>&#148;). This Plan shall be submitted for and subject to stockholder approval no later than twelve months after the Effective Date. Unless earlier terminated by the Board, this Plan
shall terminate at the close of business on the day before the tenth anniversary of the Effective Date. After the termination of this Plan either upon such stated expiration date or its earlier termination by the Board, no additional awards may be
granted under this Plan, but previously granted awards (and the authority of the Administrator with respect thereto, including the authority to amend such awards) shall remain outstanding in accordance with their applicable terms and conditions and
the terms and conditions of this Plan. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.6.2 </B><B><I>Board Authorization</I></B>. The Board may, at any time, terminate
or, from time to time, amend, modify or suspend this Plan, in whole or in part. No awards may be granted during any period that the Board suspends this Plan. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>8.6.3 </B><B><I>Stockholder Approval</I></B>. To the extent then required by applicable law or any applicable listing agency or required under Sections 162, 422 or 424 of the Code to preserve the
intended tax consequences of this Plan, or deemed necessary or advisable by the Board, any amendment to this Plan shall be subject to stockholder approval. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>8.6.4 </B><B><I>Amendments to Awards</I></B>. Without limiting any other express authority of the Administrator under (but subject to) the express limits of this Plan, the Administrator by agreement or
resolution may waive conditions of or limitations on awards to participants that the Administrator in the prior exercise of its discretion has imposed, without the consent of a participant, and (subject to the requirements of Sections 3.2 and 8.6.5)
may make other changes to the terms and conditions of awards. Any amendment or other action that would constitute a repricing of an award is subject to the limitations set forth in Section 3.2. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.6.5 </B><B><I>Limitations on Amendments to Plan and Awards</I></B>. No amendment, suspension or termination of this Plan or amendment
of any outstanding award agreement shall, without written consent of the participant, affect in any manner materially adverse to the participant any rights or benefits of the </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">
participant or obligations of the Corporation under any award granted under this Plan prior to the effective date of such change. Changes, settlements and other actions contemplated by
Section&nbsp;7 shall not be deemed to constitute changes or amendments for purposes of this Section 8.6. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.7</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Privileges of Stock Ownership</I></B>. Except as otherwise expressly authorized by the Administrator, a participant shall not be entitled to any privilege
of stock ownership as to any shares of Common Stock not actually delivered to and held of record by the participant (subject to the last sentence of Section&nbsp;5.1.4). Except as expressly required by Section&nbsp;7.1 or otherwise expressly
provided by the Administrator, no adjustment will be made for dividends or other rights as a stockholder for which a record date is prior to such date of delivery. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.8</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Governing Law; Construction; Severability</I></B>.<B><I></I></B> </FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>8.8.1 </B><B><I>Choice of Law</I></B>. This Plan, the awards, all documents evidencing awards and all other related documents shall be governed by, and construed in accordance with the laws of the
State of Delaware. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.8.2 </B><B><I>Severability</I></B>. If a court of competent jurisdiction holds any provision invalid
and unenforceable, the remaining provisions of this Plan shall continue in effect. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.8.3 </B><B><I>Plan
Construction</I></B>. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Rule 16b-3</U>. It is the intent of the Corporation that the awards and transactions permitted by awards be interpreted in a manner that, in the case of participants
who are or may be subject to Section&nbsp;16 of the Exchange Act, qualify, to the maximum extent compatible with the express terms of the award, for exemption from matching liability under Rule 16b-3 promulgated under the Exchange Act.
Notwithstanding the foregoing, the Corporation shall have no liability to any participant for Section&nbsp;16 consequences of awards or events under awards if an award or event does not so qualify. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Section&nbsp;162(m)</U>. Awards under Section&nbsp;5.1.4 to persons described in Section&nbsp;5.2 that are either granted or become vested, exercisable or payable
based on attainment of one or more performance goals related to the Business Criteria, as well as Qualifying Options and Qualifying SARs granted to persons described in Section&nbsp;5.2, that are approved by a committee composed solely of two or
more outside directors (as this requirement is applied under Section&nbsp;162(m) of the Code) shall be deemed to be intended as performance-based compensation within the meaning of Section&nbsp;162(m) of the Code unless such committee provides
otherwise at the time of grant of the award. It is the further intent of the Corporation that (to the extent the Corporation or one of its Subsidiaries or awards under this Plan may be or become subject to limitations on deductibility under
Section&nbsp;162(m) of the Code) any such awards and any other Performance-Based Awards under Section&nbsp;5.2 that are granted to or held by a person subject to Section&nbsp;162(m) will qualify as performance-based compensation or otherwise be
exempt from deductibility limitations under Section&nbsp;162(m). </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.9</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Captions</I></B>. Captions and headings are given to the sections and subsections of this Plan solely as a convenience to facilitate reference. Such
headings shall not be deemed in any way material or relevant to the construction or interpretation of this Plan or any provision thereof. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.10</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Stock-Based Awards in Substitution for Stock Options or Awards Granted by Other Corporation</I></B>. Awards may be granted to Eligible
Persons in substitution for or in connection with an assumption of employee stock options, SARs, restricted stock or other stock-based awards granted by other entities to persons who are or who will become Eligible Persons in respect of the
Corporation or one of its Subsidiaries, in connection with a distribution, merger or other reorganization by or with the granting entity or an affiliated entity, or the acquisition by the Corporation or one of its Subsidiaries, directly or
indirectly, of all or a substantial part of the stock or assets of the employing entity. The awards so granted need not comply with other specific terms of this Plan, provided the awards reflect only adjustments giving effect to the assumption or
substitution consistent with the conversion applicable to </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
the Common Stock in the transaction and any change in the issuer of the security. Any shares that are delivered and any awards that are granted by, or become obligations of, the Corporation, as a
result of the assumption by the Corporation of, or in substitution for, outstanding awards previously granted by an acquired company (or previously granted by a predecessor employer (or direct or indirect parent thereof) in the case of persons that
become employed by the Corporation or one of its Subsidiaries in connection with a business or asset acquisition or similar transaction) shall not be counted against the Share Limit or other limits on the number of shares available for issuance
under this Plan. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.11</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Non-Exclusivity of Plan</I></B>. Nothing in this Plan shall limit or be deemed to limit the authority of the Board or the Administrator to grant awards or
authorize any other compensation, with or without reference to the Common Stock, under any other plan or authority. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.12</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>No Corporate Action Restriction</I></B>. The existence of this Plan, the award agreements and the awards granted hereunder shall not limit, affect or
restrict in any way the right or power of the Board or the stockholders of the Corporation to make or authorize: (a)&nbsp;any adjustment, recapitalization, reorganization or other change in the capital structure or business of the Corporation or any
Subsidiary, (b)&nbsp;any merger, amalgamation, consolidation or change in the ownership of the Corporation or any Subsidiary, (c)&nbsp;any issue of bonds, debentures, capital, preferred or prior preference stock ahead of or affecting the capital
stock (or the rights thereof) of the Corporation or any Subsidiary, (d)&nbsp;any dissolution or liquidation of the Corporation or any Subsidiary, (e)&nbsp;any sale or transfer of all or any part of the assets or business of the Corporation or any
Subsidiary, or (f)&nbsp;any other corporate act or proceeding by the Corporation or any Subsidiary. No participant, beneficiary or any other person shall have any claim under any award or award agreement against any member of the Board or the
Administrator, or the Corporation or any employees, officers or agents of the Corporation or any Subsidiary, as a result of any such action. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.13</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Other Company Benefit and Compensation Programs</I></B>. Payments and other benefits received by a participant under an award made pursuant to this Plan
shall not be deemed a part of a participant&#146;s compensation for purposes of the determination of benefits under any other employee welfare or benefit plans or arrangements, if any, provided by the Corporation or any Subsidiary, except where the
Administrator expressly otherwise provides or authorizes in writing. Awards under this Plan may be made in addition to, in combination with, as alternatives to or in payment of grants, awards or commitments under any other plans or arrangements of
the Corporation or its Subsidiaries. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.14</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Clawback Policy</I></B>. The awards granted under this Plan are subject to the terms of the Corporation&#146;s recoupment, clawback or similar policy as it
may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require repayment or forfeiture of awards or any shares of Common Stock or other cash or property received with
respect to the awards (including any value received from a disposition of the shares acquired upon payment of the awards). </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">16 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:6.5pt" ALIGN="center">


<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:6.5pt">
<TD VALIGN="top"> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt; text-indent:6.00em"><B><I>


<IMG SRC="g913905img1.jpg" ALT="LOGO">
</I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:6.00em; font-size:6pt; font-family:ARIAL"><B><I>NEKTAR THERAPEUTICS</I></B>
<B><I></I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:6.00em; font-size:6pt; font-family:ARIAL"><B><I>ATTN: SECRETARY</I></B> <B><I></I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:6.00em; font-size:6pt; font-family:ARIAL"><B><I>455 MISSION BAY BOULEVARD SOUTH</I></B> <B><I></I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; text-indent:6.00em; font-size:6pt; font-family:ARIAL"><B><I>SAN FRANCISCO, CA 94158</I></B></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6.5pt; font-family:ARIAL" ALIGN="justify"><B>VOTE BY INTERNET - www.proxyvote.com</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6.5pt; font-family:ARIAL" ALIGN="justify">Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time on June 15, 2015. Have
your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. <B></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6.5pt; font-family:ARIAL" ALIGN="justify"><B>ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6.5pt; font-family:ARIAL" ALIGN="justify">If you would like to reduce the costs incurred by Nektar Therapeutics in mailing proxy materials, you can consent to receiving all future proxy
statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or
access stockholder communications electronically in future years. <B></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6.5pt; font-family:ARIAL" ALIGN="justify"><B>VOTE BY PHONE - 1-800-690-6903</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6.5pt; font-family:ARIAL" ALIGN="justify">Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time on June 15, 2015. Have your proxy card in hand when
you call and then follow the instructions. <B></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6.5pt; font-family:ARIAL" ALIGN="justify"><B>VOTE BY MAIL</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:6.5pt; font-family:ARIAL" ALIGN="justify">Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51
Mercedes Way, Edgewood, NY 11717.</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:ARIAL">TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:</P>
<P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:ARIAL" ALIGN="right">KEEP THIS PORTION FOR YOUR RECORDS</P></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp; &#151;&nbsp;
&#151;&nbsp; &#151;&nbsp; &#151;&nbsp; &#151;&nbsp; &#151;&nbsp; &#151;&nbsp; &#151;&nbsp; &#151;&nbsp; &#151;&nbsp; &#151;&nbsp; &#151;&nbsp; &#151;&nbsp; &#151;&nbsp; &#151;&nbsp; &#151;&nbsp; &#151;&nbsp; &#151;&nbsp; &#151;&nbsp; &#151;&nbsp;
&#151;&nbsp; &#151;&nbsp; &#151;&nbsp; &#151;&nbsp; &#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp; </P> <P STYLE="margin-top:1pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="right">DETACH AND
RETURN THIS PORTION ONLY </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>THIS&nbsp;&nbsp;PROXY&nbsp;&nbsp;CARD&nbsp;&nbsp;IS&nbsp;&nbsp;VALID&nbsp;&nbsp;ONLY&nbsp;&nbsp;WHEN&nbsp;&nbsp;SIGNED&nbsp;&nbsp;AND&nbsp;
&nbsp;DATED. </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="10" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="9"><B>The Board of Directors recommends you vote FOR</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="9"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:ARIAL"><B>the following:</B></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000"></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-RIGHT:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="6"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-left:2.00em; text-indent:-2.00em; font-size:7pt; font-family:ARIAL"><B>1.</B>&nbsp;&nbsp;&nbsp;&nbsp;Electionof Directors</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><B>For</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><B>Against</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><B>Abstain</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="6"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:ARIAL">1a. &nbsp;Robert B. Chess</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:ARIAL">1b. &nbsp;Susan Wang</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><B>For</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><B>Against</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><B>Abstain</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="6"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:ARIAL">1c. &nbsp;Roy A. Whitfield</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-2.00em; font-size:7pt; font-family:ARIAL"><B>4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>To approve a non-binding advisory resolution regarding our executive compensation (a &#147;say-on-pay&#148;
vote).</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="11"><B>The Board of Directors recommends you vote FOR</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:ARIAL"><B>proposals 2, 3 and 4.</B></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><B>For</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><B>Against</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><B>Abstain</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="6"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:ARIAL"><B>2</B>&nbsp;&nbsp;&nbsp;&nbsp;To approve an amendment to our 2012 Performance Incentive Plan to increase the aggregate number of
shares of common stock available for issuance under the plan by 7,000,000 shares.</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:ARIAL"><B>3</B>&nbsp;&nbsp;&nbsp;&nbsp;To ratify the selection of Ernst &amp; Young LLP as our independent registered public accounting firm
for the fiscal year ending December 31, 2015.</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" ROWSPAN="9" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE="margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g913905img2.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"></TD>
<TD VALIGN="bottom" ROWSPAN="9"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:ARIAL">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="7">Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must
sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:ARIAL">For address change/comments, mark here.</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:ARIAL">(see reverse for instructions)</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><B>Yes</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><B>No</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:ARIAL">Please indicate if you plan to
attend this meeting</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:ARIAL" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT
STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:ARIAL" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT
STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:ARIAL"><B><U>Materials Election</U>
</B>- Check this box if you want to</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:ARIAL" ALIGN="center"><FONT STYLE="font-family:Times New Roman"><FONT
STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:ARIAL">receive a complete set of future proxy materials by</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:ARIAL">mail, at no extra cost. If you do not take action</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:ARIAL">you may receive only a Notice to inform you of the</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:ARIAL">Internet availability of proxy materials.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-size:7pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Signature&nbsp;[PLEASE&nbsp;SIGN&nbsp;WITHIN&nbsp;BOX]</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">Date</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">Signature (Joint Owners)</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">Date</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="7"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Important Notice Regarding Internet Availability of Proxy Materials for the Annual Meeting:</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center">The Proxy Statement and Annual Report are available at www.proxyvote.com.</P>
<P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: </B>The Notice and Proxy Statement, Annual Report is/are
available at <FONT STYLE="font-family:ARIAL" COLOR="#0000f4"><U>www.proxyvote.com</U></FONT><FONT STYLE="font-family:ARIAL">.</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:Times New Roman" align="left">&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:6pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="24%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="57%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-RIGHT:1.50pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="12" STYLE="BORDER-TOP:1.50pt solid #000000; BORDER-RIGHT:1.50pt solid #000000">&nbsp;</TD></TR>

<TR STYLE="font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" ROWSPAN="6" STYLE="BORDER-RIGHT:1.50pt solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g913905img3.jpg" ALT="LOGO">
</P> <P STYLE="font-size:24pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="11" STYLE="BORDER-RIGHT:1.50pt solid #000000; padding-right:8pt"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6pt; font-family:ARIAL" ALIGN="center"><B>NEKTAR THERAPEUTICS</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6pt; font-family:ARIAL" ALIGN="center"><B>PROXY SOLICITED BY THE BOARD OF DIRECTORS</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6pt; font-family:ARIAL" ALIGN="center"><B>FOR THE ANNUAL MEETING OF STOCKHOLDERS</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6pt; font-family:ARIAL" ALIGN="center"><B>TO BE HELD ON JUNE 16, 2015</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; font-size:6pt; font-family:ARIAL" ALIGN="justify">The undersigned hereby appoints Howard W. Robin and Gil M. Labrucherie, and each of them, as attorneys-in-fact and proxies of the
undersigned, with full power of substitution, to vote all of the shares of stock of Nektar Therapeutics which the undersigned may be entitled to vote at the annual meeting of stockholders of Nektar Therapeutics to be held on Tuesday, June 16, 2015
at 2:00 p.m. local time at Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA 94158 (and at any and all postponements, continuations and adjournments thereof), with all powers that the undersigned would possess if personally
present, upon and in respect of the matters listed on the reverse side and in accordance with the instructions specified on the reverse side, with discretionary authority as to any and all matters that may properly come before the meeting. You
hereby revoke all proxies previously given.</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; font-size:6pt; font-family:ARIAL" ALIGN="justify"><B>Unless a contrary direction is indicated, this Proxy will be voted FOR all nominees listed in Proposal 1, and FOR Proposals 2, 3
and 4, as more specifically indicated in the Proxy Statement, and at the discretion of the proxies with regard to any other matter that may properly come before the meeting or any continuation, adjournment or postponement thereof.</B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:14.00em; font-size:6pt; font-family:ARIAL"><B>If you vote by telephone or Internet, you do not need to mail
back this Proxy.</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; font-size:9pt; font-family:ARIAL"><B>Address change / comments:</B></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:16pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000"></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"></TD>
<TD VALIGN="bottom" COLSPAN="3" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:16pt; font-family:ARIAL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1.50pt solid #000000; padding-right:8pt">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:16pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:16pt; font-family:ARIAL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1.50pt solid #000000; padding-right:8pt">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:16pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:16pt; font-family:ARIAL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1.50pt solid #000000; padding-right:8pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-family:ARIAL; font-size:2pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1.50pt solid #000000; padding-right:8pt">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000"></TD>
<TD VALIGN="bottom" COLSPAN="9" STYLE="BORDER-BOTTOM:1.50pt solid #000000"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="center">(If you
noted any Address Changes and/or Comments above, please mark corresponding box on the reverse side.)</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Continued and to be signed on reverse side</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1.50pt solid #000000; BORDER-BOTTOM:1.50pt solid #000000; padding-right:8pt">&nbsp;</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g913905g31b98.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g913905g31b98.jpg
M_]C_X``02D9)1@`!`0(!>@%Z``#_X4F':'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87`O,2XP+P`\/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](EA-4"!#;W)E(#4N,2XR(CX*(#QR9&8Z4D1&('AM
M;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN
M=&%X+6YS(R(^"B`@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*("`@
M('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+R(*("`@
M('AM;&YS.GAM<$=);6<](FAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]G
M+VEM9R\B"B`@("!X;6QN<SIP9&8](FAT='`Z+R]N<RYA9&]B92YC;VTO<&1F
M+S$N,R\B"B`@("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE
M;G1S+S$N,2\B"B`@("!X;6QN<SIX;7!44&<](FAT='`Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"]T+W!G+R(*("`@('AM;&YS.G-T1&EM/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C`O<U1Y<&4O1&EM96YS:6]N<R,B"B`@("!X;6QN
M<SIS=$9N=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+W-4>7!E+T9O
M;G0C(@H@("`@>&UL;G,Z>&UP1STB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O
M,2XP+V<O(@H@("`@>&UL;G,Z>&UP34T](FAT='`Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"]M;2\B"B`@("!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87`O,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(@H@("`@>&UL;G,Z
M<W12968](FAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O
M=7)C95)E9B,B"B`@("!X;6QN<SI%>'1E;G-I<T9O;G1396YS93TB:'1T<#HO
M+W=W=RYE>'1E;G-I<RYC;VTO;65T82]&;VYT4V5N<V4O(@H@("!X;7`Z0W)E
M871E1&%T93TB,C`Q-2TP-"TR.%0Q-CHQ,3HQ,"LP-3HS,"(*("`@>&UP.D-R
M96%T;W)4;V]L/2)!9&]B92!);&QU<W1R871O<B!#4S8@*%=I;F1O=W,I(@H@
M("!X;7`Z36]D:69Y1&%T93TB,C`Q-2TP-"TR.%0Q-CHQ,3HQ,"LP-3HS,"(*
M("`@>&UP.DUE=&%D871A1&%T93TB,C`Q-2TP-"TR.%0Q-CHQ,3HQ,"LP-3HS
M,"(*("`@<&1F.E!R;V1U8V5R/2)!9&]B92!01$8@;&EB<F%R>2`Q,"XP,2(*
M("`@9&,Z9F]R;6%T/2)A<'!L:6-A=&EO;B]P;W-T<V-R:7!T(@H@("!X;7!4
M4&<Z3E!A9V5S/2(Q(@H@("!X;7!44&<Z2&%S5FES:6)L951R86YS<&%R96YC
M>3TB1F%L<V4B"B`@('AM<%109SI(87-6:7-I8FQE3W9E<G!R:6YT/2)4<G5E
M(@H@("!X;7!-33I$;V-U;65N=$E$/2)X;7`N9&ED.D%"-C0U,C5%.$-%1$4T
M,3$Y,CDP.48U03!&0C9&-S)$(@H@("!X;7!-33I);G-T86YC94E$/2)X;7`N
M:6ED.D%"-C0U,C5%.$-%1$4T,3$Y,CDP.48U03!&0C9&-S)$(@H@("!X;7!-
M33I/<FEG:6YA;$1O8W5M96YT240](GAM<"YD:60Z1#0W1$0W-S,X1D5$130Q
M,4$R0S)#,S(U,S<X,S!&04,B"B`@('AM<$U-.E)E;F1I=&EO;D-L87-S/2)D
M969A=6QT(CX*("`@/'AM<#I4:'5M8FYA:6QS/@H@("`@/')D9CI!;'0^"B`@
M("`@/')D9CIL:0H@("`@("!X;7!'26UG.G=I9'1H/2(R-38B"B`@("`@('AM
M<$=);6<Z:&5I9VAT/2(U-B(*("`@("`@>&UP1TEM9SIF;W)M870](DI014<B
M"B`@("`@('AM<$=);6<Z:6UA9V4](B\Y:B\T04%14VM:2E)G04)!9T5!4T%"
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M1D=I9&MD1E4S.'%/>G=Y9W`F(WA!.S`K4'IH2E-K=$U453504FQD65=6<&)8
M1C%E6#%2;%IM9&]A5W!R8D<Q=6(R4C%D;F0T95AP-V9(,2MF,T]%:%EA2&E)
M;4MI-'E.:F\F(WA!.RM$;$I75VPU:5IM<'5C;EHV9FMQ3VMP86%N<4MM<7$V
M>71R<2MV+V%!07=$05%!0T5135)!1#A!-G!C-F@K655E<WDS0RMB9$=';'(F
M(WA!.TI+<',U3#(Q4FM#6&-Z37!F.4AS,55T8F561'8X3%)T5W9":5965%9*
M+U`X,$5-;6XK9$Y(9W4Y371,4U16-#5*25AH4C=:-31T4W4F(WA!.TI3<U-(
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M3W=G9E0O>DQV<FEX=C)3-3`K-V5+*VU+<$YC5W-A*W),1E!(15@Y4D]-=G$F
M(WA!.W%+1U5L:U=U-G%,=F)/1%=T4718,'(X=SE6=$I(=&IP,&QO24Y1-%-8
M:'193&-4.&95:$UB:C8W0DYX<CEO;&ED;DE696AE4CED,%`F(WA!.U5,5S9T
M=$\Q4UA62G)E6#9Z8W9/<S9326UO5G4W9&5.>#A155%Y<7%G8D%#;$)39T-S
M;'A6,DMU>%8R2W-"+TU#3G!.8W-Y4$TQ>F\F(WA!.V=I='=X<W)A,W9*5W5/
M5C%%3U-M0U959&M.0G=737-/5E@U4C%5<7-1:RMP2F]L>F$V,2M:5GE,95@V
M9SA..4AB,V1S9VII:5=(9UHF(WA!.UIP<'A+<WHS54PS4'@O>F,K3S51<6EB
M3WIB5'19-5A0-6=8.'EW,VQX33%V.58Q16E337I7<$9S0S`X<TQ*1TI%;UDP
M,U-4;#EI=4LF(WA!.V]B.4=X86EY4S9B*UI7<D-Y9%E&:FHY2R]K26EU:BLU
M+V5I4D<U3W5Q=T0Q1S-(1W`S42MM<3EF,%173DPQ:E-R9E5T2VXK=&%F3T0F
M(WA!.S9%-#5$:T59;U0X641D5E!807%/>%8R2W5X5C)+=DXO3U542C5P=6)I
M6'I:8S9:1$9A>#-,859"8C,X:4-+2T<V6C53,$4V<7A9478F(WA!.WE#2TYL
M1S-Q1TYW<7@K-3`R,4]K>F%4<4@U:3-Y5#,P<DY(9DY&9'=X2U=S<G%Z;UAK
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M2G`X.'-I2W@F(WA!.VMT2E=$=D))1',X6EIA.%=R5&5N53%657)B>6PU671N
M<UI9=$MT9E@P>4=+,C`K-65*2DHT66]&2U)):WIH<$%&5C)!*TQU9D4T<6\F
M(WA!.VIY3#5,1CED6'<P3WA7-W9O<&],*U)B94EF5TDW:#%K;%<T05=K=DXT
M,4HU9R]I8U9B2&MJ>6-*6C5";VQL5S9E1U<T47=2;$AL='DF(WA!.S5I;$U:
M2$0Q13E2=FIP>3DY:&EQ8E=L;F%75G1&85=C161T87=Q16AG:%99-#!59$96
M5D%!2'EX5E9X5C)+=7A6-38O-6,K650U=&8F(WA!.U9$-6=U5W0U66Y56$ML
M5G59-FM%4C`T*VYW+S%14&QM>"]/43A0:#129C)/2"M7;'@X6$55,R]W5G$S
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M3"]M:D@X>D@K6D9F0E`X-E1V.$9A="\Q3D]P+W=$0E)F.$$F(WA!.TY'4#5M
M4#A!36EV9VXK9$HS*T-T5R\V;6Y5+RM#:2\U;W@O37@O;5)8=U0O041P3R]W
M049A="\Q3D]P+SA&1B]Z4FHK6FHO36EV9VXF(WA!.RMD2C,K0W17+W=#<'`Q
M4"]!24M,+VUJ2#AZ2"M:1F9"4#@V5'8X1F%T+S%.3W`O.$9&+WI2:BM::B]-
M:79G;BMD2D4R4&Q856)9>FTF(WA!.U1Z0F8S4')1=D-O;$UF=TTT;TI&;V\K
M2F4R4FQN:68T66AL2$52+T552R]K<E=E1&5N-7`Q2791.$%Z4F=6-U9O;5,O
M37@O;5)9*T,F(WA!.V8U>%,W>3$U53AZ,V9L+U0W<E5V3E8X8C8T=#0U6GI!
M545F2C%$9D-'56MB2$@X>D@K6D909VXK8U5Y+W=6<3,O53`V;B]W55@O3D<F
M(WA!.U`U;5`X>4M00E`X04]K-R]!059Q,R]5,#9N+W=56"].1U`U;5`X>4LK
M0V8U,&YF-$LQ8B]!2VUN52\X06=O=BMA369Z368U:U8X12\F(WA!.WIP3R]W
M5G$S+U4P-FXO=U58+TY'4#5M4#AY2RM#9C4P;F8T2S%B+W%A9%0O04]#:2]W
M0V%-9GI-9C5K5CA%+WIP2E@U:#AQ96$W5S`F(WA!.W0U9$XX,#-P8S-L<D9/
M2C)7:&AL;5=.*TA&4'0O2'-4:BM::B]-:6YW5"]/2V4R;FQ855E)<FQ(.'<S
M.#5N:CE.2&M-9%EJ>4(U<%(F(WA!.V9T8E5Y37,X5%AP:6M9:5`T:6AV.$9A
M="]W0E14<68O04%56"].1U,O37@O;5)9*T-F-3!N9C1+,6(O<6%D5"]!3T-I
M+W=#84UF>DTF(WA!.V8U:U8X12]Z<$\O=U9Q,R]!1DY/<"\X04)29C@P62]M
M62]Z27(T2B]N4V0O9W)6=BMP<#%0+V=O=BMA369Z368U:U8X12]Z<$\O=U8F
M(WA!.W$S+U4P-FXO04U&1B]W03!9+VU9+W=!>4LK0V8U,&YF-$LQ8B]Q8614
M+S1+3"]M:D@X>D@K6D9F0E`X04]K-R]!059Q,R]5,#9N+W<F(WA!.U58+TY'
M4#5M4#AY2RM#9C4P:W,Q>GER-7!T:EEF55!.1C923F524EA8<DUN.7DQ969$
M:6XR+T-U,E`U;5`X>4MF0E`X-'-M,%!18C,F(WA!.U1:<%I,:E8W=E5L:U5+
M<V1Y54MQ46$Q2$96,WER3&Q%:'1%4CEZ3T5$2&U3531Y;'-12&U#5U-,4613
M;&EC>'EX,G,W239K:&Q94G,F(WA!.U%14C!)>%8U-7(S;38K,&YZ3"MI:C5:
M,64T<U!R4G1K,4M/.3%2:$EI,GE80FMI4DDU1FM0>$]O45!5;$13<#)W<6@Y
M0C@S95DY4G4F(WA!.S<K>'5V2U=P5VPQ86]S;'0V;7`V9VEY:5<U:FA137)P
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M5E0X=65C3EHF(WA!.S%8>D9A-F)D*U9D5S`V>'99-35)<G4U=CE2:&M4-G9'
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M>%<T1G,Q27!'84]V1VI5<C-P9U9K+S9!<V8Y*S-N+U-B968Y5F-643`Y:$9:
M86IP8E<X,7HK*W58:FQ74S4F(WA!.W5*5EIF<7-Z,$MY3S8O85%(<&ER2%!.
M;7$V:'!K=#=D5VUL86AR:W(S>&<K<C)L,65X3$1';6UR3T<T5W=L;T=K6&AS
M;C)N.&1I5EDF(WA!.VLS-6IE65`P6EDV<$8U3C%6-U<V:V%*,4]P-FEO06%+
M0U='6DI74E4T3UHS:BM0:CA3,$AX9D1I<5HV>#5M,74S,5,X<U0U2C%M.',F
M(WA!.W)7-FA3,W9%=CE19%IL.60Q.5965D=P=SE)3TXV8FER2TXX5E5D3S@U
M96%,<68P<'9),G,R>#5884(S,4A5*T).=&)I5T]J1TID<%HF(WA!.T0V64Q5
M2&13+U1&55A*-7`Q9$Y/3C$O:%A71VTK=5A&;W-!=3E93EEO25!55S50*VHX
M>$<W+T(Y:7`O635T5E%Q;5AL6%=:=&(Q;5@F(WA!.U1B=E%D83!L65E:6EAU
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M=%%Q>&QI1'-"-G9O1W%%,#)"-U9O+TI&0W`F(WA!.W)R,FI7,$=H-FI01%!E
M2DY&87I01S1V8G5O6EEY45(K.3=(1E5F-6PO=T-58S%8+T%*9S=J+VLP,DMV
M3G9-97`K9D8X-5AX6'IT<$\F(WA!.VAE5C=E-5=#4S%U2C=)6&%O8EI*2$ME
M<$)*-F)J:WIG4W-F1V=8<7%G6G)J>C-P-F9O6G9Z2C!I>G9,2WI+:&)I-71*
M3&US9&]K:V,F(WA!.S!W=4Q:<$]0=S@U0WA9;%=:-B]%<6]Q<7<V-S4O9S%3
M3S,Q1'HW-6949S5I;'123F)O>&QL;E=31D$W5W=Q=VA"0FI(>$944V]9:54F
M(WA!.T951F4V<"MB<VE25SEV-3$P93)C-F9A5'=A;S`K;DQA6&-K>&%&;FI5
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M0E)2=C-+3C!O>7%O9&17,#=5<GEZ5WDO33)A-#`R2S@Q5%4F(WA!.TY74FXQ
M83%U;W)E3S)I;D9S:U-30U@P;VQH9F5744AD=4981%E&87-:.4AU1C`R.&<O
M3FY66F95:W0R6&AB-G`O<$MW0U-S8U5,4W,F(WA!.T]5;C%2,5E&6$I054UZ
M<E5Q;DQA<%DV8VUN5TTO;C8W=4ER2S%L8E9::&(V=#8P<V0R4')T=$]S<7EZ
M:7%-26\K4#)I<DY(>4):57@F(WA!.U9$4F%X0DQP1VLV578U:3-.;G)-:5-1
M>3--;'1Q3G<Y,')45W-C1'@O=F\P4BM-4TQ)45I">F5A:F9B3TMV6CE6+S-U
M,&(O;4UF.$$F(WA!.S9G-VI!<D)V>D139&]B:W!R.3$U9&A'<5`V.3=:4EA%
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M.5AJ=E)0*UI/;S-G5T,S=4E)9E$Q35$R9'@F(WA!.UEW4EAO;'`V;V1M.4Y3
M-G!)>&-T,V%20U%Q<#-&,S5F*W)7,7=N-6TV,T)),7,X3%-08F$R5FUE6DQI
M1T]D66UK1E!33DXQ,D1)3U(F(WA!.W$R-G%A,W0O<'1H-79H=&)R.'AD5FIU
M2#%/,W99.4Y&;'%B8V]P2DI,=&)$:T=A2&DX8S9Q5DMC9T5#:V)C8T-V5%@X
M>#9,-6HX:3,F(WA!.S)S84QC:3@P,C1T3'-1,T-Q-D)J1W)X=#A,:%=&1U5J
M8UEQ;5AM6"]!2E)Z5F8X06U$=5`K5%19<3AX+TU$6%!Y<'0W<E9K,2]4<C8F
M(WA!.RMK:G5M4SEI9W9T<%IF,&588FA$.61I,E<S3$IX-$1I>"MY3U935E-,
M54YC+TI',3@P4S)L>G`R<#,K<E%W.#(Q05@S1D13,3E154$F(WA!.W990D4P
M8V9W."]454EY.'53:&5E2V]Z5CEC+TIZ+T5A,D1E5V14=717=5-,4T0P96-3
M,6LP-DI6:E)N=5E5:')B6$MX+W,X5W%45#<F(WA!.U)6449R<G8U3EA8;#-3
M4DXU2'5Q=7EA6$AP.7-96D]%.%5S17!H37!U66952'(S22M/4VAA:F,V9$-Q
M<%=V;6HX:&QV8DA53%!Y.7$F(WA!.U5J869%-U=D*W1X5D97>6%38U)J;F9!
M>49J15I!;D9U4F)F-'%G2W$Y-S5I+TIB5')/-#AZ>F%$<FXQ9#!S-U@P5T9X
M2'A3+VAM=4(F(WA!.S9A4U1X9D-),&%.:EAJ=T-R2%=0<7%M,VQ85W9Y9G-V
M33%L2&]U:5@Y='%N,6U/,V=U6&Q::SE2-4QU>EAK>C-4:5AJ>&QQ;T1-03,F
M(WA!.TQJ.$1C1EAQ=&@O>#)D52\U-&8X;7IG5DUS5F5B-FYD5V-&<F]8<655
M62]-1G=D3'175SAA,6QM84]K.75Q=RMO=')C2W1/8E1!8W@F(WA!.U%P56A2
M.%=&56PP;E=D3&%Z=$I,5#AS,6EN63AR>7A.=$HO;V,T;6<T>$EP<S9*5TY)
M6BMK635C5W!14U-2:%9Q*V%9=G$R:S)39FPF(WA!.U=*2&4R*W-064IB<49S
M9RMP1T1J=VMT63)53E8W:79"83=M;$MU1EAA6C5H.'=W-EIF23,U6%<X8F<S
M1GA"67=2>5%X<VMS3"MS:G,F(WA!.V)-<3AS-GAC4&A8-'E1<FA!5DQ+;V%X
M.'=3=6(R,VPO2T-','0W9$8U36)A5F\U1FU-:V9&5E144WHP3G=X:T-+,45D
M>G5A<7EQ2C$F(WA!.WI6:4Q:9%HO-59&2F8S;VQU-T5W;4],;3%V0T5T;W!#
M:7=Y1FQL:'%Q.#`K1E%1<%I$57%O934X>E1,9%A92#50:5E7,TMA0S0K<E`F
M(WA!.U(U27`T-$50*SA"8FM644]V1&M114(K>E)S2W979%)9=&0V27A8:5=U
M,DI5.5%46C-',D)72V5C3&U#,VHQ0C503%5F;61J9G5&=$HF(WA!.TE*2GA'
M4#!7:%IV,V1T9#`U,#E)+T-+:'%$:V9H2E9)3')79%!75%5'5#AT,75D4U)Y
M2C=1=U-&6DE284]96G=0<6I#<S-/84%N:'4F(WA!.W%-=DIJ=VI:5D176&UI
M,VDP2T)%+TMX3&%A5V$Y:VDP4DQ:;S)B-G9B=W0V>4DY;$8X579.67EZ2V\K
M1V=:;6]M0E8K;F59+TUA6&LF(WA!.TU+9FQF8C(Q;').=D-"0TDU67I%-GEY
M;#%V<$9S;6I#0U%Q>7)X*T569C1I,T93<4AI.'=V1TQE5U@X;E93-&EN0W=R
M0F)C>D=);6@F(WA!.UI:;&,R36%Q0CEA;4LW9SAL8BM9:T)55&(V=S$S.5AT
M5R]+85-/,G-:3$IR5U=+3EE9-&A/4F1Y:4Y:24QA6#DQ4$=V3E949WI$-&DF
M(WA!.U!H-4960TQZ4DUL>F%3>"]K.#9Z-FA,0TPQ,71G<VMF-W%&+U5K8S)I
M;S-P;60P2$IW9FA05#1G;U8V0G`Y,CDQ-4TP=5IT3$=I:C8F(WA!.WA:26UL
M:%A2645J=EDT,%9594LS9%8T<4-O84I30C)'2V]$>F1E+U9D4#%D:C5E6'I-
M:VUP=V\R;79'.'$W5U5,:5%R2$)D;EIL0V<F(WA!.SA+06M66E)5-'%W8E1D
M5V%M;3(P2#5.<D(Y8VML;30S35)#5W-V37%R>4]B2U)9,%E2<'@T;7%Q4'-"
M5E1K<7%.<C@Q,5IT868X<68F(WA!.VQH5S1T4'$X9U-0-G9W:G5B4U9*;U),
M2&),26<T,G-C2DMF<VQE;$96;%4Q830P=E-R.&%28B]L=TQI=S`Q-&1/:#%!
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M56UG<7=&9F9&5TQE8W)'-#%+5%9,87<X>G`U9G8T8FPR5D=N84@Q1$Q944I'
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M3C4O=T9N+S)4-'$W.498,R]!1F5B>B]G3%`O<VYX5E-U9$-U3&TR;'1P.5AV
M2&AN4F\U530F(WA!.S)G<7)J:7=Q24%E:'A6+R\R43T](B\^"B`@("`\+W)D
M9CI!;'0^"B`@(#PO>&UP.E1H=6UB;F%I;',^"B`@(#QD8SIT:71L93X*("`@
M(#QR9&8Z06QT/@H@("`@(#QR9&8Z;&D@>&UL.FQA;F<](G@M9&5F875L="(^
M,S@\+W)D9CIL:3X*("`@(#PO<F1F.D%L=#X*("`@/"]D8SIT:71L93X*("`@
M/&1C.F-R96%T;W(^"B`@("`\<F1F.E-E<3X*("`@("`\<F1F.FQI/G)R,30T
M-CDY/"]R9&8Z;&D^"B`@("`\+W)D9CI397$^"B`@(#PO9&,Z8W)E871O<CX*
M("`@/'AM<%109SI-87A086=E4VEZ90H@("`@<W1$:6TZ=STB-C$R+C`P,#`P
M,"(*("`@('-T1&EM.F@](C<Y,BXP,#`P,#`B"B`@("!S=$1I;3IU;FET/2)0
M;VEN=',B+SX*("`@/'AM<%109SI&;VYT<SX*("`@(#QR9&8Z0F%G/@H@("`@
M(#QR9&8Z;&D*("`@("`@<W1&;G0Z9F]N=$YA;64](D-A;&EB<FE296=U;&%R
M(@H@("`@("!S=$9N=#IF;VYT1F%M:6QY/2)#86QI8G)I(@H@("`@("!S=$9N
M=#IF;VYT1F%C93TB4F5G=6QA<B(*("`@("`@<W1&;G0Z9F]N=%1Y<&4](E1Y
M<&4@,2(*("`@("`@<W1&;G0Z=F5R<VEO;E-T<FEN9STB-2XP,#(B"B`@("`@
M('-T1FYT.F-O;7!O<VET93TB1F%L<V4B"B`@("`@('-T1FYT.F9O;G1&:6QE
M3F%M93TB0V%L:6)R:5)E9W5L87(N<&9B.R!#86QI8G)I4F5G=6QA<BYP9FTB
M+SX*("`@(#PO<F1F.D)A9SX*("`@/"]X;7!44&<Z1F]N=',^"B`@(#QX;7!4
M4&<Z4&QA=&5.86UE<SX*("`@(#QR9&8Z4V5Q/@H@("`@(#QR9&8Z;&D^0WEA
M;CPO<F1F.FQI/@H@("`@(#QR9&8Z;&D^36%G96YT83PO<F1F.FQI/@H@("`@
M(#QR9&8Z;&D^665L;&]W/"]R9&8Z;&D^"B`@("`@/')D9CIL:3Y";&%C:SPO
M<F1F.FQI/@H@("`@/"]R9&8Z4V5Q/@H@("`\+WAM<%109SI0;&%T94YA;65S
M/@H@("`\>&UP5%!G.E-W871C:$=R;W5P<SX*("`@(#QR9&8Z4V5Q/@H@("`@
M(#QR9&8Z;&D*("`@("`@>&UP1SIG<F]U<$YA;64](D1E9F%U;'0@4W=A=&-H
M($=R;W5P(@H@("`@("!X;7!'.F=R;W5P5'EP93TB,"(O/@H@("`@/"]R9&8Z
M4V5Q/@H@("`\+WAM<%109SI3=V%T8VA'<F]U<',^"B`@(#QX;7!-33I(:7-T
M;W)Y/@H@("`@/')D9CI397$^"B`@("`@/')D9CIL:0H@("`@("!S=$5V=#IA
M8W1I;VX](G-A=F5D(@H@("`@("!S=$5V=#II;G-T86YC94E$/2)X;7`N:6ED
M.D0T-T1$-S<S.$9%1$4T,3%!,D,R0S,R-3,W.#,P1D%#(@H@("`@("!S=$5V
M=#IW:&5N/2(R,#$U+3`T+3(X5#$U.C0U.C$P*S`U.C,P(@H@("`@("!S=$5V
M=#IS;V9T=V%R94%G96YT/2)!9&]B92!);&QU<W1R871O<B!#4S8@*%=I;F1O
M=W,I(@H@("`@("!S=$5V=#IC:&%N9V5D/2(O(B\^"B`@("`@/')D9CIL:0H@
M("`@("!S=$5V=#IA8W1I;VX](G-A=F5D(@H@("`@("!S=$5V=#II;G-T86YC
M94E$/2)X;7`N:6ED.D%"-C0U,C5%.$-%1$4T,3$Y,CDP.48U03!&0C9&-S)$
M(@H@("`@("!S=$5V=#IW:&5N/2(R,#$U+3`T+3(X5#$V.C$Q.C$P*S`U.C,P
M(@H@("`@("!S=$5V=#IS;V9T=V%R94%G96YT/2)!9&]B92!);&QU<W1R871O
M<B!#4S8@*%=I;F1O=W,I(@H@("`@("!S=$5V=#IC:&%N9V5D/2(O(B\^"B`@
M("`\+W)D9CI397$^"B`@(#PO>&UP34TZ2&ES=&]R>3X*("`@/'AM<$U-.D1E
M<FEV961&<F]M"B`@("!S=%)E9CII;G-T86YC94E$/2)X;7`N:6ED.D%!-C0U
M,C5%.$-%1$4T,3$Y,CDP.48U03!&0C9&-S)$(@H@("`@<W12968Z9&]C=6UE
M;G1)1#TB>&UP+F1I9#I!038T-3(U13A#141%-#$Q.3(Y,#E&-4$P1D(V1C<R
M1"(*("`@('-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#TB>&UP+F1I9#I$-#=$
M1#<W,SA&141%-#$Q03)#,D,S,C4S-S@S,$9!0R(*("`@('-T4F5F.G)E;F1I
M=&EO;D-L87-S/2)D969A=6QT(B\^"B`@(#Q%>'1E;G-I<T9O;G1396YS93IS
M;'5G/@H@("`@/')D9CI"86<^"B`@("`@/')D9CIL:0H@("`@("!%>'1E;G-I
M<T9O;G1396YS93I0;W-T4V-R:7!T3F%M93TB0V%L:6)R:5)E9W5L87(B+SX*
M("`@(#PO<F1F.D)A9SX*("`@/"]%>'1E;G-I<T9O;G1396YS93IS;'5G/@H@
M(#PO<F1F.D1E<V-R:7!T:6]N/@H@/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@"CP_>'!A8VME="!E;F0](G<B/S[_VP!#``$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0'_VP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`"%
M`EX#`1$``A$!`Q$!_\0`'@`!``("`@,!``````````````<(!08$"0(#"@'_
MQ`!0$``"`@("`0$""`<*#0,$`P$%!@0'`@,!"``)%!41$A,6%U65T59867B6
MF-@8&C@Y=YFYUM?9"ADA(R0E-3>2E[6XU2*VMR8Q07$R-#91_\0`'`$!`0$`
M`P$!`0````````````$"`P0'!@4(_\0`1Q$``@$!!`,-!04'`P0#`0````$1
M(0(Q05$#89$$!082$U-Q@9.AL='P!P@4(L$R4F)RX2,SDJ*RTO$5%B0U0D."
M%R5$-/_:``P#`0`"$0,1`#\`^T>PNX]6U(ZLZC:(2QT6"OUW9-G#GHTG[-Z8
M[+U0#UTG8T=+V!IY5F)&0$5I#^R#B"R*^=N[=OCI&YEW1)&&L6)\(Z3$9]WZ
MM'A))!G3[B43PF[JXH%I1R]>R23*E/-L2*\Q1IK?.42#,E!4TS`M)*)Z7#:W
M[`N6138MZI&UX@S570$=%S?4NGH),D=A5@?>82A3:G8@`XW0F/>BN9=;CZ:]
M>2">$$,;2"73,<K)+\$@H4QJFYR3(`.!)\P3$,$:*SQ,V)I"*3MU&L;.U:Q\
MYK@!1:\LR8'I$]J4W1_SU5X&1.6S:%16'YMBRC+8@,EO(8"+"`2LI,X..$;,
MN)L703W3-.B/)"+M?3T9$@DNQ/7X,.<#!B]*=%"*\/Z%1_*DK-2H(Y&:9,O?
M`C+;A.E&]499/R)T63"T!S6V$1VRX^^/KC9;M.S#$(>3K<:G87;"AT!;M0UA
M8J@[G*=02%E.E<H+BFL-D0E2!"A3^".2IPPQID2/-CDQ7,&:5R'#9'O0;E[;
MCA-C9;`AY7N#SM7M%5U-M$E,=\V&,R;%!9;E49!#>V;K%Y:;,"T_#5T'X)6O
M@ZW0+!<*Z`F1.SF#J&9V<B2M\WV0M)W#P2GU=C7U@S;I78&A87S]]LNZHHGT
M5;HL>T/:K)3='T;R)Y'(1!T/ORIK#YG[IA;#,9%U,/N[.01PRA:<<Y./.K@(
M>3K<<T9=]+FBZ6OAK>J\L>L<+J9*\"#']4GEWU=WP#)30?2QL4MMF-`7<,7&
M$CJ*@],Z#L@`3,O#?S'%SMF@(>3I1ZB4/!!X`\`>`/`'@$(]BV4,GU`ULI^V
M6JE10O$7MWO2()4C[OAOWEX,0<L)P!T2K%$'VEW)R(:>O@(J6?8SI4W$$*D/
MAEFBMVH%M.JV3?7<17!QN+,MB<IVC2-)=$G<_7$59J"1A=KIV1[%636S<MV3
MLT)Q/XIJ4O)B]7X_11AA##"K3)M!<7L-")*H+&O7KZ?H;^5W*]VNJ$FHKGGA
M>6Z`-5VEC/>%'*VH\G2J):]<PJHSK1?HE1<5\*V5?6KYE7J/E:@F<ASMTZ48
M)#,C%H3V(OMX)$I0TL+WX@H8<9I\M,*S.;K3Z=Y"&[L3?9+TWJTM`>Y.\F]R
MM\4U2+><2`5'Y67D5D=Z%7K?:*D&TV`"C=>)[_H%<,Z+M<_<PRJ3++IWNZ?R
M)6)H.5&C\N]EA<;5#=9^[*NJ9UF[:VM2/#_D96K`:Q=:0J4GVNPW85K_`&$J
M@1&"L[4=G*QW-;ZNUJ9CS<AQ9/7UISW5SB[KH'4Q8OVB.)4%)@TD*(G:XUW4
MJ\FXQPQI(6[N@Z[U%S>XJS5(L!ON^QZ#J(-/;;.:;*:G&JKK:*4/[2==5U43
M23D>_9Z<9:@@T#-WXA5_:(W-I<5%EE"8((PG!-TNI.+5UV!P>J_8!Y[6E+(/
MQ39>LX#WT_ZIOZB*&;1C/C5+Q:^WLK"93RYDRKNF`>E1)BPN;HN;,LXPBNM<
M%^]UR/KVS1O(-1U6FNF((+1^ZG:,6GK+&\(XEM?[6O)UZMI2"%C3MB8$:^I:
MO9X3L+9W$E%4&U\*R;6NVK[''IBEMRWQ`=3KZ8V\QA1>&[C#PK2P>$[;E5X)
MWYSJ-S<O4F94\U#AS:>'Z<\ZQ:2[.I2#;OBSUC;JQTXF]Q9E7O+1S6VJJYI2
M*M0]"V4&I+HSEAL8ZLN._7Q'*2U\4)Q=?0\U,2E,]VH[(*E//#372HRV,#5U
MIN8!F!D@`3CY1I`"8Q/9LFB(,=@,+ZM.*RHP?=`U%)>0`;HV%,9G,./Q#^0R
MY&>@D7P!X`\`>`/`'@#P!X`\`>`/`*.=PFJR`Q>FEVDKA:5:YFY[6XJI4H4%
M61Q5?%$:[ITFW7&V,F]$9&T%6=?UQM-:RK`GMB%(Q-L:\MBR)6PFFOQ.\51B
MJ9Y7Q&M^L2O=071?U@6NI1,+LE9<7>3]056D5Y-2J[)`J(PZQW_$JNOFA8CB
MUU?=YY$$.PB@'_58;FUAF!W<(!&'``#=(Y>R=?KU?]"PHF+N+URI:O\``@RT
M^\EY)?3KITQ1W1RA6&\H]26C<5W:*5S<()L)@\("L81(\97K<G7*^Z6O,:)L
MZ9G&`#=(-,6&V,N1%YK8T`E'%23=KK24].N:?YI)=KL!85Q\=L>L595P:NV*
MAN%3738;R*IL7UFQE29"99/69?`&;`F=D1NPM"1!`:QFR,;%U3OT6%+V%].V
M&.F21T7.%,5M\/69E1#=,+YUW1T8D$8^H:TU@E2G%_K\D3K\=5W9%\!-QH[M
M(LEIOE(2>S+D=IM;FIE:BT579`=;45%81NI\X5<V57.S]Z[)9RM<LVPY2\6<
M:TITQ6KU^<*"2;?[N6+1?S`&.:E3;*V%3:AO>5ZL76V7'`,B.UD5S78MDT'M
M5*1E=:VZ)E@<R(&#^>`:6_>*'Q`'Q=1XG-3@2FZ=5RKM\,ZF)+7K<B9TAL'L
MV/8R#&4Z\7OVRL6P%V5H7]TBQ^OE%=GKW`.5:Q)Q>'\406#TLO9RJZG#I@65
MDYI2:*,%^5D@QQ2$7U?BPDFTLX76TOK^A[%'M/V+3K-2^OCI6F=LO"X!HH[V
M)>@W,D,/6B78MO;]!')+P$)D=,U5G1403OC0S#>P#F>P%=:*1=>1!]#29+;1
M"B9SA=&=;WJG8::F^HU9%DE!:C7M5URP,KH\4@,KYB(-MK)U>&$*^*OOFREY
MRYD.5+`G@E&$P**(28,R`F:!#X(8@TT5+`9Y2=<4'9C'/!8-+/6=N/'P_!Q\
M/P<<_!Q\/''/P\?#_P#GX.>>..>>/A_^W/P<?_KCP9/WP!X`\`>`/`'@#P!X
M`\`>`/`*:=Y6MN4J6E[ZTMMZK6X34F>N4DO5R%JQ@9;;N`F`+\HB!L&6LA/P
MK)9Q*1_G0[DH,5>X6TQ>/-3(V`4P$QR^!5?52L;[IU1T?J5@@7EV&SO<?H)6
MW'PD0>Y`#J85HX<JI4A"G+\OI4.O`R_Z=V]>T6[L9];C/EV5`DZ;$'K7T6#H
MR[N6<)>4YGW"PHHL)G'[49Q<?NMQ[>,W7J"36K@:CK;7/<#M,M6TV*D;K77K
M\T434;+V*3P8=4CVU6;53XJ0)9153[)&XB$A%MRX$G<%G?B5)+&"`4FZ]*+X
MFFN<\ZN[+<KXORQVJNN@S/U^.W]K#]F6<:4(85LO]98-XLJ"6ZKVI<`71.A=
MDQG%.K!3$L!6C3?HC8AY\?V`@'7\N,-_(^1'AA/DPE#M)Q3IB92P_P`')A]N
M7I/?M2X;6R9.O)'9EBI5MM1W*ZB7"09D2Z)5JS3M86J*UXQ$R+-8;.-QET\S
M:\TH6UKVE5/OT3)]5]P>CB[83B,*MXX++Z&B,WJ*/ZYU?3.QF]!J'9-M.L-E
M]5M6(Q]M5N<)%61ZP)6G.@-VI+I`[#53P83$A"F5P(2M5>@"<LAKY(D9(L:/
M9@XJF)QB8\W^NHF5$=KON1"[K;*M=\@-B`KD@::(W,L,04"+W&/6SK;9P1%-
MQIHZ?'X3V5H8S@MLDQ=/)N$+:SQ!<)##6@40A18]/T1*4Z*[65M3N_M_25*I
M6L93!:U#_96L6WN&H5SHV\0I:#UYDET(+5=4`"J>HF!A1^+IS`-=WILL$_'6
ME2Q&:0L;&#E,++\I1I>+?6(<=>+SC*%,82;PW^HVT!7FRDU1K1-?.1)".+K,
MOJ9K*4EY@+0>WE<]1&8,Q,;34,*'NS$MEAZYL\]745Z7A)=;9%?5,/ZX@]B+
M!Q=?ADWGJQ@[1U_(]F!"9M.D1&9\A([)CCK\F9-`Z#N4/3R7TA)A&)`(2A.L
MAS(P'29T&',WP^-.R3%C[LL]6`R9?P!X`\`>`/`'@#P!X`\`ZYK8Z8VI=;YV
M"-/UPH<Q8M6JF>GJKXCU:P_/.@4\T,$3]4=6(;K1R534LS90`$_641G*D,I8
M&I<5%/9/"`5-=TC!J4HI=#O56NKJO/4X=/[S;D^R,]]PU/&M*X.P-#7:ZG.*
MB;]B,,&]=B%.E$A)4ECBW]1W1B2(4[$F,9\VU%-\C-L.Z!X^!HA!\8X3=1PD
MU?G.K62VN45=&':6=?C_`&563HL1U+)&0E#36;4(/U<L$PP64Y14]@V6D3`^
M];!L((-8'%C*J$\M.50*HE0<QD<'M)$A)41'2YO[LM>LT=DZ')Y[7VK,ZIX"
M%8O95]A,V%@_-3G<:5%B(NTV&^9DC+@SJV'(F4VI_>?$G"0*PQR,:M7LG/(_
M+;,";LEA.MOZFE:ND5N!7'0\I]SHH;)-OO=>=5UB3KY^9ZA6SC&E]B4.RYFX
M*=N:8SAR%@CNP69_:'1V=80U9N0X99=4HV#NZ:)@LK+"+^C5J_4U:P?3SM*T
M7.QV5U[$#",)KJ6\JK5QT-(>((Y1@75`K#3\B+3]]R$:Z#!$R776SB%I7%$4
MU-<0K&V.+D6*"LIY$.,L%BGAA.J:SGU%UK@H$);=F]8[*(YB=4[KC:S/8\37
M/`ZBLLU$8Z:LNL\@$(AG*C\A,8[&XJC[S*YT$=6TF@A^,86DAJ'%A8B<)K/S
M3*5K/IVNZ(%;H*5=<<8P["!.*BODO??<ULBU^T]@E^\WNO2_&_L+L7E'!SB`
M-*<<<J6`UJU<E-F-@AI0&?KWKLL7C++JIE&6%Z3E85)MZF=,]O6D]+9"KR.?
M"\BI`-7:YV"T6&S8N`R^.QMUDR&@JRN3RR;89G*]!(21!+,!@GND(^@R88#4
MPCKX'B-SZU):LN\O5X(/`'@#P!X`\`BJZX5)2JU9)78F#5\RH0D?4?;=MRPU
M6978R,*WZY,<N?\`GIJVKD76/E<:MT:;/XP]FD_)9:=F.[G#P.B\C:8J]1DG
M#K^5XKFEA>&P[DL];"0.LUB1B!)LJZR63,PK*8#7M_"</(+"VT.ADL'V!Q'`
MP83-%)N&O'9OR%K6_7X5-(WK_0"345FW]!K_`*R-M0-41I(V<_IU:5^^A+(^
M:+C/ULL<MN4ETYOLXQ$L0!-BXB-.EB+D7J!C$'PY;%\AJR%^:4JS@JY>7<2A
MQ8/5H"I-BQI:J/&(W7HPGB'%:AD$K2L4XQC"`@Q7X4J#B9>[$IB@&=:_/3A&
M<2`6BF>`FT)%P(\C^>1(>NL]>?3K.5O#=8KU3(-J3P='VRA3>8;M"?BP9&<U
MK9M3M)6#":,6$E%(0-4M0U;#L#64V2M<I;^,8@\[H.7MVG@*IXI]Y#S<R>G7
MFO1K,>)?4&2K]E9`O?@]LD2I)@:\<EHF.T""<UC(1]T1^A+9?>'PAF9\LG`!
M3Y0CXDR)OE0.=@1:NK*Z:>1*I^R^M/7PS@N&RE=U+/\`F!`+9_$#P5<9%0UI
MEC*RR,F%X(Z*'A:>&9VDC4)3E3=)`S,F-.2>(G8C&;9#"KU^>/ZF.)E.GUF`
MZYK<Q(ZZV"MWKL-695:$2QKEK!VQMD8D['8;"2E:5A/@..6_(D7=3+:)@S_E
M)1.:<G$,I1';(WA53>HH[Z:F:XQS>D2F\,F;D%Z_*CHNX5Q5IUC:TU-7M_.^
MT`))1KFJHKB:#0X9HJP*6Z2!'UT*+SR,94.CH4D+%",HS`@'S83G35C^I,\.
MYJ9^DG.C(%DH.-JC1F4S*L(K&&P;H8V&-%E-F.*WKD\3M7L(0R#+[X>$;C?#
M"&`Y3=HU#24&1O$AQ,4SP)4\`>`/`'@#P!X`\`>`/`'@#P"O%SJG5)A::SC=
M@U6@6%U8C,A5I_1;R]7QMH,'>=7OJ8!KO4X0I9660QTP."TR`NXY[=>N)A.D
M:\<=6&W@53A.N#47XKTJK=ANS=9XR@T<J6KI8;NPS0[*2@O"V"O'(PS*"CE:
M[N:$10C%#9"R8TA@8!G,SYI'D$0U1!NS3I^'D*TOQCI4-QM1NDH;UJHX.JU-
MPH5?6ZF\F&&<"1PJ*$!).Z>G+TZQF1F+B@H72L+X\"+5."Y!O8M8P5$+Z5^!
MF5Q/E5^'-"KS>&W#]#*R[CZ\ZDA>[%SK'J?"OIX^$#5+KDL:O\VI@I_9`(F`
M(7WS9)]BWCG)LA+$*/!'D\HI\W#!X8ZI4N+!^3"'=#G+HU:JF+=E[JW4&Z-;
M=A+M$5M+CZN$.#9#4#0E6=KTNI:;QPEP6HE$A2_DVPX=)<_-N+.YQ.E#$_+V
M*5*GR>=H5N4]!'T17Z%B;(4*#@I_5,9::=P884*J(BE54-L5=Q*+":3\]15=
M(S7-!$R`V..:2^(>)%)3!4>&Q3->R!ITS<0K?6'>ZF=*WQU%%\L%0,KQ42_$
M-/C)4YE$;,`J\`<79NY`$G%=CB3T6"$=L60U:H@.TS!^LN(+/[7-32\S>[;2
MH;`(=]<^K#P-R]BZW6E;,_9R.I:Q+PH;`#B0E9CTILLZG>&KWF17-.^;GHGL
MR%M.XC"A$7&YW"]L[7&D3=&O/#X=O(E>I]\$>U(8Z5YEU<)3XVA5UH<LVI[3
M5E;4U%*;V:-7;`SHY^QEY9X$!F$J$%E3S0/'OT$?N$$AS5.GA#,T.T^UD17.
M,Y?6/T+!+EB(3>P.ZHJN:PQLU:EAP&P@`0V.)ETDV7#Q&$6(:8$.1ND@R4\'
M/A%HL,CKCR-P^5HE8:^=6S'+D2.^[6;EX`\`>`/`'@#P!X`\`>`/`'@$#=@!
M'62>M`I?:,-1Y11TM`D.L;+U$HQ0#K=&C?@$"#`&+W&DPN&8_OD8BQT0;C[T
M)9;.8NC7MXYRP\%4X3U9&#9HO5&K+!!D&A6IQ'?Y%1.6P<X$$E9"S`]&U7BI
M"&^*3?<@VB*K5LJXNJ@+VC#)P6OX<&8$*'&V<<9Z]85>WO9HLBK>A`ZLT(C'
MI3K3.JBV7"MR%>:ENF$%A4GANL##0/KMH`"UY4(02DB:)-93X[CIB9Q@JCF5
M8"!8<LPBA".$VLW2<73,D(SV&ZJ1E<-9AJW:2V*"S8!9"6WC>UJ$X($L\>&/
M"SJHOGL)4B-!<H2_J9QI46+D:RL</K/0I>K"%@0U<!#NAF3;@G60<%@7^^@J
M/@`DO&39XNY'`,C1(2E[\B"M\Q]@O9N+KQ`;R\.`#RE,>@G$D3],(5CNE[>(
MT3C`*W5R@B@X+]/@:83Z\8UWJ3#-W0Q#;.2D\NLU-IEV,W-.DA#"/XH/+'<<
MGF=JU^]AX-G^1W%V+9B3'#)LW=A+T<!\VNE,::C?V7L)U<H\NZ@VVPJTJ64"
MV*AAWD'-@])"^\&=>):P6P@P2XXX$4.14JO<YI>-@1EEE1&$+Y9BU"%B6ORI
M(0W%&\O76<HHO]4'9F2J3-+U`-[=6ZC"?J\JLD$KYA-U\C#]X==%MZ@G28DR
M4HK4;?F$"BC0>`.'<9808,&1SQ'UZ]82[Z])J8HOTKCOA6-"&T*"LAZMH[7V
M_9.4U!9:[0M]/]P60S#0LPD('$K.8%<D(",)LH"W,.(9J5N?;9T=C5)6L:%=
M<>&'5Y$Q)MWT_8C4V(R'9B4X."'.*#'-;7&$:6+JY$(8D+QF`;A0M^[:/F"3
MT64%)1I&.&Z$4C;X,G#7)T[->(D/(E+P!X`\`>`/`'@#P!X`\`I=(MEP0NT]
MWC;)L@5C12CUA5[M@B.588%B5[%'-+X+<3)9DXVD3[%(D#5?:2G2=\P>%AP(
M\&(-6X<R,2+&QJ/E3QXT$/)+CV072704JZO<X;&[*6G:DRVJK-K@\@;"<6#1
MO9;L>L(&YL)29TL0.I+A5K^MP8I6@`L]^"J9F'C+%K-XQX0./FU7/H:7?>:_
M9%M7C*KJ^>Q=<6?M5%:'V<KBJJ_%2EV`SPB=4U?::W25C<B()N1M!KY>P;C*
MVQE,=\`IN:=K,,C8!,ALO$,R"PA47X6^MJ5L44S)E;G^RA/<$2&2;/<GFN5E
M';73L54<)$3#ZO52IK1<,:QTK1551?I>)W=8S[#WFP2/)<6C080([9NT)@K=
MBE3RX87*^CQ??$:XOBMYG#EJ6'-[)=6\%]G*!J=MU/M_`O6;+6$I1;MI]."1
M3,(\Q37*+'<P^<?Y>)%%+48*J^SX>]9IO<RZBH;4O"8/.5]?(KI`O&\5Q%[:
M,:];):[E3::K6E.I5ANJI783,_V<?396L&8>N?1JGI(EIHI,LYHK,;&9"`PT
M9B3URY-4YO8@JY$(Z7KU!84J5&+ONOUN;^XW.,T7E6G;2LJ.UV=91*LWFE;/
M7E)EN(+3CHE,-K5PL5O(69"9(KS<*OT@P!ANBP3]PR[U:P09J(X;1R+,QF2X
M<T8%&FXQ5TJ)G.G1!AEFW[=>.MU.(I&P21.Z[L[26K16RPQ`\4I&H]<4W?\`
M;NRR6K1%5H@X>LD]/7^GCBT$.CHNC7`L%A4-NS;O)D=/$P*3J5F>MI1GBT;E
M#L]\@?N[AMO]C92"MT]:*'@JV8H(*$.*UTDLM65:^<J:N`:%NR8#6?)$&.8M
MB]C0&?F%@8#W&A=$8R92\N#PBZ%,J[K?063ZMS;D)=?ZO(W_`,2<;:GK^4UI
MQ)#`H4_CJE$I^]<Q;@ZUICK(IZQ5-@/%\'+4:,N0W+@Y'`1HXC7#TZQEZO7K
M`GWP!X`\`>`/`(3[(`C3115I+:VCYV*QGT\J%7U77+68&<DX5T^P"BF,YO)"
M`4+YN3I&ACYE;Y^J9HQ$\[!.$@MC!C;A5>IN*IT^DV$T.U6:K.JAA`@^KG54
M4IP5)@X`D1+M=5F0MBHUY!C&@C,33FU)K.MHP>`6A&=XG$;V'8`1S=#*#B\`
M8*VJQBYG5EUMUZ$1K5]:7&1"U%U_L"G&:OEDCW([/]KK`E29JNPK.RM('9A_
M[-TVHYL:.:8`0ALE6G:M(^UJQ.7&WG1-:VQH"QS*X,W&.16U,W_+9L]?%2?@
M]J)1#J=SK=I=RV,-1+J#7[*UU_\`1^42GRE`#"P[U3.6O-1M;Q(L9$>"9C>L
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M7`@,=<6&OD!)'?SK%2)HF2I2M9B7T=761%7E$7C5R_Z<J].IK2Q3NNQTJ0M5
MQ5F6OOE`R=.J._*G6`A&25,+S$^N*UKM8(SO1!?`<AF$QB\&E;1N)%8026#C
MYJWW*M\I_3PD\F*H[9=NH\ID@4N::KT[$WTH]E&A>+2E%/:*Y%Y6.BM*LM,6
M3^87LQ;,@]?:YKZD2H^!GD0W,8/+";%B#=I'?#?44F^$E&>$..MMK43(PUQ=
M;[W(H:U^4]M6D.K<7/>R?/5[KD]7G()WITL"XPKE,6/:W87=\*P)H`0:9CLO
ME*B5Q#L,>!*&I#D/QB!2'F[HG/'5JSC([`/!D>`/`'@#P!X`\`>`/`'@#P"F
M?;11L!F-]<RE=U#.L>:@W>N6`R&1QVO0$M?4UW3)UDA&B0YLB_.F2&&21A3(
M\`5\O!V9+F>PMOB;]8G&2-6:3K48X]"97"SJ>LZY.J'>LO!J4JQ7-V[TWF@U
MRJ,G(%3)H21'KIJZZT>4G[W^:"W+H.4"BR[C+C\>,F83.N-OAPA,G?MW0O`3
M2M6<K+3>V7Y=2J3V!'.%EWA:MNO%.M$<95%)CZ:K>L6C2M8SFEGL@>$MV]-8
MHI-+9UZS!3\>#1%:P6&.Q252$VH=B!Y![C#45PA"7*-<ST47U=V11=VZ5]L;
M:ZBU?7L78DUFUU$)LJ+&J2RER!8@YG>6UFBR%ZSP[O7]V+PD!.5D<P[J(:(<
M'FL,>6]IERA6,S%8*0!92M-WR[U36UZBXNEVOJ:[''K]9J@-C\W^YNI@-\R@
ML437->0:RQPRD[BA.`49F"%NW#_8>)(+#?N,F6KB.9QA\Y38$@S,P"RTFG=M
MZ-9J=KSKQGWNKW$[=;7PO3W6A"9;9JT,BL5>LS<9NI@I1O`M\]A61+-+;RS"
MM*+2V4A7B8A!&B"P'G9D:Y),U'R3M0(*1"=71WW3T=#ZB-;0ZQW[-ZR4[2*R
M&.%[&G&`]LVFVBGA%#4_/OP];0>[K,F70K,6C>Z-U2S+$E,I>`N5S[Q+DA6S
ME3DXC8>R(7T`FI>5V,Q$4PNI4VFS!781-MGMZ\5?2;(OY7#2M`T33KZ%DI!N
M+!M>+;M["9-JGE)68"#5!40LKLH%LPZ;+!X><<&AO<]IV`_DQ\DB%(2FYMN^
MYI4[L\3>C](ME?W=U/&TC3^W16E(4VY5/S8N1-"V1%V`96U-/K[037R#@N.S
M:.18JEL(FXL/1ISDQ"^.@#)WSY)'B&)>G6K<^.K6<'H]U;NSK8\WOLLUVKU^
M`O4:L9PUO5$,TDL;R\#QC#,LM^<HA6T;#PU'FQL/$#QS'1A"BSSA6=.$ZQ@K
MB,&C/7K_``BVK2<0HB?TR\#L7\&1X`\`>`/`'@#P!X`\`>`/`*@]WT=WL6BY
MBG7-:;;*<9S>B31D?262P6Q<C+[<'9BYO@HZ&P<?1[0)"S%_#6*D;R4C>;TZ
M=NC$5D1E1Q5?5Q1K:C65(6XMUC=B[Y:Z=9R4T:*0*4J&KCNE:@%R"ZB18MA.
M;,(DM98>IZ93#<#L47MIO6=^;Q\91B0S`"T^+N%2]X.Y+K;\-BKG4A[JS5EK
MZ='1^J;9KDZDP>E'5-/V,/!':++KC)?TU(W==U>:H-8":37CL=5KE:N\D9%Z
MYW)86.N&MYQT>$G;],3:5$ED5N^'>^Z_QC#`UH%2EE[45\CL76.V`).#VL:;
MNIP;5MWU)7C4I1&^M62O1I86;`V+K`0="X#*%5IB79TF1"R%->B2&#-/NR2/
MTBMW57V8<IOZ$_SJR[)?N72H"UF*+V$M<OUZ34PXA`P5=+P.9=VM2!!VNP`K
M6?UIT79#Y==9)VC^\-(+7`TZN-BX#@S]`H/@)*XTJBF>J96=</4D2$47L.TB
M^E]7-W7\[A3M5#*:>K7]TOU3R&/?<-*L@K.MPQ77N=-/&->HS&IA+PES$S:Q
M,+>2AIRKCH#1Q[@$80I5IU<YW._#&8KK,`RU+<=F=0[+V0T2W8UE=RV6S+)>
MA:>XI%2OR8%?57)'IM*?]-I0_BC!JE2@2KT2TQ8K1DXC#RT4DC0$^5)FCM88
MJM+-TS]-<LVP\'NVH+:KVY,^O$MW@TWTFN!*?2U/9)VF(^VN6&]?'`8*K]!Q
M.Y602&295$D:^!1Y"YO+1-I9/B18LL)'GSQH4AJ8^91.5:Y8^)XF*!M)`1>D
M:\OU?MM=XJ^VM-PWN^@S=?KW,IM:!%@E[C*0>7)E!%9>3Y;=HFG:,*'<28.J
M)#E8S).N;J%:)H2G-8I"F<(CN4$F4;5ML(_8MT)A`#M6W7@A!O`VT)KQ9:_8
M8A[NZS;G#V.%LFHA`^>P&:X5L8I*X)K@%+D5/63+OZY%BHV7S8S,8B-TPFER
MB$EC13AF7O\`!!X`\`>`/`'@#P!X`\`KR_\`4_KA9A%L8&NEZWD.#V+P`N5@
M0$Y=%6,S+F6J)!(+1E_@#=#;.7S@.'BKG16XOE%*JTB6`DX9#I&>GP66L?+8
M;JYTA3%BLJTZO]25D[.B5MCR$MQ;4)496I.DQ).<Z'*56`V(GE5^3#G;=DV)
MN%2HN<>9GE)U\X[<LLN1)>9K7'6.@9=3(-'L]2(=AUA68P`,4%:T%<+9,(?F
MMBN0XTSNX=81O*:S<P]DGF<RR_E39&5.(S)DW=)GR]FT67?-3G"NM_7@"^Q+
M4!T+2X:SX&B)%@V.*JY''/L*-`5]"1!C1'"&"TL,;1"2XL90B:=)'#7&5X^@
M!IQP$Z=<3$)=TO;U^)F6.DJ8<'I<M!NJ*L&FRT_"%J4K$8T%4-O2MK&S9)(=
MK7&TF)E'PF$`C,F3X6`PA%QBS94F5HXU[]^W9D)+S(]7NG_6%*,*1NO**JRL
M)B:W1'@?KJY%5ZZADF(8HNR4%DL\-.%!X[1'`![":=X"`=PG0@QJ;'/C]&@N
M/@S-`LO/UZ1O.FA:,CM;:^:*8J?0\/XDB`>W/372?J:W4$8U1M!8*VL6`?$N
MR"2FF%#TD1QF9-ASM42-KDZ=N&C5Q@)+S-?2.L5!5@U`FZL:G1:TG+@=[#"A
M==K`5'6-7TEST,@ZF-ZPL018.8S&LJT3HFUDEPMQG2,%[!L:9JA3Y^F2++S]
M>F>B7U.ZLS_GIQ.ZTT!-XLB9&(V)Q+INNI/S](0C<9EASG3Y9<S^=,R(QPH9
M^-*.>W;]!N)&*ZL\)VC5OQ0)>;VDK)2,DULLC$JNDY604T+Q+X#*24O"559$
M\$)\HI/X&`042`*@<32<V:1E^RQ-7M,^7*E[OCR)&W9F(;3X`\`>`/`'@#P!
MX`\`>`/`'@#P!X`\`>`/`'@#P!X`\`>`/`'@#P!X`\`>`/`'@#P!X`\`>`/`
M'@#P!X`\`>`/`'@#P!X`\`>`/`'@#P!X`\`>`/`'@#P!X`\`>`/`'@#P!X`\
M`>`/`'@#P#CS)D0?$DSY\J/!@PH^Z5,FS-^J-$B18^O+;ODR9&[+#3HCZ-6&
M6S=NVYX:]>O'+//+''CGGC5BQ;TMNQH]'8M:32:2U9L:/1V++MV[=NTU9LV+
M%FRG:M6K3:5FRDVVTDI,V[=C1V+5O26K-BQ8LNU;MV[2LV+%FRIM6K5IM*S9
MLI-MMI)597ZF^U-*7^Z62E5"U8.V^JM2WDTL(G1SL4]DEGW'],*$"-Y9XZSV
M<;YN3,YDX;IW!OB;XG$(G-V92<(WTV_O`[?_`(-;@WJW?OWN-[WV=^+6ZEN/
M<NFM1NU6-R6=S6M)I-T;G2;W,K?Q6C5C1Z6U9T\V;?*:'1I67;_!WHX3[S;^
M[LWQW'O3NI;L>]:W/\5NC1*=RNUNFUI[-BQH--,:=V?A[;MV]&GH8M6.)I+;
M=I6;$^?+GT`\`>`/`'@#P!X`\`>`/`'@#P!X`\`>`/`'@#P!X`\`>`/`'@#P
M!X`\`>`/`'@#P!X`\`>`/`'@#P!X`\`>`/`'@#P!X`\`>`/`'@#P!X`\`>`/
M`'@#P!X`\`>`/`'@#P!X`\`>`/`'@#P!X`\`>`/`'@#P!X`\`^8?U6A'J$["
M)B58LCDGUIU3,MH?&G=1/0B0X>&[X86VRQ_.S<PX&,,>(V6Z8U[IJMJ)9\XK
M4O5GLV:./ZW]C>F]F2T6@L;UV>2X6.PEIWOX]#:WQMZ1V?VBWITL6=RO0/YN
M+H]Q*QNQZ)3NNPTE:?\`-OM0T7#UZ32VM\+7*\'%:=K1+>A:6SN*Q83^1[XZ
M.7NCEE\LVMTVK>YEI'_Q[2;=E4QZ$P>^,V3:7[B&5E%D:]";])7Q955QOCZ<
M]C1\TOA^D[_T9_%SQ9/@]R_^K'XW^L/\F4/S[SVCZ3V<Z.QO/_\`(-A6[+M;
MN_TJ;&_-N+26Y/C?^D54I[E_?T?_`([M(?'\!M'PXMVM\_\`9EOBVE9W'_J/
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M^\]K_E<MH\-[OVO[GE/WG[/_`-H(C[7"?5VDW\_[^LA#9HH_/8M_,?5C/Z^:
M>,<,5!?Q8/@U.W'SGQ^%JQ.9?ZT_R\_#\:)_H',7S]K@9IO8G8X-;VV>%NCL
MVN$"^+_U!O1<)K4SN[=+W-7>_P#XC_X;W.OV/1;_`&G'/RN%.B]JUK?W=UK@
MWI'9WE?P_P`$N4WAL_\`Y-!R]-V_\E?\GEOWO38^3BG6QW"[/^L%T<H=I["W
MX^_-A&7)(H3'YXF=89Y$\RGY>,`"NAA@B`3+$)\Z1ELD2,8`V;F.#PBAN5IQ
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M]X<DNL>?&:9B?'Y-&/.`;CWOE\8)Q.X^**_UEE\/P0?]*YU>?G;[Z?W?GO3O
MHMZ]%96^;WNW:M[GR/"Y1N][FTOP;G3_`+!1NCDZZ;]ESGR2=W>W0^V=;X[@
M>^&E;W`MV[E>[ERG!MSN-:?1_$TT/[5_L>/^Z_:?<^:"]_?>#WGFB*TXZ1RL
MHQ7629N;"YQE5=&^./RBA?F[QSS9O^8S^"1P7_R"/\]Q\/\`IG_HYC^>=>S?
M2>SS1Z??;_Y`L*WH7HMR?Z9-C?BW&E5O3_%?](^939>@_?\`R_<KQC[CAS8X
M;6]%O=_LRWQ=*M)NGX_YM[+,Z-V=#\/_`-2^5Q:Y7]U7[].*=:_N+U[OK7;]
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MIU2^[Q\1[N',V>QX9CD/;ESK[7@N8TSJ]=A=$%6`\SQ@P($-G&#1@F>ZF0AH
MH2,B[9I$D0FR,M<>)!@P]&Z5+E;]F&F/'U;-NW/'##++A\1[N',V>QX9CD/;
MGSK[7@N4ZZ/]Y/55]0E$<[!ZTV=FWAT%Y)(S-%D_N;0)<;+U8\3@1*0'8Q08
MM@*9@>W02%S_`&'*!MDZRPF/,E3`9'Y+I[AWP]WG=.AMZ3=>]=O>[2V=T;IT
M5G0:5\*MT6M)H-%I[=C<VZ5;W+I=-H[*W5H%H],]%:M+2:"U;M:&VF["MV^Y
MN[>_VV;FTMBQN??&QNVQ:W/N?2VM+HUP>T-FQIM)HK-K3[G=G=&CT=NT]SZ9
MV]%REE.QI;-FSI+#2M\6S=?W%Z]WUKM^U.J7W>=SXCW<.9L]CPS.GR'MRYU]
MKP7.T*[87=#=TW1XE/2<M?;'!;JK%QW\2:VUY9,&H6,XLOGG>Q?_`$#E\<EP
M1YYY'?Z)G_\`<+_F>=/GD/!_2<`[/#K?"WOY93X&/=>_+W#9XF^K2W,]-IO]
M)^7<O_V2C1<E^]^=?_H^;C'I>_-CA@^".X[&]-J.%*W/O9\7:XV]RG3K1Z/_
M`%'YMT?\%S;Y3]W\K_\`#2#J]]Q>O=]:[?M3JE]WGKWQ'NX<S9['AF>:<A[<
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M\>J#:?<BU^BB9<$0IV"IY>U'6=;PE=9M4/?OB<P<FD&'.;QVI?,'$[6:!?.`
M4*+SBD&1),QI4&-L5S?,;IZ/?#W>+6[=T[GM[UV]%N71:'<^DT&^%K_=5K1;
MJTVEM:;E]!8T%C2VMU:)[FLV="WI--HK%C3/36K.CIHN-I.YI-[_`&V6-Q;G
MW39WPLZ3=&ETVGL:;<2_V]9TFY]%HUHN0TUK36M&M!I%NBU:TR5C1Z2U:T2T
M5EV_WL6+R>XO7N^M=OVIU2^[SN?$>[AS-GL>&9T^0]N7.OM>"YW(=/H_8R+1
M"SI[5[N=]TXDF7EAVY;D[?SR/R/3LE[CY1#_`/IKGX`O,+CX(?\`GN/@^"7_
M`*3QL\\+X<6N"]OA'NNUP-2L[P/1;D^%2L[NLQI5N;1K=5-\O^7_`/T<I]OY
M?N?)!Z[P2L\(+.\>YK/"A\;?A:3=/Q#G<EJ='R]OX>NX?^/^YXGV*_?^:2SO
MGR)](/`'@'KW:=,G3MCR-6O?'WZ]FG?HW:\=NG=IVX\X;=6W5GQEALU[,,LL
M-FO/'G'/'GG'+CGCGGCRV;5JQ:LVK-IV;5EJU9M66U:LVDY5JRU#334IJJ=4
M1I6D[-I*U9M)JU9:3334--.C35&G1H@BJ.LM+T<YV([U0FPT<A:6I>Q;Q(++
M*(L[Y*UN.[H$\6`Q_P!!!R-WSAFX3=`C"&-W\81]N,#5)]HWR/H]^>%N_P!P
MAW!O7O?OSN[2;X:/>>UNI[BT^Z$K>Z[-C==G<]G2:/3;I_>;HLV?AM&]':T[
MMZ6S-I/2.QQ;-G\3>O@YO/O+NS?#=N]>X[&XM)OFMS_%Z+039W-:M;F>G>CT
MFCT'V-#:?Q%M6UHE8T=J++XBM<:U:GOSYL_<'@#P!X`\`>`/`'@%#O5%&#2?
MIQ]Z?>(^"0]@ZD]B2,'VV)HE^Q$(U0N'$>?$^7U[/9ID?C9LXTRM/Q-^KC//
MXF>/QN?A%LWKI7B7B&#1PB!&'"H$(8/C8<\1X(^+HA0]'&S/+=LXTQHVO5HU
M<;-NS9MSXPPQ^-LSSSR^'+++GD0Y_@#P!X`\`>`/`'@#P!X`\`>`/`'@#P!X
M`\`>`/`'@#P!X!U_]45I<%=H_4?DBP`0;)T=B*AAZ)$`5!A[],.5TLZOSI,7
M5MCZ->S7&D3<LIF_1AEQJVRLLI&S'+;SSGX*[K/1]6=@'@@\`>`/`'@#P!X`
M\`>`/`'@#P!X`\`],F-'F1]\.9HTRHDK3MC2HLG5AOCR8^_#+5OT;]&W'+5N
MT[M666O;JV8Y8;,,LL,\><>>>/`*&>G&#"B*+LC:)#BQFV3W6]1N-(V#A\2%
MLD1A?J$]H88R/NSC:=66W0.B<<18&K/G+7$C\<:(^.O5_P"GP:M7K\MC^BR7
MY\&1X`\`>`/`'@#P!X`\`>`/`'@#P!X`\`>`/`'@#P!X!U]54IJL/U)NX!2(
MLK\4GJZM]'26HC'##M$_61.63WWUFI^N9KC8R,)IC7ITZRDK'9QO(8:M>,O9
MNQUX\<3%]"^I<%TOZ'8+Y2#P!X`\`>`/`'@'74A=Y+>M96@/M9>G[V4<40W)
M,:UQIT69TW!Z#T,.;(@MA*.)9^S(5A@QY,L9)SCZ#`D?.XT_$RWQ-.67Q>).
MI]WF:=F'#:[_`"-P_=0]F?R;'9G_`)P]&OVK/$O)]WF2%FN_R'[J'LS^38[,
M_P#.'HU^U9XEY/N\Q"S7?Y#]U#V9_)L=F?\`G#T:_:L\2\GW>8A9KO\`(?NH
M>S/Y-CLS_P`X>C7[5GB7D^[S$+-=_D/W4/9G\FQV9_YP]&OVK/$O)]WF(6:[
M_(?NH>S/Y-CLS_SAZ-?M6>)>3[O,0LUW^0_=0]F?R;'9G_G#T:_:L\2\GW>8
MA9KO\BNW;RP.W'83JGV3H95].KL$'9KGHFUZL7BS!<O2?4"&&GU'.*XN>9V#
MNT!$AK%Q)I/3OGYP8$V7C%U[<H\21MXPU9)>3[O,JA-.5?K\BQ&/:#LSQCQQ
M_BV.S/\`DXXX_P!\/1K_`/''YUGB7D^[S)"S7?Y'[^ZA[,_DV.S/_.'HU^U9
MXEY/N\Q"S7?Y#]U#V9_)L=F?^</1K]JSQ+R?=YB%FN_R'[J'LS^38[,_\X>C
M7[5GB7D^[S$+-=_D/W4/9G\FQV9_YP]&OVK/$O)]WF(6:[_(?NH>S/Y-CLS_
M`,X>C7[5GB7D^[S$+-=_D/W4/9G\FQV9_P"</1K]JSQ+R?=YB%FN_P`A^ZA[
M,_DV.S/_`#AZ-?M6>)>3[O,0LUW^1KY_NS::%O2YEK=$NQ5:)K?:].5#N>BU
MB]2&00MG[PM5.IU,(%PZ'V,:FZ2)X<7D#J)[`:\6EPX.W?-]DSU1]G/#J:V?
M1E2FYJYO'!-Y:CL%\ID>`/`*]=LKE,=>.M%XWDO@QK*<JJM6EV$+YF9*'B3!
M`$-W3(D`C-A:=\R+"D;L,-<C?&T;=^O5SEEKUY9\<<<BJK2S9#_M?J5_@_T:
M_3"_/ZC>!3-[%YCVOU*_P?Z-?IA?G]1O`IF]B\Q[7ZE?X/\`1K],+\_J-X%,
MWL7F/:_4K_!_HU^F%^?U&\"F;V+S'M?J5_@_T:_3"_/ZC>!3-[%YCVOU*_P?
MZ-?IA?G]1O`IF]B\Q[7ZE?X/]&OTPOS^HW@4S>Q>8]K]2O\`!_HU^F%^?U&\
M"F;V+S'M?J5_@_T:_3"_/ZC>!3-[%YD,UQ4WJ-US8W8.Q(FKI,3E]@+!4K`*
M#9#->NB.NRE.G*WI[0.@;]25GLFQYD"N(AK;ND8:MFN83D1<,<M.C5LS%?%A
M7TU+-O/7K)F]K]2O\'^C7Z87Y_4;P2F;V+S'M?J5_@_T:_3"_/ZC>!3-[%YC
MVOU*_P`'^C7Z87Y_4;P*9O8O,>U^I7^#_1K],+\_J-X%,WL7F/:_4K_!_HU^
MF%^?U&\"F;V+S'M?J5_@_P!&OTPOS^HW@4S>Q>8]K]2O\'^C7Z87Y_4;P*9O
M8O,CFS;M[XT8,27:S4SJ.60S%[=:JB98Z(W7)L;HL#L'V(J^@^#(/4P*,$-(
MEKTFRM![F+/EZ-,K0-VQ^-G&S;AQR*DGB[F[LDWGJ.ROP9.N9>N_NS;3M>L2
MG$?JS%1:CNUJIL=*LQUMJ$VFMZH'6B<HQ-A*R07#Q-,K-BQU1].B=MSXQC\Y
M;.,><N./!85);KJUM9K(W3V_U*_P5Z-?I]?G]FO@4S>Q>8]O]2O\%>C7Z?7Y
M_9KX%,WL7F/;_4K_``5Z-?I]?G]FO@4S>Q>8]O\`4K_!7HU^GU^?V:^!3-[%
MYCV_U*_P5Z-?I]?G]FO@4S>Q>9#%#U3ZCE%))U+'0>DK!'.W)V&N'9.FN=[0
MMT>=V#ONR;X)A,-.BNMV&<1;)6/*7H$O+/C=.A"X\V1JT;Y&S3K%;3<U5$KE
M@DL]1,_M_J5_@KT:_3Z_/[-?!*9O8O,>W^I7^"O1K]/K\_LU\"F;V+S'M_J5
M_@KT:_3Z_/[-?`IF]B\Q[?ZE?X*]&OT^OS^S7P*9O8O,>W^I7^"O1K]/K\_L
MU\"F;V+S'M_J5_@KT:_3Z_/[-?`IF]B\Q[?ZE?X*]&OT^OS^S7P*9O8O,>W^
MI7^"O1K]/K\_LU\"F;V+S'M_J5_@KT:_3Z_/[-?`IF]B\Q[?ZE?X*]&OT^OS
M^S7P*9O8O,>W^I7^"O1K]/K\_LU\"F;V+S)3ZCW,TW]0JM9SN`7UANGL5HJK
M"%52)$JN1RE9VN[UC)D!B!>)`)R(!+-/]Z:.9T./(UXS/D=FOCG7_E!T[N]2
M03)NWN)8-Y]D:ZHI*ZTXIG7Y]1J\V&+9<;1&,[`5:Z-JRY9<[`>GIQP5&'P\
M;,U!HW&4WF3NR&;)&W7AQMQX\"%26ZZM;6:R-C]O]2O\%>C7Z?7Y_9KX%,WL
M7F/;_4K_``5Z-?I]?G]FO@4S>Q>8]O\`4K_!7HU^GU^?V:^!3-[%YCV_U*_P
M5Z-?I]?G]FO@4S>Q>8]O]2O\%>C7Z?7Y_9KX%,WL7F/;_4K_``5Z-?I]?G]F
MO@4S>Q>8]O\`4K_!7HU^GU^?V:^!3-[%YD,+M4^HXNW];%]ZH/2622M:KZ0K
M&:N['.]M<$1$I-BO%A'E8LW&NLM\F2>VW<0C3(VW3KU0]8&'LT;-N4S?CI:_
M6/F7Y82KC@L8UZB9_;_4K_!7HU^GU^?V:^"4S>Q>8]O]2O\`!7HU^GU^?V:^
M!3-[%YCV_P!2O\%>C7Z?7Y_9KX%,WL7F/;_4K_!7HU^GU^?V:^!3-[%YG7;Z
MF7J3]Z/3&HA2OJRZ6ZFV.";K;`U#$!HUCW!%+12QY.?7/05D;#Z%!A\CM$-!
MGQ-V&K;E)YDSHF6&OG5CNRP&[%A6W";5)NZ->L[]_!QCP"@OI\$^0G0FIS..
MGB1D(6;%)XQ^<^=7&_F`^/$KC3SLXQSYU\;>=7Q.<^,,^<.,OC?%R^#X.1JW
M]I]7@C5J([ZYO-)U3:CZI^^6&[)`30B5O1*W8;2SX;MU7X6NW1R49\7TCVR.
ME+.,F3/.ALY0@QOUP@:UL,M1L(`(`[-7JO?=F^_K)Q1^Z5'V&`4F5:G,F\4[
M3:#@`=LM>D0]NW=V321%@5CS(T;MO&R+KE+AN#M,\[>.,A$O+;$W8;,]?//(
M.RUAG/4X9"U.>H<KOW(7!JKUP`@"-?=/&C5;8Z!'VUJ:.=Q-`2`A0(4&82Q<
M5\9O:V`6`BRCPO/9KW;9GOCD9A`U[R`.S$]+48TOU$[GNW-9B*WK^SAH6PW(
M/:]D&*LK00F*.TRR.K*-V/WL,L,.SFPX^"NR0:Y-G0+42GP`6:W*$L16:)#R
M9,R&)'=5]WA)7]L]2:H)LQJ4*CGQV-_67E77M$<WC"V`F,%`[351UEN0J(U@
MV':PC\T)ELR&/@;6X8KZ66=*%L*AH<4WVHGS)\4N^"\5WNZ/HVML8&P6)ZAJ
M`ER7<`%K"T'-[K^S.NZ&=1AVM.A&=P;L5>6FBEAV@9YM<O1%BQV743PUJS1R
MLN,B;PO:"@5?!,\-HCT<77$IO'!3E^ASR'J1]7A;?8:7-8C>)6NHM@8S/8AL
M$QM866JSX51?D19"!2Y%LD.0-R/CU"&/+KP:`V,&)**DE&32$,R8`G%=-?KU
MEB8WCN^7&4'W1OTY3;E[/U5<&\1#J_9$B+5AEA*=3U86&3U,61$P5`Q)FDJY
MG?E3H.:3`R5$;!.KNMBPWQMA86*I3?CUM>N^"5H?<2M]]@"Z[GK%F`ITIO4J
MQ/,)=5B\**/<;Q7PJT%NGV\V/-$/9':<G'E^9G*$QC*3%*'P:U*<-+*6@"=X
MD.)Z^I.)Z)-+[#]J7?KI:"I#8DA-9*B9%>XFB9O6&P[)N!=6*5I)IMQMLDPH
MRE2*LZD;0P@`-1;,=#/OWZ&NRJY(;"GRA[<NP@2GIIT5<?KMRK#S%W=OM(KZ
M[23/1]92[%J"H*,[#S`X2UF'!/PJ6\.;:AZH^\W.KK(P0>4T_2CD`S'0@D4.
MV>VK)G@FI0YI2.&%BZM[:NQ4:]99FPKLLU#[(435GS.0SU?W>>;ER)+%-S!L
MM1:A)E5M-AG;/-*NU2U+FFO!+(%6JO)9:V7;NT,%DHDWWI[<:CJFT$DTW-5#
MNI>E%^N>IEK?!D>`/`'@%&O4*_W&UQ^>_P"FU_2$]9/!JS>_RV_Z+1>7P9'@
M#P"C7J9?Q?G<#^02P?\`HN_P57KI7B9WO(_V77E.K,ZIBCD(;F>]:$KWVBO(
M=537J0"?+46EEB'*>-VP"571CA$,0F0X4YOC>[86>[VGY:/OUZMV`*_;X/(A
MT[V\LJL&Q=KJ0AXM@Y58.F->VFTW%9:<JW7PU]P;3C5T,W#TFH:TG5,U2*_U
M2/;F+:L,*TNL,V*PQ%?;C$494\TN+&,WS$:NFIKI/ON1:5JHL@RQN63%A1^J
M[C.X7W8#))AHMM=YJNZT$E2?BPUTS1=H"9%8#?O^=K"C&">+CG5]6+)33B/>
M5X(AM=/<O3\T:PF]_P"Y%BKZR+735R"1>KMGVJG4YDAO1O%<;KB6[Z5Z=0*F
M-[#"'`E+D]HUMLQDV&X$=AUP$NM'QJGP=/,'8.CB\52X=U_1$S.-WT)_['=P
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M3=I7>.^YX2&N8]?5E-L-G^D@FMG'RPGZOZR)H%>5$$L8\S`CSA1HYTD,$,RP
M8*,(;.KN*!FP`AJP]3!F,@[UG6)Q5G2ER3=9UQAGD;BO7U?,=#]+C,)K3&OG
MLC`41]X'78L5%'Y>KGJDVW`2*+.D&L%X>TY,(*!8ULQW^[8TB=!'K^.$4>P3
MSJV$+YM5VV,S=.J_;YG[!&4V*RUPM)P>V^NB?VCJV8L6!-=R46NW(MI'05RT
M!\M+58RF\Z8Q(++QT`R32#($,7()!)[.$C(NP"-1CC#_`$S_`,9E9L;A["YN
M15;6.Q+DT49:'9&EZ#0>Q)E'HZ,T+39'`7@S]@X]4\B:J&5RSUYR<3:HI="9
MWI*?)L>R#-H#L3C3L#@-\86%E5)N*ZDIQI5]$&[U#=]_L)SIC+/VE&-*[O>O
M;N@G:)I15*%*ML;1.[M.+1[<)GH4+7&%[F\53%?N40578=,7^99MBW\XDU\N
M#"KH-*M,$\:3$J-4Q5NXE+KE95L[^U/8NG+(;;`-JP:NJGL>I8MG#*+X-E!K
M`Z7*MN+FE%NOPN&%CT^8Q7D:"B@+5F2KGTRQS&38M,0=-@8YB.(77GJS^E"_
MO@@\`>`/`*->H?\`P?4O\]7TT_Z1SJIX-6;W^6W_`$6B\O@R4:Z2_P"TNZ/Y
M\MR?^U*R\%=RZ/JRM'7OLQV+T4?53ZWZ+#L>R.R=E*=;5U'O(UUXKREH$\@&
MM%U+,J>6Z]5^9L@2I?-=&FCX0NV0Y9O-LO"4`'X"-I@^8Q>O7KN*TI<7*^)G
M!8OP>?0;TE>HSO9E;(\5K)=#S<1/3J=C"'V9[[&3)O:KN9;W4N7##&]B>(Y+
MPTO&KM#L+):QD?)PY8-83*`O8QM926'%^N&5E//7#R(Y4.\-^#YEK,TI*7WN
MHJEHV1<Q_`NX_)V_L$`NSG86O;"("XBC40)4/9`JYJ:825E6/!%SY>P($#S#
M9DVQ$3<<(5*U>RY-=[]7%GS?;UCD]=.+YKJN5UJ^=_813I2G1IA_D@UQY77G
MLJ`ZYJ%KDFL8GLNT2IL>9C*RPV`8"S[2*-N"[XFW=-*\Z(H16)P;=,E+75=T
ME6KE[V7>3K/N#"4:A+)NBH:N[/KD>YEZ8XS]:5;](US+(Y&=F]EJ\"CS%TPV
MQC$-,]UMYIHYA#E0^;58T9M)P$R.Y]#'%5*Y4I<^N>[K,M?GJ'6.L3[^2JD3
M*[,'$6JKV?:_>R)>UM2AM)=<;DJ"H+/76*6>I9>63QH:4M21HE1ZR:GL2L-B
M>;3&@U$E9ZB6NA6;G6)2PQ3C%Y97&V-WJ&OJ*Q7Q@7ZXEF!(ZT!K`TVZSII5
MUF:A336G5;1V8.2!Y8Y5P)(D*)F7*'5:JXR&Z.^$2K`LN$E*AKA.7K%@K,Q6
M^Z[[T9SK^IFT>^NQ>T)Z@IEIC5CA8%(!ETK7J@M/Y9XK0)-W=<@5BZ-&;1OK
MU38LM!,K/Q)$HLE6W;,OEL-T'=G`GQLM80ILY._.]K,Q8_O1;(J`IYL]55P1
MP7EOIU*NN<'M`[%+Y%>X=A\UVH;:D6)=:8X-4,#GL@G"6!XNK\G">XRE+&4L
M@O\`),D$+7C$K)36I,=ZMMI0>R-"J5.VLT3#!(M`.VI149:K4G7H^AA<5OQ;
MK,>V*<D2K.6#Q\[[B3*KTA+%"0F-R@\8QU(\O`++)!@40Y70ZW^'33Z%)Z\[
M%=H&RDC#7%O_`#GL]G>FZG]U8Y297%8D=%!/IO$J7)HZ,+#+*UIEJQF#D474
MSZ8OI+/ARM=$B9R:W?%-!-@L).&KK7%OO_QC&=(-_NGNG8BI9O3%&&,A92$L
M9/KV3ND]NJXB:B6MNNO&:%BH"P;Q42J^&A@]0XPXO<\%O"GH!(E6@I?)>[-K
MR-T"64FK4Y.-6OU2_4=O?@R/`'@#P!X!1KTY/X*(#^6/MA_W9W?X*[^I>"'5
M[^$QZD_YS=/_`/8QU1\!W+H^K*_@>RMW)^[MI;C;E;3LJUQ=;?3M7*9^9UL3
M^O4HF1M])JU"A\,*HGD^RH.2`(L6J0[-SKJ-+$!=X:"\06=F1`$7B>O45Z2P
MJ)1<GC-T]&S5K,[O]0YC6HMOQ7RKD<<>INL^[KJ;VK5L2S2H6,].!O72=D$@
M'"J`NRXNI[^G6=C.SF"O;4C<G[X>V&Q;),C?`K](<6[7&&<Z]1CXG:SL<8["
M;Z\K)33F\#O.]C(^\'8[WK`D]Q6M:CZSNBBO)I-4J/#2(7]I2VIT7=BV;F@Y
MMD329*8T<#H(D+&"%$]'B]>KU>22O=^8#QU8[,=L4>N]Q5$HJJ2KXL#R+%R*
M(V"RK%!"+J<DV5GD#DZU3-2.'M%2'9NW`M-&/JV\#B(>)O7?998<6&DW>X>J
ML3KS/4-[A73LOG71)+KU%($%.=6H2Y&!#8["9PJA.M(23/03RX?(4XOJ95/4
M17S<]^S6YB1CQF7,;="ZO;]Z<.BN8129Z+O.>Y^58*G]0ZS<JDZPJNH.L678
M-B=:D70<?R12RX>X;V"W]!9O<'GZ2)\>E>*KB;&$0!US"*FK6*>=X@AU5G#)
M9T""6X?"%M64G:P2;I2[C<6DN7L)@K?O9=AX]1E=SZ$BNC@PU'U6LNXS*`3?
MIX0&*[-MK2KPV-:D\57DMQ@Z*#3RE@N.+PSI^N5&TF%)+DL94'[80$XJK7%I
M3&'7KP1L/53M';/8>Z8!LV&4E"M[!Z=U[?=8(H5_E-I34-L)]9=2^2LB/)0U
MK<HNW`*##%,`D1,:PD$C'*#(1*;)"2),LJU#22U\:)ZNDBY;[^]@1=)@6MOJ
MNF3K["I+LIV4=OD[;8TU5V51UY=`ZM-$K4N95921(?"T@SMT2-<^+$5EJ*.%
M$31W/>U:!PP.+7&])8N6L;CMQ#$]1L.*,Z(\N+I+C8)/3%(:.8L^-JGQ=4K7
M'FQ<N<LHTO3AMXUR=&67/.G=CGKYYYYQ^'P9,EX`\`^73_"U_P"+CI7\]FN/
M_@KLCX.;0?;?Y7XH^HOP<(\`H?Z=4",5Z+4V+F8Y9PR0-]@2\,<\M>6<:983
MK'WXX[,.>,L,LM6S+CC/'GC+'GGX>.>.>./!JW]I]7@C81'1VM@R56Z/'L2]
MLXE/2H'-6'OI/FPFY$"1$4A6DI1`L0@>-F8+)A))R0Y&),]LFZY.H8Q"B(QH
M"!#8X2:S"K?XXZS3*>]/BM*Z6.OF@^RNQAKI.N^MR\6Y7VLZN5\\OO6M"AHB
MA8QA(QF2M>\A@+URX6(Z;/E"]H_D3L)0YYQ?"&8`K=7A,ZX3PGUWLY3=T%KK
MFD[)JBJCK(D;G/J>J=50<HF;*'0*\,K)=(`*?LC,;IDCBVVQ:UXG\3A+&(/`
MYLJ1%B[MV[7/CPR,,.,YG7/6[]NPLE#H.M1RQ1"</$R(*]UOG+4^JAT2;MT:
M@VQ1KIBJP%IE\8<<>\(D1/:"L/V;=\&O.1E'EY?YR/AQX,S?KO\`$C2!TTJ,
M;%:0L:<]<)C.[Q;$P0<VC+)36VO3<8B^I<Y:T\0>#$2,2LT/I,[!4\R2%"8$
MJ>O+$("`D^[<!9\NZ/`T0/Z=W7P`,<1@;=8P_P"=F^NM\2='=I6)!+SJ.Z97
M82M<E#=S#YU:)*I;4S>TX$C^AA+'^<M8QMGL`G1HA:PE^NB/!>1N4KI53TR%
M:('=/L'%-MK<V%V%(CN,J&OBG-X98[LT6$J2(D;0RK[D1>]&QZTS(K!D+$-\
MXD>""!LTA+SVA+IFL<?7CB;$,ZGU;"J>\*=*2WIM6^QF;?(MXLV.98JW,\Y[
M0`E;,L_4Q8919(+;)65\;I'10&L8,7=NG#4MP!(^/"@10ERGE=X^IZS%C.GE
M6P+`'V-+-60>+:&I5L@R'..LN2IM]OIE>"JK7[@:UR+&A0"#W$2`0,=E[+C`
M5=I((%9\E?YTAQAJ($N(ZNA-S"]35UALYASJ973%<3K=!<_8DTO8J>/KQV4)
M33A+K\^@C@I4-K2MJ_-&R9(Y7DY'31P@$#%1L">S%2!Z5IV$)6W;D$TC*YXF
MA[^A-02:T>*PD-US2A]C!4Y.;VB=8\PH]%:WKT4;#H]89,I2!-WZ4E:CL9V5
M$BZ-&!F<9,%F`T;)G2Y0C-";J*FK'/UU$@!NK*J%N?1?&FP[AG/?*<H(97DJ
MYQB`4^LI<*5I'C2(S>#YXB1212?/:6&&O[P@\TV3-QV7#RE<:OD@FD=?K]9+
M*2I<6%J^7F28\31\K'T?+2MVO1J^7ER-42)I^4VY88?*RI6_3&CZ_A^/ND;M
M6G7QELV88\B'NRRQPQRSSRQPPPQYRRRRYXQQQQQX^'++++GX.,<<>..>>>>>
M>..../AY\`]<:3'F1]$R'OTRHDK3JDQ94;;AOCR8^_#';HWZ-^K++5NT[M66
M.S5MUY98;,,L<\,N<>>.?`/=X!1KU"O]QM<?GO\`IM?TA/63P:LWO\MO^BT7
ME\&1X`\`HUZF7\7YW`_D$L'_`*+O\%5ZZ5XEM7NO$"TEJ8F6:CI]BIY#="D3
MU1[60K<M3I`V7IGCM\P$P0B`N3N@3X\>;"V[HN><67HTR=&6O=JPSQ$(<;>H
M76YNT5_CLIVNUV?51RL#-='E!'3UYB2HM2VBO6\KJJN9A@?;%]-D-RW&Y-K0
M;."/(CB!F+QA'VD=LG$67G?Y0>!9/ZJ5(V`86VJZL67:\;`CR!^I7IX9,8WI
M]$'(-B_.P]DI*<Z?GM7&<*(=R-@L^4<6L,4$*PDV`<5Q&2^0J\7"UW8?I!L!
M+K73,Y@K]AAHR^M[:YN-C[`C!JF#`K@<Y<C4B.5=E[";H8P5IR8FC<`>V'=D
M8F;N)\@SM@&)TB7-%C]D<)?='42M.4E4G)-322ROD)C(OZ%)BES@PV7)/*L;
M87VQEDUOWQMFTHOQ]K`>VZ`T[/>-U;#9?/7&QR)3.=PA'0WKGU\#+.U+$433
M0I.WCV(3O4QM8),%9W"F_P!R\-HS:!B@]0O8/:.%M=X8H><7F,;]PA?>6N3[
MK@_("R\V<X=0U&A]"?&$4S5`N/7FYBDH$<=7:A!T(TAOC[(C;O3]48/JUK.Y
MHB[=L9BVA<869N/LV:2>4G7GECR)+SOO,#HZN]9HJQ&2(W7:BHZ9#:=#S$4=
M%1H&I8BNL:!P*C.$8!K7\16AICC,>!VA@U1,2VJ!QQ#UR\8_'&OP67F]IOA2
ML*U."$\`:KQ&,`:\+KI]`"%%,`0$(QY0T915,VGC98_=#62ZO&SSC+I(+IA3
M`NC/+2-W1M>7./(DG'2*EJJLYC,1K>LZ^K\@ZDO?3E.2$Q<5)C:8^6F2/>S-
M*`C8&\\2]H(3]_MY7.7*^6G3-OROQY.[+,)(P&=8.H2[%8*\#]>.MX*%8HS1
M/:D894M8BXKV&42\&5&F,"S%7]&IG&+!XP-D:)!*%.BA2Y2#MUYQIDV/EM%E
MYO:9QFHWK;$P5W=KI:F<\J2!0]R*R%*Q39LZK%Y*QV%Q>"1.V`M\Y1'K/.C9
M/$Q5O*#K&;=?.X?JU;O@Y\"7FZ]YHL5JZ5=7E>)8$*7UXZ[JMS9P&/!FB#T6
MI8-AY[X7!6*P%)6F(`S,\Q!YGV^67+\;.!$8EG((2(>N5GEF'S/-QUP279'8
M&F:?)0Q=H6&O(NR:KDW/&<R2-@T%%71;B@5]G-)L6_5B!$;B3K:".M+HXH1B
M$F@J9SC+D,ID,+^P`DW<I]-_1F0VW95F`&O&C0YBR:_;#(.4JZ+!.)1V&VG2
MD$P5T1A6P/'F_*1]`==/FB9+9QJ&B`H,L6*2X8\?*D:A#B:NP-%[ZJ-WG'N&
MM)%+KF++F=M>.ZKTBO!6"<9GKK3G,<-)#,#JQ`GQ9`*2RYG?!&*0]\'/GVG#
MG7X+#F(<Y1782O%E1IT:--A[],J',T:9465'V8;H\F-(UX[=&_1MU\Y8;=.[
M5GCLU;,,N<,\,L<L>>>.>.?!"D/J'_P?4O\`/5]-/^D<ZJ>#5F]_EM_T6B\O
M@R4:Z2_[2[H_GRW)_P"U*R\%=RZ/JR:8_5/J[$$MX")UMH.*"L&8*(/H6/3M
M>:1+O/!DI!D).;QVM=QALLP.8ERBHJ29TS=P\E)D3HF>F5NV;<@EYNEQJ,?K
MCU6I>OUXZU5Y6>U<Z\AFMJ7K"L=34#9BK5R*=)68=("&@@#XE*P@`0QW&M/(
MC*!J&ZA<*1C_`)^#KW\!+>+KWX&XP*RI.RE<8VKJ"&7I!A'<%]2<==8QD2R4
M]=LKF9(:]0+0WJ(]I2Y1PE+W&BXHD&AXD3/Q9YT5-VY9\;`EW33*:.#=5*IZ
M\2JW0*D"*@?Z/ZO"(0!'7"$"(2@`8588!N$'=#TS-.W7K(*LA?"D0I'##"8.
M*#(1*'MT3(VG=@)+F<7?UWF-(411Y9G9G8I354DG-U!2U=R;B%>*,QG;5F>.
MCB)RZS'Y`?85/`IHF)$%RQ!67*'R1T6/"W1\XVG7JQ"7F>K*@:(R+N[!E2E2
M9'K,$&U^R#>5<)W)>P`+-Q#X8PCN2Y#>V-8A@X'#^#8T]NGPRO$&'Q/T[_9M
M'Q`EYGY!H"AQC`.;!M)U&/:A"O%1Q+-!K=-B,`M+@A<EN$H#C,<-K(PE>&NY
MY@(J_&DZA,<+GD*U1,(.7.CD67FS+H5/U+50.8L5?5U=5NMD>><B"\A)*TG@
MYW/.K+1SS,$KPP=`E<\Z,\]//.^/GSSJSRU__P`,N>.1&V[W/2:\,ZY=>@L]
M$*AJ'ID24JV'M'5D2&5>D0)]<C]\N;/WP429%!ZI"C#W3R)";MBK^P?HV2Y\
MV3GASNE;\\Q9>;/%UIGKP5<!=SV+5%+DGY3S!<A;7=45'F."UL#%.9*SR+>C
MHO8:#9BC<[*0"]D*1N8)29SM'_)2Y'.68DO,_/W-O7;W&[K'T!TM\VK,+Z#]
MD+WT6(WN.P3T6?D5C&W<3[B]@:R\<IED2T$CT>?,TS\LIFO=C(YYV>"R\W2X
M]ZH+HN)"(5DG+E=B0M$&PW,A+#JP4*N5B>WAHCT$E"Q.D9#"`)N`ABCL,6>'
MUZLHG!/;(]HTR=DCC@*[>]7?0P!?M?UC`U\!MDQV`IX=5[02."5NPI-A*^"8
M>G+!$F)9=8AD]Y\B2&E=GA2^@],BR]L,-P,G[R,B-'B[MN`0[H<FROM\T_5Q
M2`)L-_7T_<13C[]'F'9&<$)K5%MC15$@3FL.W5P"'9RFBRDD"`'SR,8FTE3>
M$):AEM\,AA$$AOUZR//7>M1REJOG$4^`F%7M5I'I5>&U?=L:(#6S$<BWP#!>
MY?U$>,\QNI?893!OW<:HJU"7CTQ@WC8P8EMC"P]G4?D:^Z0FUHRW-"MVMYM1
MIW#1RU6=#<U^4A+_``DS)@YOY*M>B?L"0^%LA`FP3/.V;CQ`EQ=\;?\`$W:\
ML.!(=T5R).'$8!<?!+"ID8B,*0XI$<0A;M<F'.@3=&$F',B2-666K?&E1]NO
M?HW:LLM>W5GAGAESCEQSX!2;TY/X*(#^6/MA_P!V=W^"N_J7@AU>_A,>I/\`
MG-T__P!C'5'P'<NCZLR6>WT]9-@WMGOB=1,[.'I3?)[(3Y8FH\&[*O,-L6%8
M>RW2LF)B2()\23$@0'WYTRI(<?+TCX+-Q'D<1=/(?-2_5?U0:*FHOIMZ$,)I
M@:NK[565D7U.^C,"T0ZH-I\*[F$>%0MZ%4ZV1&80`;/SH"117"@!@8GXV6Z?
MKWZ>(^[/7@+-K7*5;YB9KZR)[%%>I;W:4ZOP_%%-EPU>S27^<M0QB68=T-TB
M"0:[+<LH^$3>37FR,"GKP.0=U\Q36D3(%C-DG&'[/HX$KKB[]#<:[HFM:UJN
M530D!%-(1638,YE$-408;CM\ZUVID=+'DM,'9`TB"W#DR-['/.0M@S6-E<%9
M,7V+&'EQHX":ST=UVPSYBHZH8G@'9K!6->G;)6(N$%:L$PEK9-X7H6O.9LPA
M@VR:-WGA,7#81(9X1X$^/JQSGS,N,.,I6_G,2<,"*ZA4.JE@Z5R[*AJRK=^8
MX7I4TFRAM/C%8MBJ``6U0$14AA)J84M+0,5*3M!J9-:W[TTJGR_D%F;-79>/
M.T67<V^B3;8'6[KL+VHF\90E+#MU6_*?1CN@5:C0]M<_*E]C!M^8FR."UYJ'
MRA[=N-[/F_R/^.7V["67PS<\MW(2\WM-B2Z<J*MRI\[7=5UPA'&N9,(-)E+1
MUA6*LI`C,Y(D)Q\B#%P99B9.(993IDDCND[I4S+F3OSSW<\Y^"2W>Y-<G]:^
MNA75%TE*"I4EIA.I>RH6J?5:+,U1+&8-\:2>?XNN0"V8QW4W)APY!=JU<8'2
M6^+&VS)^[9HU98BR\WD35X(/`'@'RZ?X6O\`Q<=*_GLUQ_\`!79'P<V@^V_R
MOQ1]1?@X1X!UV]&2\Y?].I#/#-F&HD$0;7+C]NS7ANPUSAK@_3(FS/5LXYU[
M<,-^G7EEKSXYPSXXYQRXYQYYX\&K?VGU>"*+JW;GN8RUNI,"LV-CDCN<?JL3
ML&\F2EYM1[ZA8++JGL8VW:H*4;#KK9T?E-4'5'ZT+XUF9:8MK)>TWJ7',KC(
MRB:&=-%BS+N5\*9N:B:K!O%77&\6X/[A7Q0MVK-C6*?@PM%,=6A&Y9I^I!7S
M8LUBLR6`DW06U;[;JB4ZE5_:/C9P\DO<LJ_``4<:!KJ((ZY0V&O`H35V-[F(
MF/IBYP/-VO7MK68JW0%5\.A!MJY5[?K0:C\.NXZ'7M<5K2%*V!/ZI6XEL:[7
M8*(W,UKMRO4>CE'%LYA1-XV>RJ*77JULJTSC!#Y:3^&LU;<<:5-+W6EVLF6U
M2G==6L.8I*=VN90&G1.D0?<P\T571'6]DNRG96T:NO=DE[(:EKA0N*7K34I-
MJJ-7]L.$G[`PDY:FQZ"%3$8P)\L3&-JDW0DUM<].$$7S.S?;D0RT2G\Z+3(,
ML&^!E=O,TI58T:F6Q56SOZ\]9RCM+T@:58)?+D)H-2@W.U3`#M0%>)\1J3GB
M)RZ+K3!1](L*M5=G5/BIQ?FXN=4U2\\?IV[MK:F!-M3&]3!ME*Z*Q.C#`H43
MO)==`W/9\%6;L52UP.F3Y1V?'I<_L;"6FP1K_K!E`DVRN`>*#"*)FL(LST:[
MZ._K58B^*7DD)UV=J#O:533(+C\O34/?6^H%+L6O'!,-7Q61JM)!AULK(*+Z
MR9Q13\->M\H3HPU6W4*D!TJ6G8P5EP.>%DC.$I'E@\,;HU/I(PN/MEV,B]F.
MR*2BN+<O`*H@VT`K`#C5H,K7%K/`'I`OW6H5\LM\FM&$RTWL/L@DZ.1M+@6*
M#A;ZT2H$".KR245BQ*"I*$^B:_BB<*1TUQ)+9;F[0(%\=;JPT,EI6!Q.VT]N
MN$H;JU9#H+<&MYFL.,V$`.I*I4I.&95'KA@1TN21MRNH*2-Q0X[;A;#(X3R$
MX1)--T5\5K2->/16MQ`L^P^[ARBT<S8-O7@K3S*+Z7W85T:*^IQ87&>O9]I=
M@IH'L]6<</"K-AV$4U*0!@1M<5AA"'V45Q#/<NDR56+)-18TEY5IWW["_+-R
M_P"Y5=+J/;KCQ-NF=C.]6!CL41YD11H]0,6N"THVJO7-H?*_K\-V53$"N[P1
M52-US`"&7=^YMEMET%`!6Y[BXLEAV@LT9/6Q01N28E)%FG5M:N=<Z80KR7:-
M/!U;J[W#=[ATW1;:-LO2U67VC563<HVM<"=P$0HP#8$1%8$ASY^QQRB:!6N8
M`!JR0SZ=LLOE&"I4^7KB`ZPJ*F=U7ZB_`CNC1A5N2>K_`%[%E)!GV1\NGN(_
M+!/Y[;0%>KR39Y5UH+K["(/PX0TRE^N[GL:K-"*=EPH8E@!=<FKYO#Q(77$#
MAP=[?0E&-$F^M7ZV0#0#1;<VA"-!,(:;KL_L\E]9:D;;ASKFWZKLC;<]MC[4
MW]N%IUEVBV-?#K;U`TPE6!:NYX2=JXN:B4\$LQU5;$15K#F>O.,2N+\II*:B
MD46;O7>7(XD5ZG=L.UZ?IVV='2"O4*H@NT;F%[!,R$'.*IN^8C"OH,!9TY0P
M,,"@E*_W$EJH)8.1(BS-<Z/\9AED"'-)@KOM/*<+_-T).].+0Q0:=LD69@3X
MX<=V$M/A")Z13TMH#"B%<P;"&(T^H65J^>JC6PR69)J<8*5G&!^UL6VTTIEY
MB877?DPM7]2G.=?KJF3/>H5_N-KC\]_TVOZ0GK)X%F]_EM_T6B\O@R/`'@%&
MO4R_B_.X'\@E@_\`1=_@JO72O$]O?@:UF*KK<6IJS6[[9W8VC-#"G)[642"C
M0G9.6CEJ!2&47.%X0A1,/Q(B$8YHH+6"VG;[G9B8X'/G3=`*_J?@_2QRJ4F4
M>G_:Z,_4P3=3]FZ4<!DN34X&AVDK&"77K$9VYNBX.5-L-OAR+-8P7'7IMI.A
MV0LAZ7LBX`*K8$R="Y5BP\P0&I4.Z<76M%=&M-US3-MA=!;)U!Z=8QDC@->R
MPF=N]Q6U&"PVAK(+-KVL)U#*=:=.T@7*[)XY7RA!<-`L=%S&@`X2`)AC<(D2
M+%Q$E5I1M4A7*_O/2D].;?8VJOM3&G-=64-HLFGRUA4K/[!L363+3D'KYVJ6
MK*L>6S+KA-WEPMK6;877V!.6<SV)%SCUC+>;"7(!(Z9&9BMK.76L1BHPO23K
MKH:^W]"[S)!K"/AB;9A99VM^]A@&1^GRP8\/B^F7L7'>>DK+E`^=W`2/]'5<
MSF*`"SY'\!T71/W!.8.&.W'#@%:6J/EFBN2KA-^V\YCQU?[@O5QWB=T0<T=4
M=P5EJ_,E,M,JM1W#1O[04&V5`SPRD-_)N\=J$4`J6="-F)<9!^8[0RG4>MA7
M"?O$EYXDJ%CU*E']:Q7.]DA#.K]RI=IJO$A+/670:Q8-];:_KT?>19;^C+<]
MN-+--863)V$F2'+*`E".!MP7&&Q9QEI0=3)B.3%0@(:"^(<)49.%,XWSG?3Q
MHS<^DE!7A2S!83+=1FS#K3*6Y(MI+36=18:^MAGCMY\_JLA4#!RA1YUG)0R;
MS`U_.T*HSQ(:?`180LT&5EV4.!M.Z[KGKP]9MG7AT>I.S+P!H@ZRAU@2"$)B
MZSNG8DCK9+)2U9G58=#=D5LRILQDHZ;&QIO_`#M4LO&^SJSCBNAR6@ZD;B"E
M"T2"D.0*Z5Z8NF]=T?9?2DZ%DMW53MRX6)<,X\.S2E"Q;%IW-B@IEK&5\<SK
M*1WO1;*9#X0D-L$R[:YA;JQ%9@<\X0DHS',+RS*$$5%M1AJ$?8$V86,+&Z79
MZ%C7'6W4];-T>OV).TDT&%L&/HVD_4TI*G;.YL^?[?1N-U7-F\]12^R7-+R#
MG*PM(6,]1B<K\-E8*YWSUJ)H`;18&/)`"2NKY96<*'JV^)A373>_)M<:@>I)
MM9N4C<N]=4FC'2\E"O\`%(?GBIZI3*LL\`9JYP)"(5?)AY3LDD3#1&(RX1V>
MT"]K!TV2UYY"M`J:G#!RDZYU=9<]T7%L;]K*]2W4ZI.M"M6<EU`.E<`:@[-2
M%EQ2@C2&JW17T-??%=$VN1M=#R3-C?!+1^&G65XVIH$@6:1<&>>C`M6(B:EO
M7*GIQB;LL3'$ZG,6[J['V0[4S9)/@H[TE6E45PN-D2IK%&U]U3=!-A`VM682
MS"I#!)//L=,L!I$EXS2+#6!7JK7!&&7)AI`C':$W*5BV[ZO.CPA;3]H^O;[/
MV#74+L=`,M>/76K[.:!DHY[$8BMCS?UAV"!K19WMO`E?6'6QNO\`U<7L:QLA
MM'Q]8-F.7<8*;)&_*5(WZ@;4.,8ZH5>INNJ(*_.74+LY<_5&R:BC"%BE)F5Q
M=PK7&UM8@5=LM;M'&YW"W7BE1.PG6US+L%-DUJ3?PIWC8:UG10NS%M79(0XF
M.4HVTK(IM??)92:=]RI-(B</2D[=:S#L:]72&!<)@D@UA$Y:$LDX".DB`LLX
M.#PXA/>)%S##!+@#]DS3NRB19)PMNTZ.<,-A"5EQSMRI@JCZA_\`!]2_SU?3
M3_I'.JG@U9O?Y;?]%HO+X,E&NDO^TNZ/Y\MR?^U*R\%=RZ/JSK$J/K1V\?:!
M4V!:$6#76DW4_7G"TE]DN::QMO9,@O6Q"=6TC"@NAW9#2)NJK=<E2DKCU(3H
M+9[USIL][+5B\)99`U*3P=7%*+T\LI563JT]!+)?Z>OY59<7UJFG>B;14-#A
M+3M;7LDK=ONC1VZ)2A;`(26257FO2LJUETZBK+#(V,W`),#:ER*Q$\!IB>2$
MFJ>/&EM+**^+)).]6[QAWW.G)84L-`#[22F&M[:T6\2T@47KBM]=0%>L77'9
M74@[D3G$6>U![4R<:M@$@H[\'2+91)PT/2B'`:PFFVD8S,^'A$,CB;T`MC*L
M*Y78)!UBM2GU?IH1**P^PMFP"W'9D?8JNP6P]9L45UTD9[$0`P3L6.Z;Y>V1
MS#*%@PG?$A'",:4+QE+IB\%=@NJ%0X5N]3NVNL3'0:F"Z,5)>MNXW2IF#59I
M+)GK*&5L"K6ZOXD8@POH[`$J9BX%F:<.!H)[;!A'>$38&A00#;-)DB)J]]>N
M93[HQ69L[3T[[,Z=#ZQ(IXY"=K`X[ZX.FS;=CC!UM2W8G;Q1LGKBF#)7!B='
M1-G-`#&])7CJJ/%;JEG.!G;$V09Q@S)F!*RHN+@KU9A[777B<TEU?NX[=M0-
MHE7MBIZ=!"*FP4:]4;91C9>CFE,[!V/8-F$&Z:QN!"-DMVZA&T!>-BJLF6'E
M(5`ABIY$"$J:14Z2$J'<WT7T\ZUZ;S4;XP>3'J7)GO46ZE4%=GT%I4A2]!<=
MK)N.2Q-NQ"AX!\H?#I.%+@2[DNL]Y%-8!CG8R4(%GN+Z)ZX*$QP4<5W37+5W
MWQUG"V=.^T2JC=)TI+"9<FZV7NLS1;]D[[9/GG'5<"Q8]7&^Q^T\RM]BY;Y"
M^YHRVR"XFQ.56R:_22,Y/99"HBY:-90)4VGG-(I#3B%J</OO/-YZ$7,?KMM#
M[A\UL(O:'>L^Q0)VX&,C&>+`@=N:^MGKU"TYG6&0+%;A=0P7]47I4;D0#5=9
M>(MS]D$5AHYABJTI6J+E^&'WQ.9DVCJ5VN.OM^'U)ELVN3S6AV7$Z_LHVQU"
M(D(H=IZI:ZMKJHWS*&=,V"-^C2W-O#K'T(P`VJ\-R^)MJ$Z2V`NR`)XDJ%3I
MSOEZM6>%Q:3J%1[%5,?M"5-4I(KY7M9T6V1*J`K9(^T3&T*$H]"0S(<P4('C
M2T,VGF9:-\1P^MFG@,X,^.5GS8DHH5B0A&[JW8W8MD!2JT[4[>I;)U^B]>S@
MN-<-_=K/I<X'6/3N+8%ZZ=@[LMZWI>BO]VUVQ6>'9A5K&@5=(FSS,7E!*;&!
MS%0&G`&NQ3PJB9FY*+XE0JTZ]=QOI6D3EOP+ZL@W6EKK94,X]?D'KVG)DZOU
M:RE=6ZGMX)_%-2MLMSB75NV1OO<Q8DW'<RX%4JS*U2$"9IVF1LX%LQ"Z%3&;
MXK3"MT==YC^KW7^U%JPE$#;\(Z<@4_$[#]A94XWI#RQ3)>G="Z[6-0!8\Z!5
MD=%-N%,4[O=%>PIBHNAU*:9OZ7*%PHD#=KTZ0;6&,+J26MWN-EY'![J;V5MW
MKK:-6Q@:S1/$F^K[N077UA@UJSU>SACW*>&"I%:1MK"Z%F.G;*Z:S"NW?*3]
MQ(7$>%14G1H18(&F1R0LI-.^BNI$1FJS&K%':72:VU)M.U6HO,H/-<5>O4]>
M9I0"!(&!=QH,`@#B&0R!+,'Y$>)Q(CYX:L=IDAEGQC\IQ(RQSXQQ&"M/IR?P
M40'\L?;#_NSN_P`%=_4O!#J]_"8]2?\`.;I__L8ZH^`[ET?5E=KWHKL9V!L:
M\&`_46(J6I)^ZO\`J]/W/B+\P3",-MJGKD>HCCLA%YKM&:.R+!3:>OSO>"=P
MN5XH+(:%S[:0+-DXN*FDE#OOOOAI882\:ASI.^"()^>H=`2B#I<'?&A.SNA*
MT.E4X'ZLKBC^>GHDVOFF,BUP5V2T6/`ZQD&?`8EFCP/2;/B!YPWQ[#O+XBRJ
M*;K+6-6^-=T3'>3X@U=;2[VM,-RBN.]:TV>D66Q7#";;.7W5*M9Q8M*E$1#U
M9(T0@?-H)@=P'(S6V=OY11W.O9L#8A7;,C%/KPS2,)PS7GW]10Z10';*U3?8
MPG4F+I4[3O>N^JS`N5BN=IBP7Q<:S!U<J&MUM1RG$"5?1`#1AK:PKB)6XP9*
MAC-#:CDC#`]M`P>-2J2Z?+1+:\$Z3MK<3_3G39RW.54S+&A6IIJI<GWZUDZV
M>K)`P(RPU,L+K,.K<6*5Z9<R:K/28Y&O;2=QX(D<8HPAQ9BK)NBBYI@8-$"-
MWW3FE??/BEK6=2%$OHYV&KM!Z^UXOK4K003>NO4%*4V\!<TX.`ZUW/6;Z?9>
MRSK.7??L?<Y1;,7B2V*@_-H:TZGG4K;:Y;X"J@SN2TL5VDW:>;;Z4[EU?K5D
MID.BUBFTQ<$F=K++,EFON4WV;(XNU^T;CA=]F/N'7//=-B-FC/</4!Q-1]P@
MXN6D*C20P>7#'Q9Z^/D11$U-V"6&J=M=II#EU#[1BJ\.U^HA=C@ON^^FR[-K
M8;:861G&OT/K\]JME6`%GMMC!8N90G<'-=E&HP;*,.?N_$[82JE,5D00TO0*
MFIRJXZ)3CQVY2;*.Z@]K]N>E\R>#`:\\W=)CQ'R;:S*7&!$;#TXU^F&[;(6,
M2TE;GZY':W1-=#$'`#O(,A`0">).4N2%7]\`&[/5T?BP_P#4TAWZD=AFQ%IT
M&`1+=J=9`J=K+=A)25V`56^Q=MS-*Y18Q.[(`VU\=_F]'S7I:=:6(Q@TGOI%
M"E6338VI'E-3LXCAHDJN-UZZ:4ZM5,DCO`T:\]6C3JV;MDG9JU:]><C;QJQV
M[\\,.,<MVW'3KU:<=FW+CG//C5JUZN,LN>->O#'X,>!D]O@'RZ?X6O\`Q<=*
M_GLUQ_\`!79'P<V@^V_ROQ1]1?@X1X!0KT\=<+;T0J'43@\DQVQ>L'60&\0L
MB7)"%F_NV,N#P.PU[<Y_,O1SLT<0L-6W*5SL^0QUY\[.,>1JW]I]7@C.KO;5
M'%H+S'5J"O,=/H(P!0&BDA".EQ'!,!YUO"L-;+Q(<=[UH&I*XKS.')'XPG+W
MA&E\1TWD)H;\XZ[L$C6JUFN<9&]UQVJ3;>=`RQ6J99#8N%DE$?MUJ11*V.KT
M(!LQ'V6"D<&.#K8*>L)QT!S!^3BCD<CQ"GE8,4EMA\8SML(&H5=?=><%U[AU
M,@63.KYCC-\<8`9EE#=[4UAX'-65]8CLJX.R<AN!S<8T&X9YA6)8,GHE#5LJ
MM#/G6H0F$^'(LP>)*"*33.,87KN-`#^H!59W4-'CJ]NK)^:_HWFUG5$Q271=
M@6HLVZL6B[5ZXJ,<HY0U@:OG$^D;=89NJP&A(8%6+7QV$Y`EXSM$#"8<7H\H
MIY$G<]QNN,-$HRQ62S@*.M]C#(]9JK-ZVY*DXPU3PA@YDKD81;C1L`G!NL"4
M%%XQCF)J',6C0N[]_!<@-B3`ARU%U_A]3,:^U/7Z''#_`#PMVL:W,'N3F8E6
M?K1K(,QSH8$\UKTDE#AQ7(E%G#]\M)9MVG?`FRLM&H,5C$M8\H'-#AP0\F^I
MFR8]A:"S@U\3QO"G\AMM2,H=5D,;+2^8-F2\9\45E%KZ7P:^0<Y&)2="&Y:%
MS82V\3YD6'SC[1(TZ\PAUHZ7TNZ3!EDKK&E6.:MLZMTBIVM!6SEAL-A&!Z2#
M=H*J$"Q5=FL`LQ3<(I>&'%+?$)9/N4N3JC0P&,,&2)ZQF&B)P%;JQD;!*[`4
M-"E/<&;=E1Q)M6Z=$BS8<JR$V/*KK1)E80HVY[C[3.&U1TR)NS7$T;&#`?AM
ME;,(^O++;ECAR)#RON--$=P.K1U@L!8&=@*DD%:M4E-^??C/:Y'&KJ.\#H!9
M7<)9J20U!]JR5'E@LK6<BSMXS1K.@?:I.G(T+QEB\5T<.LQ3*\X-H=P^NM5J
M*DW%;503NJQ-P#&LPBR^(Q`_9T4\U`E/@I7,"2R0L708)FL$.:9F+^^=KACM
M<C=_G-N.K1M"'E=?XDM-MN50@L"FI/=G5ZE-3[,X'(JRVNBVN,#H0YE0X'$%
M3#&"4,BQS.9Q"!#XBAXTS?S*G0X_Q/EI.G#,2"'G3M?T_K;5:SZSWE1XXA5(
M*#&N">/<E$NY*`(0U3ET2*<!H.9/:X4>`[L!,&*#SX?'.AI,D!L*+B6(2=.T
M6'2CU&3(]C.MVF+,>7>Q:D5%E*;@RXJ6<\V#5<%6+EW>J%>QQLY#:=K9+XB^
M_D%ZC\Z-,_)?.FP^,XL/%D4HB%8380\NY]!('TWTO\^,:R^EZK_I)RA[R&->
M_/\`5/GQD/C`HC1)G8J?O;W]S#CK)"`Q;Y/$#Y'4"FQ"^S/$?)TR,PAQ,.,\
M#84>P4*SE_0VUL[J%A*LK?)BQ69'90S8OR9,/9\C+CZ#(&;/';M\7;QSJDZM
M<G+9HV<?$VXXY?Y/!(B\J3ZA7^XVN/SW_3:_I">LG@U9O?Y;?]%HO+X,CP!X
M!1KU,OXOSN!_()8/_1=_@JO72O$L_;!MS7$4V=1ME=1"PF/D2FE[68"RVC@`
M$#7LF'3QF>&%%)>>D6.T;I/,?9L$0^<,=F^6:@Z8^7RHGK,I@)[=W424ND]B
MRJ>20X+M1MJ8&;KN8Z-?-O`V&Q01QG:"*H%DH8X<14:M3Q&-@&Y+#L"'R:?I
M8\B05+++\2&PC4*6INFN%.O%Y3UWDD=4>R39>)!]!6.%6Z]=U?`:3UU7F&M%
M9L0$MDCS<%@GF499R>GX&P1C8N8Z@;<B8'5`C.C&HFDQLV1-6.8C25WT[H\+
MRKHKU$;2*[:)A:ZE0-,[N:H+%@=5L\G=BV1!ZF==%441SNKX%3#;!,!*\>5:
MP]4%1]LT&#.XO7.,P;[MCO)(7BWR[G#_`$ZZ;'T>X;ZB5EE(SJ0TU$D:H77<
MF##]E<=CP=V2=TPAVVO#JB8W4W\53QP)Q@F=!-=K1\6_$7M-!CRJE8^[3&PV
M<$!Q=<S=3\*M?6._IL;<?</.L+&N"M>:W8]6JJZ-K^Z=]I$.!\]!V:'QQ>5*
M."FB1A74W8;M.]&EXQ)<*#*XG3MTN/(CC8@W20+"11:W$;.K$U=I]2.CU&6X
M:R25>L@4DZ.P90LT#JQD2EK>K=3K"^C3LJZ#R/);5GO5J>8]PS$Y-WQHTMDU
MF1\*O(+D>UD@P\7BO5ACG=?GL6,&[#^_766;<C32LE]'`S2E*=11%H8"ZL(3
M<F"ML!F=@`,IDECX.B)2K[SQU2BK.O`5<M+'G(*T?.3@96/$#BN)]5/)N[[]
M:T@>TECS=,Q%IAMK&,)$8,S-PXPE1H@3V,E/$/<'W3>#"(7K=F3,EIC#>\-)
MUF>%-8@Z<RQ7Y'0)Q7ZZ8ZJYF$1/4'HFR#B0I*$=I+N3H]-]?9+$.17LS<MF
MT0-5S*SYE&(?8$Q'/:AZO=%:LW`^NFIY8I((\0GQ@>W6FO7"P#37IX^L?(B[
M1ZJ%%@*U4K!N%6=J<D-/TO&,E=FF(THF&KNE&^&GNMF2M^ENC:2@&`1)P-."
MVN8&;'+3=)_2J)+,/7"1?@7BN85;KIO=RZ]A+X+N'!>.RR52J0H,NY,+_NDA
M!BS#JY*@K1MPZZM"HB-P-!,:BN?,GE6>R+.IL_SA!C?>)('MWI^XP*@$26(D
M4GH[YO/!H[^T6F<OLYC@61`4$6#>^[18&"5OFJ+T:ZR["T>\U!"R@3I3"7:D
M.:NL\#.`17PT5HEJS-@DSV76"([8X0Z:XZINDX,+O2`,6G6=3A*7N+8Q.-K-
M-2/$0Z-65TI41H!5:U<8TJTC);)NP+`V-`<%]GA2EH@2V0Q.PM%G:=3<#GJ.
M(1>Y5T]-8]>F<>K>_%8O("GITP>U3-=A`.O<=GL5;4YN%3)5F=D4=1<ZOKXU
M/+D=;2-+ND5X3^1&G`&8@A/GLE07`V%(,8W7)%=F_KC-I.)\=C,8&]2:A#B5
M'=]"]:XV&:!42UI(QG5`R=.?U/LA-:A=2,Z\0;&D*JC`[(61VT7AM=V-1D8S
M!<#'5&WZ6]%W-`.RTX<8IURONKZU.+^Q)'M<6-*^1WQ_:8^F1[/*U_)2='RV
MO'9\C)U<99<:]^KXWQ-VOC++XFS'+'XW/P?#X,E(O4/_`(/J7^>KZ:?](YU4
M\&K-[_+;_HM%Y?!DHUTE_P!I=T?SY;D_]J5EX*[ET?5G#7NPG8$TS]F*]FJ?
M7\.P40+JIASL';9+MNJ$+HL*$ZGVI+=C$I!%E=3Y5*6L*[P>TZ=`8465+71"
M\G<J:]V[5N"%2^LTQIY]U;XK'%?]Y;';#G6[<[UH`I5'NZHZ$=IC&]0;<F!9
M5A78T/"WJJ=1L"#74*OAC1JR`),A7$6<726EMWV@IB8BSH,[\AV0L7XPWEAC
M%]TW702-?';9TJRRG(`L(2NPHE++_79KN4N;92HIGD!^Q%KME;0XU>C(((@.
MD$T`2F$W@QP?G1HK-A-$J@O:+E;9YP>"4XU<QU*:^O(@6%ZB-G2\*:X^B1#Q
MW=O%1==^J_P/#!EJBKARW:RKN1LNGGE3QR'$!*=;Z59N4-1]OP(2L6"N],B/
MO&PG,J'%OU4?3#?T:_S"G*1W3/+/7?1;S+31EJ<A7:,=U2;D>L#8V=&P:I/:
M6/UBY<E\JW9+?M*^4G3!K4"#SM4<ES*."5$M.'X\$VH<$5B:1->B<-AQS_J$
M5A7L$S)?`3^3Y"%NPI$[NKJOS;)&2:UZ\6N.K![<''#B7E)Y^:\X^"R*PEK6
M=,'OE"$M,`&8\+?JT@K+>2NO=[:E>&-QZGCU+^N%:`]A%_UO::P#SECB&2OF
M80N@WA7B5*O(3>_'B4$HV1`Q.`'4;5K)BAAU,XR.;'%>P(U853+#P3##@XK=
MU;KM=W@[XN)I;^X_7-+W8<$[-7)T'`'89HJ87R@Q@&+6=9(I&S6($T[!<Z1*
M7F7?7X!N;`X0E$T2R(=*;-^'&O,1GKVB0_"EU]/$A2;ZG'5P6;>`)8NS"YJ`
MKO#`=PEC@G,O`K62O!;K%2<@49CD-`MF3!4W;K,S6,$#2<B`=E@CG"?M63WN
M\7BOOC;2>@R1?O\`(JJRMT9ZK:PTNODOKNI=AC=FDI**7"Q13>SNRJ*5_95-
MN8>"14F23]<-;)+)!B#,<\O'U1)>D=C%+D1(VS$>O2(RM;U0:O#4':5C5`LM
MUAV.C5?V'=<D<<%$MT)*G4(L+Y0R4LLPCN)!<WI>HJ^5QCMEU\X-),T%:-I%
M<U2XP!HF+PJLU2;2F*]/IWHMC=W:)#H;:.ALH)]:RF]$=+5-#*[6>&6:J596
M_(#6^6&?T[2`[X`H#<SA=&D,'S,.[+NDR-*<J,>T67Q@")3ZQ=R]4(+LCU&Z
MC1Q5C$`Z3:+GPDP[0@`"\%>BBD>Q;%JRGBM\%ZV5'`D1XQW%I=5!"[I%.Y",
MU?,0%/1(Q:8T!Y*UR+Q73JV-Q.WKVFPQ^[0+0=T@2Z`^9M[,-J3YATX#!C9]
MJDV&QU&V'V8)GRM[/&KO1'$IU2,[)M*R6T4)@CA>V/.(Y&BP,1*$C7GGJZ\<
MCD"?4`HD^;218.#9A06Y#J0GR'#4A$(BHD[>Q;P?K"HPSU*)R()0,PL5F+9%
M"G`H@@F15V#F/RU:`HK;R3P#BOQIC12^Y]>!.5`WRG=D*]C6@@0CD=/)SY$8
M#./8@].\[!TQXDC68CP@ITY($ZMOM?,24`:<`#LO%89$(VJJ^9@28&L&HH39
MX(4:].3^"B`_EC[8?]V=W^"N_J7@AU>_A,>I/^<W3_\`V,=4?`=RZ/JS@SO4
M>ZT07.SDK$NPDIU3P[.GLLP&.%'->Z-1K.(4[QS@!!1V6YZ?HG)%=V]A]^*P
M7@^.`M$RN^7;!?(XZ0XKI2^(ZZK;_DYDGU"**U<BID,3:!E6)+*A8$A\#H^V
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MOM$LLL^V#P((6``9088HA&6\>6A`"KG#GYU_`E-6`JLUK2L=.-.K,LU<O:^O
MJ4=EI`-K[VSL##)K?1)Q3A025#6=5OVB-IBM)C!)/L:[\>.UV03UKT;6OZS\
MT9Q'E%#T04'PU3]PB4J?5T^!%QGU":;7JO\`IK-J-M!ZHQ9&0%D[FUI=7AV0
MY/E^[6=NA0&!P%'C*^-*:"D&%!!""CBU:PA4RE*C(N:HYF4+Q7,8^O4W9LQ%
MI^HG6==KUXE!M=6LTD:;3NQ9^'JR7HJZLV&R=8=?&VT$I6:R<_9CQ,#Q]T4M
MM-R!'(64%X,<@9!YC6CZS`#BNFN.J;I)]=^QX&OURL29U`M*2V6S,DPE>JE]
M;&L-CZ]@E9*N3-N)C19_>$CQ%9;"SIY7='8)64N5D,7U_6::3H(&1$2GSP*U
MUWZA:R2K7K.0?4IBU6GV'ZW*MR+P%3TK^M?:':?UV,=AC]>IL0XY<N6KX%I2
M<.!#$=#8H^F6*U+A1ZP:=^D;(%=F_4X>V)U]5<8@Y*UZF%$S(E`Q'H8T5LZW
MLCTH\?,L]*3Y,]"']A&^77M19G<H[/JGL$%Y=!T^`*EHP=FF`PFK2UV*)00.
M_*5I#BNL52G/"KV+]).Q3P9/ET_PM?\`BXZ5_/9KC_X*[(^#FT'VW^5^*/J+
M\'"/`*'>G9@1V=%:<UAY,.&6V`G[`7,(PMQ$?%(YV"ZXPI,\?&G"Y$^'HD\Z
MMLJ%')CMTK1CGHU3HFS/&1K&K7VGU>"(NPZ6=E=E!MU1$.QE43&NV+,B.U_6
M;KHU\@&[S`D@>X2_JS9[#V$CD5[%PABTE(A2T8PN1$BFEO96:8+"X9@3ZR'&
M4S%RA*;N[IPO<DAM74IG-6M4%R2=-`PS-):0)^)+JBBMM>W(Y35>M3RC]$\*
MV"UI&HZ[3Q\T;WR^%6>((Q(BWJ&J$R3MVQ-KCM":.^N;E=,1?K-!+]%[.M?4
M;B7-:2%I5+O:J6O+LJCH-?L,>;/OZLJ6KNKRFJIWHW8$WA9JLJ5JFNF"$(94
M]H9XFA9)C=Q^5RW9S5T)2N55*3;PG*+ZYQJ.&%Z&W(,::RN";?=>E[RI,73*
M=79?*EV&!7)!$J"M.R=7[8SPGZKBDL!!I>!_:-Z82AD`Z`A0,RN(D4<`F#QK
M!PS!*NC/&M8U:N^\G&+U+-K=0]8T!0L47BV=<[,$VCN:V9+ED0KX?G`+$`6'
ME)5Q+>&EKVECRM1L.+\>*RDL%N?J#P969V#'E921)JZ7]471AJ(C&>G3$BZF
M'43L$.:X.E>J\WGVVO\`7MXT0NM_?>WN[,\9GC(9)'&^.]Z;/AUYEC_F]0:2
MMX-F[2:QFZEZ`_3N]=Q>-JP:VV>+W7F`)>FOE+=/G-E94`T&/,EWR7A,.Q;@
M"KI)8MCMI9/:<3!@0*KO>M(DXFMS+*)*AC%XBMX!HD"UYGT!EW(5+!F@XVK*
M+KTDIJM4X=),-W]%5RTYU:2EZP759TKEA%2-FZW)I?[EE6=2CJ51V2U*$T$[
M'>RT]*2["8*HK'.9`"[]RR%$!#P\,I1IC/)*103CU%:PZ8J61"*]-_8&U67H
MS<E1PY.%[+*UL6=\NR4H^D:[4[+*?9LWHC;5_M"!`*9L.YIBW.!/50KE;->#
MJJI=B[96!`&7"-`<;];JPFLM>LYC)T"M!I6S81A[(8L9<ZN]2"Q5S()K>OM1
MNY>J3<-9(K:4,H-NJ1B,H/T<?SHFA`1<4[K)S9&9Q]C$IL#"/O#C1AB\KFHB
M[#/N,62].9HQC[8"G9U=K`EV`U<,MD:2K6QK!D3BM6]JK3[8:&-`9GZ^CS6%
M87AVN-OTOYEW,6#M)$8X1D"15_.%K#:@XWZ5U1EDJ7$U]A^G[+=5@/#"$LI=
M5E.Y:GJ:F+;"FZ_FM3-'4ZALVPK($EJH9XKNMPTIK-Y6>S!B1$VOMT2#-'I+
M4.A8S57>,/`G'2G*KXJ-6:*P+7I]6^\*UHPK(>TE!XGR/486JC"@JY]X&PT#
MMWVTE7`'=[+8Q]HRQS[`X"I:2=@*H.!7A+F&S;Q;5+BM"U'EZA>,J4G[,U^Z
MHA4IWW+`G$WTOM399S->2U;U:Q+1;F9L+EX3939MMK+2.L7K1UDH9RTP%35:
MX(SP6B'>M@YO6"4MHDZ]*JVLM;EHL_WEM<,1)PK'36C;6&OZF)3O3E#(B^"6
M0[V,.#UFU:]?1V;RB_./<87JZ]/<+T1'*#GE$:`FYBUEM`N8_G)L>4'URXAP
MNH1X<3*9M8\F0=J=D4I_WNUU>F6LZRT^W4;6>*$W6%ML'.(?*3%SGXC3L@)2
MEOUP]`-`"DWQRL)]-AU[7%W9PR;DZ'BW'MVP=%W0`(\,('B-RYB/5Y#_`*A7
M^XVN/SW_`$VOZ0GK)X+9O?Y;?]%HO+X,CP!X!1KU,OXOSN!_()8/_1=_@JO7
M2O$L!?-&I_8JNY=8/A!J@JY`POFB&M2/;@$HEL6B\4Y`&%L\-,F*87I)"%%S
M,+I:)-"G(^GV$M"EPMFZ/L!.*D=?N2E'.T4"XY-E7=-?*\3XB&,)3[!YF1BB
MQK;,W`N/,CI`C.'\=O(X"X3O+#:@\QM#+2D,-;Y6E7!\P0FC4*KFZ[H]>+./
MIZGBQ;)RY`[5MG!T)'ZMX8G1D;R3,U2:NJEYDV,-IE>G[)(^"N)[2R[\X%@S
M=@LR?>4T@:6F4B1V2`99<"?KM>/5AE3KU"+Z?'7V#"]DAY61'VA/F[HJTCC8
MA[,C1`M3=L;#7P-,;]VS;K404)IU1=LD9)TE]!M?'"4=@][(H<4MPPE^>OI]
M:[ZG.C]!NOD.8"E1(KW&UP\5_)S'X/[%D/N.8K6\W7^")7%IW2=NQU(1KJL%
M]L6;OV;H.)XLYL@EBUEE0EM7^!>,_6%$J94274259_6"LK;9F%I:LFK5+;ZU
M@5.X#PK)+%AFE/"L19J6HY<?KPV8\SU@XPLDL*1A;(<C7PP$M,[F=JX@XPA)
M\9-=.=,J+8E]G628<[L$MR-V_KLUJU,9'3MW+'>6RAML]@8^G=AE\>/*-N0F
M'*7YFOGC<L0L<X`SG#1LRX\"7WI_PT7B;>F]=$%">7!R6IS7%ANYA@:#M>[S
MW,ZN^6QOD1Y;2T1%Z9%W28I!B(1MI4A"Q)Y+W)N<7-Q0L8P4(3MXD_Y-7>>F
MG7RQGRP;&;DV008K.HV7UX;,8QXV)&;:X($-!$AB*'B9T'4!:YFP<O1MCJ&Y
MA-&J"H)\6,3T:UH5[.++A+)R>HQU&0VD,BK[JZ6N["42P`=EZ(;&X1]FA@:5
M-C4VU.DL.D:&&:>=2DQI0$F%]Q:P4K++@Q%*2R4!E8XI4)\O7Z^1A(72*I`\
MX*47#]I+)1=+V;)"$0KU*URQZO;S<)?7>M]64R'-PS1I+@&B'0>C?KVLBE*V
MD-:JRAHA4E'E!/T[J(V=+ZDU0@VOE;R_(>\34<K;AP$LSGD].0%4O?31&>;B
M(+B=OD<C(DM]=X^;:3WRN)NT>7GE,0&0@:3FC]P2WW=RA=WJB(<M_P!/:K;"
M1[Q7E\VW@"EJIO8D0JQ2S2Q&4*JG/L]',[[;?TU1TDAVP>=<6`\8.E)&LMSO
M%[SS1H3]JQ'9SNJ>+QG35'=<NC])F%$HKW3BJULPO-4,W9LU[!6_G=4FP#3\
M5,-[.T[JZ'5%O%M9"=CNC%E+?6`4$E[%_&#&T>P!HA/';BQ[R1N<)+?AU3/B
M8%/Z&T$B2D+%:CO$)<K^)3',1"R>CFY%9&3KTHKR-3CVXK^S;SK/.:2N*"?'
MAD]F_1#(S4Y0+&QI,JJ@)@X)?CAG?ZV'-V=(:6UHD6O`V]Y6P,6B*DZUY<AF
MG/F5.IVF(;N.450MP6A%1Y;7('V&T13THA`D22?,F%-QV1B8D9.BAQG,NKEO
MK?06D6%L,FK2\H+D3D>O*H,2M@8&4F5,YA!@<".,%Q.9<[?)FRN8T&+HT\R9
MDF1*W\X?*R-^W=EGLR$*;>H?_!]2_P`]7TT_Z1SJIX-6;W^6W_1:+R^#)1KI
M+_M+NC^?+<G_`+4K+P5W+H^K/1I]/JH==4N%+[WR]2"`\MD5V8AA.SI,Z428
M\'&0^F)I0CO%Y2V/!Q99',M[BMFP_%<HV&`Y@TSA^6Z-N%XSE.%2EVJ/\1=@
M2H:ZN*+5O0^'1]N%V#(15*9(ZHRV#-DJ[.W5LZ:[#K]M<AD&(/S-&5-QB!CD
M'5KDP@T^6MKF1T26X#Q.,!)ONK.&?KU4TB+TE0BTA08++<[&L)X'!Z\'V2<W
M-AD("NB35EBG[=KW%\4]$^=IDKR'8[6QEDU<P*;,(B_/UI+.1;EB-[#M%XUZ
M24;8E0XZ5>S@1_3[Z^18$J!HXL3#&#P"TUK*YL-@SF47`6;''VT!$TONV;<N
M$X2/?PX0OG`VX%=)04!`I1K@DAA1BQ%$XS\Z*LIKP?UOJ2=(ZKU;NI+&A]6;
M=#6.'<;:/+'&:B/+]MM49<</L#JLJ0U2N9,B6U[[D@Z7N9G*C[@\F?SL&9B/
MF]EP'Q":SZBZ-E#7R72VBRP]R&D!;%(T/JI?":R[,F8CQ(F!NR#T)L:TN->[
M'+CF/+)M(2!*&RM7&.P3'QVQ(O'&K;GQX$OP[KCR:>G-1L3J6LJ)->DVPS;8
MTM$YT36V0),Y_/M,J-#=%O7C+CD1N"RS!J*JJ1,@<#^9<,ZH#CP2>**\9R<@
MEQ&'^8V2_P#!O%V=;:A[!+`=1LQ:R)A@CPN6#%Q&SY82;(/+G$R)EJ)3QFR/
M+)"&1>+,"8XB9FW;$9TQG8UPIAN'F)6&0)M7>?K-&"A]7D@,QV(PJK79R;C9
M<]A8#0%8<ML%=&NC7['L8G=>@[X,O>,.%Y<+$I.@<S)"E),3"Q;<LYD#1:3-
M"?7T]5UD=1?3_P"N\)>R5(T!RC@)M>GZX8AT1T+#]32,/6&SVWB:)\CLH>P:
MT+MG.S:[)Y94R7,50P<V:@D6(+&`1PD.,_K<NC9%(N>)[K"Z)U):JQI6WUMN
M8ULVHUFU>PLD2RR:TRN59V]PO\O*"SS%.,"@R%LCO5%R3&CC!HN6.V#I.J',
MU1&)KC'@3:NU.Y.J_P`]'<2-=G5VL[YF#"#?*=PTZ$E.=8DIB*Z&4V2TU=8N
MP!M>*[9MPC=KV35YAW+`3=S+BY068'MB[]BNP`LRA?F>";6U/K5Q"2[Z?E5X
MM-H'GXFRN8-X>K.:5JN<6-@$UPC1K1J331YS>$58I+V:$U<UA+:$O`T,VP(,
M4,TF-PT/!.$2)B8+QG"2I"2G%PY\:F[R^DM3S-@0QRQ6I'?EGA#S7K4AODJ-
M80B97BM9",$G:2>N'[JE;9:7;3XL'(I,+.%EAIC5MWC^"0L5/A"3_C"L>2,R
M%Z94*NB(P((O&(`J)IZVZ=4?AG-S-V>75.T9MQU+,ED2$N83(D]3^1FFFTJ1
MFRR3CLE2.3TJ5MW[MVP)?CWT?<;_`$U0R51^+YO5YC.9-6:W:G=Z9G`UD</L
M3!$6%],@2YTK"-"C99PE=6!"O:<(>,\ES!Y)G)A4U+G$I(-SU?Y\6V35X(4:
M].3^"B`_EC[8?]V=W^"N_J7@AU>_A,>I/^<W3_\`V,=4?`=RZ/JS>-_3FI]^
MBT0O!&P(Z)<$YO)NU9Q7*9'19<VRG#4\6KG$@8:/>L.+:!S8;R<QF!G,3(C-
M[AJ$00^QBG[LPXSI=*BN-*+9]%D0]H].>J==AY$\6%WA5!"KBN*_#4P';F$6
ML9BT"[+8NN*J,.F.0XC&JQ&EG\`!34?V6-J4U!4S18,_)#.%EB8+QGUU<XUA
M>LYF^I*'[B:G\5IJ2XY6R82<?:(3ROK4!Z(0X%8N@RT(-T"F:M9&C3@6!SA%
MG#83,&AD2)H*'T:.586+B)>^2M[A)\NJ(\#W,/2ZI6S>:F,IJT#9!D1ZP36`
MF0L0YO(E2%*6:0N*H[$W2\LOE8UB5[8A8F>738[F$.U:Y6L+,"S`(X0+'A.I
M7M[:-='A@8UTZ-U'842!H;V6W2<OA0W(;86C606`DK*4\7"8_AP=@<KFH1"+
M#EEN($2:]#'0A$2'")EEK?HEJ9@L"FA+U;%2Z[9Z9H'8+I0Q7#V;0>QBY8H5
M/,I"U6RV$FR5PZ49$OA*L9M<FPHK>RMPQ2-RK-66S:@3HKNLF82E$A>_1FLK
ML)3P^8J<*.GPIA@ZFYV!T"Z]60FIR(=AN<1?24RW*Z&ZPCB2&RYR+>18`>LE
M9*S,<=N[?#.F55;F^V1>89B)I$\AXY+``881)@3C/P=RO5WKZP;HP].Z+:Q1
MT(P`"Q$2R[>PV9N#DPE-&N=AVBC3H=OQ\MD7?HD:=!F*1EZ1O$?=IVA,=G&0
M[;JV88Y\!+\.ZXSCGUL3GU<K`,PM=H^_*DF2)JG8P9]*+EE<YE%HJG,>DHU`
M,1VV9'9ULV0'E]>$:/SID^[CH3,.Q@@)@8$WW5U:Y\?*XB=*]/CKC7[77;6M
MBV^/E5XQ4'K`"2Y%9:[S)3.NQ3JF#,%H>[GF85(Z*,+25'+3)(<AN)/'+-H$
MZ&B62,3@XS<Z[W"F^;^FILB+TOJVMR-<EE!EM081KI(1*SURLWF1-VN5=56P
MLC'6"<]938._DT-0Y#<PC0\Z'R*8)X`G(!LADZ.R^1\"?6O%]>SN+=>"'RZ?
MX6O_`!<=*_GLUQ_\%=D?!S:#[;_*_%'U%^#A'@%$/3HXV9=&*9XU3.!VWD(^
M<:R&6&G;C!V<V&Z\83,M<C_,;.(N7P;^<-W^9SXP^+L_]'.7@U;^T^KP17B-
M:MPYT!>SSEVDN`BG;K:B!>GEJ!*YZYS+M[#X[JV$B8::DJ^=*85>UI[S>>T_
MHK)ET5H+,,:0`W.?SQRK*:.L&2+%4H4PY3F%WRFL:T=(FA(HNP>S-;WI1V78
MYI=M:=94.IZJB!*FT]?Y=.;[_+TZQF[!BNXY@4I'8V.)E.`0L34B:&X^Z!L>
M&O9L0W6KY,LS@2D4OK,S,32(ITD87QVINM,=[JL9%?=A1=I/L71='JO7L<!1
M"2W="?:="UI:1E^D,.:Q.L_(_H(VFP2%V4FNPA3U!Z8GXSP!CF2P2>`2NUIN
M9NAN_53'/H(]4NPO8\I:U!4)([+'C@KL8G]5[$)W>)1Z.CM-?3+>HKO7:[.E
M5OHXK&97'*VRE>K2!@C_`$A)EA-@I88W33-:#I4BHE@XL*KBZ:32CLKIQ\**
MI9Y+[7VYSUSZ7L&E>1K'MCLM84FG=1]J:Y%6I!"4$K"\["TVILWKJ:[YY1G8
M12>LF(60`+3"(2G.#'%3A\#"/EX)%7DJTKBE%ZNDU6F/46<+R=*Y!)O7,Y+!
M%PE*R[/+#RS@<^9<ZX11(CN,KQT?5W%=L%>)GLL&1DSLKPBF'0+),D5U5U3P
M$(*S@[,37/+#KOU*=9!Q'O#V+GZ.M'99P0E5)IDUT1["=T2E3H]VER95BU"A
MO7&17(UU,%:1"#OE`T:W.8!>'K*:50-J96%PG3C,RO5J,;:O6'F6%57OC)3'
M3,5U9;"T8KN-=4VX!?7O?2M8<VAHM^37[@5'7.RRZW%+$6D5&^-K&&,[*<CL
M11H^;K/RO9))!:#8Z2G`8[N8<`)W7E#$C&<)[XS[R)U?U%[J+P%5J,]=*W%I
M!Y%ZU6P0G#[Y8BK(-KWL5=$NDX6F*"WT<+'D')=(0MSCO&[#\$)-$_$7\3N@
MCER3P"%GGADIS,Y*]1QEWL5B*ZG5"<Y3AC-0H2KC,=WM)62G2+=W:C]RWQ/*
MM#GU_!<\CU@QEI:-[%68JT%<SKX*@0Y:5R*A&V!/T[Z#BYZYHJ4G/'J)`K'N
MQ8-ELV*G$J5%$$D""^D+VW$K6.\:(&BO^SMT=7B&JE-$:K),VS)Q%BH=T:(,
M)CT5YEJBEZ^6)NV.3;]Y(`#48]%-2=:TOUXG/ZS=WFB[E`>]N77RQDI4<@-.
M,];GE)2ME^''8%Q"FHQJ&%/:JG49T/-"@KPJ2WO(J"9JW;'=5C,.Y2M^V9%C
M`[,8S?EAUOS(;Q]3<Z6'J\%9HO81<BCLG4.V#]1]R8Q*#V?]P]AVFYZB(:D&
MKFYR.:JC`]>Y&_$T)4>)#3(LJN^=PE:$33)@0'%S>M:U2'5J^<7AT'KNOOS?
M294-MG^*'#4T_!^FKU?E:P;;/NTG2=L1(JV98+PI1-P6K=JK*W5IC#G>T*36
MTH]B-\,?J.:D\"K2"!D0"2E5QAQEG?CLUX$D&N]5BK-KO=?D^O!(^#I/@0,O
M%G02+^QZEXT2HB-><LPHSYM2A$@ZF#8II64M6QD=DUR,%RIJ7$4=.I;AQ&D.
M+2^^ZZM8SE/JC6;+U'O:X+EN6Y==G04I;$1:(ZD6"G)-?V#OLI?!86W]/!TC
M/E,4U$0IV#`3&"5@<2A<0)XR1"7Q#`(FZXQ[*%%!I*[-JM+HULS_`*A7^XVN
M/SW_`$VOZ0GK)X%F]_EM_P!%HO+X,CP!X!1KU,OXOSN!_()8/_1=_@JO72O$
MWGNBT(RA0#.6?JT:KB&;"`$8(K-6@N,[YV-18GI@+<-HY3(A"4.1HA/?J*N!
MPP/)!`0.!*+[A1<C#&"Y@*^^-9UV"1"Q!9/3HJ7YR6^QVG7*I39]Q[23U+L3
M$%EE-0GL"SKJP-R6&2M7)BZW?DD$=HC]EJWAJ:';#UI,4DU]%G)<:^\Z0YA3
M9]4PC&[$D[I^V+M"M]GK!B1I8Z[*SJ=%Q^P7-'WI5;.SW%;MPM:`L4Z[!K#+
MNFYX<AA%C`3B[BH:%@*G#6'.38"XJB=<8QD(Z]])32275&K/`I"!$/\`[/1,
MPJKWSBNZT^MXGJH:YBO<_P`#7;65U*>V9)E1=@[VEV&1#VFRI+[*KS48!X]>
M2`&,P[,JFFKNC)A4OZ\3TJK")_[M<F3"KUH_'+P2RW?G#%L(H<OT[MLL!<7/
MS36MGJ*=GBF.$F3G"YUI&N!UGW]<^+"@VCL$2\.N^@"O,<?:+@.(W6\*>O`M
M-6,J57Y5TS68=8=2\W9?L->2IVSG536+>W:\@-=]+W%.JI;IGAX`V86N/LM>
M5>7%"L2PL$X[N0E\35%>13HV5K:4/<%VAS#OD3,+RRV!)8RDHFG_`'8Y)1"Z
M>GJ(;4[P]0!O77C;/88Z:TF+/HY'(*\*MCS.W47L=NYB%6+M*6Q#!UR0$V2J
M!Z$8&TUD6:;'OCVC:"%6D(/[$+?-PS%^6G0\;_EI-6U7"F5YXZE^VZ*N'L.V
M3K)N@0%N#N*"4+&[%Q:)K%UL5>JY(Z1U^P(N2W@M4"2A9*3';&W&O]YU@4'1
M&7Y8>0N+HM:L9Y/MI">NFGFQ1Q14LNDN)XSS>53:5ZU._C37IAU/&FFOG""J
M]'`(Y"AT:#Y'9L]WNM>#+V>30MB!E6S*8GKD\K.R28;"+AUGG,:(KE(,28`B
M4KTD+QK.4Q].D\L;@[D5IJ:2SFT7+:2YK#]W%J+%`4@@0FT+KHNYDI.HFQH.
M\+7.(V>X.Z499SS%*F+Q.OV85`B,*+5,7!>*#FD*.Z$Z8N+FW]%_DC_&^N_!
MJHS+$)/.T`Y6-+]^+2&R8M,C3\^[6B@K&KG#K<F&I##2E<\RA-H)Q]DA;N:_
MJRKF6QAL?6P(?S?VP\YV\*3A?9QS5<?JR4+([!]H1@F^YBV<L2/9:_=^23S6
M&ZE"<=!JCKWKO]52@UYJ%CP*%LF<U,#+2<_Z0R$DE],`(/*83YF/5_(.GW0-
MR]>NH0J9=-9B;ISIATXDNZK*[K0>K7+_`*!%=OC*H+IBQY+.J%7*2^V8&KVX
M"9[&KQ%2LO7.LH)-BM'K^OQU+?8`S)`C[[/9I9Q!KL>KX+DS>'RSW5Z*N9P=
MVJ]D";+][V&K"IGC7G#KU1LH,H6NKQ'%&;1T<Z+LKL.]Y;*->AZ]UUM@S`<J
MOZRQ*GT%(4AUHEAAV$[,+4;.GUE9.!E4(LPZUZLKU53+G!TBYG#%6AV1;[`H
M?-LM/L*&"IO>:<N6.SU[6XV#43I7+CUW["2TM8VB3/78`]CE$+88VM$5Q`/\
M5HX1GAV@;_I=:6Z`AN:2+1)W5LYU336N^,HG*]/6J_[']Z"]?;66T6&>CQSC
M'1XNW]:=5C.X6AU8F,S,VZK5C*ZR<ZLJJG/6P_LJJF0]QN1V7E*L/:1M0JVL
MB1,%D\PBSAKB7$W1-7&.61V!^G_!8H'5M3UM>MDQ/2K#[#%YF]O4"B`R$M1W
ML9;!H><*I)J",**^X^-(1#>L+,'P]D&.0TZ<=&&O'#CR*[;XT[C-J_9KP6)A
M_4/_`(/J7^>KZ:?](YU4\I;-[_+;_HM%Y?!DHUTE_P!I=T?SY;D_]J5EX*[E
MT?5E"%ARI:"H]Q[8XJ*\&"K6PQ4"<A]62"EV,C%7!E461]#1[JL'6>#2-H/;
M=K2VQ)+_`+Y.3#P%J*JZ^=;*'\O,V<F"AK[JE36LJFJ_#"ZKA7)G-6$TI6+)
MTQ/B6DEV:L$77'4VFY2DZT=V0S+XB!-N.H6T+Z0+<.GAH%`Q3%YZ-MC2,MQ2
M:CQI0IQ)!%F$8:;`)24%'QE<JN]8*4HQZJ)NZAF^P35G;]RDW5`UVDU3SJKT
M^RZ4-JHLVMK4HCF`[1V@/[&$H1&`(C+P#5PN#D[;;I-MR@!VRC\0^6&\XER9
MW&\%15_%QE28A13I=,GDRM0H18ONVI)F]9OO"!J4T"+ZHN.Y9N;#:U61EVDJ
M*04W_([!W$AV&1!$>\M[ENK?`P+QZW$1,$CEE6!%6C;1:5JOPW8V7C@[KZSK
MJ7+UV/8U&]'1S$OG7NN`YCN7L3*]+F:]8'=^4^LEI]V)BFH[0E?-8(XR98Q*
M;8H^^L!)E8*25M2Y4-<E;D1160/P9OM879PI5F;^F\CT#V'[WFFNI0F)+8!4
MYLXCN47VQJU:U7;V"!P^W-K(4'Y]JZKUFL+8OG#/6%5J=^A#`Q3K5EF:M64]
M:_CIH4LKJ`L68>?2J?*KJU^9O.BS#HH=H[(W=;;?<2[W9;BDVMW"L]1I<G4]
M6BJY$,U3KUH".NHLAJ*UD0:14HUB!!1QKU-<8++N+N9DXE&UKF:NZ`0)I2J5
M2K+FL3C&>&'2;.C6[V[L)C0D=0M>W)]?NCQ1PYGOIIZU+J0ZIYADI#M6Z7S7
M(=4:*L75@<"0V.MZ!T+[2TI;)*5FFSIR*UL;V8$RPV(E+Z36D]$.9UNFK`PS
MQ9O?X:'LUX!6`^9<B:[]1FUU>OXE!)<J)[[ZE=C8:3UJJ>!+VI<QDGA[_K$W
MM(,?$B80>7C0`@,-1G4N/[YS)"_+_2KZU7S/J:Z%,.3FOW9CN!G<U\+-7P[+
MCK0M+M[4N:72I=)K!*?J\[$]?*U39R[!$TXJ0)JK8=>O5G/B]`-7/;[`\)@8
M0\ZHM418LH5.!*S"EK"YYION<+#KO-_B6]V37K37:OLNQK>!UV"L2]P4*ZPO
M7T0VM%LF%<Q01"G$1SAJ=2&%$,!95RQ+6C2C22EHQ!QQKO3L`-RR2`,G!T2D
M4B:4FZ^;^A8XXG,ZMW+WI>RUA3V\'7!TSHB2_;:<L`[8M5<UDV1[!,CN`XMO
M&]/,86"SPG:]?L<>>SWH3;Y0X8W+SQ$43GR^P&DH\:.FW/HBN*-%LKL#WM#[
MKQ6E];,1^*$<P*>=L#97LO6+>U"]^QBV53['K^:-K.R."4OKMU/U2X5D$@%=
MO:X-?V^6RLZ6>CHQ%8U!"IK[H6-<7W8HXVRV>X)3.MDPY8+<<EV?3UR"!L^@
M$2;H+AV;&3V+SKJUWQ@M+JTH"2,+%+6:H%YET?*F](6ZL-)'55;O6MP(^I>%
MBSU2IE]$Q#SF+Y6M.<+5EU=PY#7U83!CRRS$>55'5PH6:[L2&H:R6^=9K!;`
MO9P"V:%[JH7W_/6N%`'`%*$7:\T+(63,@+8-KE;%5&"?/C!"^9]-T878J]].
MHD'HJU7%978"?8]O$K+(M9?J16L>Q0;C3,^L5BG[DDV0Y%;`HY).9):I!<@R
M!+DZ1\&7+)/#+G!UZC91V-P6`3C#$M44*Z7C?=#=7ZN.W;P9*->G)_!1`?RQ
M]L/^[.[_``5W]2\$.KW\)CU)_P`YNG_^QCJCX#N71]64D&P&N'=9TE5"?<6[
MLU![QVL889VT+;@"MSO6[7&9=V\/8;>6@Q:A+IAE?X%#JT'[B!(M$>=RL748
M6KD,6FP1K9$*+J.F%]]^KJ.%6W8SND3KQ'.VT]GE18<GFI!5NN:'330T6UUW
MW&:?O=JL81\T&KJ8EJX1=SM]7HBL@PXPF7VT($=T<.'E^)9$TMJ'A"PBBQ='
M5*^;XEX=&>1<^Q/?",4[23U.?AIV5U55[$JN0SU4O>;"SPUGKW@U4G9BTD\=
M<1N$QK;;1X';6(,=[`S5_P"2*'JIT5J#L5:RC8L_`19I.J:ZZXY8QKDVUY,=
MQQ!NT$@\_/UM(.VW+>Z[ZH,VF4P/B?K,QZ<[!V6$VG*-)"6(E[C0KL!LCT0N
ME0>\4DRA/&E0-@V&T=F;/M!<6EV#OQXT0YU5B_&8H00IWYW)5ZW0%!)8+&*U
MA"PZ\++;=3]2I.I&>ICI"C;H*V;6`L7NZQ6?[,I)SVDT4#T.KA25B21<NRS5
M=,3UM:,X36L!%G5C295ZC%9O'"8S['>J9WLRYN;N7O9SXX&*B328(>G*M><J
MM=L;LUTA6#K9SV%-.Z>&M6<-@OTUD#*@(CFM;%J)..BG8$1/QQ,50&7%(UUG
M6XU'780V@FAJOIY0EZ[4^CBUS]9$NUJHW*?8#%D=:SK>\'#.YNP3,.+BMI&0
M,LTJX+Z\RAUS<28SG7JO=[#96.Q</9K"@-9+&'#E9*%U?U.F;W]"D9I['T(*
MD_IW'1(W<[MKJ4`1`=?$D("ZFMRYW@#T=N=5+*'(`!@^Z<<HL4B2+"&1VE45
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MZ-K#!;VL@H:3#"V#:#Q5^!FPX-#FC(J`6RB\SX8TL3@QY&N+/E:MJ"2\WM9^
M%:CZJH9'>VXH=)UFX+28NHT.P`"JB)K^BIK)HSK-'$`FP>+B,"H&D8Q.5!-C
M0Y409CD-X#"=/.L?E%U!+NE^JFU*?7*@T>=7Q=5IJLQ#!5*(#K"MVO2EK^YQ
M2Z]6PVU>")R\XRH&]G'+X\+ODC=([06QC\Q9<S7LPS]LD\[0EN:WU>MG%U]8
MNM>E./5WIZ]4;JK]I.Z6AG1M=3(6"<QLT;/1LCL1Y9Q`<!2YW1LC1L])<A"D
M$-6<?1EA(QRU:^<0EWRYSD\;2ZV4Q<PJJUJQ$-;8TJH&[YXJM?$@"^1K^1+U
MU@_U)"$'$\H)G@R*X+5K'-;10?")&TCS$`#/CYX8"\8VX$VIC&CVI_0V+.C:
M3VL:>X[:>JW8W5Z''KR"TYU\I9L:.`$X;]0H&GG,A')-9#C-<J3K'C`LJ%"A
M82-^$;1KQW;.,A)>9G=-;5U''B!$=!2M`E?2I];`1FE6!ZAX2NBF@+&)H(B%
MA`QC#4HC&6EV//5H>K2#EZ``75(@;-8J#CH"?,Q273%/5N/"B:[JBM4(4M3B
MY-=&I:*KJP\`2/QL81T@%A@Q<&,*G&H>.,0O+@Z]&\E&QQT3-F[5QQAX*VW>
MV^DYNNJJOTPM(W36Z%J'1A"XOQX&M/7L(4<"GF-C"I!-,7$=QHU"%8_MVG%P
M;AKQAA#&S83&:8LW/+?R)/KIO,$&H.BEPB;,+U+5*"+,IX>TL90-7*>+(GV<
M0RZ7,4QFYL(-HDE3PQPCQVP>7G;=Y"$RZ-)V-(UE-6$K$)>9R9]'4J5,JS&4
MJ"KB3"C'V%K23T^OU.893VAN8-K:ULBL4D"=DY?/L[5OW,S"8$[XA$TP;MID
ME)DD=F<GD)>9SD.HZHJS,]LK&L:\KC8U3<";/FAI:VH9L9'7LE[=9`]DO#1V
M1B;KVSYVS"60YD;\-DV7GCLXRD[N<PDXAJDZ99`+.K,51UB>6'9G^>[FN&D)
M5*`6YSY]W?"W,XB<)WCS[/S[H$_Z_*QY97_5@[_2_P#0HWR02\S'PNOE"#9\
MDH.I"H8!.8DXUG,(PJU3(L^57&`R($QK^3,T!=<C>DXAH$$1BJ;=F0+@9"B0
M.('$6-IU8"R\WF!O7VA`QY4:A%(5"*:$,#%54=D&UJF03R8KP8DZ!"6U0Q%"
MZB"Z!AP2A.%%#B)$,?'B$9T;3'PTRY&&P27F9>O*<J*HM!"+4]5UQ6$8MQ%Q
M*QZ\1UA*T$\8.\E*A8D-2V+&:YG$.28+R(O$G'9Q'WE26[3\39.E9;0EN]R5
MA]0K_<;7'Y[_`*;7](3UD\&K-[_+;_HM%Y?!D>`/`*->IE_%^=P/Y!+!_P"B
M[_!5>NE>);US=TNN%LDY6$WJZ&H!^(V1=J<SXI76Q>,R7H@1.2)PW+@C(7$J
M=*C0HW,F5J^7ER-$;5\;=NUX9"&@;.Q_7C3)28>V^:8U2[+T+\JN(NRT4?"0
M_P`9MFS!JK(2=&1SC8U:&8B.(#U_<"QGZS4V#,B#<I.^-NUX"P\F1XI=K^LE
MP9C2:4_5_8`-=:KD@3W&.R(N8FN&JAY9%7?I9;$Z?@,`S*)'WE<QS*!#$14M
M/G8-&1:.F,H0P9"&KU%U*UFXV[?VLZNQD^!8<GLE0<=`*S20T6\;[AKS4GDB
M`7;#T&($!EV,6(69-$[R$#23BQYNS?`VS8FN5AJSDZ>,PAY/82*+LRN#;D:K
MH+8"27L%;'0S#$BBVL%/<0(@AI@28!0TL1)^TV+'3HY47(AS9T'1&DZ"0_;I
MVYZYD;+8)&.!G="VOQ6(JWQ@@J.U'`H!;,LFF!%UG"J^JSF0FLA")3#5Q-F"
ME\BY-L\-`D;MD4;,9CTB)JT[2L[/>!FO`'@#P!X`\`>`/`'@#P!X`\`HUZA_
M\'U+_/5]-/\`I'.JG@U9O?Y;?]%HO+X,E&NDO^TNZ/Y\MR?^U*R\%=RZ/JR>
MM?97KGN@NY/3?U*;1M9$80>R".NU$7.#7Q<D5W@APMWEXG>8ZH1GFXLH-"A'
MMD"3**QI`[1JSF:=FG$(>3K<1VP]WNK8:5[G'716[BS$*3=^P*HLJK^AR)#[
M62#I*[#QI183+.%1)>KXP,WAIEE&T2'TZ`;`6)E!P%;82HL(>3O2NS)(B7/U
M[5RIJKHEJTVLGJM3LSK)7&AZ1PYBMT%<#CYFXL<4=!71*4%%?`RQ<G;/FP(`
M06(DP-_._3"W1L\PAWUKWGA$[)]=)X06S0;]I6:N&W#97@5@B6FC2`A=_P!6
MO';M1A972=S@SW#5JSPV[%J)OVFL->>.S*%QAEQSR$/)YDH'5M?9XT*&QA!1
MZ(--`V0?&+P(I'1!8%DK%.+IN)JEZMN$<J",P8143/U<8RAY")'F1=NK?IUY
MXB&:\`>`/`'@#P!X`\`>`/`'@#P!X!1KTY/X*(#^6/MA_P!V=W^"N_J7@BOR
M-VHZ^]=NV/J$K]VV>!K<PTWY3[2N0F+06TY&E[CI?UD`9&!NV..D:)4'$T$+
MB\]NK;EQA.'2X^?'&S3GQP+Q6TH6'U98'_&6=$_QEJ^_XCG_`(?P.):R[UYC
M_&6=$_QEJ^_XCG_A_`XEK+O7F/\`&6=$_P`9:OO^(Y_X?P.):R[UYC_&6=$_
MQEJ^_P"(Y_X?P.):R[UYC_&6=$_QEJ^_XCG_`(?P.):R[UYC_&6=$_QEJ^_X
MCG_A_`XEK+O7F/\`&6=$_P`9:OO^(Y_X?P.):R[UYC_&6=$_QEJ^_P"(Y_X?
MP.):R[UYC_&6=$_QEJ^_XCG_`(?P.):R[UYC_&6=$_QEJ^_XCG_A_`XEK+O7
MF/\`&6=$_P`9:OO^(Y_X?P.):R[UYC_&6=$_QEJ^_P"(Y_X?P.):R[UYGSQ_
MX2UV8HWM+T4J>ONNS_!N)U#]M$1Q*+*,*8#):"K#Z>O@)-.R(NH1QEK'1BS"
M$'[M_/\`Z<9).)KY_P`NWCP<NB3LVFW1<5XK-'V`^#@'@'77T;&M9GTZ$4.B
M&HZV\%:_MD:FL4S5SOB`&N<WO\5>-2M/&F1SNCBR^V'.WZN(^_G9JT98?([?
MA^)D-6OM/J\$4C,4[V#3-M2XDJKOV+7C9:77%0:*$T]F9K*[OSFC4EV^G]@K
M&XL2/;<@+#3[5S+T_!U#7*Q$S18YFM^-]B@$V6S[=T\6E;J2YC6HE1TX8FX*
M'3KLNKDY;/,"-A"S7/KKU$1^+`T7=O*;4>92W:2TWUWKQR*FW>$:;26%'/R,
MICG(<$9XK;/2'J08,#2+-A(<0=I1&NT[L[*5%@I4QT9'.)=7.WQO>ZPXGTE*
M[$0&7()LNQ\>Q!+6+O>8Z=F*S=*E.5F,$/VTS6?T:TP">`WM,L+6!9!P-:JW
M0=+6N3-IV"$K)12D)Q3&56N<W$E8]<NPJ59E8[4P:^'TY$[+NQ)7#,EJ\GJM
M7Z">VVG31\LSY$[9!VE@_*(X+8^VE-<`;9X*%R88:Y<4T:CN6HN%$E=V6-;J
M1%TW9JIVT>#(\`>`/`'@#P!X`\`>`/`'@#P"C7J%?[C:X_/?]-K^D)ZR>#5F
M]_EM_P!%HO+X,CP!X!1KU,OXOSN!_()8/_1=_@JO72O$F?L)3QVW@2%DI-0=
M1<ZNM12MI2G,ZS*<E"<86-!<;L$-2S`8E(@0'31)\IR/EP&(=,7V72!9]'$_
M,)P+G`G'70ZZX_IXV[\_'!4XL%)BU>_ULFY6D][ZRQDFF=S8NZ?9'ME:BU38
MK1:NN?3\$,3LT<)4Y3-#L:$-$&%F9H('F)"G<$GKU4UQKLUAA<DII7N[R57/
MT\S[TKL286N0-$";&_N@TINZ%6DO;.&X]N[3DW1R.<M,RP=PYP@H[J3)BY\*
M%&6(KPD_(!96L%.WS"NT3C74^[CDH]7]9L,7HHP&GEPM2Q;,4C#[84NY2+1H
M5JQF@$R'-L[K]4W741FMAC+\TE8NP"HU1#GGB!0Z3(-DT\2@:MJ\$BCAT<.-
M=JC')MY9LD6@.JK;2%HS'#59XV2DSZN7TLW7ZXN-X6`[O*\MU8IB+=;M#!9S
MDK0'4,M5S.6]<ROU))VM(-HCZ'S>R3$I6FQP;E1&.Q5I=XSJB677\&1X`\`>
M`/`'@#P!X`\`>`/`'@%&O4/_`(/J7^>KZ:?](YU4\&K-[_+;_HM%Y?!DHSTF
MX^$CW1X__P"]Y+DX_P`G//'/_P#E*R_^W/'P<\?_`+XY^'C_`/'@KN71]65,
M9O3QNE;K*K5]3L9!?66D8W3*G*?RVU7DOCQU243VJIRV#KY=$(G;G.%HM@U7
MKJ"2FP50I7'MLL<W[U.#'-OL0:$&E:4NE_&FN+35,K\9UDEE/3O=":0^+'-U
MJL<C<M)]YZMM@AJJ@IB-]]]T'X]:7+)7`C"S\,E8573B?WQ\P#!.<)CF!U<\
MR3X)@ERS>P16H<Q<[+5?NYTQZC]L_P!.AFLX+9Z%-N=<&URSE.X3HBX1ZKF[
MK#`/_<.L+3K9DR=W+.Q\!CRBI&%R.A(`KP552(DHL&NPLUAC:Z_PG,(<;56B
M?5%U*7*LO',D&Q>D;(PO#@]5Y:82MC[1="Q:H9F')K7J<*ZA@Z4INER0%3(+
M%IJ*^:BL0:J-F9P!8*NWU^:BE@<(VDDN$N'L+`GFII%_3JUG89X,CP!X`\`>
M`/`'@#P!X`\`>`/`'@%&O3D_@H@/Y8^V'_=G=_@KOZEX(O+X(/`'@#P!X`\`
M>`/`'@#P!X`\`>`/`'@#P#X0ZR_PI/GITJY=8?W#'%B_0JUV"E?/?]TU\T?G
M+[%8#/(]Y_-K]SZS^YOE/:OB>Q^_ROQ/B?&]JR^-\7$=AZ'C5XT3%(U=)O\`
M^_*.?R<G'ZWG/[,'@<A^/^7]1^_*.?R<G'ZWG/[,'@<A^/\`E_4?ORCG\G)Q
M^MYS^S!X'(?C_E_4?ORCG\G)Q^MYS^S!X'(?C_E_4?ORCG\G)Q^MYS^S!X'(
M?C_E_4?ORCG\G)Q^MYS^S!X'(?C_`)?U'[\HY_)R<?K><_LP>!R'X_Y?U'[\
MHY_)R<?K><_LP>!R'X_Y?U'[\HY_)R<?K><_LP>!R'X_Y?U'[\HY_)R<?K><
M_LP>!R'X_P"7]1^_*.?R<G'ZWG/[,'@<A^/^7]1^_*.?R<G'ZWG/[,'@<A^/
M^7]1^_*.?R<G'ZWG/[,'@<A^/^7]1^_*.?R<G'ZWG/[,'@<A^/\`E_4?ORCG
M\G)Q^MYS^S!X'(?C_E_4?ORCG\G)Q^MYS^S!X'(?C_E_4!O\)9Y]0>V>K?4?
MGI9Q4?TJ=V>CFWZ0/W1GS]]P_,3MW2UC_%^:GT$)?O3WK\T?<WP_.0=[#[P]
MX_!,]D]ADAR7%3M<:8LVJ1%]EK,^WWP=<>`/`(-[,TOCV,Z^W%1.3+L3>+8K
M]C1N&O4)P/;%[(_`VPL"V(780$X%>86>S'?[!D3@<2>,>=7,O1\;Y3$%1IY$
M&?1%W_\`QUZ._4F(_M4^2N:V/S+3)[5Y#Z(N_P#^.O1WZDQ']JGQ7-;'YBF3
MVKR'T1=__P`=>COU)B/[5/BN:V/S%,GM7D/HB[__`(Z]'?J3$?VJ?%<UL?F*
M9/:O(?1%W_\`QUZ._4F(_M4^*YK8_,4R>U>0^B+O_P#CKT=^I,1_:I\5S6Q^
M8ID]J\A]$7?_`/'7H[]28C^U3XKFMC\Q3)[5Y#Z(N_\`^.O1WZDQ']JGQ7-;
M'YBF3VKR'T1=_P#\=>COU)B/[5/BN:V/S%,GM7D/HB[_`/XZ]'?J3$?VJ?%<
MUL?F*9/:O(?1%W__`!UZ._4F(_M4^*YK8_,4R>U>0^B+O_\`CKT=^I,1_:I\
M5S6Q^8ID]J\A]$7?_P#'7H[]28C^U3XKFMC\Q3)[5Y#Z(N__`..O1WZDQ']J
MGQ7-;'YBF3VKR'T1=_\`\=>COU)B/[5/BN:V/S%,GM7D/HB[_P#XZ]'?J3$?
MVJ?%<UL?F*9/:O(?1%W_`/QUZ._4F(_M4^*YK8_,4R>U>1ICMU3[;VW'35NW
M.X%8L%?KUR4';YM?4^I<E-/'Y%`7A7M[`041IE=BFC2#TF6.N1`TB0Y7RV>D
M9*F?(Q,]W.O+%7-;/U*FE<G<U?FFLM9V,>4R=<0WK_W%JYYNXA2'9;K2!1[<
MN-FN+!<M3IS:-EM:Z6:A*Z,(",G-2[PT^(,#]/S>T;X>WA#$R=?M&W5ORD?%
MPV>#4V84JU3*TEC/W7GF;+\UO4D_&IZ0_P`W]>_]YAX$V/NVOXE_8/FMZDGX
MU/2'^;^O?^\P\";'W;7\2_L'S6]23\:GI#_-_7O_`'F'@38^[:_B7]@^:WJ2
M?C4](?YOZ]_[S#P)L?=M?Q+^P?-;U)/QJ>D/\W]>_P#>8>!-C[MK^)?V#YK>
MI)^-3TA_F_KW_O,/`FQ]VU_$O[!\UO4D_&IZ0_S?U[_WF'@38^[:_B7]@^:W
MJ2?C4](?YOZ]_P"\P\";'W;7\2_L'S6]23\:GI#_`#?U[_WF'@38^[:_B7]@
M^:WJ2?C4](?YOZ]_[S#P)L?=M?Q+^P?-;U)/QJ>D/\W]>_\`>8>!-C[MK^)?
MV#YK>I)^-3TA_F_KW_O,/`FQ]VU_$O[!\UO4D_&IZ0_S?U[_`-YAX$V/NVOX
ME_8/FMZDGXU/2'^;^O?^\P\";'W;7\2_L'S6]23\:GI#_-_7O_>8>!-C[MK^
M)?V#YK>I)^-3TA_F_KW_`+S#P)L?=M?Q+^P?-;U)/QJ>D/\`-_7O_>8>!-C[
MMK^)?V$V]4*6-=?:)5:N9'(78+$-.62T'FX(HRD(*6-67:#G9I7W0GSV]^G`
M1<"<X;Q8^%,<F*7[)"T[I!+=NVY\8B-R_3N4:O`L7X(/`'@#P!X`\`>`/`'@
+#P!X`\`>`/`/_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g913905g36i66.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g913905g36i66.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0@<4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````)P```,`````&`&<`,P`V
M`&D`-@`V`````0`````````````````````````!``````````````#`````
M)P`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````!8`````!````<````!<`
M``%0```>,```!60`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``7`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#HL7)LQ,AE]>I8=6\;F_GL784W5WU,NJ.YE@#FGR*YCI.(W,=DX[C&
MZH%KO!P=['*WT+,?CY#^GY'MEQV`GZ-@^G7_`-<^FS_U(DI%]9#&<P^%(_ZI
MZ)_S;R#K]H9_FG_R2']9(^W,GCT1_P!4]%_9O7_^Y7_@KO\`R"2F&3TRS`Z?
MDE]C;/5=2!M!$;7N\2?WT7I.;3A=*LNMU_3.#&#ESMK?:U-ET9M'1K6YEGJV
M&YI:=Q=#98(EP;^<LRG%RKZ;+:VEU6."XGM)@O;6/SK-OO?_`.<(J;-.-G=9
MOLO>X-:--Y!+1X4U-_ZM0ZATRS`;67V-L]0D`-!$0)[DK2^K_4&OJ^Q/@/K$
MU$:;F?\`DV*/UF^AC?UG?D04U,?H%^5BLN;<UHN9(!:3$_VD+JMSLG/L#)<S
M':6"/"O6Y_\`GK8Q\D8O0*[^[*1M'BX^U@_SUE='MP:#<[-L@V,](`AQEKM;
M7'8UWTO:DIU^@Y/K8#:W&7T'TS\!K7_X&L1]!R>KVXX=L-E]@W1,?2=]&6_N
MHW0;QCY_H[MU=P+`[@%S)=6_7]YN]!><@=7M.,)O%]GIC3GW?O[6_114VLGZ
MOW44/N;>+#6"XMV%I@:G:[>_W(G2'/ZA0_&R+'N%#FOK?,NAV[VESOW=OM0<
MVWKXQGC+:64.]KRT,X/9WIN>YK7*]]76XWV5[JMWJET7;HY`]@9'^#VN]J"G
M_]#L_JW_`$R[_BA_U2GU_'J-[+\>QHR06LLK:X>I.GH6-9]/U&_^07SHDDI]
M^ZM=9D64OO8:K?1VV-<"W4.=[F[OS'JZ.I=>C3'T_P")?_Y)?.B2*GZ(RLKJ
M.1@9`S:O3:TU&L[',DE_N^F3N5WZM_T%_P#QKOR,7S4D@I^@,VEM&>Q_3K&V
M!YWTBHAY:X?3KVLGV?\`HO\`1JSUN]V1B8EKZW5/+G!];P00X#W?2_-_=7SL
MDBI^@\ZVS]D8-0:[T@P/>^#MF-M;-WT=WT_:KF-@]#&/7]HLJ==M!L/JQ[C]
M+Z+U\X)(*?H#J--%&94[ISFO:=IK:QV^+&NXY<[W^Q2Q';^NM?!;NN>[:X01
M(?[7#^2OGU))3]1Y[0[!R&D@`U/$DP/HGDK(^K#O=D@@ZBL\:?GKYS224__9
M.$))300A``````!5`````0$````/`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S
M`&@`;P!P````$P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H`&\`<``@`#8`
M+@`P`````0`X0DE-!`8```````<`"``!``$!`/_N``Y!9&]B90!D0`````'_
MVP"$``$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$"`@("`@("`@("`@,#`P,#`P,#`P,!`0$!`0$!`0$!`0("`0("`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`__`
M`!$(`"<`P`,!$0`"$0$#$0'_W0`$`!C_Q`"6```"`P`#`0$````````````)
M"@8'"`(#!0`!`0`#`0$``````````````````P0!`A```00!`P("!0@%"`L`
M`````@$#!`4&`!$'$@@A$S$B%':VM!5UM18V-SA!83+4"2.4-5:6%U<847%2
M8C/3)"55E281``("`04!`0$!`0`````````!$0(Q(5$2,@-Q84$B0O_:``P#
M`0`"$0,1`#\`*[JLF#+]B/.RYIB;O%61S2=R;"88.T#\AU3=M,/;)J.U'0C4
MB-_'7G`9VW3_`*5QE!39LUTCTK#E8&TM*AY"":6,/M`"T?*_XI<D^_V8_$5C
MJI81/;+^GA1<1RR=':EPL8R&9$?!'&)46ELI$=X%540VGFHQMN`JIZ454T2M
MS(>QW_8;-OZGY3_9^V_=-$K<(>QIWLWQ3**WN1XYFV.-W]?#9^U_G2YM/8Q8
MK7F8'E#3?FOOQFVF_,=<$1W5-R)$3Q77-VN+U.J)\EH9BSG[[9A[TY!];2]=
M+".7EA].UK\O?%/NLQ\JE:GOV8^O5&:.\#NT'"FK#BWC.R7[9NHL7*,BAEX8
MM'<;$CK:R2V>WVC>$]G'!W]B'=$V?7=GJE)U>#F]HT601];17MWYY5%/;6_D
M*'M)5M?,G^23W6K?GK%9=\M7?++IZMNKI7;T+IPH]%S"<R:`W7<2R=MML"<<
M<<H;4`;`$4C,S*(@B`BFZJO@B:)6X0]B,:T"4#A&:$*$.(900DB$)#06RB0J
MFZ*BI$V5%362MPA[!&>Q"1)XSQ?N$RS,*JUI:RDIL.NG5LH,FN.5'J(N>RI+
M,/VUI@7Y!;@`B.ZJXX`^DDW7Z:NJ0RFBLV#=RK([+,,FO\KN7$=M<CN+&ZGF
M/5T)*LI;LMT&1)54&&B=Z6Q]``B"G@FF)0DA;<N0E'\.;DA`>S/B>:YLCZ?;
M>AZC5$\UM(-1?110O!3-KV-T!%?0#I;+XJBO188SS>4%4TH:+1\K_BER3[_9
MC\16.JEA$]LOZ<J?B7E7(:V+<T'&7(-Y43@-R%:T^&9'9ULP&W39,XLZ%6OQ
M9``\T0*H$J(0JGI1=$K=!#V.NZXJY0QJ`[:Y%QOGM!5L;>?976'Y#50&=UV3
MS9DZN8CM[KZ-R31*>&9#646QP=W0<C<.7M>JW-KDF$^>`7&'V<]V7#.$:JCS
ME*4PGEIK%I#ZP)E0;<,41T3#PUS:BM].JV:^!*N4^)LMY=R?&N0,,L1D4=M2
M0K7'K=+UZM6OC6L'&W*89<9$,F:ZAD1Y%W&=B-R94F7*<87V=/+D@I-)0QC3
M>J/_T"NZK)BQJ.WS+A#DV-9,M.5&88#D+S,F'(0D!9$)UR'95LI`45>K[**3
MC+BBNSC#JJ)>*+K-++\-UJ_T8<XVY`H>4<)H,XQUU#KKR$#Y1U<!R16S@_DY
M]5,\OP&972A)H_!$51ZD]5459FFG#'IRI)SK#1:/E?\`%+DGW^S'XBL=5+")
M[9?T-YVR9?B4#@3BZ'.RC'8<N/C##;\67=UD>0R?M,E>AUAZ2#K9[+Z%1%TB
MR?)Z#JM<5J7M]N\(_KEBO]H:C]\US#V-E;GJ5E_171/#3753;%'0"?&LLH<\
MF!<4D;)Y(KSJMH:@NREMOLNWHUAHM'G/WVS#WIR#ZVEZJ6$3/+"`V_=:WQ?V
MW\7\>\?6#3O(MAA\5;.TCJQ(;PN"[+D$GF"XV\P=_/9W1IDDZHS1><:(I,H:
M^$V;>!G**I+)C#B'B/,><\V;QG'?6=<5;'(;Z>9.1:>M)\1EVLXR-'I;YNN[
M-M"JN/O$B;HG48]MJJEG"3LP^W$_%6*\.8;7X;B<90C1MY%A8OBVMC=VCHBD
MJULG0$4<D/**"(IZC+0BV"(`HFI[-V<L>DDH1(,[^Y&9>ZN0_5$S0LH'ABQV
MJB<:&HOZ$IOHJO\`DC.I7EE)A;^(+R2N-\95.`07^BRS^S0YX@:HX&.8^Y'F
MRA7H)"#VRV<B`F_JN-@Z.R^.W?FI<[''HX4`WN"^$;+F4.23@B__`/%X'97L
M$6`)PYV2JO504J"*HO5:C$DHB[+XM[;>.Z-M;C`JJF2*<+<@/<7<I85G#9F,
M>ENF/G4`]+U'.$ZZ\81.DT4W*J6\@>"])]*IXHFBRE-`G#3&167FI++4B.X#
MS#[3;S+S1(;;K3HH;;C9BJB8&!(J*G@J+J8H%J.5_P`4N2??[,?B*QU4L(GM
ME_0Y7:%^7#B[Z*M?B2ZU/?LQU.J-$S&8DF)*CSVHS\!^,^S-8F-M.Q'HCK1!
M):E-/(3+D9QDB0Q-%%1547PUR="Q64)3CDN1#CRFM`-[;)1JXNYK3I/D)6*:
M_I-871O^O52P3/+C`PMVYU\^KX)XGAV2.#+'!Z)\@=14=:9F0PF1&'!55)LV
M(D@`45V4>G9414V2>W9E%>J/_]$KNJR8+%W^<$K/AL\W8U#4IE>U%K,\88$B
M<D5P^7$I\@\M$7J*O]6+)+Q7R%9+9`:,M)\[?\L;Z5_Z*-[&.=$X_P`X/CG(
M9GE8EG\QAN`X^9(Q3Y@HA&@/IZ1;9O@$(;R[?\48Y*H@!JO7I65*R<TM#C^!
MJ]('"T?*_P"*7)/O]F/Q%8ZJ6$3VR_I)J#MZYKRFFK\@Q_CG(K6EM8Z2JZQB
M,,%'EQR(A1UHBD"2@I"J>*)Z-9RJM&PXM_P]C_*WW!_X495_-XW[SHYUW#C;
M8W]V'<4<C<;6W)+^=8C;8PU;5V,M5KEFVTV,QR))N3D@SY;KFZLC(!5WV_:3
M2_1II0QE$U,H%;G/WVS#WIR#ZVEZ:L(4\L_,9PK*\S*W'%J"RO%H*>;?W/L#
M"NC75%>VKLJ9(+<1$1$=A!%5QTO5`2+PT-I98)-X)3PYRM?\-9[49O0F3BQ2
M*)<5BN$W'NZ.23?SA5RMO!1=1L7&B5%\J0VVXB*H)K++DH-3AR,185F-!R!B
MM'F6,3$G4>006YT)[U$=;0E4'XDML#<%B=`D@;+[74JM/-D*KNFIVFG#'IRI
M1QSO[D9E[JY#]43-"R@>&+':J)QH:B_H2F^BJ_Y(SJ5Y92`:[P>2/[Q^<LH=
MBOJ]2XB0X73;*JMJW1NOA:R`VV!P95\]*,'$_;9\OQ5$1=/HHJA%W-F$:[&<
M5I\&X5BW-A,K8EYGME)R&8C\R.U+;JF"*MH8KHFX*HTL6.<MM-M]IB[K^A%^
MCFWX,HH0+#N*PF-@',^>8_7$P=.5R[<T912;.*E1?"-O#C1S:(@(*X9BQ5_W
MF%TVKFJ%64-H,%V9<C?W@\%XXS*D>=<X2IX7:(1)YBM5+;14;RIX$H'0OQ@4
MUWZW6C\55%TFZBPZCFJ`H<K_`(I<D^_V8_$5CIZPA-LOZ2+'.X#F?$*2!CF-
M<B9#34=6VXU7UD-]@8T1MU]V2X#0DP9(AOO&2[JOB2ZQUJ]6@Y-89RR'N#YK
MRJHF4-_R7E5A46#:LSH!6"L,S&"\#CRO908-^,XB[&V2J!IX$BZ%6JU2!V;R
MR0]M&+\4Y=RA14_*MU,KJZ3,CM5-6,/_`+5D5LZZ+<.GM;EN8#]2Q*?(139@
MA?5>A76MT4BTI.#:I-J1A1IIMEMMEEL&F6@!IIIH!;;:;;%!!ML!1!``%$1$
M1$1$34P\_](KNJR8:-LZV!<UT^HM8C%A66D.376,&4VCL:9!F,G'E17VR]5Q
ME]APA)%]*+J0I%Y^X7ANRX.Y+M,87VEVBDE\\8?;.>F=12736.!O"J(MA5/"
M4:1X`JN->8@H#@;TU?)23V7%A=NT3G0>9>.&HMS*1W.L,"+49*CA)Y]G'5LA
MJ<CV01%?G-E@P?V]$IEQ=A$PW3>O%_@ZEI7Z!3Y7_%+DGW^S'XBL=/6$)ME_
M0YW:_;U+';_Q6R_:5S+K>+L"XT[-C-N`7M4I=C`W4(5_UIJ>R_TQU>J+Y^?:
M3_S-5_[")_SM9#V.CL:N*E]P&6+2N>=<7I;::FQG'#+_`&0`'5(E_4B:R&`L
M]G/WVS#WIR#ZVEZJ6$3/+#H=GN(8YC?`V$SZ:JC0Y^5U@W>13A%3EVU@X_):
M%R6^XI&;49@4;::14;;'?I%%(E)%VW9CZ+_*!E]XO;^7#^<ED6/0U;X^S25(
ME5`LM[1Z"X+=^QQPNA$!EA%4GX2;#O&56TZE8,E;2W):Y%WK#E8)-V5=Q*\9
MY0/'>5S4#!,QL&QBRY+JBSC&2R$"/'FJ9;@U5VZBVQ*ZND&C1MY2`0=Z\O65
M*R%+0X>`PV=_<C,O=7(?JB9I*RAKPQ8[51.,4\M\B#Q7P5>YH+HMV%=B<.+1
M[[*IW]K&C5E+LVHGYHLV$H'3'9?Y)LE79$54F2FT%%G";%[Z.CO,MNX-%0U\
MR[OKB5Y$&!$`I$R;*<0G"045=R+I$B(B79$12541%75&/A/DN3_*WW!_X495
M_-XW[SK.==S>-MB*9CPEROQ_4)?9G@E]CU.LMF#\XSV&QC)+D`Z;#)&TZXH$
MZ+);*J(FZ;;[JFA63PP=6LHU%_#^Y'^S'*UA@LMQ!K>1*M6HZ$I(@9!CK4RR
MKUW\0`9%:Y-:7?93<)M-]T1%Y]%*G8Z\W#@R5RO^*7)/O]F/Q%8Z[6$<VR_H
M<KM"_+AQ=]%6OQ)=:GOV8ZG5%OY[@&*\E8U98KEU3%M*RQBR(Z$\PPY+KWGV
MU`+"KD.MN'!L8I[&TZ&Q"8IZ4\-8FTY1K2:ABT]E!D4]I/K7RZ9=7/E07B;)
M/5D09#C#A`0$J>#C2[*BK^I=4DXRGQC>R\HXVX]R:>O5/R+!\3O9I?Z9=O0P
M+"2OALGB](+4ST;10M4F?__3*[JLF&F]2%)COO0PG`\WXT2-D&4XCBN:5"3[
MK`)&39!3T#MJ_#:8^>J*(Y:2(YR6+.,;0$+:](2DC&:H*>/=&T\:'%TFLZ@I
M^VK+N0<&Y0J\DP'&LHS#V(.C*\<Q:HL+F59XI(?89LFWHM?'D$VK9F#D=UQ$
M!N4+>Z[;HKK)-0V*JVG*16W)<D)O(_($QMN0TW+S;*I+;4R+(A2VP?O9[H-R
MH4MMF5$D`)[&TZ`N-DBB2(J*FM6$#RR$ZTP^T`7[VM_F#XH]ZH_R:3KF_5FU
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M3Q(4KO\`LAR0L0XNQ2'378XHU$AY!>9`E9/^S[MT]!=KL?I_GA&$KOG)B*S/
M?.,KBN*#C9]*(B*JO.);_HSTG1?PJ?\`A]4./3>7K"_N;:FC6='0R(V*T\VR
M@1K:UN;AN0$N33US[PS;$*O'X4SVA6`+R1?$C44].^D\3//(:G2!Q1G<I08[
MD_"6?4F2VU/1QI=.3E79WEG7T\%C)(3K<_'&BL;-^-%CE,N(K3*[F*F#A"G[
M6VNJRK*#FT-.1?\`PB?D55F6*VF)19D[**W(*B?C\*!$>GS)EO#GL2($6/!C
MMO/37)$EL0\H0)7-^G9=]M4.(<X$+*@[<^GN6N=YK:.P9=8[99;D<]RMGM&Q
M.KW)EQ,D'!FL.@VZS+B$YY;@$(D)BJ*B+X:%A`\L.YVA?EPXN^BK7XDNM3W[
M,?3JC26N3H6VYOKXM7S#R?"@S8EA"#.LF=B2X,B-*CN1I=M*EL@+T-QV.KK#
M;Z-N"*HH."0J@DBBE-<(GMEAS.URTE6W`'%KLR#8U\B)BL"K\FRA383CL6L!
@8==.B^VM-K+KK&L:9D1WFE-EQIQ.@O#9$7[,=7JC_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g913905g45u09.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g913905g45u09.jpg
M_]C_X``02D9)1@`!`0$#P`/```#_[1.B4&AO=&]S:&]P(#,N,``X0DE-!`0`
M`````&$<`5H``QLE1QP"```"```<`E``"')R,30T-CDY'`(%`$!-:6-R;W-O
M9G0@5V]R9"`M($YE:W1A<B`M+2`R,#$U(%!R;WAY(%-T871E;65N="!$<F%F
M="`P-"XR-RXR,#$U`#A"24T$)0``````$-;).OTX+TUY8&I/N>"4$[4X0DE-
M!#H``````.4````0`````0``````"W!R:6YT3W5T<'5T````!0````!0<W13
M8F]O;`$`````26YT965N=6T`````26YT90````!#;')M````#W!R:6YT4VEX
M=&5E;D)I=&)O;VP`````"W!R:6YT97).86UE5$585`````$```````]P<FEN
M=%!R;V]F4V5T=7!/8FIC````#`!0`'(`;P!O`&8`(`!3`&4`=`!U`'``````
M``IP<F]O9E-E='5P`````0````!";'1N96YU;0````QB=6EL=&EN4')O;V8`
M```)<')O;V9#35E+`#A"24T$.P`````"+0```!`````!```````2<')I;G1/
M=71P=71/<'1I;VYS````%P````!#<'1N8F]O;```````0VQB<F)O;VP`````
M`%)G<TUB;V]L``````!#<FY#8F]O;```````0VYT0V)O;VP``````$QB;'-B
M;V]L``````!.9W1V8F]O;```````16UL1&)O;VP``````$EN=')B;V]L````
M``!"8VMG3V)J8P````$```````!21T)#`````P````!29"`@9&]U8D!OX```
M`````````$=R;B!D;W5B0&_@````````````0FP@(&1O=6)`;^``````````
M``!"<F1456YT1B-2;'0```````````````!";&0@56YT1B-2;'0`````````
M``````!2<VQT56YT1B-0>&Q`9.K0X`````````IV96-T;W)$871A8F]O;`$`
M````4&=0<V5N=6T`````4&=0<P````!09U!#`````$QE9G15;G1&(U)L=```
M`````````````%1O<"!5;G1&(U)L=````````````````%-C;"!5;G1&(U!R
M8T!9````````````$&-R;W!7:&5N4')I;G1I;F=B;V]L``````YC<F]P4F5C
M=$)O='1O;6QO;F<`````````#&-R;W!296-T3&5F=&QO;F<`````````#6-R
M;W!296-T4FEG:'1L;VYG``````````MC<F]P4F5C=%1O<&QO;F<``````#A"
M24T#[0``````$`/``````0`!`\`````!``$X0DE-!"8```````X`````````
M````/X```#A"24T$#0``````!````'@X0DE-!!D```````0````>.$))30/S
M```````)```````````!`#A"24TG$```````"@`!``````````$X0DE-`_0`
M`````!(`-0````$`+0````8```````$X0DE-`_<``````!P``/__________
M__________________\#Z```.$))300(```````0`````0```D````)`````
M`#A"24T$'@``````!``````X0DE-!!H``````S4````&``````````````(4
M```#T@`````````!``````````````````````````$``````````````](`
M``(4``````````````````````$`````````````````````````$`````$`
M``````!N=6QL`````@````9B;W5N9'-/8FIC`````0```````%)C=#$````$
M`````%1O<"!L;VYG``````````!,969T;&]N9P``````````0G1O;6QO;F<`
M``(4`````%)G:'1L;VYG```#T@````9S;&EC97-6;$QS`````4]B:F,````!
M```````%<VQI8V4````2````!W-L:6-E241L;VYG``````````=G<F]U<$E$
M;&]N9P`````````&;W)I9VEN96YU;0````Q%4VQI8V5/<FEG:6X````-875T
M;T=E;F5R871E9`````!4>7!E96YU;0````I%4VQI8V54>7!E`````$EM9R``
M```&8F]U;F1S3V)J8P````$```````!28W0Q````!`````!4;W`@;&]N9P``
M````````3&5F=&QO;F<``````````$)T;VUL;VYG```"%`````!29VAT;&]N
M9P```](````#=7)L5$585`````$```````!N=6QL5$585`````$```````!-
M<V=E5$585`````$```````9A;'1486=415A4`````0``````#F-E;&Q497AT
M27-(5$U,8F]O;`$````(8V5L;%1E>'1415A4`````0``````"6AO<GI!;&EG
M;F5N=6T````/15-L:6-E2&]R>D%L:6=N````!V1E9F%U;'0````)=F5R=$%L
M:6=N96YU;0````]%4VQI8V5697)T06QI9VX````'9&5F875L=`````MB9T-O
M;&]R5'EP965N=6T````115-L:6-E0D=#;VQO<E1Y<&4`````3F]N90````ET
M;W!/=71S971L;VYG``````````IL969T3W5T<V5T;&]N9P`````````,8F]T
M=&]M3W5T<V5T;&]N9P`````````+<FEG:'1/=71S971L;VYG```````X0DE-
M!"@```````P````"/_`````````X0DE-!!$```````$!`#A"24T$%```````
M!`````(X0DE-!`P`````"9L````!````H````%<```'@``"C(```"7\`&``!
M_]C_[0`,061O8F5?0TT``?_N``Y!9&]B90!D@`````'_VP"$``P("`@)"`P)
M"0P1"PH+$14/#`P/%1@3$Q43$Q@1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P!#0L+#0X-$`X.$!0.#@X4%`X.#@X4$0P,#`P,$1$,#`P,
M#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`%<`H`,!(@`"
M$0$#$0'_W0`$``K_Q`$_```!!0$!`0$!`0`````````#``$"!`4&!P@)"@L!
M``$%`0$!`0$!``````````$``@,$!08'"`D*"Q```00!`P($`@4'!@@%`PPS
M`0`"$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S
M-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U
M5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1
M`R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,'
M)C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6
MIK;&UN;V)S='5V=WAY>GM\?_V@`,`P$``A$#$0`_`/3,6FHT-EC2=>1/<J=U
M0%9--3'6#AK@`"GQ?YAOS_*4][2ZIP%GI'3]((T@_P`I)35C+W']5JVZ[=1/
M\G=_K_ZC)0RTM><FBMD?1#/=.GNY#4WHV;B?M9UF6Z0/&/ZJG36YC+`Z\WDC
MO&D#^2DI+Z-/^C;]P2]&G_1M^X*:22F'HT_Z-OW!+T:?]&W[@II)*8>C3_HV
M_<$O1I_T;?N"FDDIAZ-/^C;]P2]&G_1M^X*:22F'HT_Z-OW!+T:?]&W[@II)
M*8>C3_HV_<$O1I_T;?N"FAW7U4,+[7;6@3W)_LM;[G)*7]&G_1M^X)G54@?S
M;3J!P.ZJX=&6,S(R;GO%=H'ITEVYK0/Y/YC_`-_:KC^!\1^5)2!E;S>YKZ*Q
M0`=KQ&XG2/;_`)R-Z-/[C?N"BQCA<YWJES3,5Z:<?VD5)3__T/4,7^8;\_RE
M4L1]#79Y<UK:VY&TN9)+I%;BZWW.]S;'N9^YZ:NXO\PWY_E*J8>X7=0-;07_
M`&AOMG0_HJ/\USFI*6W=+WF&'=K+H=KQ^?\`G;O8BXAPS7;]E86"!N]I;V]O
MTOY*EZF?)_0MVZQ[M?Y,_P"O_F$ZW9+F6?:&-9`]NT[ITU24G01;8VYS+6AK
M'&*7`\Z?1?\`NN_=1E79DXF4^[&:\6/I@7,U]I/T?^I24V$D%CG5N%5AF?YM
MY_._DN_X3_JT9)2DDDDE*223$@`DF`-22DI=1>]C!+W!H\3HH>J^S^9$C_2.
M^C_9'TK/^H_X1,,9GJ-M>2^UD[7$F!(@PQOL24ONML^@/39^^X>[^RP_1_ZY
M_P!MJOCUMR'^O!-`,U3J;"/^U#S^Y_W&9]#_``W^A]*=GZW8:6_T9AB\_ON'
M_:<?R/\`N1_VQ_I]EI)2E%_`GQ'Y5)1?P/B/RI*:UEE%;K[:F3D,8XG0DF`W
MV_VO8C8UCK<>NQ\;GM!=M@B?S@-KK&_]-0M-SFW,>T"K8Z'2"3I^Z[V_O?22
MP"UV#CN;(:ZMK@'$$ZC=[C7^C_S$E/\`_]'U#%_F&_/\I53&H>+,]TFEUUP+
M;=L&&LKKB7M;ZC=S'[=G^D_?5O%_F&_/\I5+%J;7]O?<PBJZ\D""V1M95.UW
M[SV_39_._P`XDI/Z-NXG[6=9EL"!X]_S5.JM];+-]QO)'>-('\E5IZ9O/Z)V
M[670X3_:GW;O;_JQ%Q/LGIV_9JS6(&Z6ELZ>WZ7\E)3<0'8.&Y[K/1:VQYEU
MC1M>3X^JS;9_TD=))35?CWAI:RSU6'_!V\Z<;+F;;&?UW^LDW+=2-N6QS")B
MP#>UP`W%Q=6WV?VV5JTHO8U[2UPD'MPDIKT]4Z=?6+*\BLM=,2X-.FGT7[7*
M9SL(!Q]>LAOTH<#'W*.-B>E2VMY'M_-K'ILY_<KVH[6M:(:`T>`T24T,SK6+
MCX[K@YK@V`-1W/[@_2?]%%%^,\A[W.O.A;M8\M'AM8QKO^DK3V,>W:]H<T\@
MB0I)*0?:VGZ%5KO[!;_Y]]-5\C)S76U8]6-8RNZ19D$MFL#N&L-GN=^;N_\`
M!%?224PKK956VNL;6-$`*:222E*+^!\1^5247\"?$?E24@NJ/V;*:^USA8'P
M1ME@+=NQDM<WV_2][4_3WLLP,:QGT'U,+=0="T1[F>S_`#$MC+*LFJB:7.+F
MN?!'O<T?I&SMW?2_-4\6G[/C54;M_I,:S=$3M&W=`24__]+U#%_F&_/\I4["
M\,)K&YPX'BH8O\PWY_E**DIJ^KG;C^A;MU@[M?Y,J=;\ES+/7K;7`]NUVZ=-
M4=,1((/=)2Z2B00"2XP.>/[D!F9CV.:QEI+G<"(YGQ;_`"4E-E)1VG]X_A_<
MHVO;4S?8\M;($P._R24D20:KJ[I].PF!)TC0ES.[?WJWHFT_O'\/[DE,DD"[
M(JHCU;"V02-)T'/T6J;'"P;F/)`)$Z<@[3V24D24=I_>/X?W(+\JAEAK=:0\
M<B)[;_W?W4E-A)0'N`<'$@B0=/[D^T_O'\/[DE,E%_`^(_*@,S<9[@UMIEQ`
M:(Y)F/S?Y*/M)Y<?'M_<DI9A>2[>(`=#/,0-?\Y34*V.:7[GE^YQ(GL/W5-)
M3__3]0QOYEOS_*45"Q_YEOS_`"E%24I))))2DT)TDE*3)TDE+)TDDE(;SE!S
M3CLKL;^>'N+3RWZ+@U_YN]2H-QJ:;V-KL/TF,.YH^#RUF[_,1$DE*30/!.DD
MI22222EH"=)))2DDDDE/_]3T_'<!4T:]^Q\2B;QY_<5\KI)*?JC>//[BEO'G
M]Q7RNDDI^J-X\_N*9^U[=IW`?R=P.GFU?+"22GZ=JQ**J/3%USVR?>][G'6?
M'V_G(AII(V^I9)W:@D&#MW\#^2OEY))3]0^C7JWU;=Q)),G=KK^[YJ+Z*PV'
M6V072TN),:?1&X+Y@224_4[MKA!W?$;@?P074U^F&.LMY'N)<"5\O))*?J'[
M.((]6Z7<F3/.[33VI>C6&D&RR#$$DF()=[=P\U\O))*?J*IE3+-S7N<X`@@R
M?`R1'TD;>//[BOE=))3]4;QY_<4MX\_N*^5TDE/U1O'G]Q2WCS^XKY7224__
MV0`X0DE-!"$``````%4````!`0````\`00!D`&\`8@!E`"``4`!H`&\`=`!O
M`',`:`!O`'`````3`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P`"``
M0P!3`#8````!`#A"24T$(@`````!1DU-`"H````(``@!$@`#`````0`!```!
M&@`%`````0```&X!&P`%`````0```'8!*``#`````0`"```!,0`"````'@``
M`'X!,@`"````%````)P!.P`"````"0```+"':0`$`````0```+P```#H`!F(
MI```)Q``&8BD```G$$%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I`#(P
M,34Z,#0Z,C@@,34Z,#(Z,S0`<G(Q-#0V.3D```````.@`0`#`````?__``"@
M`@`$`````0```]*@`P`$`````0```A0`````````!@$#``,````!``8```$:
M``4````!```!-@$;``4````!```!/@$H``,````!``(```(!``0````!```!
M1@("``0````!``````````````!(`````0```$@````!.$))30/]```````(
M``````````#_X0%(34T`*@````@`"`$2``,````!``````$:``4````!````
M;@$;``4````!````=@$H``,````!``(```$Q``(````>````?@$R``(````4
M````G`$[``(````)````L(=I``0````!````O````.@```/``````0```\``
M```!061O8F4@4&AO=&]S:&]P($-3-B`H5VEN9&]W<RD`,C`Q-3HP-#HR."`Q
M-3HP,CHS-`!R<C$T-#8Y.0```````Z`!``,````!__\``*`"``0````!```#
MTJ`#``0````!```"%``````````&`0,``P````$`!@```1H`!0````$```$V
M`1L`!0````$```$^`2@``P````$``@```@$`!`````$```%&`@(`!`````$`
M`````````````\`````!```#P`````'_X4`C:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87`O,2XP+P`\/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E
M:&E(>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z
M;G,Z;65T82\B('@Z>&UP=&L](EA-4"!#;W)E(#4N,2XR(CX*(#QR9&8Z4D1&
M('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M
M<WEN=&%X+6YS(R(^"B`@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*
M("`@('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+R(*
M("`@('AM;&YS.G!D9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R(*
M("`@('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ
M+R(*("`@('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C`O;6TO(@H@("`@>&UL;G,Z<W1%=G0](FAT='`Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"]S5'EP92]297-O=7)C945V96YT(R(*("`@('AM;&YS.G-T4F5F
M/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O<U1Y<&4O4F5S;W5R8V52
M968C(@H@("`@>&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O8F4N8V]M
M+W!H;W1O<VAO<"\Q+C`O(@H@("!X;7`Z0W)E871E1&%T93TB,C`Q-2TP-"TR
M.%0Q-#HT,CHS,RLP-3HS,"(*("`@>&UP.D-R96%T;W)4;V]L/2)04V-R:7!T
M-2YD;&P@5F5R<VEO;B`U+C(N,B(*("`@>&UP.DUO9&EF>41A=&4](C(P,34M
M,#0M,CA4,34Z,#(Z,S0K,#4Z,S`B"B`@('AM<#I-971A9&%T841A=&4](C(P
M,34M,#0M,CA4,34Z,#(Z,S0K,#4Z,S`B"B`@('!D9CI0<F]D=6-E<CTB06-R
M;V)A="!$:7-T:6QL97(@,3`N,2XY("A7:6YD;W=S*2(*("`@9&,Z9F]R;6%T
M/2)I;6%G92]E<'-F(@H@("!X;7!-33I);G-T86YC94E$/2)X;7`N:6ED.C<W
M-S)#1C=!.#E%1$4T,3%".38P1C0Y1D8P0C(Y-T4X(@H@("!X;7!-33I$;V-U
M;65N=$E$/2)X;7`N9&ED.C<U-S)#1C=!.#E%1$4T,3%".38P1C0Y1D8P0C(Y
M-T4X(@H@("!X;7!-33I/<FEG:6YA;$1O8W5M96YT240](GAM<"YD:60Z-S4W
M,D-&-T$X.45$130Q,4(Y-C!&-#E&1C!",CDW13@B"B`@('!H;W1O<VAO<#I#
M;VQO<DUO9&4](C$B/@H@("`\9&,Z=&ET;&4^"B`@("`\<F1F.D%L=#X*("`@
M("`\<F1F.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/DUI8W)O<V]F="!7;W)D
M("T@3F5K=&%R("TM(#(P,34@4')O>'D@4W1A=&5M96YT($1R869T(#`T+C(W
M+C(P,34@=C(N9&]C>#PO<F1F.FQI/@H@("`@/"]R9&8Z06QT/@H@("`\+V1C
M.G1I=&QE/@H@("`\9&,Z8W)E871O<CX*("`@(#QR9&8Z4V5Q/@H@("`@(#QR
M9&8Z;&D^<G(Q-#0V.3D\+W)D9CIL:3X*("`@(#PO<F1F.E-E<3X*("`@/"]D
M8SIC<F5A=&]R/@H@("`\>&UP34TZ2&ES=&]R>3X*("`@(#QR9&8Z4V5Q/@H@
M("`@(#QR9&8Z;&D*("`@("`@<W1%=G0Z86-T:6]N/2)S879E9"(*("`@("`@
M<W1%=G0Z:6YS=&%N8V5)1#TB>&UP+FEI9#HW-3<R0T8W03@Y141%-#$Q0CDV
M,$8T.49&,$(R.3=%."(*("`@("`@<W1%=G0Z=VAE;CTB,C`Q-2TP-"TR.%0Q
M-3HP,CHR-2LP-3HS,"(*("`@("`@<W1%=G0Z<V]F='=A<F5!9V5N=#TB061O
M8F4@4&AO=&]S:&]P($-3-B`H5VEN9&]W<RDB"B`@("`@('-T179T.F-H86YG
M960](B\B+SX*("`@("`\<F1F.FQI"B`@("`@('-T179T.F%C=&EO;CTB<V%V
M960B"B`@("`@('-T179T.FEN<W1A;F-E240](GAM<"YI:60Z-S8W,D-&-T$X
M.45$130Q,4(Y-C!&-#E&1C!",CDW13@B"B`@("`@('-T179T.G=H96X](C(P
M,34M,#0M,CA4,34Z,#(Z,S0K,#4Z,S`B"B`@("`@('-T179T.G-O9G1W87)E
M06=E;G0](D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I(@H@("`@("!S
M=$5V=#IC:&%N9V5D/2(O(B\^"B`@("`@/')D9CIL:0H@("`@("!S=$5V=#IA
M8W1I;VX](F-O;G9E<G1E9"(*("`@("`@<W1%=G0Z<&%R86UE=&5R<STB9G)O
M;2!A<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P
M<V8B+SX*("`@("`\<F1F.FQI"B`@("`@('-T179T.F%C=&EO;CTB9&5R:79E
M9"(*("`@("`@<W1%=G0Z<&%R86UE=&5R<STB8V]N=F5R=&5D(&9R;VT@87!P
M;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO<"!T;R!I;6%G92]E<'-F(B\^
M"B`@("`@/')D9CIL:0H@("`@("!S=$5V=#IA8W1I;VX](G-A=F5D(@H@("`@
M("!S=$5V=#II;G-T86YC94E$/2)X;7`N:6ED.C<W-S)#1C=!.#E%1$4T,3%"
M.38P1C0Y1D8P0C(Y-T4X(@H@("`@("!S=$5V=#IW:&5N/2(R,#$U+3`T+3(X
M5#$U.C`R.C,T*S`U.C,P(@H@("`@("!S=$5V=#IS;V9T=V%R94%G96YT/2)!
M9&]B92!0:&]T;W-H;W`@0U,V("A7:6YD;W=S*2(*("`@("`@<W1%=G0Z8VAA
M;F=E9#TB+R(O/@H@("`@/"]R9&8Z4V5Q/@H@("`\+WAM<$U-.DAI<W1O<GD^
M"B`@(#QX;7!-33I$97)I=F5D1G)O;0H@("`@<W12968Z:6YS=&%N8V5)1#TB
M>&UP+FEI9#HW-C<R0T8W03@Y141%-#$Q0CDV,$8T.49&,$(R.3=%."(*("`@
M('-T4F5F.F1O8W5M96YT240](GAM<"YD:60Z-S4W,D-&-T$X.45$130Q,4(Y
M-C!&-#E&1C!",CDW13@B"B`@("!S=%)E9CIO<FEG:6YA;$1O8W5M96YT240]
M(GAM<"YD:60Z-S4W,D-&-T$X.45$130Q,4(Y-C!&-#E&1C!",CDW13@B+SX*
M("`\+W)D9CI$97-C<FEP=&EO;CX*(#PO<F1F.E)$1CX*/"]X.GAM<&UE=&$^
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M/#]X<&%C:V5T(&5N9#TB=R(_/O_;`$,``0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`?_;
M`$,!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`?_``!$(`3$",0,!$0`"$0$#$0'_Q``>
M``$``@,!`0$!`0``````````!@<%"`D$"@,!`O_$`%`0``$$`@$!!`,.`P4%
M!@,)``0"`P4&``$'"!$2$Q05(5<6&"(U-U1UDY26MM+5UC%VM`D7(T&U,D)1
M<70D)3-A@9$F-$,V15)356*QM]/_Q``5`0$!`````````````````````?_$
M`!X1`0`!!`(#```````````````!$2%18<'1,9&A_]H`#`,!``(1`Q$`/P#[
M/>&>$.'+7Q^#8;/Q9Q_89Z4G[T_)3,S4H.2E#WDWRRLI=,.,">)(<2RTVTE;
MKBU:;;0C6^ZG6M!:7O<.G[V*<6?<2M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<
M6?<2M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<6?<2M?IV`][AT_>Q3BS[B5K].
MP'O<.G[V*<6?<2M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<6?<2M?IV`][AT_>
MQ3BS[B5K].P'O<.G[V*<6?<2M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<6?<2M
M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<6?<2M?IV`][AT_>Q3BS[B5K].P'O<.
MG[V*<6?<2M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<6?<2M?IV`][AT_>Q3BS[
MB5K].P'O<.G[V*<6?<2M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<6?<2M?IV`]
M[AT_>Q3BS[B5K].P'O<.G[V*<6?<2M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<
M6?<2M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<6?<2M?IV`][AT_>Q3BS[B5K].
MP'O<.G[V*<6?<2M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<6?<2M?IV`][AT_>
MQ3BS[B5K].P'O<.G[V*<6?<2M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<6?<2M
M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<6?<2M?IV`][AT_>Q3BS[B5K].P'O<.
MG[V*<6?<2M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<6?<2M?IV`][AT_>Q3BS[
MB5K].P'O<.G[V*<6?<2M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<6?<2M?IV`]
M[AT_>Q3BS[B5K].P'O<.G[V*<6?<2M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<
M6?<2M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<6?<2M?IV`][AT_>Q3BS[B5K].
MP'O<.G[V*<6?<2M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<6?<2M?IV`][AT_>
MQ3BS[B5K].P'O<.G[V*<6?<2M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<6?<2M
M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<6?<2M?IV`][AT_>Q3BS[B5K].P'O<.
MG[V*<6?<2M?IV`][AT_>Q3BS[B5K].P'O<.G[V*<6?<2M?IV`][AT_>Q3BS[
MB5K].P,?+].?`345)NM<+<7-N-QYKC;B*-6TK0M`SBD+2K4=K:5)5K6T[UZ]
M;UK>L#YX_/G?/2_M+WY\#Z*^GKY)X+Z:OG_]@VG`NK`8#`8%5<W\I@\)\4W7
ME*1C'ID:H123M1;);,?HXHDP:-`8)DR&W6(F/4<:-N3EWF7VHJ.T5(+'(2-M
ME851&]3>HVL]1DIR14`ZW.]-,;Z=N$/3[6[>HR:@2Z`QR!#&UV<.K-**<+D@
MU%Q2XZ1@0%B20>U^.1'E"F.A!3>KFXU^V!<5VSB""C.8+4UQ(;Q]6XKE$V:J
M,_'\I%78=]V?N;O&<2?6"Z6QQM=3YX4:GV)DP4**U"F'D2JQP`\L=UAVZQ'V
M&E53AZ%D>5Z"#RY)\CU24Y0+AZS"B<5SL?!,)K=T9XVEB+.5=G)B+-@&3JK6
M&@Q%F^G"8T@)+!(6.[U*D6:(X"=XDI0ENL/4)Q^;RG68BX6HJAQD-1XVKP%@
M--G)N.J=Z(1*:.MU5@!XL2$(2\5)DEN&CAQSJW0HT/\`M`QY[C^S<JUCBM1U
M%XMI5$N'-#\O=E0]AJ2[;)R(DU!5&'&ITR!>I"FQL/(S,B\7.T\.38]'BQ3S
MY1CB!`M?BGJJ/Y&G^)DR''@M<HW/D+?9WA^T#W)^<G)8&DNCFC>Z^J.4^%'J
MCEFJKRK+%I`LUI2*AI47)J%-6CO!N)@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@:\\@<XS5'YSX-X
MB1QI*2E?YCD[%#$<G.V"*C86NR\+Q]R'?QH8&"2R?-V24($X]):E-.-P$5$"
M3,48S+2Q:GXEH*OHG6$W>.H<[@,>DQC,C&S7(T7.#BW4H[D:CQM$;#5%73DC
MCAVE1XE3HW([A8Z:!8![M.^G6Y6ON#B*4;*M0(;K8#`8#`QDU\32WT8?_2NX
M'RY8'T<]/K:VN*8-#B=I5J9O6]ZW_'L5?[0I._\`U3O6_P#EO`N?`8#`8&#L
MT63.5Z9APWHI@B4CB@$.3L*FR0VM%-*9<3*0*CHQ,N"XVM;9("SQ$$M+4VIY
M*=[[0TV9Z1WPA[51`I2`$XYYOC+^WU#$5^NQ%1*EVI:@C\>4BI<95F-CRP*+
M"5X<@NT[E'9>8DE3@+WG=2^[,:1'!FC>DA^<E@+[9N4)"7Y?K3W&&J3>V*I&
M1L97P.*'K<[#`&5)N0?;F4V1/(%V8NS^YJ/7)LS;>H)-97%@+:#\6.C_`%$2
M!EKJ_)\O"<BVJ+Y-A.2;B[6HF21;([EB?"LDZY&P3A0XE;DZX?&QXU#,41-C
M0T4-H.>C[6ZZ\6L/SJ_3-=8KW''@7J.H\CPP[8Z!P6+'P(UMCZ[P.94*G21Z
MM;?,JKC]FGY8FDQ7(>I9+P+E=FGQZ\I=AB(\I4J&&%Z#J1#5^<HE:N4_&<=<
M@U&AT_EVN'1\=*R5[#H)9Q3$B)/:V`FL2UM:DSXR[OLQ,F-)1CS:(,.MGLHD
M-A8O%'2Y&\82O'RE7*2LM7X9B+C`\.5LV(!"?J<7=2F%')F9H=YQZT&0\.,U
M6*X4D.$0)!+)U*#S,L]J5;#:G`A0&W/[QK5K>U>#JE4#:$[5ON:<W.\E>+M*
M>WLTI2=,Z6K6M;5I*-;WONZ[`FN`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!`^2!FC*RP(^PV2.3;N.F"AG
MVT.L$".\A5=!3#[+FE-O,/#J<;?:<2I#K2EMK2I*MIV$KC(B)A1U"0T7'1(B
MG5/J%C`A@!U/K2A"WE,BM--[=6AMM*G-I[ZDH0G>]Z2G6@I'E'AZS\@\D<-W
MR-OT;6P^&[-(VZ*@7Z4N=<F)F;IERX^F=2$OJUQ'@Q[U6NAZ0!AXW3X,R*+)
M/&'">+%+"OZ9TBP52Y+K%^W:ER+%'N_+'(%7:]S48%<B9OF+4]JSQUWY!;)>
MDKA6`-60Y,!";C8?8J8JHZDC9?W+A;<#;_`8#`8&-F=;W#RVM>O>XT[6O^>Q
M7<#Y@_1$E\T<_P#='YL#Z,N"_DRAOI:Z?CBQX%N8#`8#`8#`8#`8#`8#`AP/
MR@6;^3J+_K?(F!,<!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@865LE=@ELMSD_"PRR$K6.B5E`8Y;Z&]I2XIE);[.W4
MHVI.EJ1I6D[4G6]ZWO6!^<7::Q./K%A;'`RY+;6WW!XN7CY!]#*5)0IY;(A#
MKB6M+6A&W%)TC2EI3O?:K6MAGL!@,"'7KXD#_F_CW\?5K`F.`P&`P&`P&!CY
M;XJD_H\W^F<P/G'P.]G!?R90WTM=/QQ8\"W,!@,!@4GU(620J7`_*\_$6$BJ
M30-*F405A$!U(E1D\:/L"#='&4\.WXSDL4&.V2\2,.$I[1I!([`[CR`T^IW+
M?*=6XDZOWK4J2I_*G'\)*SM0XZF;LOEKW'I:X=9GXLV`O\FXZ==6Y@R,E+B3
M!F"#DUW?C1[D?N-4,::'DLEOME9Y>J7%U?Y'NDGQ?>!^FAVV6<VY2LQ,PLG<
MSN7=FLQ5R>,>DJZCDU-)H\6^''&ACL)FG':NU$%SK#R@Q]<NUOL%SY%X]LG)
M=SB^/J'6NIN;HEO$N4G$3$PJE7>%A0RY.X,%M%V5GB]N0EHMMJ5+.%>\!IZT
ML2Y`.W]A:<)R!:>0FND6MW>U2M<W?.&IZX\H.UJ>+ILL3R-$\<T689KTC(PA
M8,E!J9%M=AN;L"P4$\[J$%?);>B`#!W@U?K?,_,MEX6Y9N\W>;4/R#Q5Q7PM
M,\5C!21,0-<#;'-SWHRR3<``L6-NSW)Q,=%UIYF0$.CWD>*U`"QLB>Z^H-@^
M`KU=YV3Z8+(7<+'/R_,=1YBF>7:_(S9DC#0Y<&6`0-Z-KC[ZPJAJD65]%#91
M%"@>(R3L&=U(2_<+0'1+`AP/R@6;^3J+_K?(F!,<!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<6_P"TU"(DN5^*8\5K
M;Y)E-+'':_CWWGK$\VC7^>M=N]Z[5?Y:UV[]6L"'?V;X!$7U(V>.+:\$H+C*
MU"DM^KX+S%IIC:]=NO4K6E:WW5?PWK?;KU;P.ZN`P&!".0EO-UQIP=GS+[=I
MH2V!_$2SYAY-[K:FV?&7K:&O%7I*/$5K:6^]WE:WK6]8$EBR9$H=3DG&:BB-
M.J0D;1K)^E-:2C:7O&80VC7>4I:?#VGO)[G>WOL5K`UFY=?N41U$=+1D=?K"
M#4;3<KE4)OCT%((M=F%!\+<OVQ4Q-OH'5*2Q2)"&KOHT%TQJ+C%Q*S$"/FF>
M.,%5\/\`+EOD>1X8F^19YJ^2N:^?>-JT_'\I6!;519XM*NFHD"6X<9AH^M!1
M)-6I2"W+&1,6"<W.S\:>0D4&:CVXX-_\!@,!@8^6^*I/Z/-_IG,#YQ\#O9P7
M\F4-]+73\<6/`MS`8#`8'E.!"DPRHZ2#%D(\X=X0T$T=HH,P4A"FGQBAGT.,
MD#O-J4VZRZA;;B%*0M.T[WK`KL?AOC0*?K-AC:C"Q)%0;L>Z_'P\>'$P@1MK
M!%BIN7W#QS`P)$P3#BJAT2)#3K[$69(AL[0V<_WPS8O'''H4(?60J)31*Y*O
M-D2<`-6(1B%D2&ML[:?/BF@D`EO-[&'VVX0PXM&V&>[O7A([H?[+X\H$A&Q$
M,?1Z@;$5]?BP,476H8F-A7.Q6O$B07@EC1R^Q2M;4&TRK?>5Z_7O`P(7#?&@
MP]B&,J$+8$6RX'7NP*M$>)8E2-F-&9C6Y!Q,JP2TWN,A!0:]#MLMMHCH*/#C
MA]::;5M82DNETZ0D(B7/J=:-E:^VVU`R9<%%DR$(TUM*FFX@QX59$:VTI"%-
MH#<92C:4[3K6TZ[`_P!Q50J<')R<U"5>O0\Q-*4N8EHN%C8^2E5K=4^M<D<(
M,T4<I;ZE/*44Z[M3JMN;WM>][P)%@0X'Y0+-_)U%_P!;Y$P)C@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@16XW.`HL&9
M/6$UL885EUQH?2V]FR#R$;4@*.&4M"BBWE=B&VT>K6U=]U3;25K2'(*W@<@\
MG\A%<KW^#/=(,%2-0X4<`]^,J5:;((\)L%_326Y$XM6U*-E/"TTZ2HO8VM(V
MSH<-O^DJ%K,?*V1XJDAQ5Z4.XZS;%P:@Y:3@"W0='19$FH=M;S8QP8#^FG'-
MJ<2XUW=;2+\`-Z,!@,"'7KXD#_F_CW\?5K`F.!$)OCZA666CY^QTFHS\[$Z9
MU%S4U6X>5EHW0[CSH^@)$X-\P/3#I)#C.AWF_#<(>6CL4ZO:@]HM0J8,^;:@
MJO71+1(M[9D+&+"QK$\>RI(Z%-&2[0R)`IO:!!4[0^0M.TC,)WKL9;TD)%@,
M!@,#'RWQ5)_1YO\`3.8'SCX'>S@OY,H;Z6NGXXL>!;F`P&`P,;+RHD'&F2QZ
M35!@M;>(3'1<G-';1I6D_P#9HN&#/E#7.U6O\$(,A[>NU6D=U*MZ"&5;EB@7
M$2V&PD_W!Z&7Y*Z;G8J:J;M7)U#"6)3<X-:XV%)CDH@3PIA;I++;*(TL<Q;B
M6'FUJ##!<]<1R$1*S8US#T%#.0#1K)($R%+.;MCJ!ZBN-@#8T>=FA[>2O0M1
M*AHT\:TEI=%@'9$AEYM`?Y,Y]X@!@HZR/W8'<5*>GU,*&"F#3QVZD0L2W$2T
M,%'$3,$+4"VU"6TN;`CQJN7W19YV/?6AM02:R\F4:HQ4-,S=A&2!9-Z]SFXH
M<ZQ%V%'HUZ96]`QE>%E9*9&8AAR)@HJ-$)'$BF'I(EUH)M;Z0P!?.O$(2H/Q
M;]`O,6*-@IF-D0'7Y.'1#V@U,;6)>6FXU@N(K\59))6XZOR4^;&!3<@V\%&/
ME%,/M-ADZYRWQS;;"35J[:@)2;'1+N-CL-&H&DFZ_(HA["Y`2CXK459$5Z7=
M;BK`N`-DDP<DX@"5V(4M+6PL;`AP/R@6;^3J+_K?(F!,<!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#RG'!1@KQTB6,`$.C;
MCY9C[0P[*-?Q4Z\\I#:$_P#FI6O7ZOXX&NU@YQ-F6Y,?B^,9-!BF"GIOD&Q]
M^,I<"*(VI91BBG_"\UY9I*WM[4I">XWXB&"VM[P-3^#*G;^I3D`[DVYS$G)\
M05J3<&KSI[+X;G)$H&YO3CPXCVD^1I@;Z>_L0=L?S[GA!$=[29$5D.H*4I0E
M*$)2A"$Z2E"=:2E*4Z[-)2G79K2=:]6M:UK6M>K6!_K`8#`8$.O7Q('_`#?Q
M[^/JU@3'`A<OR-1(&X57CZ8MD&!>;NF175*F^>SJ?G&8F.D):1*"C$J45L(0
M"*D7W37&VQ.T1UA+RB-::V']WR)2$W]OBS=FB]\AN5ARZ)J27MKE]59J1;B5
MS;C*4;0R'Z1>;%0IUQ#CKF][;0M"5J2$SP&`P&!CY;XJD_H\W^F<P/G'P.]G
M!?R90WTM=/QQ8\"W,!@:2]6,=U>1TQ2K]TS;$O@D$'88>:X4*FX*BL2DY/U^
MPQ4#R#(W.9(2U,1%/EI&%E3Z*\D5,@S$+(`+=D76V4!#NDWA/J0X(Y!L=9MM
MNG^2.*)FB\?S5BNO)W(QEILIO.#PEDWR(5QI#]R2(AZ,2M57%(BK`17F0GPE
M$UT*0:(+6V&_LF24'&R!@,>]+G"@EDAQ0[X@Q$F4P.XZ/'L$GOC`CO&O)0,T
M^:2.(TMU+A#[3*5N)#0\BC6H#@J9X,.ABR>=.J"G<VV^]2@KXQ%?JEULU9*+
M+U9IA@E?AU:&D)2K\5U\B.W)/O`B1FV6R1!C2V@P]DXMY>M_*-1YV3QA,0.Z
M"UP7%N\9'66@.6.V#TXCEI=K/CBXNW%T]MJ!_O1!*KK4Y9(TB3?KDFE0\;LB
M-<(#RU_B/F"G7B\<J)XSDK#OE>!YSCE4,&S45F3HA]UMD'+55<X7*6<&N$`S
M<9!I=M+M:D9\J+DGV61QIIEMTG09#CJ"O4$K@4NO4&S7R.Z9Z9;.G6Q:!/JL
M1NWRX]&XY$,O=(5;K'7@#ZW%6ZGR]!D%G%`2B3?/O@!G@!NN.A5%?Z5^9:IQ
M7RMQ`NL:FG.<^/.-(%-NC)^MIA>,Y4$V=1:H^;9E9F.G#(^LL36I2ND5.%F=
M2Q+9(RF8Q2FB'`O/@SB#DN!+Z<H"VU$FN"].M8Y)A).V.S=8D8V_FS[8U=A2
M:Z-$3<C/H%EH]IZTRR[-%P+X1FA@/`-(4X\P&^F!#@?E`LW\G47_`%OD3`F.
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!_-[TG
M6U*WK6M:WO>][[-:UKU[WO>_5K6M>O>]_P`,"D+/S9&#2*ZS08PCD&W=Y3>P
M(?>U1<>K6^ZIV3E])4*VVVKU.::<5I"M>&\\.K>MX&%!XCL=V*9F^9IY4HEM
M?CAT>%=<#K<<K?KT@MQI?BR#C>M]S:M.=O\`M:460VKLV&N=X-)ZGKXYT^<7
MK]!\%<?F#_WPVV$;T*).'!/_`.%08!YG3;+C:G&%Z-(9\=IQUM12]J'$81(A
MO_`0,/5X6+KM?CQHF$A0AXZ+CA$>&.&&*VEIEEM/;O>])0G7>6M2G'%;4MQ2
MEJ4K89?`8#`8#`A'(32GZXTPE]X93UIH3221]MZ('4Y>ZVC3[&WFWF=/-;WX
MC6W676^^E/?;6GM3L)-%@.QPRF'I21EE[=4YHJ44$HE*5)0G3*=@A`,^$C:-
MJ3VL[<[RU]YQ2>ZE(:R<RUBSR'.'3G;:OQ3,V46CW.9F+M=8@KCD!0E=DN+.
M5Z3%1CJK%<H&S2>HB?N@\FX"'&%AC`R9Y<>X3(**"V$+IO!?*M6ZGHSE&7-K
M%FAYNO<RKN-M%"(C))!-GL/&_N$J[<:7832-,P=4J(<.$^"(Y%Z:A),X_0\K
M/(VL-X,!@,!@8^6^*I/Z/-_IG,#YQ\#O9P7\F4-]+73\<6/`MS`8&N_5GR;:
M^&^G'ESDRC-`O6^I5,@^OIDHF3GA&Y%XD8%DA<+$:\_+.B^:V2-'M*::+)::
M9*>8$6^Z@-<>@KG>W<TN\FIM743!<\;KS-06&U"]-W(G`&ZLJ558]$;)=O8H
MR+5Z6\@TEM,5MST/Z-<47O6I,;O!T6P&`P&`P&`P&!#@?E`LW\G47_6^1,"8
MX#`8'ADY(*'CCI61?0,!'"OFED+WV):'';4ZZO?^>^Q*=]FM=NU;[$ZUO>]:
MP-5^!>:#+G;[?!SKR]*F329^LLNK[=!B-=UA^&;WO?9K3`:!"&D)[.\ML][?
M>4XI6!MM@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@5?=^6Z
MG27$QSCST[97U):#JT"CTA,OO+UVH0ZRQI?DTJ]6];([KB];[66G=^K`KQ-3
MY0Y75HB^R+M"ISJM+:ID"]I,T>QV[VWJ;D]=]37B(WV/#:WV?Y;"&=3I>@N^
ML5"MTV/1&5J($BA4I3I?@(VI\A2==GB%E.;624[O^.W"'7%=N]]F]:]6!J7U
M$<IVNUV</IGX0*[.0;.-XM\M8_?<&XTIKJ4)+,)(9[-#RY[+R$#)TXD@=IYI
M#.D&G@N-ALAQ/Q95.'*/#T6H">!'QK*5%F.ZUL^:E7$(\_-2;VO6\<>ZGQ'-
M^IME'AC#H;&99:0%D8#`8#`8#`AUZ^)`_P";^/?Q]6L"8X#`8%,=0G,P73WP
M_<>8)*I6F\1U,9BB3JY360'[`4))3L9"OEC(E#8X!`L2B2W+2I!1K#(L4":2
MI?8UV;#63B_K*Y#Y,YWXZXNE>FCE?A*N6RJ<AV$J<Y@B840B:?JH]<>C!:>5
M6[;+"JTCTN^[-:D07=.,.@;!>95I[OAT"P&!CY;XJD_H\W^F<P/G'P.]G!?R
M90WTM=/QQ8\"W,!@:K]9,CI[I^Y/IL/RE4>+KU;:-8$U.1M'($=QRHMJ+W'K
MG6@K(68*5#,N@F-0YEC#TK5=<FPCGW&.\RI0:D?V9@0`\ASB14(ZK<=\;$IX
MZ1`<*P?5-!]4Q]8L8S-L3:KT=8H.UW)BLAWQ#L($##N2Z7"7ZD>7L1CU=X.C
M7+G)$5Q!QG=N3)H=TV.ID`;-.@L.MCO2#S"-("CFB'M;9&7(&N#AZ*>UMD;Q
M_'>UMMM6!5\5SX.)Q1RAR39#*S-&<70$I8;#5Z:W8@Y*,U'UGW1M0AXUM!CI
M9!DDUKLB95^'CP9(1UD]@=+7BI0$`D.I._5NXQW$UEIU2UR=<&>+#J0N(FII
M^G^3Y%)N[4JW8"2(MN5:)I8W'-I.4H0=#-G0N&&8]!N%&.`AYHWJ<OMDEK'0
M:Y3*GKDKCT#E23O+4M-S#53>8XYFX^&BF*X<+%NGJ>NOI<`U#D@SI-8:;/8)
M9F766%$!/T<^2MQC.!T<9P,8J?YVX^-Y1C47(LX:,KE4C:Y7I@EN05#CDOG2
M[LI;JY",CL.#C-M/R4MLA[4>Q'R`4H!UN2=AH%LY1@*''M5;B:GTNT<K1\K,
M%^G/-V*0D6;#!TQT4#0!JJK%1!DJQ(R7@M6%T@"-0+$[408T%I\7]1D]>9GB
M4J5J\1&4OGJ&N\WQL4!)'DV&/%J?@24:BV"E!#!Z<LU6=7,_]VN=V#/;U"N[
MDTN)E-!MM@0X'Y0+-_)U%_UOD3`F.`P&!#[U3Q[Y7"ZR;)R<4$<XSLQV*4*@
MDAAE?B>46HL4MO3#KFFUNZ0VEQ7AI1W]-J<2L-=RNF)NK(;L7'5HG&[?#/(/
MB$2[D:L$EUGMVL-[R\>*I&BV]J8[SJUC[TM3;[>VEJ4@+HXSY*$O@)(I@JX2
MW0B]"V2N%:4T2$4C?<6^PVYOQ'077-*TVYZU-*_PGOA=Q;@6A@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"'W"^U2B@[.LLN.#K:=['#UOQI$U?K
MTEL,%KO$/J4KX/?2C32-[[77&T]JM!37I7EKESX,`P_Q?1GU>N:D&^VW2PWK
M[=@B:WV@-NZ[-I=TICX"N\T80GO-["T*/Q;4*$WMR)`V5+O:5LVPRBO.S1KB
M]]KBW#'=;VREQ7K4T,EEK>_A*2I?:K86+@:R]1_.I/%T7$U*C`:L_,O(+_HF
M@59A&B%H=<WX;]AE&^\E+$5&)VI>EOJ;;((3V+5H0<]\<,GT[<%#<,5@Q^8/
MW9>2[D3J<Y&N9*E/F3,V1M;[HK)+NM/>BH]]]]`:-I;V\M;I;K:''NXV&P^`
MP&`P&`P&!">07V!:ZR22\T.,/:J"^00^XAIAAAJ]UMQUYYUS:6VFFFTJ6XXM
M24(0G:E;UK6]X$HCY2,EV%%14B#)C)<4RHB/+'-82\E*%J:4Z,XXWIQ*7$*4
MC:N]I*T;WKL5K>PI2^<LVBH<S<*\<CT9HNH\IRT_"'WPJ?$85'3$50+_`'<>
M)B*Z.V3('/(8HZ?2Q\DJ*CV!YJ/1%N2Q:9)J,#_+?)UPCN<X3B>=A*T7'VRI
M7.XQ9]:DY0J6K$74Y>#BPG;>,?'C#>7M'IO2(TH)3"1Y6/D(Q#<DT.J2T$:Z
MO[5<Z[PI,1W&-HAZOR=;YRFU:HE2`M:FI+8<K<J^/>SZW4K4YJ+N,U7..W+5
M9&*^X.;HI$4M2A'TH\-0:Y].U%ZR:KSO"3O.E_LM]A;)6N7(FSQ9,-3(_CNH
MB4BTUFN\/6BFLUI#RZ_:>4*RQ(6FUP3<FZVI<D8T9&QJX408<.EF`P,?+?%4
MG]'F_P!,Y@?./@=[."_DRAOI:Z?CBQX%N8#`T'_M':9*S_39;;/`3W%-.D:2
M"1(R]OY3X^`O@@5'(>"5:X:)02,89'/S:@8E1#,>#)O3NHX>&1%EE%!J8"A_
M[,62XRGI_G2<H/,/$?))A$;QF#+P7#?2U.=,U;K`P!-_U'R!@4["QKUHE)\I
MZ5%>?8)*:C40"&U,C.DJV\'3WD2BPG)M&M-`L6S$0ULARX<U^.?T-(AZ)1_@
M2$<0IMU#$A'$I9.!=<9>:04.TIYAYK2VEAK^;TV2LE.6!B9O\K9*GRA7I^"Y
MM=F!X$:Q7>)]Q3E'I=5C&H.LQ<=6H>`1+3MK?G(E\2PDV'R@SZRXHAQD(,B]
MTNQ$@0Q89WD*[SG(<6]Q\NL\B%L5$>;K0W&SD\Y!@@1<?60ZR4.?[K;<W8%2
M<*:1*M6,UO3PR1(G4>'YZZ5X$1Y<O!WZ\0-QE8^_Q5RNH2*H_-70#DB8'GK`
MW*"R%:,A`'A)$,+=>)A(N-<A11&@VO&86^ET/P@NG*8$W"%*Y`DJF;QU(3M>
MX<13@JZ8S1.'BZK7Z:'02G;)62O=)N0158J[2,C,"$RD5:%ZBXV7+@H_7I$/
M(UT;\<`1AM;A)NUPU-LM;I=6Y#JC#\.6#R''T<LDH!^=.D(<J7!/ET'&@V4J
MOG1&Y<`E3/<'6VP\T$SXYZ=:YQS*54H.RV><AN/(ZTQ/&E9FMPFXRC1UN.:)
MD1X\J.AP)>44("PS`13\](R3P4(E8^UO%/.F*#87`AP/R@6;^3J+_K?(F!,<
M!@,!@,"D>3..)$\X:_T!Y$3R#"(VI&T]Q`ME#0GX<5)H5M+3BW&];:8>=[-;
MTK3+RTITRZ.$EXVY'CN08MY7@+BK%$N>4L=>*[R#(LU&]H7\!>DN+%=<0OP'
M=IUOX*FG-)=0K6!9.`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!B9N>AJ
MW'ORL[)!Q<>.G:G"3'D,H]6NW2$=[>E.NJ_@AIK2W%JWI*$[WOLP-(*MS;R3
M>+E8*S5"HH)=ME'2($V:4I::Y&1X:FEI`&VE;;Q+X(S1:V%-NIV6DE[3&UO.
MNI#8^G\+0$$=JQV4HJ\7)Q6G7I^?WLA+#O\`EJ-`<6X.(VUV:TRI6G7VNS_!
M<91O3:0N;`8%1\U\Q5GA"BGW*Q+40]WTQ]>@Q][5(V2P%)7Z/AP&DZ4I3CRD
M*<?>[NT##-NO*[=I0A84OTW\-V5J6E>H#FA.C>9+\SXHT>^G>V..:N1KO@U:
M+94I212DB;9:D%ZUI]E*=A+<6\N1>,#<3`8#`8#`8#`8$.O7Q('_`#?Q[^/J
MU@3'`IGD'B)^^WKC*[^[VQUU7%<X98X*#B8ZK$QALM)UFSTZ3>E'I>"D9-QH
MRN6N1"\N*<*V.\V,:QW"$+4X'EI'##M+Y$O/(F^0+18S[_)J.F0I\"K/I'CQ
M6%"UZM14D)!"2T;6:LRMS<1$"EML.%DR$I)^?EI22/+"&=84;TXKX/L=CZHJ
M7'W7C.ID11Z@G((Z=GF)Z6E0:W`)I[<-MJP"V:4F)@&'C'H,L(Y3QR6]E-,*
M=7H-`.#DUEKDWB:O=('5-SS6JY8)*UOVSI^YKA5\@P--`XZ=K!-JX_FHKD]Z
M-YAXIGE05C&15UARDK'O;&".VHJ,4^[*!VBP&!CY;XJD_H\W^F<P/G'P.]G!
M?R90WTM=/QQ8\"W,!@:^=5<<W*=/G)PCM+E^0&O08Y3E5@')!N;-;`EXXY9D
M2F(CY>5)D(-(VYT0&-B90Z1>C4`"QI[Q*!70U`Z`*E8H7DKJ1M<WQ)8N-XOD
MURGWRC/6&6Y&-,'I,[;^7BXVE2,1>4-1U3L$?(.2G(<M5JJTR+#-\H`#2XH<
MMXXR`ZA8#`8#`8#`8#`AP/R@6;^3J+_K?(F!,<!@,!@,!@47R5QW+;DV>2..
M5I`O<2WOS8>O@AVV/;UVKC#VN\AI9*D)[C#J^[MWX"''4+:&>8"9<<\B17(<
M.HL5"X^8CW/)V"!*[4'P\@CM2ZTZTO27-CK6E?EW]H3IS25-KTA]IYI`6%@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#RFFAQPKQL@6."&,VIT@HMYL<=EM.N
MU2W7G5(;0G6OX[4K6L"@Y3F>3LQK\!P[7GK8<A?@$V<Q"Q*I&*]>EN**>VSL
MQ;6OAH0E3:'NS2A]%IWI"@Q1'3T1<V'3^4+M.3EA([FVU1*V`HF&1WM*6-&!
M/BNC[TM.O#<>4*SWM?"2REW_`!=A_(;I:J4!+1TW%VJX#R$48P<&]IZ$WW'Q
MUZ6GO)W"[2MM79M#C:M;0XVI2%:VE6]8&SF`P(W<+=7J'69FWVN28B*_`A.G
MR1Y"NQ#3+?9I*&TZ[5O$$.J0.*.UI3Q!#C3+2%.+2G8:3\-U"P]1W(0W4MRK
M&/@4^'4^QP1Q_(IWX84;XNE-WF6$WO;;LE(:1IX)3NEZ<<[A;.MAAQ#J@W\P
M&`P&`P&`P&`P(=>OB0/^;^/?Q]6L"8X#`8&LG6+9./:?TZ<@6GE2@6[DZB0#
ME0E9JH45:F;42Z#>:T1#RT24B<K;@*ZQ.-QMF(D$3D>H`.((+\;>F=MK#3[C
M7EJM\L=:_%5K.Z..6.$K_+<5\GQ;G*7,4$U6I6?@85JK$B0D&FKWN5@[$IG9
MZE'&6:%//CPEA-0L@&TZ2VX'5S`8&/EOBJ3^CS?Z9S`^<?`[V<%_)E#?2UT_
M'%CP+<P&!K#UH0]EG^ECG"(J$Z#69XRBR2!IZ4N*Z!%1HS:V'I1^6N#78]!Q
M6XILUJ3*8<'?6"X0.P4(\\@EH-2/[,^`KD0SR1(5[CGC^B"V:N\<V($VC=4'
M)?48W:H(HV^`QLNZCD)QQ%7CM'1DR-'%0V]HG"&9-@Q6U0C.DAT$YNKT;;>'
M^2ZK,6=NE1EFI5AKYUN>:T\S6AYF-?CES3S6RP$K9CO,^9>TX<$UX;:MNEC-
MZ4\@--A.1'X7A;J*HE$%H$/:`H^_PG"EDX4K;U/C.6[$!PZU;SY&D0C$G.+.
MMU66@F,.D(>>FA2)&'92(:T>,5%@A5LSNMC\@0FN.GV-=+LAKIK8YE5$/D[H
M[T\4=RNN2=LSNE^347(N(XD&Y7?+<4Z=&.Q(U^VZ$Z:G8>*)U":G[6!R,M6^
MGO=?ZE#.`V999WN<U*L76%8B4TW2MZ7N:#!W/JXC1&Z5(#0+I*N/>Y'Z'[H6
M@-:HZP"=+5<YVFP9B`K/&4O!<]"VDC3T1'\^M<5<=S\/$<BZ(WH'=BW`35NF
MHD:62MM<X\,:`GT\U$*;#6Z)_O"?XJOPO(!%D5S>'Q5PLOI778GI+5R;+-FY
MM<:33G#%>DMVAR2U!#\D$-I],*@V8]F\K5!Z[-AL-TW;++M'3L>"\4KD]^J<
MP.=4ZG5E>G'9I!P3(['(27^\YHX*\=H]%9D^ZZ)7&RV*FENL)?;P.FF!#@?E
M`LW\G47_`%OD3`F.`P&`P&`P&!0G(W'\S'RZ>3N,](%N`#>U3,,GX`-PC6^U
M;PI3".ZER1VC6TM.]J7']Z;UIQ!#3#F@G_'W($-R'":E(S:QC!EZ&F8<GX!\
M0>G6].#$M;[%=W:DJVP]I.D/(UO_`&7$.MMA/,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,#_#CB&D+<=6AMMM.UK<<5I"$)3KM4I:E;TE*=:]>][WK6M>O>\"B['S
M>!N0<K7'$25R#:>W;>T1FNR!CW-[[NER4OO:&-MHW\)6QU[8WK2D+,87K?8&
M,#XALMV)9F.9K&Y+)0XE\:DP+SH58"[N^U*"MM^&Z>ZGU:<7I7>WOM0HLAKL
MU@7U%Q49"!,QL0`'&`#I[K`8([0P[>O\^ZVTE*>\K^*E[UM2U=JE;VK>]X&0
MP&`P/R??8%8>))>:'&':<???>6EIEEEI.UNNNN+WI#;;:$J6M:MZ2E.M[WO6
MM8'/#6SNMCDOL["F.EWC":VKUZ=%3RY<@%;1K6_A:6_6H]>UKU_LH6PI.EMZ
M+._[N#H<...(.P((PR,**RT.,,.VAE@<=E"6V6&6F]);:9:;2EMMM"4H0A*4
MIUI.M:P/VP&`P&`P&`P&`P(1R$HA-<:4(TR^4FTT)0S)#ZQ1WB-7NM[9:?);
M'+<'9<<[J'7VQ25M(VIQ([RDZ;4$EBW9=X=2IH&.CR].J2EB,E"9<?;&DHVA
MQ1141"N)=4O;B5,Z$4A"4H5I]>W-H;#3KG<FM0O4YTF3IUY)CI15SM<.?6#+
MJL"O"5\SAGF=(<T34MG#QZBYRTO1$*U8)(4AY\P"(AHLAA]3S!85/Q2HDOD;
MA<UMPA/-6^;.HYKGS>EE:L.^.!V>4V*J)=D=Y3FJBR2CB)7'3$CV1R1=0S]9
M3H=1J]AT9GWQ!8.9*/!W*`BQ<@29&I';,4>,.*Z\\&D5W6VR5DMH4RAAS6T.
MJ7I"O4K>!SCZ4^O,3J3Y$A:471J/!3SB.0S&`ZW>P+O.5:IPM;XFL=<D9C0,
M6,W$*GV.0GJ[/"(>0S%6RKF0*'3GQ2M"!TRP&!CY;XJD_H\W^F<P/G'P.]G!
M?R90WTM=/QQ8\"W,!@:U]82:$KIEYDWR:98H^EMU`AZ4.J46U.680I@L1Z#?
M@X4IE\"6DFYYN,4-&RC2X<Y>M#3&M1CA:M!I3_9@0@]>?Y@@[1)\ZO<MP,7Q
M[%2T'SAQ'4>'#*_QF5*\D6FBM5JNT:P6N`,BY&U6;DLTB2<G79+S._)+CX\`
M,%+P=:L#!$UF`-L$3:BXL4FPP4?*Q<-*/)4X_%A3:P7)=H%*E;:'7(;C04%$
M-MI(<9'2/MWP%.-K#.=FOX=FNS`_O9K_`(8&#@JU`UEJ19@8L2,1+S4K8I38
MZ-^+(SDV6LV3DS7W%+>)*)?<[OB/.+\`9L<(?308HS#09S`=F`P(<#\H%F_D
MZB_ZWR)@3'`8#`U=ZQ.2+CQ1P58+E0Y5$+9`Y:MABR*X^.D],,R,R*(7V!RP
MAH+BG&'%HTIX9SN=[O([J])5H.3%-ZX^I^1M]4CI+DMHF.D++`@'CKI=!80^
M$9*B#%-*>'K#!#6G&'7$[<9>:=1V]YMQ"M:5H/H)UOM]>O7K?KUO7^>`P&!K
M[R#0YNOS:N4N,6]-V$='>L]:;[R0[A'HWI3VMLZWX>I)MK2U(VA'BD*TEQG?
MG$ZT2%FT.]PG(,"S-PSBD*TK8\C'/]B38H]O7^,&8U_%*D[];;FM>&\WO2T;
M[>\E(37`8#`8#`8#`8#`8#`8#`8#`8#`IRX\U5BMF^@(9HNYVYQ7A#UVNHV6
MXE[?JTDXUM+@P:4J_P#&3K;Y+2=;4L?2?A8$01Q]R/R:XDOE*<57*VM>G&^/
MZR1W-NM=O;IN;EF5;4_M2?@N-)<)3KL[S6Q'.W6@O.NU:O5*/;BZY$AQ`2.S
MM:$:TE;JM:[/%)?5WGRGMZ_B\0XZ[O\`AM?9K6L#/X#`8#`8&@G,UML74;R"
M7TS\529$=489;3O._(0&_P##CP$*[_N(B2==B7Y`]Q*1I!([BM^+XP9&MA!R
M[:@W6I]0KM"K,-4*I&#P]?@0F@8X`9/8EMIO7PG'%[[5ODD.;6^42\I;Y)#C
MC[RUN.*5L)+@,!@,!@,!@,!@,"'7KXD#_F_CW\?5K`F.`[-?\,!V?Y_YX$8M
M\_'UZ#*(-L5?K!1R5Q4%(V61#CHQ=A.8>1#B[6:ZR@EYXI*5)":VX02AMQ+3
M2]ZWK`Y.=$=\L]DYUCH_5!Z<>/'A>-;,SS/;>->0^EFW6;J'Y!1*0+D=>XV+
MX6CA;W$1@SZ+!*F-V3T='-B3(;!T6],M(,;#L5@,#'RWQ5)_1YO],Y@?./@=
M[."_DRAOI:Z?CBQX%N8#`U0ZYG8=CI%Y](L-6%ND&/Q[*D2M9D+-,T^-D@F%
ML.OZE)^NE!3XD6(A&SI,>&);E)($8B,!TX28VVL.;/\`9O\`3?P7-\B6;E`>
M:Z=K?<N.G:G)5X_IJZC^I3D?481)BV8%?]Y,/RA9W8I]AP5KPJR.Z&<UM;,R
MIUII8XRL#NFM:&T*<<4E#:$J6M:U:2A"$ZVI2E*5O24I2G6]J5O>M:UK>][[
M,"EJ+U!\7<ATB[\CP,V0U2>/96SQEDGY:-,C1&FJE'LR\I-!)=;V^?`/0Y(\
MM%R@S2VI2.>9+"2ZT\UM88-KJ9X^VV:P=&W2&LC.Z1N+I$O6W!+A91^2"3@J
M097XI)3K)(TV7$S3#VS#`7:[Z#F7[8U`BQQ+Z`_-SJ?XYW'(*``N<Q+,M7<B
M>J,36W2K;4Q.-CT1=X+LD4HEI`K4'(OB"M-AE'DV%1P3M48GAR6WMA,)SFFF
M1<31I2)]+W9?)<<N:HD72X_4M)V2"8@T60J=$;)(CQ!H<6'>$(=-D3`FW"9"
M+BQO'EY2.`)"#N=6'#NXT6?CI.8FJQJOU2TV*T14(4["T6!NTD[$UL^Z.$[$
M-B5%G"G(.!9"-DH`8`R1L0<3&M:,4$GIO/M!O-ABZ_"[G6T64:S&4F>DHAP&
MNWP6FR+4797ZI(..J=,;C27VGF5&BQ_IF+5N;K_I6%0N02%V8$.!^4"S?R=1
M?];Y$P)C@,!@4MS_`,.L\[\9RG'+\^[6421\.=Z79CD2JV%1,@R>EOR3A@"7
M$O[9\)6_,M[1I7?UI79W=AH0)_9:PK18KIO,DB6&T2.Z4*U26!'"1VWD+>';
M+3:G5#+>;2IM)"6W%,J5IS2%[3W=A>7O<N?N*=[=X!YY.D(5KX35`Y?;788E
MMI'K2''S:&"B@&E:[4H0,&%V*[-N%:TM:TA_IOJPY$XU6@+J,X(ME48;4EMV
M]4-O5MI:T[WW?-O[9>6]&M*WZ]LJ,++3VZ[1D][6DALSQ[S;Q1RH.A^A7NO6
M!Q:-+5','('F6-;UKMT3"F^6E&-IWOL5MT1*>WL[%;UO6]A:>!KM?:5.4V>>
MY4XS'[QVD]^YU)K2DBV:/;WI3Q(P[:=I3*-(TMW>VTZ<<7K;[.EDJ=:*"VZ3
M=H.^P(T]!$=]IS_"+$<VE)D::E.MO`G,ZWO;3[6]^K_<=1M+K:E(7K>!+L!@
M,!@,!@,!@,!@,!@,!@5G=^6:?1=I$.,<DYU_>D!UN%1J0F2G5^IIO8S2NP;3
MBMZ2A1*FN_V_X27-Z[,"M?0O+O+/P[&6YQA27]_$,8YWK5)B[]?=/-[NMA(>
M1\!QO>VO@J4AT!S78K87)3J!4Z&%L*LQ`X/?UKS)BM>/(F*UZ^\6>[WB'O7O
M>THVO33>][\-M&M]F!,L!@,!@,!@:>=2',=E9E8K@'ACL.YDOS.DD'-?#%X]
MJCVMID;/+/([V@RO+=_<>E:?$:0KSB4[?5&LF!<W"7#E:X/HD=3:_K91.M[/
ML4^0GMDK+8"=:7(2\@[O:G%J==WM`K*W'-""(9'2I7<4M86[@,!@,!@,!@,!
M@,!@0Z]?$@?\W\>_CZM8$QP*0N_4#0*!9BJO.>G77XABE$VB4C(K9L/4!N1;
M&35*4_/D>8:*TB=G`RA4)B0Y5V/99V?+MQ\>MHIP+OP*4ZAICBVL<26RW\OO
M5`&H5$/4VW-76(;FXF`L.E>CJU+#A>BILS<PW,R`@L3N(BS9EPPIL:,&(*?0
MPX'.?^S8X\MGHZG<CBU'^S[GJ"Q59JK[YGZ>Z-:JSS9-SH3XXCXED]-<=TAJ
M-4^ZPOW41A(<27MU`;J(Q+3B,#L'@,#'RWQ5)_1YO],Y@?./@=[."_DRAOI:
MZ?CBQX%N8#`U$Z]`X&0Z0>=P[+*R<+$$4Q3;I\)6HZWS:2MRD=N,&AJ[+RD+
M%R,J?)Z#`CDR$M'ACEDM%D%--L*5@:X?V<TCS*+-\T4CGYV4A^2:['<;RZJ/
M)\/\&<=;BZO8_=DB#L8MEX/EI6-M[,^1#2H3P4SL<JN$P3NF$N>E2%)#HCR7
M2O[QZ'::(J>E:TQ:XDB$-F(3R^I1B..[K,DP*LEMU#6Y`#9$>Z^WI!3+!3KH
M;XQ:&2&@TS9X+Y,AH#F3@G_NR8K74*=RN<FZ``;BH7BZLD<85^H5;SD:Q$#A
M2<])61B/$34P#$#CUP`^4'DE*&<$5,[Z&6G.G_F"V7RM\U3#7&\7R!0_[H0:
MY4(ZUV22J<U&T5SD?W5/2]J)HD=)0Y<TQRC+I@F1*E+HC'H&+<+**U)%(`H\
M\3TZ\O52UVGDZ!WQQ)W/DV%Y<B;G7Y2RV2.KE<=OEDBIJL&UV<&I4E)V!$"%
M#C1\X&="UOTR^^Z:&3&Z9;'6'[47B[EB#7Q*?4ZQ7D-].4!:.!:T/?K#,5ES
MDBC:I]$B'N1-[CJA93*R4J^4=QF)B7`9`6=J"]SK$H+H\!A802(Z+^0*Q0.0
M^*(N;ILK6.;*30:[?[$=(S47,U25ABI5%S,JL*Q790:R`2L;+O:KH\K.UQV,
M/82X:LM@A:&@MWAOI^OU,+X/B+:13U5CIWK]Z@*A*UZ7F39RXZL:1X*$.GH4
MZMQ(%:4!567%2@P4W9/.3C^E#D,",]YX-S\"'`_*!9OY.HO^M\B8$QP&`P&`
MP&!_AQMMU"VG4(<;<2I#C;B=+0M"M=BD+0K6TJ2K6]Z4E6MZWK?9O79@:T\B
M=(G!?(A&Y1^I-U*R)7MYBTT)[=3F6"NW:M%*W&)0`61WM[WMTT$AW?\`'2]*
MUI6@JK^ZOJZX@WM?%G+43S%6!^U2*AR^V\BP:91_L#!6@?:G27M)^"E14E%C
M:_CY?>])3@>R/ZTA:D6S"=0G%=ZX;E]K2RN8<CG+)27E]O=4Z/.1FEO*;W_M
MZT.&<A*.WM(5V=J@D;\E!H.=YEX`L4%;HLG6G[U4H&2'*&E0M?XC\D.`POQ`
M94='?=<:=89?2OQ'DMKVX4.^&R]/N$'>8(2P0!/CAE)['&E]U)01*=:\8,UG
M2E;8)95OL6C>]I4G:7&U+:6A:@E&`P&`P&`P&`P&`P&!KARCSP#0+O5H)&TF
M1FD$%V_RJ&BBAQ26UL1K0VN^GNDM/)6:^UWVUJ80RCUZ>P/PU)\N\MZ[(5A?
M%M&(_P#O8Y.UW"4%5_!80R-ZT`E:?7I>G!]I[=*:,(3VHP+.I'%5/H:5/Q8*
MC9E[>UF6&77H^:*=7_XB]F.I[1TN;]:VA4LH5OUN:6KX6PLC`8#`8#`8$%Y*
MY&K'$U+F+]<B"A:[!^0T>\$&Z>3I4G)!Q(:&A6/\1U3IQPS6^SLTC2]K5O24
M[WH-)[K_`&C/#[58EM<<M6*P7@AC0=9C)*`(C(UR6,<0,*](F$O-H0&*MSS#
MS:-[=(TWH=&V_%V\V%\=-_!9'%\5*VZ\&)LG,O(3^YB_VA]7F'6GB=I>:K<6
M\K7:S$16DMM>&UW6B"&M*0E(C`+`P;-8#`8#`8#`8#`8#`8#`A'(3#95<:&=
MVYIHBTT)AS;+[PSVFWKW6VU[:)&<:('<[JM^&^.ZT\TKL<:<0M*5:"31D4)$
M#J%#4:II3JGM[/DY*6>[ZTH1O6B94LTE+?8VGNLI=TRE7>4E&E+7M0:.\Z=+
MUTY1Y>5R-':IJCHYKB_7'MP/L<["3?&KE,M!=@GDD4Z,J<K`\G#R3Q*SHP>U
MSP3();ZQPV8I;&I5\-\]?PUV[[=_Y[_AV_\`G@4KU`\+A<_<9G\<&VZS439$
M_3;/'VVG;B=6*#FJ+;8:YPAL=N;CI:,\1N6@P^_YJ/(3X6U]S27.ZM(:R]+G
M3Q7.(;_8YVM=9?(_-6K),7*2L]`L-IXNEH22NZTP0=GL)P-0K<9*(L4)I$.Q
M(MH*:;!<.&](B)=+9VL.@F`P,?+?%4G]'F_TSF!\X^!WLX+^3*&^EKI^.+'@
M6Y@,#2_K3Y'JM$JW'L+RN%`IZ?>3KP_QUSO8;/%'2D%`4^=JT_J*;D7P7V%5
MT><M;4)$*MK^_+UW;Z3E.B.::,'"D>@5/3\'RCU+P_2XB.LW#X`O#Z]<IC3M
MUNI<_=R8^Y;L5,7?[K/V!ZS1]/BVZY)@,1)#,="/6X\)3:R%N.*#I]@,!@,!
M@,!@,"'`_*!9OY.HO^M\B8$QP&`P&`P&`P&`P/'(1T?*B/Q\H"')`$HVV2$>
M,R8(0VK79M#PQ"'&74;UZMI6A6M_\,#4VX]$_#<W(*L-(:G.';<E:G1K#QE+
M%5[3+V]]_6_1##GHM#>G.Q>T`L`JWV:UXFM=FL"MJYQGU!=.ID]90['$\KUI
M2'"Y#3C3\),FM(TI6W9J)89)&V\/M>WTS,446:G6R-E@O,;7M82VH]=W$,B8
MU"<A#SG%4\IWP/\`XD"<,K1;F]]B78VS1B'QW!%=J=[)D18QMK>^QW:>ZI6@
MG?(?6)P)QF?#Q\_;EGKGH1FPQA-9CR;)'OQ;YIL>T]Y^*T^*EQ14<6WMC;OC
M-^%VN(1I:.\&8X@ZH^(><I^1K7'TM+'2\5$+G2V)""D8I&HYHT,!QUMXMI#3
MBTDGBHVUI7B;TYM>M;2A>TAL/@,!@,#\WGF1VUO$.ML,MIVIQUYQ+3:$ZUV[
M4M:]I2E.M:WO>][UK6O7@5'8.=^,J^ZH55@3-2&E;0F.K@[LR2XYK?9X:'!M
M>2TYM7P=(<+1OM_\O7@1C^\7EVV:[*/Q@J%!=_\`"F[V:D#NI5_LN>B65)*W
MK6NW>]MJ*3K_`&>S>]Z[0_O]U/(MH1V\@\JRFF'-[\:#I;*82.4A7\6'#$H9
M?*:UV]W7F!%*WK6E*5WNW`XOVOG6*A[19(=NNR+R(J>F(S3JCV=[=T!($">)
MO;OB.;[_`(/;VK<6O?;VJ5M7;O`[)=,?+(_(G!=1N<X4/%+WJ5AW5RAHS*]H
M@),R*:=(?<=2VMQP<)+BW.U/?[%+VG6^]O`LF5YGXB@]*W+<G4(':>]WDO6N
M$TM.TZWM6E-I-4M.]:UO?9M.MX%<2O5_TT0VU:,YAJ;FT]O>U&N'S6^U.NW>
MM:A@3^W?^79KMWO?;K6M[UO6!!#>OKIF&5M`EOFIE?;W4)B:=9WE.J_W4MZ*
MC1.W:]_!3WN[KM_CO6O7@8[W]-)D-;]RW$7/]KWOU-/1?':$`KWO_8[Q1$RA
MQ&G/]W?EE;[.W>]:[,![Z?EZ5UKW+=(G+1>G-_X3T^2!7F5]N]=W>U$#.(1K
ML[>]O;N])WV=N^S?;@/[W>M"4WKT7TMUN#2OLVARQ\GPI?8E7KTIUJ.(%<1O
ML_VF]_#3O>M;]>MZP/[HWK_FE;\"$Z>J:A?_`.IR=GEEM:WZ_5Z-;DTK4G7P
M-=OP=KWK>]]WMW@4-U,<>=8\GPI<%WKD*FVR#\6M+.H''E&(*DY?NVJ%6QL,
M]4.U+MIC"DL2K_@:WMT4)Y#VO"4YK8<O8+B[DY,Y"J5QO?T)3+QJE+73+(A"
M4I-8VI2EJC-)2E.M;VI2MZUK6M[WO6L#ZF,!@,!@,!@,!@,!@,!@,"'7KXD#
M_F_CW\?5K`F.`P&!'[8H1%6LJSW"V04U^948Z`XVR<T(F.)V0X$\\ZPTT6AG
M2U#..OLMMO:0I;K:=;7H.'/]F'!\1N\BQ$S3>I[B:XA:K5MLE$X*J-0B:/R1
M"O6B`XVJEGG>3XR-LT^(NP,1'',&38F(A1,?)7&:G+.[)/K,'[X=YL!@8^6^
M*I/Z/-_IG,#YQ\#O9P7\F4-]+73\<6/`MS`8&MW4-SDUQ`%"@&=/?/'/,;;1
MYEJ1$X:H%=O8$,+'I"2ZS;V+#;*RP*S*H.7H!M*#VRD!GZ?TSIE/BAX.FSG&
M)Y;%LD3!]/'-G`,;4=1;K(/+/'U6H,?-JG')-3ON6%J]LLK!;@#D?MR9\9H#
MP52`"T;)4^[X(;#6/<BF`F51)Z8N21&&K"DE0I5D\B0@=:D%)KX+XQDTXSO7
MB,Q@KR7S74H';TXI>FUAJ36NH2U@<2]3MWL3(L^;P1*W1%=29"&4:=L41!4"
M$ML6];J=(N^E*FZ9+R$A'"K*9!=EJX)'V48!AJ3:;V$5F^<>8:?R1`<(2LW5
MINS\A#\-GUZ^CU-R.CZPB\$\EZN81==W8'VY7R8'%DBY3WE22'-&SX[<RB08
MBE>D`\D'SUS';K1=.*(V7JD);N+HKF66FKF15'CXNW:H]CB8:ECC5_<\.J(9
M-&FVWK>ZP82O18"F898+9J=C!8P'-EUY)C^FB.I[D719KG7B>2Y<F).2BO=,
MU`Q\75JB?NOQ8+I\6D@DF?O43M<@5MS286*D&T"MFGCE@AKW#]8O*MJXMY&Y
M8`#K$*SP51:%8KA5E1!)Z;]-RA\N[;V(N1<E6RJY#KA(7:*HKRYI;<I(*=DW
MCQ`M#OA=/#_.W(MNE.!9ZQ.P1-4ZC*_R%.Q%>CH9P&0H.J\T//UEAZ9W)FZG
M?'K;CL=8E/BB[58/"+C4A@]\#`W:P(<#\H%F_DZB_P"M\B8$QP&`P&`P&`P&
M`P&`P&]:WK>MZ[=;]6];]>MZW_'6]8&HW)7&85+,D;7'U.)N/'$NOQ>0..I.
M+$E`66]ZWI^?A@3&G1F7&$?XKJ4(1MC:=[[^A%;V&'*[JRX5KP-_K<IT_P!`
ML!5(LU%CYPOW-1-@G8T2PNSUB$.![6FST11(X8<=I^)TXVD=2M.H:TE_2EAD
MNCKA/FR9Y$L3,%9;QP.0U2RG7K0302RT2K/IR#3Z`TW.+B!DK>6I$CI;1#C^
MM1VTZ9VVIQ:`Z-;Z9>?U[VM[K-Y"VZKUKVQ3XX9K:M__`);"+#M#2?\`@A.^
MS7^6!@)SI_Y+@6-F6GKCY&BD:UO27%L`0[:D:]?8D?4\I3[O;WNU2-*7M/=3
MW?@]NPJ`JIV\XE<=5NJKJ7Y",3_X:*F$['B(<[>[K9,D1*:7IG?KUKNB.M[5
MO2N]KLUVA,*ATY=2TF]M^=YQY8B8U>T[2/.<G3NY!*.W6_\`P:XZRI2_\]I<
M,"[-?!WWO7K`NZ9Z5#K'&BA3G-?(QKS#?<6220U,*]>][WX.[*Y.NMZUO?JV
MX\ZOMUVZVG^&!"1.A&-CWW"8[GOG.+?=WO:UQ5G'B];[WJWI+8`8[:$[_P#P
M(0E.M>K6L#)^\D!<^&3S_P!0A3ZO6X^Y?R.^O?\`EO?^#O\`AKLUKU[]6L#^
MZZ&ZNYZSN9^?#5Z]2%N<@OIVA/\`FG7_`&1?\=^O^.O^6!RPL'11U*-3\ZW%
M\7SLG&(F91,=)/S]4<?D`-'/^3-?<>GVGEO%#^&^ZMUIMQ3BU;6A*M[3H-]^
MG7H-X[(XTA3N<N/I1KD11TUN2CR;5()''$3+E>B^Z+`S"HO7C1VAG'/#<<6K
M:M[=[KFUIP-I(OH^Z:(GN>7X?J9*D=G8J48*E]J[N];UWTR913:^W>OA=Y&]
M*UVZ5VZWO6!9$7PKP[![0J&XIXXBU-]WN+CZ36Q'-;3Z]*\1B-0O:NWU]_:M
MJWOMWO>][WO`G84/$1NNR.BXX#6M=FM!`C"ZUKU^KL8:;]7KWZOX>O>!D<!@
M,!@,!@,!@,!@,!@,!@,!@,!@,"$\@O('KK)#FG5-L6J@O+2PP\2]M#5[K:U:
M9&&;=((=VE.]-L#M.O.K[&VFUK4E.PD\=(CRC&R!D'-MI<4UM,A&242_WDI0
MK>]#2H@1*F^Q>NZ\EK;2U:4E*]J0O20U&Y"Z@I2O<OVJJO$R=5X[XP@^.)2Y
MVP.DN6IMV1Y"EY-AAJ5.7(#MP%<C8^.$00;'QLO([)E"SC/1D;#I<D`W(UO6
M]:WK?;K?KUO7KUO6_P"&];P,3/(/<@IIN*0,Y*.1,BB-;,0AP1P]8;R0T%-N
M:VVL91&VTOH7K:%-;5I6MIWO`XA="D+S3"=6#0-PY.@;M7M\6G3,X,#8>G-.
MHJU2<!1-S-2%J_&S*KT/)U"^*OL<0HAS=>W56*V2X<Y*;)8>#NG@,#'RWQ5)
M_1YO],Y@?./@=[."_DRAOI:Z?CBQX%N8#`T;_M%^0>-:+TH<D"<H6\ZG0MZ%
M%I(1<=&RTF3*GR931+L`XS#N#$-QTQ%@R(4R\LX)*8=TY++CY2APB0T]_LI:
MMP36^1^JK73_`&^&N=(?WQMZ,DJOQ];ZA#"Q),_RY,P\5,3%VD7)2PW>'$E_
M0TOZ.AH>#&KT94R&%'21\JZT'9"=AV+!$'PQ)<L`R>QME9L%+R$%+C?"2M+P
M$M%$"GA/H6E.]+8?3WT]YIU+C+CC:PHI?3=5E3>R%3=B*K,XS<%\EUR6F9R8
M>Y9.M%2&H8;5]ESIESTO6JW5-'!P]6=CE`BR+P$P&\$5'*28'O;Z:^+TQ[XA
M#%IDI%PFG%"6R6NEGD[K#JX_=(>IS4';#)-V:B181TZ56T*&4VP;N<GO2:#M
M3<IHH/\`)/31Q40"`&T'9(XD06W@&3L1<K/%V:P`7^13+W,.SV(.3:EY]BPR
MB&I`O4B6\L<H<9<<L+0S"6P\('3=6=)==F;#:R30+/,2M((KM@GJ@UQK53JU
M'4D+CRC,1<PZY!U!FK0T5Z6B!B4Q<Q:VB;>W&QD@X"S&A[W.F3AS:@FQ:T1&
M1@T)4Z[(5Z)FYB.KEGAJ,8Y(50&WPHQJ`K0B(+>?6ER8;*>.:))%E'#A'W6%
M!G:3P5QUQ],#35:CY-ER,&GPJY&GS\Q*P=/!M$HW,SP50A9`PB.K@LB:RQI3
M4:PRD8%AJ*"\M%HT'@7!@0X'Y0+-_)U%_P!;Y$P)C@,!@,!@,!@,!@,!@,#_
M`"I*5I4A:4K0M.TJ2K6E)4E6NQ25)WVZ4E6M[UO6];UO6^S>!ISR>/-\"/R%
MHH)PHU:N2R0"JR2K>F8BPE#/N,S4$-K_``D):2SXBF>YM#?<TPXAP93"10D=
M9YUN=RA0$4OC>1GI=H4<:8F#RF(RNL2K;+?FMMO=Y6WVU+WXR6/&'?2AQ.N[
MZNU09[=,YPMWKM?($?3`%[^%%T45S9OA[_BWN7(4R0RYO7J4MMXAO6]?!1O6
M_4&<A.`..HPCS\F`9;I16]*=D;::Y,..JUOM[5C.Z0$K6M]O9IP=S?K^$I7J
MW@7`$`#&CH$C@Q0!6]=C8P8[(K"-?\$,L(0VG_T3K`]>`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&!#KU\2!_S?Q[^/JU@3'`IVX<$<<7FR$VBP
M1TFZ=)@UR,L8(4_,QL%;HZHS!,[6P;=!`FL1=A&BY$PM3;<B,[HD,EV+.V5%
MJ\G@7%K79ZM>K6O5K6O\L#6#J]LO(-4X8/D>.;-2:I,2-EI].(/O=6L]OC"F
M.0[''\?Q\2#$5*8A)=,M*6&S0@@IZ3D#@-N/DD:TAOQ&PY9?V<[`5)ZDS>'E
MUCII==XYJ-UI@G,''72\;Q]9N3)NBE5R'N@4)S:5.G/7$ZMGR0C%^8-BPB),
MSL-:(.0RX2X'>S`8&/EOBJ3^CS?Z9S`^<?`[V<%_)E#?2UT_'%CP+<P&!JEU
MGMRL_P!/W(?'-,<B#>4>0:M-@\<U0U<`Y,6J4@AV[#+B5("R)7%&V>.@0#I2
M%44VI@"4'"/>6PACQVPHWH$;Y9;/Y?U8FNJYKB'NT37'6NLLF-)Y?W;M#V/^
M\?R6QB29!-(\'=.]"^?7X&Y#TQY#?9HE*`Z+F&"1XA1YY0X((([Q9IIC[0P@
M8@S:GB"BB7E(9'''90MUYYU:&VFT*6M24IWO08^"L,!:8L>;K,Y#V.%+V[H2
M7@I(*7BRML.K'?T.?'O$"/;9?;<9=TVZKPW6UMK[%H4G08D/D"A2,-+6./N]
M1.KT`^0-.SP=EABH:%)$0TX6/+2C!JP8Y\5MYEPAHQ]EQE#K2G$I2XG>P&<@
M4*/AHFQ'W>H@U^?>''@ITRR0PT--/EI6L5B)DWC4!2+Q*6W%#MAOO+>2A>VT
MJTE78&2L-FK=2C53-KL,'68A#S(ZY6PRP$+&H?(5W!V5'21`PJ7GU_!9;V[I
M;JO@H2K?JP/Q.MU3BSH.+D[/78Z3LZE(K4<=-1HAUA6A+:EI@Q""6R)924O,
MJ4D!LC:4NM[WK6G$]H?[C[75Y:8EJ]%62`DY^`\+T[!Q\Q'&3$+X_K8]+1@Q
M+AL=XVO6UYQAGQ/]SMP,_@0X'Y0+-_)U%_UOD3`F.`P&`P&`P&`P&`P&`P&!
M0G+G"A?*TE&$O7%<-'Q0JV18M$+YY'F7W.\2:M_<L)I3CJ$L-)3X&O#;9[-*
M5WU8'MXAXA-XI5+LHMJIV+EDLNJCW(;T?Y8]C>D),9>U*FZ_Q!^\R^UX.MN]
MT=?BITQW'`N[`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8$
M.O7Q('_-_'OX^K6!,<#&R,S$1"@$RTK&Q:I4]F*BTR)PH2I*4)2XL>-`T2ZU
MLP]]#+JV0Q_$(=2TXI#:M(5O09+`@7)_&5,YCHEAXVY!B5351LXXK$H"V:=&
M$Z<`D!):,.`DXP@22C).*E@`92,D0"AS`9`,8H=Y#K25:"!<<],_#7$ZN._<
M'55PC?%=6M=1I0^IB8,'CH^\S`$];SR633B$2MAL4M',F2ECD]%S)+CI?>,[
MIA.G`OK`8&/EOBJ3^CS?Z9S`^<?`[V<%_)E#?2UT_'%CP+<P&!I[U1]-,_U$
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M1`82RT^P3O+%.Y2K''-TCN**LQTQQ5SJ[]#G8:5E7Z/(\N%J)#HQ,8Q-3P_&
M9MOX^D'B(Z(*;1Z)<W!NGN5[3;8>&O4>SUR[\@W*R\;7.4XXY"K/4X'0ZJ+2
M)B8/A3[Y=X.0;`E*H,`075O[S@8^2EVB)H:+"0@I8UC>BC#7&%!+*(0>"]TS
M,S\1:KN!T\\?V;ACEE4-5IZXHB.8U<4<<;2<,/&`295A'1&^ZREF66*:-&CY
MB:-@Y,D51<AI`4-6^$N68#ASEKC.?I-J>N_)?%/"D!Q(</#'RX%17#3E@,$K
MDG8H]DN,I+O%TK)@V$GTG(QXS:4)(@'CS`_`0&P?3[1+@%(],$;(U"S5RQ\/
MU3F4#F";EJ])14?,3%G."8=0'8B!F(ZX;NEJ:5?$E1!<HPXT+J2DW19!QEI8
M=%L"'`_*!9OY.HO^M\B8$QP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P(1R$DA5<:2(ZRR4JTT)(SQ#"R1VB
M-WNMZ9=?&:($<(9;<[JG6&RAENHTIM!#*E:<2$FBVI=H=29DV./+\56TO1<8
M3$CZ8VE&D-J&+EYIQ3J5Z<4I[1:4*2I"-,(VA2W`T(ZG.-N9K;RQQM=8ZGPM
MPJ-%Y*X871H\2S2K,E`OZNHDIR-=9R':IL@,,IZ/'CH)F4;E7TP5<`EB>S>[
M">&U)\3NWL=!]=O9KMUV;[/7K6^WLW_GKM[-=O\`S[-?\LH_N`P&`P,?+?%4
MG]'F_P!,Y@?./@=[."_DRAOI:Z?CBQX%N8#`8#`8'D4`"HYN34&(J29%>!9D
M%#L[.:"(=8?(#;+VCQT"OOC#//#I<TTZZ.PXM"EM-[2'KP&!Y0P0H]E0X`8H
M+"R##%L!CM#,J+D"WCSRE-LH0A1!QQ)!IC^T[=)+?>(>4MYU:U!ZL!@,"'`_
M*!9OY.HO^M\B8$QP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P(=>OB0/^;^/?Q]6L"8X#`8#`8#`8&/EOBJ3
M^CS?Z9S`^<?`[V<%_)E#?2UT_'%CP+<P&`P&!C)N4;@X:6FG0Y.1:B(TZ3<C
MX6/)EYDY`(SI2@XF*#0X7)21*6ML@@#-K?+)6TPTG:W$ZP*7IO4!7++P9,\\
MS,'/4VNUQCDPJP0<SJ.*L,4UQ;9;36I]EYJ+-+CGCG2*H:Z,,*>^VI3S(^B5
MK[5X$,>ZHD1DLBF6+CJ;A.3)A/')%-I*IV#-39@N32;$)$/[GQUZCXMVOJIU
ML(N0SC9:HL*$61#KL*SH]DD/Q8ZJ6)1<A!5[CJ<F>0:R+R.?>:1Z;A`7JR%Q
MC*BPTNMF9(7L&9?L!<C&.4UEA`S<J(;X\L_`*&)::";F\^11\7Q,1Q]`&WF7
MYIJQ%YI</L\.N:]QP-?C;";-S!LCI[4>EM$W`Q+(;0QA;LU-A,.-C@M2$B"%
M6M=:M)DJO(WNOU6Q2M*IU6I]LY1EG2(R/.H(-PD3(]("XA;[[L],5MN,DI2S
MB`$,CB18S;L4;,F%,@["?<?=1\3?IRD"-U66AZURM'6^4XKM11\<4S;0J82R
MDUPN+$6LJ`W,13WNCKB272MFPC;JI'T1*)U%J#9'`AP/R@6;^3J+_K?(F!,<
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,"'7KXD#_F_CW\?5K`F.!3')G+97%\E6W9>F2!M,GK91J0]:PIB)
MV2%8>0K&Q5(%#%96YZ1D(X>:/B6IDQ#P[X0I[APH,@+'FN-!<^`P&`P&!CY;
MXJD_H\W^F<P/G'P.]G!?R90WTM=/QQ8\"W,!@,!@>.03(+`-1%/AC2BQ"$QQ
M$@*\<`P<II>A7C0AC(\@L1I_:%D#,'A//M)6TV6.M6G4!I?#\!\JQ_'973[,
MV*J3G'-]UU!&<@W>(K9M<FHH7E>5M%AB82M1IMVL2US8-HO))R)<L=Z)]S]:
M4"4,F3DV'T!E)'IDM]@L45R58N2*^3RQ55\8,T^;C*(?'U,*-XY<N2BA9FLO
MW8^3E7K:UR';F)(@:S1C<>EZ'4`/I<8^J1#\0^ENTP4O+72L\DPH/(5UBN38
MCD.7DJ*7(P$JUR//`SS15=K[%QCB(,RI*C0H^(V?,SS)P*7_`$HT^0^EYH%4
MX)Y+BMT0V%G*O1WN#V+'Q;Q*'+U\NWZD^%W:G4JPT]>$1=OA&G[7*V2EA72+
M-BC06`(-X2!EXC<HZ>\,$<!Z)6H*K6?CV`OZ&J'R94J-5^50I6L+.G9MRIE'
MN3$M5Y06PQP-9)N(,F7'R+!D//L1NM#EQW8\TO3P61Q7TXR/'TAQFS+70&QU
M;A.&N,%Q=&#UA^'FA`K4\P(.[:IIRPR@LV5!5D?5?%5'0\"R6IYZ3*9V]MIA
MH-J<"'`_*!9OY.HO^M\B8$QP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P(3R"PP5761B66B!B+506"!WVT.L
M/L.WNMMNLO-.:4VZTZVI2'&UI4A:%;2K6];WK`E$?%QD0PH6*C@8P93BGE#Q
MX@X3"GE)0A3JFAFVV]N*2VA*E[3WMI0C6]]B=:T%#W;B:]VWF&G7_=UJSU)H
MH@[]<XZG:9*2+8%P?=.&F+VJ8`N<2T;8-0!?H.KI.AWPJPEZ4D&ASCI%+H@;
M#8#`8#`8&/EOBJ3^CS?Z9S`^<?`[V<%_)E#?2UT_'%CP+<P&`P&`P&`P&`P&
M`P&!#@?E`LW\G47_`%OD3`F.`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!#KU\2!_P`W\>_CZM8$QP&`P&`P
M&`P,?+?%4G]'F_TSF!\X^!WLX+^3*&^EKI^.+'@6Y@,!@,!@,!@,!@8"QV6.
MJP")*48GB!UDM"Z;KU6L]O.TZ]I>T*5%U.'FY-`^M(5XIBQ$B,;VG3S[>W$:
M4&=0K2T)6G2M:6E*M:6A;:]:5K6]:4VXE*T*[-_"0M*5IWVI4G6];U@?ZP($
M8Y,1-PE94>L3$Z!)UJLQ[3\237&_`+B)2W$E-$-S<_#NZ[69D);2V6WVU]KJ
M5+0IOLV'L]T\S[/+C]LH7[XP'NGF?9Y<?ME"_?&`]T\S[/+C]LH7[XP'NGF?
M9Y<?ME"_?&`]T\S[/+C]LH7[XP'NGF?9Y<?ME"_?&`]T\S[/+C]LH7[XP'NG
MF?9Y<?ME"_?&`]T\S[/+C]LH7[XP'NGF?9Y<?ME"_?&`]T\S[/+C]LH7[XP'
MNGF?9Y<?ME"_?&`]T\S[/+C]LH7[XP'NGF?9Y<?ME"_?&`]T\S[/+C]LH7[X
MP'NGF?9Y<?ME"_?&`]T\S[/+C]LH7[XP'NGF?9Y<?ME"_?&`]T\S[/+C]LH7
M[XP'NGF?9Y<?ME"_?&`]T\S[/+C]LH7[XP'NGF?9Y<?ME"_?&`]T\S[/+C]L
MH7[XP'NGF?9Y<?ME"_?&`]T\S[/+C]LH7[XP'NGF?9Y<?ME"_?&`]T\S[/+C
M]LH7[XP'NGF?9Y<?ME"_?&`]T\S[/+C]LH7[XP'NGF?9Y<?ME"_?&`]T\S[/
M+C]LH7[XP'NGF?9Y<?ME"_?&`]T\S[/+C]LH7[XP'NGF?9Y<?ME"_?&`]T\S
M[/+C]LH7[XP'NGF?9Y<?ME"_?&`]T\S[/+C]LH7[XP'NGF?9Y<?ME"_?&`]T
M\S[/+C]LH7[XP'NGF?9Y<?ME"_?&`]T\S[/+C]LH7[XP'NGF?9Y<?ME"_?&`
M]T\S[/+C]LH7[XP'NGF?9Y<?ME"_?&`]T\S[/+C]LH7[XP'NGF?9Y<?ME"_?
M&`]T\S[/+C]LH7[XP(_9I2Q2\:.(+Q[;-.M3]4DE>*=0T(\M"VF&F#-:WJZK
MWMS8@#^F4]G8M[:$*4C2MK2$_BSB9`=3Y4/)0CFG5-Z#E'(ETA2$I0K3Z50T
MI+">$O:E(3I127]*;7WV4(VVI8:-<R<E<B@S/4+8*]=)2O?W#)X?15:<$-#.
MP]M>LB@9V;=LK<A$$R<@U:FY+=+!:C9(/4=Z+<*C.Y+NNNX&^J=[VE.]Z[N]
MIUO:=_Y;WKMWK_TWZL#_`%@,!@,#'RWQ5)_1YO\`3.8'SCX'>S@OY,H;Z6NG
MXXL>!;F`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P(%-\7<=V2R@7&>IM?EK1&
M)C$AS9L>R\<VF$/>E(33CBM=TGT+)D/R4/YI+WHL]YPP#RY"U.;">X#`8#`8
M&/EOBJ3^CS?Z9S`^<?`[V<%_)E#?2UT_'%CP+<P&`P&`P&`P&`P&`P&`P&`P
M,3/:$W"2_GY9V!!]&F[-FV368QV)$T.YLB1;D7];9`6&SI9&C'==P;;?C*WK
M2.W0<[HZT7,QNB(C[5R%%\)<V]3T=6Z2=/6:T>[ASBX/B:SS*7!+I+2#MWAX
M+DOD:I-EUATJ89G]UF4'&CBP&YP,04/'7K3RJ_(\$2)'*-O=JP76+ROPR%$Z
M?$=9OO']?_OL9KDE<;$\P1-VU8`-4@P`"%2##,@1&D3DVJ=EBF#`@DE?NUQ,
MN%$MR+I92;/9.K[E?B"QTER?,=K`W&M6"Y('#BF*0I_41'%0D;4ZK;-V8>/9
ML)!$D\\;*DQ$RV"H.A^`P&`P&`P-=>IB5C8KC]Q*IJZBW"94;7>,*Y0+7,5:
MR6[D69CB!:V"(Y!EA$F,QA'>F))4DX]6(:(#D9^SBNQ,6\XR&JEYM/*T1$\P
M/V7DB>'Y0X+H?3FU5@Z],E05>M5QL0X3ECG#JH*L:.MXW(]S](TMH&8#D`AQ
M0?(5P>*FU$&+"\.+G.1'N=NK"F2G)M@E]#0'$TM3WI,2-?B^/RKE&<AJVQ6Z
M^RR.!H..3'P^WD'.%$S1,=YJ5,>40I#823H]E;++<+K5;+7/W:9BN6^H2L*L
MMH*9,G)&.J7//(]9A='/##!B:V)#10`3+`8880PX[0P8HPS33*`VAP&`P&`P
M&!J+=I*8?Y\K<9QC8KE)SU:;E;=S&`NPRY_'T/2'J;,1]4I!-;43NMQ]PM5M
M]#V"!4!'MVEN)AYZ1DI%,2<",>%#\16'DFY;Z>VHOEBYM'\^=,=OY(Y6F%R#
M=F56;A'37%#\?*U&#L29*OT$COV^]U0&*CH@>$3Y(5PV#DCJQO`RH%QEYOHC
MX!F9.Z<B2G--_P"(*O'<>,UNZS4);+SRU9*:$Y'3$J5&$CNRPT,6EVPV,N?T
M958V(1*RMBCRV6F$H#H'6QID.NP(EC/8E;"+"Q8\])BL:%&D9E@%AJ4/'&UK
M6AV"S4OD-,:UK32'$MZUK2>S`S6`P&`P&!X9/3.XV0T2<N+'V"7HB2:(;$<C
MF=CN>*<V6]I3(JQ$=XA!#J5-LJ;TXO6TIWK`YQ"6BXOL).@+Q?!.`^6>HCC&
MC46PS=KL!MK73&:_(MVZ<K]SG#"K3#U7E"]Q,=7:L6Y*(,>CS29BH%QH]G@7
M6`\!=EY/&UQX0!RM<]U*M=<G]TL</H]D]Z]4<JR+&5'VRUEH+G+(#624S549
M;6<VZ8N-2JQ%R\D!MW`O>]RTW5^H/AB0C9NT#U6[\B6*G64K=[-LE;G#/[KK
M25$T8+C-)BXNK*CYV`:L!EPCX]F4CWX`H&660#9SRP0W#P&`P&`P&!1G4'-5
MN`H3I]BDKTT\X:F-J];XWLLU6+G=[A*"E!U^KP)-<.C)<L\HIS938Z3F8L9`
MCLM/:W#1ICC0:17VV<V5^I<TBW/D6<'Y5Z?.E+AJYU5VL2Q<'$6GEZ;&OF[-
M.R4'';!C[X'/VVG0E8'@)@*0AVV2"A(^+$D)Q3J@O:&NEWX_YKZJ#K+.WWDZ
M)K'!O#7)]>X\B(M![\2=-6'J*8*J5!K4""LDH^3"J%<BW"B-2<O-2(C9996A
MDBA`AY>B^\76TF]049R#:+19K+"\I1!CK<W`V^#AJPW9>,*'/F5.HCVJ%AW0
MZ[!SITP/%QJFM2.@?+3$@SVS#)1<O6<6YKP-Y,H8#`8#`8#`8#`8&/EOBJ3^
MCS?Z9S`^<?`[Y<*->!QQ$-:5WM)E;COM[.S_`&[I85_P[=_P[W9_Y]G;ZOX8
M%K8#`8#`8#`8#`8#`8#`8#`8'@E(N,G(TZ&FHX&7B)01\"3BI00<^.D02FU,
MDAG`EMNC%BD,K6T^.0TXRZVI2'$*3O>MA"@N(>)XZ$DJS'\8\>@5R9<$=EZ^
M'2ZX+"2KH"M+!=DHIB-0"<X$O6E"+)8=4.K6ML[1O6`E>(>)YU,&B;XPX]F4
MU@5@&MIE:77)!->"%[WE@X31<:]J*%'[RO`'`\!IKO*\-">W>!GAZ530[(7<
MA*E61;?(,>5/M0\%%LV,T;N,->7+G&Q4R9+'AC#-^$\4MON#L([O=:1I(2;`
M8#`8#`8$1M=`HE\1'MWBE5*Y-Q+SQ$6W:JY#V%$:02UX!#X"9<,M(;S[&M,O
M.CZ;6ZU_AK4I'JP/R5QSQZLVO22J)352-1%9!JAZJQ"*-K(0_P#\N)7RM@[?
MAAF/_HL1RQFFO]Q*<#PB<2\5@2<W-@\:4`*9LPQX=DEQ*=71Y.P"2JEJDQ9L
M]F.05*CR*G7%','.OME[<7LA+FUJ[0RM2H5%H(Q85%IE4I89Y'FSA*G78BNC
M&E_#WYHMB(##:(([7'/\9Y"W/AK^%\+?:$LP&`P&`P&!!5<7<9JM"KNKCNC*
MNBRFCEV[=3@=V=9K#"!6#%3^P/2JBF16VQFB-E[=;80AE"]-ITG0$\7\:(8L
M8J>/*,D:X/()MHZ:G`I8M!#93AS;]B9T!IN:>0:\Z6AV222M)+KC^E:=6I>P
MP[G!W"KL5%03O$'%[D)!/G%0D.Y0:HN+AB9-L9F2(BH]43L2/?D&@Q&C71&6
M7"FQ1T/J<2RWI(60""%&!B1T:&+'QX`[(8((0[0H88@S:61Q11F$-LCCL-(0
MTRRRA#;3:4H0E*=:UH/5@,!@,!@>4X$*3",C9(,60CI`4@$\`X=HL(X(MI;!
M098KZ'&"126''&2!WD+:>:6MMQ"D*WK802.X?XEAX>4KT3Q?QW%P$XV(S-0D
M=2JV%$3#0"MK!:E(T:-:#/;#6K:Q4%LNI'5O:FM(WO>\#^2G#_$LX'!QTUQ=
MQW+Q]9;VS6P9.E5L\.OL[<2]MJ$&*C768IO;J4N[0`AA.W$I7O7>UK>!F`N/
MZ'&V,BX1U)J(%M+:VP5:`JW#BV(EA3+`ZF7YI@-$D\UL<89C;;A*D;9'9:WK
MN-(2D)=@,!@,!@,"*VNBTB]C!AW>G5:Y"1Q6SH\6U5^)L(X)JF7!]F!LRPA;
M8I6QW76-D,)0[MEQQK:^XM2=AXU\:\=.*K2UT&EK72TZ13UKJT&I541IQE[2
M*VI0.]P:=.C#NZ3&;%UIQAE>M=YI&T@C>-..8:S&W2(H%*BKC);)W(VR-JT&
M#93]F../%[-G1@6I0K93SSKI'CE.>,XZXMSO*6K>PDXD7&1Y$B6!'`A%3!:#
MY<D00<8B4.;$&CVS)%YEM#AI38`882""5.O)$%&&2O3+#2$A[\!@,!@,!@,!
M@,!@>"5UVQ<EK_B`9K_W'<P/GL]SZ/G2OJM?_P"F!W2X;^3V*^E+=^,9_`M#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`TIY[ZJK)
MPGR.'QHGCGW1S')%?A-<"/CG&LAW:_OV8.O62G6!]L`A$$FO!RT5:W9%O;Z7
M*[J3>VTET%7>"6QO6%P\9R6_Q,HV?<LH<K8*JY,!5F5*J,G>JC#N35HID!(L
M-O2,K.QH@LAML9B+4R80`3&A%E2B4!N!$T=>?"BP91Y41R@W,Q5WIO'[U.W0
MC7;@38.0XJ:EJ4D&&&*?V4-86H"3%&4A_1(IK.F9,4%&]NI#<F.,](1X)_E3
M`?/!BF>2D6?+2`?F6$/>5.'TMS0Y@_?\$IG3B_"?0M'?5W>W8>S`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`\,G\6R'_0E_P!.Y@<#<#MAPW\G
ML5]*6[\8S^!:&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&!5UXXFKU^N/%-VES)8>4X@LDQ9ZXP`X"@(XZ:KDA6269A!0!1#HC84BZ
M^P@$F/>28VRMQ]QI*F5A0#/0SQ,-R%<K\++6<3W<3%QL<K7Q@./6FQ+#>X<Z
M'L$I$735$WRI&)=1)''!Q(]_U!@R+^B!XU"6FVDA&^-O[/?B;C(\"2B[?R!)
M&1]ZXHOZ%&M\>1;#\KP[&6J(JXI`52H%;!<%,!MA:;`3Y;4S+DAB'O2J3W)`
M@X-],!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@>&3^+9#_H2_
MZ=S`X&X';#AOY/8KZ4MWXQG\"T,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@>&3^+9#_`*$O^G<P.!N!VPX;^3V*^E+=^,9_`M#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8'AD_BV0_Z$O^G<P.!N!VPX;^3V*^E+=^
M,9_`M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8'AD_BV0_Z$O\`
MIW,#@;@=L.&_D]BOI2W?C&?P+0P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&!X9/XMD/^A+_IW,#@;@=L.&_D]BOI2W?C&?P+0P&`P&`P&`P&`P&`
MP&`P&`P&`P&!6W)W*U1XCA1)ZX.2B`33T1HVHJ)-EGUDK9=?[%MB-JTRWIMI
M>]N/+;3O>M)1WE;[,#3+F3KJ@`ZH.[Q`L]5I5-!MOZM53D&(W4/L4]1>T+?>
M'1LOS*0=-)[^U;;V]O2=]F]Z"LN'NO.TEVY;/+JH]-4W$&K1NKU@M^3U+)>$
M\GK:&"R%^6VRHKQ5;;[NE>'VJUO>M;#<6O=6W%%L=E@Z][J2I*+KL_8]"&5F
M2CT%C5Z+)EC&&RWFU#M/N#"N:8T^IM#CFTMI5MQ:$*"*V7D;E:`X(C>87[5$
M;.MP_&)C,''4W<B+5V>0;C4P%-0NV2B)2>?C("?*%[AHI[TM*LC&"#AM[5&O
M!+&[K=)B]U+BN"M9@KTA2+/R/.76PT7T1/.QT588NKQM>C:I+!0[0#KDA)N'
M'R<C&/*]'AC,BC*5*MGBA+>-[3;N0J+8&)"3%@;A5[K;*(?8X:*9?CI$BG6!
MV/W-QT3*N',L-3(#+6R@GGRDQQSQK`[[J1F7=A5?%G,E_DJ%Q"7(M#\@\A\Q
M5F4M0,6M4=1JW`QU:"&?G5O2@<9-F=QXF4B`(UC<;(OO&FH\=X(%HHQD/VHW
M4-9[Q>)Y^.K]?8XT&X/H?)8"YBS(A[#'RM@FN0XF5&FG7XER"8&$/J6XTUS4
MVH2.&CG9H4J5W):C`P_M8ZABN0+[QM"P#\2($OD3DRAWH>"EXVXU^6(K'&R;
MC#E5ZV-QP3I<>I,C%%K?'#BB6S$F11C"T#*4\$YK-UMMRFN1+&W/@5JE<;WJ
M8I_H'<`U*&38E1#">L\K+2#IK!0;YQ!)C<`S&:8:#$$!/.1*[+?"2$%D>JY,
M+!"3DMQU(-ILW'<7REQ_'@V./+.LE5DK;3JHH:6\P"`)6K(*N_560<C?-3$6
MXP>\RW/^,$3W`ST;U%2"K.BMV'CQV#2-R:]Q%+R8UI%EQV+B]1R^0X=R*91$
MA$2=?-KS0(YLD8B&/C9R1;!:AY$`8F70&4X@Y^7RB_26SJ0;46N2.,'N5:8M
M^;#F72X"-D*Y%S(\NT&(.U$G,$VV`*C&VB9%,E%F[()5%2`Q44R%.2_)'*<U
M!7*?AI*T#5$WGSD.ASD[3*VW:[3QC1^/8\NG,R,#6=-.E2"9*\5LN3FY`>/G
MY`$.74H.)=9UHN/"V*=R4_+\J\?QH%L'N52Y/X!,OD5*@!J`BB)2DV*IQYT[
M&`.K?)C6;.'R*$X]&D$O.!JAF6'%>,V[M0;+8'Y//('9=?=WO33#3CSFTI4M
M6D-HVM>TH1I2U[TE.^Q*$J4K?J3K>]ZU@4IOJ$XZUO>O$GM]F]Z[=0!_9OLW
MV>KM1K?_`+ZU@1]SJ5IZ;"R&AB2W`[CW5/R.X]_1J)7;R=,"I!WO3NV/!2OO
MN=W:O%=:UK7=2O>!(-=0G'6]ZUXL]KMWK7;N`/[-=O\`GOL1O?9_Z;P(KR)R
MC9:AR%`JF#2*=Q"?"U9\"\ZJ+UEA#[5,6(P"4K=Y,9):.HH>XU=;;KLP\,)'
M$R,Y(;DI5OT2@%\(AQ%U!6N28&`OD(DQR?M?4+'U6R,2D*!H]OB6\3PS$3)1
MFA(Z/A1$UH9@0&<*E'W"R8@]Z:8!TZ,:>&4B>J/4^<%7Z[4H6S6<OE;?%>]5
MOD*/EZ<@A7&SG)R+$W;V8-*R8IF':>!D168'<J))#DM,!G-I'<*"3<:]1(')
M=R57(RIR[4*5[LT0]J:3)E!+>HD\W7)9F?2[!`QT$J6.V2_5=#34VY+@`%NF
MMPY;>@5!X".I'0=@EPS:(>/5XGE60X<59O3@3KY5P'KF[''OL03(:W4U\]&V
MHAV1(/9-"EWD)]$DQB791L(>UU.%-Q]'OMAKDU7H2V<-VGDV*IH$K`3;DF(U
M*<:@5I$J8[!`E1]BD"[HV$$)'SJH(44A9,PX04IIN*"57_J,EN-R(Z#GN.'C
M;B17;#<S:]7)\^>;55J\1%BN*@#0JCLR9LDH5*H"B8(^'KXA!H1[1$Z*QZ/*
MD0D?45?+]1N'9J_<<HKK!T,$Q-2+MM%D7UC0Z4(=<9!B!-CZ)ER77!PN[('A
M#1S;Q!RT'/"MQY(?ZO\`;[I6^2N+H6`G(R81>;4B//H2H5O18%&CZ_)&VFZN
MS39JC1MPLHW&(:+>8:B"'9*-KF@ERDBP>H(^BUV^QV#EZR1=GF8.FU2PP_'M
M>U"U`N]$21M;CR"KO*14%',F/K+7;9MFIE&O`FM"LTZ1:\(;S'GQ0@M>YNY:
MF&NDN6+111H/ENQ'U/D)H))ALYNP@T#E"Q$!!-((5&UO47(48%N8%69-G-2I
M,C!J\FW$[*D@W9P&`P&`P&`P&`P&`P&`P&`P&`P&!X9/XMD/^A+_`*=S`X&X
M';#AOY/8KZ4MWXQG\"T,!@,!@,!@,!@,!@,!@,!@,!@,!@?S>M;_`(ZUO_GK
MMP*NY:XAJG,]88J=N5*-18TP+-MKABF0B_.!C&B-:4\\*6C;.VCW^^CPM;4K
MN;TO7=WK85WQ/TI\8<-VE=OJ3]G>E5Q1D/M,Q*"&B>5-=%>>WIEF,$7XVEB-
M=Q>W=Z3K:];1O>];T&R+C#+K;C+K+3K3K:VG6G&T+;=:<3M#C;B%:VE;:T[V
ME:%:VE2=[UO6];[,"EW>GWCAZND5):+;[F'%1Z@8'5]NFHN"]$SX-EBD5T/T
MYX,&W%RT8`N-;CTLHCPQ6XP)+$=WA5!FCN'JE([A"2C+@J8KOI5$39F[Q:Q[
M2.%-I'U*13M@'EFI,R&+6($0N),((CT%A!F-#H*%8>;"856IP%*@0ZW6P-1\
M2%LIQ#2GR3"""CBGCI&0//->(.D9.2/))/DI(XD@TXTA\HI]UYU:]A!=\'<=
MH@*37`8^7B`^.PS(ZG&PEFL41.0T?(A[!D06I\"38EWPY`;3:3!RC'VGW1@R
M5IV2&*\R'B.Z>^*#QG`55T@0!^A1W&A($;.3L:$54(<LZ0A0BA@I%EL@R'D9
M.1D(R8=TJ7%--()0;XKBE;#VUO@[CJJS(MABXV4<G!;-,W!,K*V2P3)KUBGZ
MN%3961*>E)(K96R:['B`I'>TL4?;6GQF67][<P,H]Q/3W;')V=IN=CS)TP.0
MGX^*M-CBJ[/R`([8C1TU6X^3'A)$IX1@820>("4J6$$$%E/.#CM-I"+L=.G$
M[$>]%*@Y(L!43&5X%B0LUDD-0-<AY^-LP%=K:C)1Y=>@VIF&AR7(R)4(,2U$
MQ8A*'1(\-AD)&9Q#12S2I142YJ3)OC7)JB=R4GW?=N-4TTD:6VSHO37@MUYM
M`>X[2-1RUI\TH79>]O;"$<"=/U?X6JU,#62;.W"M\?Q5$)GS)F?D@6@AU"F2
MP]:C)F1-'KD7,2X@\@4#&M#(>4'&M/:4S'!-,!Y5<"&=EO"`O=AK<78.6'N1
MP4UB2F8<QB+L34"_?:F?N-E`&"F+)+`SA0DDI#I4+Z=<("1HUC3K@2JL</P]
M5O<+8XAL*.KE+XL&XOH=;":?3J$C2ID:6L;SY#SKFR-R.H"HCL;5M;^O113Y
M+SKI6U8%RX#`_G9K_AK_`-M8%)D\"4HJ9>GW2K'Z5>D%2:BTRVDN),4_YC3J
M-^6^#M#O9M&O]W6M:_AK)3<_.A=FDZ_X:W_SUK**[MW%M3O)B2;.F=D@]ZBM
M$U[=HL(]4D?0L@J5CE2=7&DFH,]31VT//;(!7YW3`K)WF6!F&D!&S>GSB>1@
MT5LVLK)A6]\F;T$Y,S7=5KF!<HOD!*W-2&GEIFE3,AX:5.;U&:>UJ+\GIIKN
M!Z*]P1QQ6902<CHZ7?F0[1JYM2<M9['-&+L*::1Q^@U]V4DRMO-M5(ER):"<
MUL)I&FR4#I+:0_H)'5^-:O39$^0KJ9H!J0*E3E0GNCGGZP&9.'[E)<F+K)$@
M["1CA\DMXY[80+.DE%&/-:;683MT*MJ_3A6(^V7>W6=TNP&V/DV?Y"A@-35A
M:@(=Z8K0589(<KFY+T$[80XY$@PW-(`T2TT6TIEQ!`[3R`F9/!7%YD/`P)E;
M\U$UKCP_BR'$?DY5Q(M+D?<]LB.\39OC.EI<JT$\-,.N+EPR`4D"',O..K6'
M]=X4ICST4:X7==S$,S)AB6'7(-U18EQ<QL!4A#%S:)Q,B9"ON14<0F+(?6&P
M8(V<.TT9MQ]82#D/C>L\HU8JF6STTY7CTZ:D`XBPS4`X>/W-HV*:9#'!&$#*
M^"XIEQ_:%.H;=WK:T)5H(TUPC40[<1R!'G6YFZ$0L/`*F2;I:ST/1D`AS<6`
M8`_,^5)CM%.N'R(&M,LRYSKYDAXQ;RB,#^U?AZ+K_'=5H1$]97GJ^X1*'V.!
MG9NH2<_9I=Z3/LLX>J!E&'7$STS-2TL1&EE'#-%E-.]YTD0<E`>)_I\XU=30
MVV!+%&,\:RQ,_41XBXVF,9"L)X\^+)V`U`DLUZ9FY=BT6%$M)S&SBY+<L8X8
MXZZYW]!=N`P&`P&`P&`P&`P&`P&`P&`P&`P/#)_%LA_T)?\`3N8'`W`[5<.D
M,(X^BDK>92K4I;NU*G$)WK_XQG_XZVK6]8%G^:&^<,?6M_FP'FAOG#'UK?YL
M!YH;YPQ]:W^;`>:&^<,?6M_FP'FAOG#'UK?YL!YH;YPQ]:W^;`>:&^<,?6M_
MFP'FAOG#'UK?YL!YH;YPQ]:W^;`>:&^<,?6M_FP'FAOG#'UK?YL!YH;YPQ]:
MW^;`>:&^<,?6M_FP'FAOG#'UK?YL!YH;YPQ]:W^;`>:&^<,?6M_FP'FAOG#'
MUK?YL!YH;YPQ]:W^;`>:&^<,?6M_FP'FAOG#'UK?YL!YH;YPQ]:W^;`>:&^<
M,?6M_FP'FAOG#'UK?YL!YH;YPQ]:W^;`>:&^<,?6M_FP'FAOG#'UK?YL!YH;
MYPQ]:W^;`>:&^<,?6M_FP'FAOG#'UK?YL!YH;YPQ]:W^;`>:&^<,?6M_FP'F
MAOG#'UK?YL!YH;YPQ]:W^;`>:&^<,?6M_FP'FAOG#'UK?YL!YH;YPQ]:W^;`
M>:&^<,?6M_FP'FAOG#'UK?YL!YH;YPQ]:W^;`>:&^<,?6M_FP'FAOG#'UK?Y
ML!YH;YPQ]:W^;`>:&^<,?6M_FP'FAOG#'UK?YL!YH;YPQ]:W^;`>:&^<,?6M
M_FP'FAOG#'UK?YL!YH;YPQ]:W^;`>:&^<,?6M_FP'FAOG#'UK?YL!YH;YPQ]
M:W^;`>:&^<,?6M_FP'FAOG#'UK?YL!YH;YPQ]:W^;`>:&^<,?6M_FP'FAOG#
M'UK?YL!YH;YPQ]:W^;`>:&^<,?6M_FP'FAOG#'UK?YL!YH;YPQ]:W^;`>:&^
M<,?6M_FP'FAOG#'UK?YL!YH;YPQ]:W^;`>:&^<,?6M_FP'FAOG#'UK?YL!YH
M;YPQ]:W^;`>:&^<,?6M_FP'FAOG#'UK?YL#PR90WHV0_[0Q_\B7_`/5;^;N?
M_NP."F!LU9/_`+26'Z>F?]2)P,+@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
7@,!@,!@,#^;_`(;_`.6__P","0X'_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g913905g60i22.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g913905g60i22.jpg
M_]C_X``02D9)1@`!`0(!>@%Z``#_X5'&:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87`O,2XP+P`\/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](EA-4"!#;W)E(#4N,2XR(CX*(#QR9&8Z4D1&('AM
M;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN
M=&%X+6YS(R(^"B`@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*("`@
M('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+R(*("`@
M('AM;&YS.GAM<$=);6<](FAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]G
M+VEM9R\B"B`@("!X;6QN<SIP9&8](FAT='`Z+R]N<RYA9&]B92YC;VTO<&1F
M+S$N,R\B"B`@("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE
M;G1S+S$N,2\B"B`@("!X;6QN<SIX;7!44&<](FAT='`Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"]T+W!G+R(*("`@('AM;&YS.G-T1&EM/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C`O<U1Y<&4O1&EM96YS:6]N<R,B"B`@("!X;6QN
M<SIS=$9N=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+W-4>7!E+T9O
M;G0C(@H@("`@>&UL;G,Z>&UP1STB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O
M,2XP+V<O(@H@("`@>&UL;G,Z>&UP34T](FAT='`Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"]M;2\B"B`@("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87`O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(*("`@('AM;&YS.G-T
M179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O<U1Y<&4O4F5S;W5R
M8V5%=F5N=",B"B`@("!X;6QN<SI%>'1E;G-I<T9O;G1396YS93TB:'1T<#HO
M+W=W=RYE>'1E;G-I<RYC;VTO;65T82]&;VYT4V5N<V4O(@H@("!X;7`Z0W)E
M871E1&%T93TB,C`Q-2TP-"TR.%0Q-3HR,SHQ-"LP-3HS,"(*("`@>&UP.D-R
M96%T;W)4;V]L/2)!9&]B92!);&QU<W1R871O<B!#4S8@*%=I;F1O=W,I(@H@
M("!X;7`Z36]D:69Y1&%T93TB,C`Q-2TP-"TR.%0Q-3HR,SHQ-"LP-3HS,"(*
M("`@>&UP.DUE=&%D871A1&%T93TB,C`Q-2TP-"TR.%0Q-3HR,SHQ-"LP-3HS
M,"(*("`@<&1F.E!R;V1U8V5R/2)!8W)O8F%T($1I<W1I;&QE<B`Q,"XQ+CD@
M*%=I;F1O=W,I(@H@("!D8SIF;W)M870](F%P<&QI8V%T:6]N+W!O<W1S8W)I
M<'0B"B`@('AM<%109SI.4&%G97,](C$B"B`@('AM<%109SI(87-6:7-I8FQE
M5')A;G-P87)E;F-Y/2)&86QS92(*("`@>&UP5%!G.DAA<U9I<VEB;&5/=F5R
M<')I;G0](E1R=64B"B`@('AM<$U-.D1O8W5M96YT240](GAM<"YD:60Z03DV
M-#4R-44X0T5$130Q,3DR.3`Y1C5!,$9"-D8W,D0B"B`@('AM<$U-.DEN<W1A
M;F-E240](GAM<"YI:60Z03DV-#4R-44X0T5$130Q,3DR.3`Y1C5!,$9"-D8W
M,D0B"B`@('AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#TB>&UP+F1I9#I!.#8T
M-3(U13A#141%-#$Q.3(Y,#E&-4$P1D(V1C<R1"(*("`@>&UP34TZ4F5N9&ET
M:6]N0VQA<W,](F1E9F%U;'0B/@H@("`\>&UP.E1H=6UB;F%I;',^"B`@("`\
M<F1F.D%L=#X*("`@("`\<F1F.FQI"B`@("`@('AM<$=);6<Z=VED=&@](C(U
M-B(*("`@("`@>&UP1TEM9SIH96EG:'0](C$X-"(*("`@("`@>&UP1TEM9SIF
M;W)M870](DI014<B"B`@("`@('AM<$=);6<Z:6UA9V4](B\Y:B\T04%14VM:
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M56MW9TI#:&=:2FI:1D=I9&MD1E4S.'%/>G=Y9W`F(WA!.S`K4'IH2E-K=$U4
M53504FQD65=6<&)81C%E6#%2;%IM9&]A5W!R8D<Q=6(R4C%D;F0T95AP-V9(
M,2MF,T]%:%EA2&E);4MI-'E.:F\F(WA!.RM$;$I75VPU:5IM<'5C;EHV9FMQ
M3VMP86%N<4MM<7$V>71R<2MV+V%!07=$05%!0T5135)!1#A!.54T<3=&6%EQ
M-T9867$W1EA9<3<F(WA!.T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3AM2&M0
M.#(R=#=7=79,0DI$9%A5,'-+-FQE4W$P8W9P1TY22SA!8V=,2$I(=V--<48O
M550F(WA!.V1644959EDK4R]Z5U0P-4QJ>E9'<D1Y.&1+14MI85E2-FEQ4DMT
M-WIF:C9Z=39/-T\V0FQ"-&=..7)!<59X9FPQ*V%#6$8Y3BMM2"LF(WA!.W(S
M16QS66103W4V:SA99VEI-'E10V,R-&YJ6C5A4T=D5S5-0G<T9T5N1E4V=2]+
M9C5N>'99>5=E=G@S3GIB86)"871C5%13=TM,<5`F(WA!.VM,;5DR-GA4=WI'
M-%9L-'9-<F5K5C5"5W%2:7%36&5N9C@U1#96<$]R86AC-B]:86Y,8GAZ4%DR
M9&QB2UI:0C9%,T1J1V)A<&M78C`F(WA!.U-Q.&E#3U%.9'-64F8K2&8K8VA7
M;FM*.#`V6$AB*VXK-5)956%14T-+6&E(8S)O5F@V<&DU<W%,>55%<7%D0W%L
M=7-A2BMF161P850F(WA!.V%T-3`P<E1,1TMB,4Y1:U=28EE.4S1%:U535'1A
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M4S0O3T,R;'5:4'%S5C=-;&YA3&)24FTQ1FLP-5-)6&IK3SA.>3`F(WA!.W%Y
M1U5X<GI336]&2$E.:7)(=&4X.69N=&]M;D,O=G9,*VQ2<$IE5SEO:U5:37I$
M-C%C4$%H0BMT>&AY3TUF6&A8,4)8:G=B1E5W="\F(WA!.TUF.$%Z:TUD9'0T
M<FIY;G!3-E$P.%,S33A6,D=D641W.5(Q3%1+4U9Q+SA!=78R;V5R2W)*3EDO
M-7E$=6=%+U%D;'`V2VQV2S`P5%$F(WA!.U-3331U,44X25-3-F1+1S%Q,6%J
M8U5$5DEO<7(R3W(O04HK2F\P275.1#`V5%59:VE%<&MK:DIL2U<P<GDQ36,X
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M;V9E44)U6DAG;W`F(WA!.S=J0W)Y>E9V>G@O34<O9'92=DDY4&E04TLQ:5%B
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M=C%A-%`K:W%+<3,X-$@X4F=3;E=+=7A6,DMU>%8R2W5X5C)+=7A6,DMS63@K
M=#5K4W=T,S!45C=04FY-;VIK=6(U:U=-=$E1<V$F(WA!.VHQ235G-4IQ3T$T
M;&E24G1Q1E9*=DQU<RMF<&1F5W<Q1%<O3$XS84LU.6%',&%:<CA%>5-T-EE1
M3W%F0VM,24MR6#172G)X3E98;T<F(WA!.TMU>%8R2W5X5C)+=7A6,DMU>%8R
M2W5X5C)+=7A6,DMS2R].-WI9+VQZ>6)C4U<W.$PV*U`Q4S!91VA5>4%L,T@K
M<6=.1#0P>%8X;C,F(WA!.VES,&%"659N26M1;%=!24%R=3(U1S1(5$-Q6%-1
M,WI1;U`P9&)S,4%8:DMP445C>%%F1C1C868U,%94:D98<78U3VLO;VY54&$U
M2"\F(WA!.T%#8EA&0S8O,')75S%I*V%,>6YP<SA%>3-A3&5V8C)V<5-N9T=G
M.5=S-%IK:V1N5C8W.39+1&EL3V9*;'9R;'(Y9G0Y4C!Q,C!Y1#$F(WA!.U1,
M86TP649*9E5D-FQL-75564ES93-4=U`W2W%%+T]R=S)5>5-O.5IO>4=65C,S
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M97`O:SAW1VPV:41S4')#=%@U>&=F.&$T;UIP8V%T8E(Q0V9V1SEU;C,T5E,R
M-#%'-6YQ0S-&4#56,BLO1E5,:7(P>CAV3&MY-D,F(WA!.UEI82MH339+4#AK
M9U`K=&IG2U%Y9D%R<U9D:7)S5F1I<G-695DO;4PK9&5M*U@S;#!Z4FQ454Y8
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M9$U66C,U3FMI1G9C4GA,-F%U56M+,$M6,DDS53`F(WA!.S-(>7=O4D]O6&9M
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M>34U96QU67E0<C`U.4=Y53!0-WAH.7-J=U%B+T%(1'9I<C5T=3!&,EA.=U1)
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M259E33A3>D5T.5DF(WA!.TLX95!"-D96;V]**UAJ9U-N;FPW.45Z,G`Q1%1O
M5VA7-2M&,6-N;"LV6F=!5C5-;S-*3S-7=%1H5E`X051*9E,Q0S-F<TA!4'E/
M>"\F(WA!.UAI:&TK2W5X5FLO:VYY-"MO6'$S='=V*VA7>E8S1S!K9S-#+TED
M5&=+=E1-0UA9<3=&6%EQ-T989S,U=S8V,F]E851:23%B8E1%15,F(WA!.V=D
M4%9C0G!$*W!F;W=H1$)-2W1-<7-P5FA65'-18U93:2LP<&MR2F)I<69T2C-(
M>7=*4S-&6%EQ.7DO3'HO;$1D3R\Q6E`X06LX*TLF(WA!.T4K=6)H3&5)>5`X
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M57(R8BLS1E5M9$=2:7)G<7<R24]"3#-$.'8S5E`F(WA!.TIE;G5X;W%R25-F
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M6"M/2W!N:7)$-VTV=$QM-VYM,#=Z5"MJ6G`U;6DY1V5J04]I2VYP>'<S5&-2
M4F<F(WA!.U<K0F0V-'%T3B]-635'2&Y$,#%U540R.7A*83(T:&ER4#!$;%94
M;'AJ85!G-V-Q,4Y.<U953%(W<3139&@U-&IK:6Q%16),-DU%4E<F(WA!.U(Q
M4W!&5T1Q6E%0:%55;U=.3CA66G1$3D100VLP3'),1$MO94]20T=6;%E61$M2
M<U%2:7(P5#AT25-,1SEM-U!+<40U;W1F*TXX0E4F(WA!.TUY=TID:7%&,6$O
M5%1T3'9.469J=W,T2DQH=6)E;6Q):TQN:S5"-&IB8S`R>%8U6DPO>FM$16QH
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M>'DT,&9J=UI35E5V,4PO;DE73WDQ8E5D34AL,C1K;3`R9E9)<$I$3GAI84Q4
M;S4S:6M6=E-0.$$F(WA!.W93.7!+9U@Y;FE4531Q;79M8C@T:S`W4W1%,6I4
M-T9:3$161FYD>&9Y9E9/06EU<F5Z2'%3<C9W:&\Q>C9J8VM9:%5A;T)R4E92
M,"\F(WA!.R]N241Y,4YE439B96%B9E<R<%-*1S=G26AT85-Y1TY':G5P5V=6
M,&5G6DA)2$]O0S%F-&-66#-F-38V3EIE8C(X=5A/;GI.33$V=6TF(WA!.S)Y
M=T9M=41-.'!H4C59-4DT65DT;EI7-$XV-TU24G5!56<T<6]A:"]Z:TPU8FAT
M8E-A>3!J56)V-C5*1$=R34E)26LY5S1N9U!Q3S@F(WA!.W`T,$9N32]4:G-+
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M:U8F(WA!.T=95&]F9TI!36Q004-P<%=V5#9&57IX47EF>7$S*VE43#135G`X
M,4@Y3594<D95='5D03!6:TUQ-EAA4UA%9DHT4S!%4E!Q13AQ9VLF(WA!.T1C
M<T%E;WA6:3DY<%AM1V)29V\X=6%:2G%"84MS1'AX<D(V9%!56D-6;7%E3G=#
M,SAR2U)T56UI<DE.1S!I,VMS56PQ3%(W3S%V,V,F(WA!.W101DA(1WDX;S-)
M:EE-2S$K1VA"3R]Y-EEQ;3A-34U%2U%W>')&1$5O4T].04965E550W%"<T%"
M:7(Q>GEB64=Z.'8R>7-+4U1!>D\F(WA!.U`Y9F-F.$Q4055P,6=6,DMU>%8R
M2W5X5C)+=7A60V%L<%=N-FY&1D1F4F5T2$)01&1X2U-Y.%IR85):;VXK16HW
M3&]$5'`T-'%I.%8F(WA!.U-N>E)B95DW:E-7:CAV6$UD<'%*66-:6F%"94Y$
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M=G`F(WA!.W!/:WI.>49++UI3;G=Q;SA&,G=Q9SA6974O;$U9-"]+,7I)>$-+
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M2#`O9&%T+WAT6$-R>F)&5GE)-VUI2U=05V=&9'-64DUE;#-J,"M$9T-+,5DP
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M5F1I<G-69&ER<U9F+SEK/2(O/@H@("`@/"]R9&8Z06QT/@H@("`\+WAM<#I4
M:'5M8FYA:6QS/@H@("`\9&,Z=&ET;&4^"B`@("`\<F1F.D%L=#X*("`@("`\
M<F1F.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/DUI8W)O<V]F="!7;W)D("T@
M3F5K=&%R("TM(#(P,34@4')O>'D@4W1A=&5M96YT($1R869T(#`T+C(W+C(P
M,34@=C(N9&]C>#PO<F1F.FQI/@H@("`@/"]R9&8Z06QT/@H@("`\+V1C.G1I
M=&QE/@H@("`\9&,Z8W)E871O<CX*("`@(#QR9&8Z4V5Q/@H@("`@(#QR9&8Z
M;&D^<G(Q-#0V.3D\+W)D9CIL:3X*("`@(#PO<F1F.E-E<3X*("`@/"]D8SIC
M<F5A=&]R/@H@("`\>&UP5%!G.DUA>%!A9V53:7IE"B`@("!S=$1I;3IW/2(V
M,3(N,#`P,#`P(@H@("`@<W1$:6TZ:#TB-SDR+C`P,#`P,"(*("`@('-T1&EM
M.G5N:70](E!O:6YT<R(O/@H@("`\>&UP5%!G.D9O;G1S/@H@("`@/')D9CI"
M86<^"B`@("`@/')D9CIL:0H@("`@("!S=$9N=#IF;VYT3F%M93TB0V%L:6)R
M:5)E9W5L87(B"B`@("`@('-T1FYT.F9O;G1&86UI;'D](D-A;&EB<FDB"B`@
M("`@('-T1FYT.F9O;G1&86-E/2)296=U;&%R(@H@("`@("!S=$9N=#IF;VYT
M5'EP93TB5'EP92`Q(@H@("`@("!S=$9N=#IV97)S:6]N4W1R:6YG/2(U+C`P
M,B(*("`@("`@<W1&;G0Z8V]M<&]S:71E/2)&86QS92(*("`@("`@<W1&;G0Z
M9F]N=$9I;&5.86UE/2)#86QI8G)I4F5G=6QA<BYP9F([($-A;&EB<FE296=U
M;&%R+G!F;2(O/@H@("`@(#QR9&8Z;&D*("`@("`@<W1&;G0Z9F]N=$YA;64]
M(D-A;&EB<FE";VQD(@H@("`@("!S=$9N=#IF;VYT1F%M:6QY/2)#86QI8G)I
M(@H@("`@("!S=$9N=#IF;VYT1F%C93TB0F]L9"(*("`@("`@<W1&;G0Z9F]N
M=%1Y<&4](E1Y<&4@,2(*("`@("`@<W1&;G0Z=F5R<VEO;E-T<FEN9STB,#`Q
M+C`P,2(*("`@("`@<W1&;G0Z8V]M<&]S:71E/2)&86QS92(*("`@("`@<W1&
M;G0Z9F]N=$9I;&5.86UE/2)#86QI8G)I0F]L9"YP9F([($-A;&EB<FE";VQD
M+G!F;2(O/@H@("`@/"]R9&8Z0F%G/@H@("`\+WAM<%109SI&;VYT<SX*("`@
M/'AM<%109SI0;&%T94YA;65S/@H@("`@/')D9CI397$^"B`@("`@/')D9CIL
M:3Y";&%C:SPO<F1F.FQI/@H@("`@/"]R9&8Z4V5Q/@H@("`\+WAM<%109SI0
M;&%T94YA;65S/@H@("`\>&UP5%!G.E-W871C:$=R;W5P<SX*("`@(#QR9&8Z
M4V5Q/@H@("`@(#QR9&8Z;&D*("`@("`@>&UP1SIG<F]U<$YA;64](D1E9F%U
M;'0@4W=A=&-H($=R;W5P(@H@("`@("!X;7!'.F=R;W5P5'EP93TB,"(O/@H@
M("`@/"]R9&8Z4V5Q/@H@("`\+WAM<%109SI3=V%T8VA'<F]U<',^"B`@(#QX
M;7!-33I$97)I=F5D1G)O;0H@("`@<W12968Z:6YS=&%N8V5)1#TB>&UP+FEI
M9#I!.#8T-3(U13A#141%-#$Q.3(Y,#E&-4$P1D(V1C<R1"(*("`@('-T4F5F
M.F1O8W5M96YT240](GAM<"YD:60Z03@V-#4R-44X0T5$130Q,3DR.3`Y1C5!
M,$9"-D8W,D0B"B`@("!S=%)E9CIO<FEG:6YA;$1O8W5M96YT240](GAM<"YD
M:60Z03@V-#4R-44X0T5$130Q,3DR.3`Y1C5!,$9"-D8W,D0B"B`@("!S=%)E
M9CIR96YD:71I;VY#;&%S<STB9&5F875L="(O/@H@("`\>&UP34TZ2&ES=&]R
M>3X*("`@(#QR9&8Z4V5Q/@H@("`@(#QR9&8Z;&D*("`@("`@<W1%=G0Z86-T
M:6]N/2)S879E9"(*("`@("`@<W1%=G0Z:6YS=&%N8V5)1#TB>&UP+FEI9#I!
M.#8T-3(U13A#141%-#$Q.3(Y,#E&-4$P1D(V1C<R1"(*("`@("`@<W1%=G0Z
M=VAE;CTB,C`Q-2TP-"TR.%0Q-3HR,SHP-BLP-3HS,"(*("`@("`@<W1%=G0Z
M<V]F='=A<F5!9V5N=#TB061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S
M*2(*("`@("`@<W1%=G0Z8VAA;F=E9#TB+R(O/@H@("`@(#QR9&8Z;&D*("`@
M("`@<W1%=G0Z86-T:6]N/2)S879E9"(*("`@("`@<W1%=G0Z:6YS=&%N8V5)
M1#TB>&UP+FEI9#I!.38T-3(U13A#141%-#$Q.3(Y,#E&-4$P1D(V1C<R1"(*
M("`@("`@<W1%=G0Z=VAE;CTB,C`Q-2TP-"TR.%0Q-3HR,SHQ-"LP-3HS,"(*
M("`@("`@<W1%=G0Z<V]F='=A<F5!9V5N=#TB061O8F4@26QL=7-T<F%T;W(@
M0U,V("A7:6YD;W=S*2(*("`@("`@<W1%=G0Z8VAA;F=E9#TB+R(O/@H@("`@
M/"]R9&8Z4V5Q/@H@("`\+WAM<$U-.DAI<W1O<GD^"B`@(#Q%>'1E;G-I<T9O
M;G1396YS93IS;'5G/@H@("`@/')D9CI"86<^"B`@("`@/')D9CIL:0H@("`@
M("!%>'1E;G-I<T9O;G1396YS93I0;W-T4V-R:7!T3F%M93TB0V%L:6)R:5)E
M9W5L87(B+SX*("`@("`\<F1F.FQI"B`@("`@($5X=&5N<VES1F]N=%-E;G-E
M.E!O<W138W)I<'1.86UE/2)#86QI8G)I0F]L9"(O/@H@("`@/"]R9&8Z0F%G
M/@H@("`\+T5X=&5N<VES1F]N=%-E;G-E.G-L=6<^"B`@/"]R9&8Z1&5S8W)I
M<'1I;VX^"B`\+W)D9CI21$8^"CPO>#IX;7!M971A/@H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*/#]X<&%C:V5T(&5N9#TB=R(_/O_;`$,``0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`?_;`$,!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`?_``!$(`8$"(@,!
M$0`"$0$#$0'_Q``?``$``00#`0$!````````````!P4&"`D#!`H"`0O_Q`!2
M$```!@(!`@4!!`0'#`@$!P`!`@,$!08`!P@1$@D3%!4A,18B05$7(S)A"C,V
M0E)Q@1@D0V)R=H*1DJ&UPADF)S1TL;+!-3=HID138Y.4I_'_Q``9`0$!`0$!
M`0```````````````0(#!`7_Q``W$0`"`0,#`@0&`@(!!`(#`0```1$"(3$2
M05%A<8&1L?`#(C*AP=%"X1/Q<C-28K*2PB-S@M+_V@`,`P$``A$#$0`_`/?Q
M@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`
M,`8`P#5OXLFW^2''?C+;-_Z(Y#:CT.PU-4+A8I>,V)IU?;-BW5L,Y8-IIW3%
M(,>[UF/JZU_L*DK6GTB2!N$\I)RM<4B6+-FRF%5ANA)N&FYX<0MWX+MN:W=Z
M>)%XA$76>0=_KQ-2Z5FO#[X:\*.0O)31UKUL_MCC;>X.1\%*7+9>KD;4YM["
M3UG5:%!5J7@H=>)9S5A-:%!]QEGS,I2-WM^_?'4TJ:92SJJJ2<Q"6'&\Y\#8
M1!<I^2ZOBB4;0%L>:ICN,6T>'>P>0.OH.`B)I;8C9Q4[;JB";R^Q;?-K-6#>
M07/;[$F%:K,2G#1L:WCUW<W-2"JQF0Q"T3OJ2\TW^"$>'OB*[LY.^)%9==`Y
MHK+AIL#C)M;</&5@TBT_T@VV+U3O'6VF6FUIR?4?>H+";3>/=BVVDUKVMH8-
M<&I5B7$Z[]R;!72E1/\`)5)/BZ;CPCSDOMWO3F_REYH\N-(\7MNZ9X]:RX0.
M=/5:47V'I:0W+/;XV?LRBI;*DXZ952V'13Z\US`Q#B/KB+ZNI/K.]D5I"90=
M.&Q6\:U"*52FTVZIPXB''#GG8@'1?B"[\N?+#FJQV%N=^QU7Q-W]RBJ;'1E7
MX3;"G82YZKT;K4EPCW$KS*9R1=7T:\J.GJQOLE.IGL$E[)&IIL@1N<4)!72H
MIA7:5W4MW'TYCK[=KUCF_P"(13-)<'>?>U]DZ*MNCN9&[-#4FU<5JMIU_!2>
MHM:\FYLT30)ZD;J/?9*?NU[IK9[7I"T1=CJC2'G%G<RP8)1`,&[M4--,U4I-
M.E5/5,SIS:+3WX,YN7W(;DI*\QN//`KBQ=:%IBU[.U'L_D)L_>=]UZ?:R]3U
MWKZ9@JG#5N@Z^5LU2AINSVFV38)2SZ>EP:P4"V,]9LWCI3L3&4EI=3O=)).,
MRW/@O,M/;'B5V7BB-NU;L/45^Y8[&XM:)KF\N:NV./\`"T+6]"UMKV??65.&
MMC2D[.VFE.RMFF*S49RZR&OJI)V`L7$QSYPWG%$03:H"JG5=12FXI3EW\%B^
M>?%EI;1\;+6>O;U>X2O\8>1VVM<ZTV-H#6]OW%KQ+5YZV$QRCUQ1[_HQ*N5Z
MU;"K-QL;ZX+7F/K[I@UA4$JZX30>34@U)+P[9Z"H;B]*E-WG^,SA-6@N!#Q@
MJ\>G0*JO$[D%^FN4YF6[@C)<>&<II][=(7?-;U<\VNQ;*6[](J&L7U0F8(T&
MDI;VUP"'B/<WLDZ65B8=5ZZ#1?*C3JF^)C$3GH1]9/'?T!7]?Z_F%M47B/VU
M:)CD+!7/2-YV'HS5DOJN6XN6%"J[:B+)?-A[(K^O)J?5L#R/CM>5^I3TU+WI
M5V84&L4#"3]&+_C<Y46AWOJQ:)[\>4U/9?CBZAI\2XN%%XX<A=Q:Y@N,&B.8
M][O=1)K&'C]?Z$WB[FV;69GXRWW^#EWMMK*\4@D]IE<:S;Z1,M*.&KM**KTG
M)E$7PV[2E\SIO.5V3,C:AXE]*V%R%Y%:%H>H[G9W'&RM2LU:Y8E]TA6[59'K
M'6\'LR+)4-17;9=7V2^IUMC[#&UNK[1DH6+U^ZMZBK&3FHB&;.)](33"3;SC
M,9C.)Z<>1@ON'QQYQIQXY,WG1W&P\YNGC#LSBC5;[4I/;NB-I:YCJ;R@OWV5
MKUL+?]/[G=5Z>D#NXJ6U\YK->L3N;I^P[#4I6QL'-$96R6BAI?#NI=FJHLU>
ME=5XXNNMB:Y+Q-7NH=O<JF.V:QN64L=6_P"CQH>K^(3&L:2/:(+?',.NW=.*
MU15]JUN^NH&\S<W9(,YKI/VNS-:54$*ZX7I,Q8(]X(.1-$I1'\KR\4[Q$]H4
M\I%>?>,)6HJ,8UV2XI\@`Y$ARP2X:6#C7'2>H9"YPNWYK4<UN*E/&]S'8C;6
M4K0+?6XUD#6XEMK)K%)O'LG+-6T;$J.'(:.JC3J3O#4QQ-MU!,\3SS#<GAR<
M@^8^JJA.ZYN^JM5\I5U=?[,:Q$E*4;<?'6,OL7+URQEKLM(04]'L;A3_`#"N
M(B8.VEH9=`PJ,G*R[5J(Z8J2=TXNMTS4#'^,ARN7X`O8]=+6G_20$VHTJ#-J
M6I+A4C:??:*3YI$Y`+:]"7$XP"7%M.19>067(R&^-T%3@+-4&ZHWH6J;Z8G[
MZ8GOGH93ZY\4^XU"L6O=&X$MA[0K=$\/;P^>4VV-:ZXUS0(R(H"7(:/GG&V]
ML52<-/\`VXM,;7T6;BS6>ERB1&M:J=>5<UMQ(N3R!<&71>%_W54IMYB(VZI=
M^$9Z,.?=9N_`_D)SKH%.GVVM]8T3D;>]7O;4FV;%V_4=&Q-J5B-BPL<T<'D8
MZE[$DZJ^6J:<TG'3;VO&8S3ABS;R;4,$TM5*EY<8VG;N:B+9SLY8:OM'`'1%
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MG#4^WO$G-]*C5F;J34!43_)1I=2:3VF;1-FO%8,N^=O*G>>JZWQ`UEI*&K6N
M=_\`-3>50TQ'3.U8YM>H+0[!Y2YV^;%L,M`U.S,X>_6ZHQ<"O"5^"C[<C5YR
M?7!X,X[B&I4Y`9I2>IN8I4VWNDETF<QX&'SOQ*=U\&=C<N--<U'K?E*GH&G\
M5MIZ]V3HO6,9K.^76I\FMO-=&J56R:Y>7:3J2=GJ%X>M'D0K#6!@6R5_U!UF
M[:0.@BF]^T:TJI)TVG4H;F]*FUL/U*AL[Q.MEWUQH.NT&@[(XQ[5JWBO<>.(
M');46Q4M36V<DJ'LC6-OV0$*TLE;E-@4X(J[P2E7>)SE8G64_#/F#QHWE$68
M@]D@T))NS6AU)J<II=,7R7Y(>)O!\K-+EU[QQC=I:PY`;AXI\QMILY)9"G*6
M#BE:N-<TOJPH[5C7KJ78FDG^Z#HUR$CV3&7:RS>.?.G0M&#ALY,,Z8<N&DZ9
MS=.]K<>J,AN,?B(Z[VQQLX];3NPOX^Y[+T=J;8%N81L848YE9[E0H"Q3S1@(
M+$ZLFTK).T6H]A.J!$Q[2_0!*E#:X;7DS9+@@P!@#`&`,`8`P!@#`&`,`8`P
M!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`P(YF>'U0.:]MT+=;GN;
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M``JN#&D.456Y::9T/1=4[$INL+-K*OP&OZ;1JM0V`VR30<RVP48:*JK>70V:
M,&$E1D;.VL""04:PV"OKQBZ<D9=,'74UI;;3<W;;[9QOW.OMKPT]:;&W_=N2
M-(WORIXT[`VW!5"N[S;\;-K15`@-VL:&Q/#U%Y>FLM3+7)L;%`U\XUN,ME#E
MZ79V4(*B#260<JJO#`JVE#2:4Q*Q.8NCLZV\.*B:IW9MK;M2W]R:2K&]-M[&
MW5MGCK(6O63_`(]W>Z;2KB=6M0S-74U(6Y+1*L8TB0:L"W\ATUH2,]0X=($<
MH.@=4I*%9))WE0YY_!%NK?![T!K"P:;*IN3E/L?3?'*_M]H<?>,.S]JPMDT+
MJ*\1+F1=U":@(II1XB^SWZ/7,H[6H#.^;!MS*LG/U;H*_'05UMS92U#J2NUZ
M7WA(R'Y5<$M;\J+GJ;:Z^Q]V:&WAI(EH8:[W=QYN,-3=A1M;NS9HVMU,E?M1
M5+Q4K+4YT&#)=>)L-5DA9.VXN8EQ'J.WXNQ%4TFK-/*>.^S7@S';97A`:4V<
MYDG<MR$YA12^P-.U[0_(QS%;?@'$CRLUO6I6>E8^-WM,6+7T_+NY(Q+//P*T
MUKE]KJ0)499Y4V2K.#],S;BJMJ+4V<JV'TC\R2-8?"XXVSZFVP)([*@(_<.[
M^+6^)J%K\[66D37;)Q"A=?5_55<J"#JFOEHZF.(O6T`WM$;).)B6?@M(^T3D
M$"K0K(34[=%4O_E,SYF./)SPH7%\N6M9G1FS]@:_"P^([*<ZMYW5K>HR`V!2
MY.8X^2^HEU-&NFVOY6**HQD8NENVE;N["P1[U)Q8DIY]+PKKV/!57F5/R:5Y
MS>_?'AR7XP\&WCU6J_J,NO-N\C]<;5U-);EEC\A8&TZSL.WMG/>05D:6_;JV
MV?TD:EO.MK<I:K)'QTPBJGKF+6K[Z.:+5Y2,Z."N`UN\I-.+7A1B(:=N_<E/
M87AA:)VA%[VC[C=]T2+GD5Q3U;Q#V-.!9*<G,K4#4Z]C=PELBUOL`9DUV--/
M+1).K-+NF+^NO%BMQCJK$D*L1<15-1$6JU>-EY6+5VGX3&A-X[%F=@;@V=OR
M_H+Z=VWI"FTV3LFNXJ!UA3-WT#]&M_3IL]6-706RGYG-;.Z]CB+_`'V\5*M2
M,A(/(6MM?.320!5-82RG-]O&/L1>OX/W%"C:3Y,TO8N]]Z.J[R,I?&JG;&V=
M=;IIFE2U-9\4K6]LFC)FDNJEJ&B:_J<K7II_%(.3R%6E(N>-!Q*DG&NI9]8'
M\\+K<JR4:K7_`)9F\_?\%_7[PP^,MUB]CW6_[NW8_MVYG/"F1)OQYLC7\/=X
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M$/6FGZZ+?]&B50#7I=B>G"H`/Z:/L$`4X;7YOV=]@ZLRTTHF,H(:W$;:M7C^
MCJR7A$<:Y6MRM-<W3>1:I9]#<2^-%W@6UNI[9K>M,\/Y!X_IE.LKA'7Q)$6>
MQ4GBD1N$T*^AC6B#\R)@PJK1[)$>AK<S:9J<]:DDWX18FBD<`]1:TXD[SX7T
MJ<NI=)[F8[\B(RMV1_$2[/4M8Y`LYU.P:^UJE'0D"JPUY6I"RS<E482:<S<O
M&&DW316Q.F9&*+('4VU5NHORUN^I9/$3A)(ZS/Q9W?O&9.\Y2Z+X01/":REI
M%C)*ZCGJM&6*G3SRWMD)>GPMI7LTS(4"%D2N5'D='1Z$I*Q9X5ZJFUE"`ZIE
M+Z75JZ[]7R5NA>'=KO5G(6Y[ZUMN'>U-B]B[:L&];SHB,E-7O--6/:UM9)M[
M7:53SFJ9;;<2G9'R1+!,5^O;7AZVYL`&>EB4D%5F:H:I4-)[3>8XS&T8(PXJ
M^$=H#B9?].WJK[6Y)[,:\=J=L*H:!H>Y-B5NTT/3QMMJ-S;1LM+BX*A5221L
M%W305:R/NDQ)P4:T?OFM>@X=N=JFT%=;JF8NY<+,8+MY(>&+J;D'M"^;D@]S
M<DN-U_W!KMCJ?>DCQSOM6K,9O&AQ3"0AX6+V96KW0=C5R4DX&"E9.!@[5%1<
M-:8V&>JQJ4P9H1%)(15-0H32NI6'X1QO8KE`\,_CEKEM9XV#=[(<0ELX2:XX
M!RD)(VIB9J71>L(FW0D&Z9/X^`CIYK?7\;=)5&8L99@S-0Z+!Q&0L4X165<!
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M^V?5%W5Y7W9YYE=3`C$&0BJARHO9IX:X,<2>$AQ_DZ%NBL;"V?R(VY?N0=ST
M3<ML;^V3>:G,;EL!..%\KVP]4TY@\C]?1-!K%$@YJO%;K5ZM4"*];'RTJ*SP
M908Z4CA=;E0DHE)+%U#RYOW)$L/AIZ#LVV)[<<A8=IIVBP\Q-+<W'K1K8*PG
M");:T3JX^I*=#-6JM,6>DH+VMJ'>V&(5D5IU[-F]2PLT6Q`(X`U.(M$.GP;G
MU,1J!X:^T-2W?QA-ZZVC]:0^X>;J=FK7&J+?VZ?7K-(AI.CS"TC9[9)DJBSJ
MLN=B[ON5EV=<:S`14ZV14CHM%"17=.5W"8KJ35">*?JQ+OCK"LI-@6@.%NG]
M):'TGIA>N15G7U'J/6^L%K(Y172<6%6@TV&JBDXND58"IK2QXD7ZJ8``$.X,
M4```Z8,MRV^6WYF8."#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P
M!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`,4.3&N[;:[#Q
M^O5>HC';43I[9D];K-JQY)5^,>3K:<U=>J+$V6L&MZ[*HO;73I>SMG+-A9)>
M!9#!R=C?L9E.=CXB.DA5OM*C[HU\PO`?;4>I.M74+(QC?8R6C9(&='W5986G
M:9AZ9XCFT.4T_K.'@VL]7H\'5"TUM.OTW5=LIU023B)#6]A3@%:86>CB3PUJ
M_.5GY4NNZNIBY)K'0'-6.V;7"N-G;$6UM7W%I94I:-V=-3\G"149R0Y"V&&;
M;2>VC:\)]N&ETXYV+0E$2L%IIF];Q$OJM-ND'5"MS?[=S@DJ,7\MEBVSENZG
MJ;`>.]#L.M-(ZPIMRG;19KS$TNNA?9^XWBQ[$G9:^.(IJXN;Y:T6>3E7SEJY
MLBLFK'LF:S:!BF1T(ZO1<5"MF4>W$=VR9\$&`,`8`P!@#`&`,`8`P!@#`&`,
M`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!
M@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P""N2^S)[4&D;S?ZNE$GL,2E!1T.Z
ML#9R]KL*_M5HA*DA9[&R9OXET^KM4-.?::>8MY>(5>1$2\;$EXL5?7MQ4I?O
M928RK\J;K3]);3=VB2J<_M&G;TM&@:A;V-7F6=+E783+1C#[)M]9BY>9>1M<
MU\QD'_Z2D6,^T1G9Z@V*`K"T//V"#KK46+KM+Y\.^5W\3&:O<_\`>OV)T;L*
MXQU/0HN[]%:FV*%KJ54?V!:K%L%7T@[NMH2K$=:9>V+NANMBW128.LRM:1CC
M/&NI9J+E;)7HG<[^O!I5U>9:\5/]??E3N<CI!G+1[&4CERNH^29MI!BY(!@(
MX9O$2.&RY`.4IP*L@H10H'*4P`8.XH#U#!D[F`,`8`P!@#`&`,`8`P!@#`&`
M,`8!#]7Y"Z!N^Q+)J"E[QT_;MLTU-RK;]7UC9=+G]B55)DX39O%+)2HJ:=V2
M#(T=K)-71I.,:E;N%4D5A(HH0HBPTIAP\.+,^M>\@]";;=7%CJG=VH=FO==N
MA8[`9Z^V53+FZHKTHN@,TN+>N34DK670"R>E%":(R5`S-T`EZMU@(#364UW*
M_7MKZMMU`/MBI[*H%GU8FQGI1395>N-=FJ`2,JKJ28VB1/<HV1<UTK&MO8>7
M9SSL9$&\.ZBI)O(*-U6+HB0D;;E5I-ZI&RZM$7K7-QJM_I-@05=0%QI-AB+5
M5IQLW=+LEW$188)X_B9)!%ZU<M%563M9--TW7;G,"J*A"A$6=F0ZSYA\1Y%E
M?I*/Y2\<WT=JDS0FT7[/=VLW3+6QW\LW@6)+\Z0LYT*>9[..VL*T+83QPN99
MRWCD0.\631,+IJM9WQ9W[%58<I>,<KK:=W+%\C-$26H*O*'A++M9AM[7SS6U
M=FDT8]PI$3MY;V%2KQ,H1O+12YX]_*-W949./5%("/6QE`AS$.>(<^1?.M=K
M:NW/56UZT]LF@[7I+UPNU9W'6MPKUZJSMTU$@.FS:P5>1E(E=PV%1,'"*3LR
MJ(G("A2B8.HC35FH?#L6Z7D-H$^U?T$DWCI\V[P;G=CILNS*6;:OI4V0R1W/
MZ/`FQMWIR1Y3/SK>T>65D`NA,"`"?!8<3#CF+>9,&"#`&`,`8`P"V;-<ZC2X
M2S62W6:!K4!2ZW(W&W3$W*LHV/K-3B&;V0E++.NG2R247!Q[&-D';N4>&19H
M-V+M518"-U1*!V*K::W>:O6[M39V)M-0N$##VFJ6:!?-Y2#L=;L$>WEH*=AI
M-FHJTD8F7BW;60CGS551N[9N$7""ATE"F$"O8!8-KVOJZAV*DT^\;)H--MNR
MI!U$ZYJ]KN-=KMBO\JR.P3>1E)A)>19R=JD&BDI&$=,H)L_<MSR+`JJ9!=MP
M4""F6?>&EZ39UJ1<=N:SJUV;TV7V*M3+!>ZQ$6XE`@&\B[G+O]F7\HA-FJ4.
MVB)5>3L16(Q+)*,?G<NTRLW`IBP\PXP772[I4MCU"LW^@V2%N-(ND%%V>I6N
MMR+67@+'79MFC(Q$U#2C)19H_C9%BX1=-'3=4Z2R*I#D,(#@A;]YVWKC6LSK
M>NWBUQU?GMOW8FNM:0[@CMQ(W"Y&@)NTGAHIFQ;.EQ,UKM;FYA^_<$0C(UC'
MJK/WK8#H^8'/3/IZLMG6W);CEN:?E:II_?\`I/:UH@F*TG-UO6VU:+>I^'C6
M[UO&N)"5AZO/2DC'L4)%VU8+.W;=%ND]<MVIU"KK)IF%::RFIY31==XVMKG6
MLGKV&OEPA:M*;7NS;6^N6,LX%!>X7IY#3-A:UB&*!#^HE%X6O34BFB82%%O'
M.![^X"E,)#<QM=]B_P`YRIE,<YBD(0HG.<X@4I"E`1,8QA$`*4H`(B(B```"
M(CTP#'C3/+OBQR*L-LJ6A.16EMRV>C%\RW0&L]D5.Z2T`V%V+`'S]C`2KY=.
M-%^`L0DR$/'B]_O4'(KB">"M-934\IHN;9W(KC[I.0A(G<V]=.:CE;*BNXKD
M9L[9U)H4A/MVJR+9TO",[5-Q+F51;.'"""ZK%-<B*RR*2ABG4(4P)-X3<<)L
ME>.D8^78,I6)?,Y.+DVC=_'24<Y1>L)!B\1(X:/63QL=5N[:.D%$UV[E!11%
M=$Y%$CF(8IA$.Y@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`IDQ-0U
M=C74S8):,@HABF*SZ5F'[6,C6:(?`JNGSU5!JW3`1^3K*D*'YX!@7MOQ+?#J
MIT?-5G8O)'45GC9%B^AIZNUXKO<$?)L'S=5G)0TK&T.'N+%XV>-U5F3^/?)F
M05245;O$_+%0N:TU<?CU,ZDM_+^C"&2\;SPH]%P"TI4&$\Q@Z=7',2S+K708
MUY*/K'N2TRO"0S-TWJAFD0M+NG$L:*22:LSR*Z[Y1`'2JBICI:4P55*JI).[
MA7Y-B;;:O$VUU=&)>T.MKU*<K%.A3P4QK&&=0KFIU(ZLI1J^\ARQ[UDI"U!R
M_<NZS#G;J,:\[=.5HENU564.=HJ)K2>7*GSW\?<D_0^[-43(D28W6&1,/0I$
MY(7$)T'H``0/=T&)>OT*`%$0$?@O7&FI;?GT+JIY1)K9TV>(IN6;A!TW5#N2
M<-E4UT5"_FFJD8Q#A^\IA#,E.?`&`,`8`P!@#`&`,`8`P!@#`&`>1N9D=+\H
MO$!W]8]&:[6XU[!T3H/FCQVXFU&K<>]@T"]<GN2.TM=WH=A;QOE[@]<QVOX2
MAQK\LLTU>SN5P^UEEM3V6O+Y6$=2K*%D1UO30IAINEMRG"6$EZM<P=+@G"<<
M[/>]/VB9TS,U_C;H3P5J7QVY],[)H38]?@7F^$=GZRDWNJ+Q5_L0SF-GWF.D
M*M?[!9O:8FT^LB9-R21<NFEA7:KBU3>'=_$U4W6+W5[3:.W0J?$%CN/<WA$\
M<^*N@]%VC:D'6N26U4.:.GS2#'C[95=`2G(;>&XZMK."EMRMZ177M>W(U<4"
M&NAZM(RB[#6,M9JTNT:R$R)6`5-*MMO^*AYO"4^%VNJ1DWPBH_)2U_P=:X:F
MI&M+9K'>2N@N55)U57EG[-I:[.XF+'LE[%.()LS.@]JDK-NIJ3J5=9RGMTFA
M),6DXBHVC9",>B,U-+XLRFM2;_/EXF'?(FV\.-G>#/L+4W%7CY8*7R!U?Q\X
MH5O:,:3A_LBJW;7P5_D_QC4V#1+O:)36T(2ZV12TPSRWSE9C+'8WEK)5)RZ.
MA7:M#RQQJF5\1-N5-4?-9V<0Y^^Q+VTIO7$FW\-S>%ODF?)SA3H;EYOQUROG
MM=<&K]I"D0&P;#H5M'<?K_=^-`5V:G):#UQ8IAH#S9",1+Q+=W)QZ)ERR"`1
MHB*?G6*G2H^:\:E,/MM-S.WPLX>'LG+#Q,^16D*'-Z^X<;QN7&Q#1I'NOIW5
M%<V%?M=ZNG(7>NT:/K^Q0M:D&$!8)^2K<6YM)*^R:W69@W\@"KERQ='`9J?R
MTIY6J>S=E/F_$PA\/ZW:VTAI;9.@M@<?)B5\8*N[=YB[#;/[EQCN]JG]@;LD
M9G;%NU?N=AO!2A/:FA0;!2W=:K<?;UK]%LG#,R\2V,=*=9C*EUSN:KEM.?D:
MIP]H5HZ-3$=3'&F<B^7KG2VT[!HWD'S<VM:B^$]N/8O+P=N0.P&`Z"YWL659
M6JE>T[[[1:N-$O3:PN=B1#/6^NUGD(2I0,?.D8N7#5K,"+%,J52E_D2IC>F;
MS?$1?^RX-Z->>^KJ]S9LU/YC<\K'*\>^-_![E#J>,DIF/DH^W[RW%..66W:W
M*L(O7+-2?UZQ95MP`:5@E&%+@/M`_7?0*JC:,49@M#TVINZJ7=V2QOF^<ER[
M)Y/<C'W.C>E)UKR0Y;2F[J)XI>C=;:3XZ5N'LTOQQFN.LY6=3OM]M+T]:49Y
M5U(2!K,C/3<\A8KTS/KA`T+9X"+@W-LDIJ2$TJ%91H;;F\WB+\Q'-U-H53T3
MO+GM:N1NVG&P-^VJD;,KTYSXC]E\<9V7Y"2CMY1:]3-GK<>OT5ZN+QX:Z+UC
M'5!6#U[:J3MV!W>^?[0CW3UI*2T]9K(UK28-4PHP],.V9O._*B+1."DZZM'.
M>KT*`1F>:?)JN.^27@P5OD+<=I;LA+3L2N:,Y.J;;TU5&2M8AZ/KUS8M=I_8
MR\3]<LIX>'E;/%L"K;7LH2T[7'LV`KTS]*M\2$E::;_I>V6[MOF#OJ<X>Z(A
MJ['\V=:WB98\TF]5V>')_D`I2KW<M72%=8T"4J6Q(3B]<]][]^WLDHZE..FN
M]B1.M8"4@%+5'7&8LB#"%?Q@BI4OZ8^796GO5"C>[O!VH,VT"<A+YOK96P.2
MT=OGD1X">LMETB,0C[<6B;`WPRXY[B<[-I;V(B*:O5HL:+*$2V)#T&8?PBL1
MLJQ'D8]LZ>ST?$*A%H6EI?$:ZPW3#\8@M/9O(+F3&4N282FX^9&M>059X6>'
M'+^'%JK4M1N0TCD-M.W:GJK_`'\ILN$B*+,538<XVV@J]JESK^R9**8T^J(G
M?-H]/N5=MWOW_HL4MX3IU5ZG.%M%^+I[F3U]MO.!EO\`VQN9'>7)V/)K+Q=.
M)6B:UI"$?.'&AY#0VUJMI-ENA!Y6%*RXD+14U5+)+@REEYY6$I3U@YFJ^2&G
M).?D7XD4PE"_Z;<[ZE-L],9)0\;CC7L'DGR0X;1>L8F;-L77?'7GAMS4-KBH
MMXY)5]]:C7XO[4TN3W5%$[>)D+'<:0WKS;SE2+/6+^4002<%\](1*&DJIQ-*
M?9ZD_LS`ND-]Y[XY,Z5\2ZWZNO=!V-RKU9XH[FK5ES7Y<974^G=*<6]>:LT!
M4Y5LLR4/#2MANL?LZ_QC9YV!//[R+B.2>`J"S@:LJ73,I.B>&VW+\H7@79&[
M]YEUZ=\/:/AMB\GV?'*<XL>&$AXC$O$P4\*FD[M;UF+RM.*'(B9C,U%WM,C!
MK7^3Q*?&J&KM%EHZ;=D]\EU&[:?U[S/O?`BGY[*9KT=4O6,K\FY;E697_I:?
M"=3F^[[-?8'Q`%*L!O\`NH[1+J[61$>_K]SW,NNE+W[5W?K?0&L7D?J_5=*8
M7T5__P`^4O\`,&E[BWK[G/QN\$ZV[LTZUH$)=Y2OS$-6HG7O&BP5/EM0Z=(<
MR'C';EIM6TB2][G+V$9K`MML<"E%:9;2]4B"PMAB&DV]J;-.4BPNR-N'6D^F
M7\K>FRB%%[.Y0MF3&TKEJ'C%:MA<E]L;"TC5O%4J5@@]H:.6Y(;LW#QZU(EQ
M/V8ILA']+>U>.-'V+<X^$E'LC/H75C0;0ZU[&6*1B4[",Q66Q(ZA9=DFZ'9P
MDWJ46F%Q$[=3;?PLVOR+D/"RY([#LU;V[RCDZS*<R"\6XG;S.P1&Z.1_'^M2
MEM2T.2Z`O%0US=S]_AD`C&\@>':VB:BE8US'-5W;M@9<8J2UI2E],QA-I3Y9
MSXFBOPK=L;&XS<H^--7&+F]\1%NK6BN,[_E=*:0W_`T+BOQWMD-<+>]X42=*
M3HU>"F;H/RD0JL7$;5NUEV3&3]<.S=696J((.2LGOW^_P=*TFJG],-O3*^:J
MTU3Q&4DNYN4\0.QZ/UUXI/%?8G*"@N[CHHO"KDI37_J=%7/?,`YN<YL;5SJ$
MKRM5J%%OJRLQ*QC&8(R(O$E*=(5D3+)E=%*J,4SH:3OJ3S%H?:QJBCW/-_CO
MQ]XCZN>2>V^'_%_8<ESHOM"1F[;NW3TQJ(+)M5"6XL:PVO;=.Z>WE?:BO6Z%
M-S=QINHYZ&@JW;';MQ7K4]7<UE.M$>X]_@U\K;?U5?*GAIV^9J7RL\W-B&G=
MR[M?\T=/TGFGR9Y-UURAH?@%)\74>/U"VC5]'<L-A7.-<K<EK1M*$-IPYC,W
MUO"$C;A7MJQNMW.LM?24K.$BZ._:'E82<9]\F6EI<)9<R[K_`+?]J9=CTE93
MF,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`0/R"Y-:,XM4M6^[TV)!4.#'SDX
MQ!\JHZGK&]0("AHVKUQ@1S-V&0`#$%1"+8N0:)'!R^.U:%4<$J3>$1M+)YCN
M5G\(7V=:%Y*L\2*(RUG7^Y5NALG8;./LU]>)_()O8FJ=[RFUDWY)2YKN95/M
M4Z,51%(FU1S?I[_HYNO98YW-#&W>06\-^3!IW<^U[YLN1\XZS?[6V63E6,<8
M_7N3AXA9?VF$;!W&[&D0Q9-4P,8$T2@8>NTDL(RVWED/Y2$;[A)WZLOX?3I5
M9<_Y_P`6T4/_`+^WI^[ZYFKZ6=/A?]2C_DCW.T[^2-6_S<A/^&-<T8>7W?J7
M'@A7H&TV2KN`=5V<E(9?N`QACWB[<BO3Z%<(D."+DGYIKIJ)F#X$HAAI/)4V
ML,R@H_+&=8&19WN,2G&GW2&EXM-%C+)A\`*BS,!3C7H]/YB(1HAU$PG4'H4>
M;HXMT]_V;5?-^OO^C,^I7>KWF."3K$NVDD"]H.$B"*;QDH8!$$GS)4".6J@]
M#=OFI@14"B=$ZB?0XX::RC::>&77D*,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#
M`&`,`8`P"*]=Z3U?J>?VO:-?51"N3V\+\;:&TI!&1F7QK9>S5R!J1I]="5DG
MS6,4&O5B#CA8PB$9%]&/JO0^M<NW+@5MN)V4+M[97-B;-UMJ&K/KSMG8-'U?
M28PZ*<E<-B6R!I56CU'!A(W3>V"R/XR):G7.`D1(N[3,J8!*0##\8)$V5V?.
MN=H:TW#56=ZU)L2B[2I,BJNA'W'7-M@+O5GRS4P$<HL[!69"3B7*K8X@1=-%
MV<Z)A`J@%$>F!$6=F7U@'&LLDW2577530003.LLLL<J:2*291.HJJH<2D333
M(43G.<0*0H"8P@`".`$5DG"22Z"J:Z"Z9%D5D3E42624*!TU4E""8BB:A#`<
MAR")3E$#%$0$!P"/M;;:USM^.LLKK:UQUK94Z^W/5]K.Q*[07KVP=>3;BNW.
MIR[)^V:/6,O`R[51NY07;D*LD9N^:'<,'C1TN#36>_@\$BX`P!@$9W[3FM-H
M3FL+->JJTGK#IB\EV1K":,[DX^2J%R^STY5%I6/=Q+U@LLB]KEDFX>3B'YW<
M)+,GQDY.-=B@V,B'/7/KZHDS`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`
M,`8`P!@#`-.7B5>+;KOA:T?:PUNC$[*Y(O&0&+7E'!EJKK1)X@"C*6V`LR62
M<+22R2B;R,I;)RUDWC4R;Z5>PD<YC5I35-,WPO4S55&+L\6^[-[;;Y%WV4V9
MNB\SE]N,J82GD9AP`MX]F"AU$8F"BT"HQ<!"-#**"SAX=HRCFPG4.FW!154Y
M^R26#CF[(DP!@#`+!VH3OUEL(OY4NS'_`/VX9XI_R_&1X?9^AT^%_P!2C_E3
MZGN3IW\D:M_FY"?\,:Y3#R^[]2X\$&`,`K=?L<Y591"9KTFZBI)L/ZMPU/V]
MQ!$!,BNF8#(N6ZG:`*MG":J"H!T43,&&D\E3:PS8AIO?T7L`$("P`WA[>!.U
M,A3"2/G.PO4RD<*AA%!X``)E8Y0YSF#JJT46("J3;C52UBZ]/?)T5:=L/[&1
MN9-C`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`T.^*W&I5OE?P5WENFG
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M_P`'CEG=]J5*VRCATE`[KUB%-#5T#1X]G3V#FI3=NB9%U1K5%N57D_LV'E9=
M2=<2,W)*2B8KTIV5-OB)+M#F;XDN2I[HN^IM-^%#):DWYR<W#0V>H=54VZ\6
M8RP;YUCNV?VG.;!H]3LDU2;&33+ZE[;JNC7D;9Z-*Z`V1(P=7@M:PYI5C-J$
MDXZ<$(3=<I++3LX23>$]^5-]C<9X<IEO[JGQ?D8'N_1LGSCK*D-Y/_PX-DK<
M:-,&W$"`E_5>N]^"(-+`3]8#HP"N'F&'J.=6*.=-_P#Y./M]H-MV#(P!@#`&
M`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`-*WBX>)VUX<TX-/ZA
MD&3[DE?(<R[=UT0>MM359Z"B!+?*-5`507LTB)5B4Z%=IG0*9)6PRZ*D<U81
ML_JFF;O'J8JJBV[^QXBIF:E['+RE@L$I(3D[-R#N6F9F6>.)&4E920<*.GTC
M(OW:BKIZ]>.557#ITX546764.HJ<QS"(]CD4W`&`,`8!9NQB>9KV]I_'ZRFV
M@GS]/O0CXOS^[Y^<CP^S]#5%JZ'_`.5/JCW#T[^2-6_S<A/^&-<I'E]WZEQ"
M8"@)C"!2A\B(B``']8C\!@AQ.'+=HF"SIPBV2%5N@"KA5-%,5W:Z;5JB!U#%
M**KETLBV;I]>]9=5-%,#*'*40.;`&`<B2JJ"J:Z"BB*R*A%45DCF35253,!T
MU$U""!R*$.`&(<H@8I@`Q1`0`<`V,:`W;]N&I*I9G!0MK!N)FKLXE(%A9(%^
M^KT^`]T:D#N>)E`/4H@+U(H]CHJ/*JF+K'H=::IL\^IDYF#8P!@#`&`,`8`P
M!@#`&`,`8`P!@#`&`,`8`P!@#`&`<+=RW=I%7:KHN4#B<"+-U2+)&%,YDE`*
MHF8Q#"10ATS@`B)3E,0W0Q1``.;`&`1EJW3FM-+1MJB=8U5I565XV)=]LW#R
M'<G(N[)L;8\VO8;I;)>2F7TC)/9.:E%Q.;SG9F[%FBRB8Q!E$Q[%DW%;;SPE
MX*R)-P08`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P#%+FIR
MKJ/#3CQ>-WVDJ#YY$MR0]'K*J_D*W&_2Z:Z=:KJ1BB"H-U5D5I*:70`ZS"NQ
MDQ))I*F9@D>I2X(W"D_G=[4VA=]T[%N.UMD3CFQWB]SCRP6*7="/5=Z[.':@
MV1`139QL>V(A'1,:W`C2,C&K2/9II-6R*9>^+(X9NS%*7K-L+;K!.04>"3MP
MO(+1THK[$1`R2FO642R`'/J3S)G"5E9I%+&R#%2"!+S9%0@N2-U,S#EM>=N(
M[Y\#LJJ=*IJ=K2OF_P"^7M'TO*<[="H*1M]6!V=HO.,FS=O8'4(S>R4,K("]
M(WJ`P;2872</$G2*TBC;%B$%ZL@5BNB@^62ZMVR:\[QQ;I&'W_)$Z+3#^F83
MB/FEJ8:MIG?,'T_3V"L5^BDWEB`W4FA;JH.H022A3VHSV(11$)N/>-&XUT$V
M*SHZC-TS$QNB+LR9DUU^/2]\9X]\U?X^EXY^7Y8>UW-TL/E$K-Q5%N@*Y/+7
M%%(5DP4!8$U1(45"`J!$P5[#]2^8"9`/T[@(7KVAHXO+C&QS8!;%W)YE,MR?
M0!\RL3Y.@_0>Z*=EZ#^[Y^<CP^S]#5'UT_\`*GU1[?*=_)&K?YN0G_#&N4CR
M^[]2&>3U`/L;6B4(A6+/;7S&SPE@C(FM1^LIU(9.&!XY9*VBJ;>L-:HUNJ1E
MA*UEX)]))20G=-9.!<1$W&,+!#QX_P!?DU0X>4K1=M>32;3ZF*#BC\NK=;H9
ME9:2G7*0UB],.YRLU^S55WKA&UT7;7%.X'=45)W=?>HJ+K\-![U0;PX46`45
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M]JB#A`X'3.7Z@/0P=#$,`D.41(<IB&,40-L6JM@M-D4]C/)`FE()_P!XS;(@
M_#.50(05RD*(B8&[DITW;01$P^0N1,YA535`.%2AQY=CNFFB2,A1@#`&`,`8
M`P!@#`&`,`8`P!@#`&`,`8`P!@$/\A:Q?KKH+>%-U3-C6MHVW4&RZSK>QA(N
M(@8"^SU,FHJGS02S4BKJ+&+L+J.?!(MDU'#$4/5(IG42*415":FZE2N4:P%>
M.>QB7%A=]'\=MF\6-9Q%AXLJ673M!M6EJ9:;_,TVX[+_`$CVQ:*H^QIN@R#6
MO5*Y5F.G[!,VAK;-G(00I*-9EE2J<>9%GEZL\](RNG'EE?$=IOGGK&D-ZOKZ
M<OQ:Q+RD+.6^**]U98+!5&KW<6^I.T0VJ6J-KUJ9J5[6)?3CJ>37O3)Z>JL9
MAS7Y9SL=66:S8*+>^,V>\[/98,X^+5-Y"P[N_3G(38%UM4D!-6UJFLYIEKVN
M0,A$QG'O22M\NXTVA/[.WKMKL&]#;;1FXU6[V&)CC-!;U(RM75BY>6>_L1QM
MUYY?/2#+_!!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`
M,`\3OCO<ME]V<GB:(K4F9;7?'(CB#>(MEA%G+[5E4D%KG(+`0Q2K'K2)&%-;
MI.$S*QTE&686Z@)2JH&ZT*%.[.5=4N-EZFC'-F"Q9FT.8.:<E<J,7$(S@WLO
M($;MUB2,41`&Q&!G+Q1\9DJ:9="];1[(S1FH<&RJQ7*J;9R!8W':&WT_WLOO
M8VJ4Z5$ZFX7#S,*)LHER\QP=6)MLC+463L;?V%>6CU+*B=-F[5=0Y5(.5D6I
M/UZ)U%G`'8M$71>TZ`/!53.0S-!P0Z1.5M-^V2NA*M4O4D].5#^9+GKY=6=2
M3NLO&.VI7+%JBPDHYJJR>`@Y>>6X7-"D5=K-V;E1ZNU24D7C8&2+(B@O$8M`
MT@3WI([8W'OVWX+OFU5":M+:;35ES"EJ-E+X;<69):*R3A%)=`Y545TR+(J$
M'J11)0H'3.4?Q*<A@,4?Q`0RG(Y,`H=G)YE:L*?0![X.6)T'Z#W,'!>@_N'K
MD>'V9JGZJ?\`DO4]N-._DC5O\W(3_AC7*1Y?=^I'W(.]6S6&E]D[&IC&O2,W
M1*?8;>5K9U)((M9G6HA[-/$11BO*=NG+I%B+-LB#V.234<@[5=F*U]&[CLF^
MA:4G4DYAM*W5D2QW("XNN4DGIIQ$PR%$0DY"O1E@&%ERDD)IAJZJ;#/&MKX6
M?6K[F]`M+6$KC5'V3:R[6DU]>_FM*C<IX04WCP^R?YQ'4UH6C5OQXQB,<.<V
M@L[9O(/=],N.VZI`5NHSAJG2VVPJNZFZM-TU`M=9S4NRLISR-CV$PA=A1E?:
M_9,EHMD/)4B/IBMF0?NXN=;I^C&3=KA3QZ^NQ512U2Y=W#O-X_XVOWF(R3[H
M_<C3<$?9WY?*CGL78'R*586A[!$3D#7DI"2KL8:PFGFS(LC+2,W5K2=\I#M$
M(Z`D&SZBN_4V&H3K]WHQ53ICUM=](GE=\X:)RP9&`3-Q]W)!T#9<;5Y6:;(M
M;RX:5]5EYHJ&1EUU?+@G2Q$^X&W<\6%@*KD44P1?J*")A2*`9JI;IF,7\-_3
M\;FZ'#C9^IM2SB=1@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`,&]&\F+]
MLC;\?5;'#T]O2MAP_*V=UZG!M)IM:JFUXH\B*=H*69WJ2?S4A%V1_L/[<Q=O
M8%AH*I!2%HV9J3TEM.FA8SC32CR^ZG[8S?-B(I?ESR+JK*YSCBDZ^V30M=\@
MH#6]BV=KJNVAK"2]<4CZF2]UNIUJ3O<K+3EPI%PFYW7)+A`25EC[)L>M*:[8
M:U;WIT[KL2$+S3MZ;;^%KR9E\<MR--ZZNB;XF[ACR;U<YYF(A&\N@A5S331E
M;ZS7G2LTFDXEWC>@V:H/C6R/22K-Z;R#:[TU,E1L4&4!&H?OWX;8)VP08`P!
M@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@$,<BMO1N@=#[=W3
M*E25;:TU]9[:BT6-V$DI.*BW"T+#@8!+T5FIGT$2A]XO59XF'<7KW`5VER'9
M-G\TZQ6"8ME@G;38GZ\K8++,2=@G)1T;O<R4Q,O5Y&3?N#=`[EWCURNX5-T#
MJHH8>GSGH/.4?`*42#ATI-:93C6:<LX[1<2!$$RNUA*W3:%%58``Z@E:I)-P
M$PB((ID3`>TH`""ZG$2XXFWD?*T!".$ED%XI@JBX*[(NF=LD)%B2#[W)\10.
MWH<KN0$7CDINH+.1%4X&.(C@:JN7M]E"\E8^35Z#,V%F:)8F:BV;,_3F;IF2
M!LR<'=M$2D$!*5-LZ.9PB!0#RUNU0O0Q2B4755F7,SXQ$^15R$(F0J:92D(0
MI2$(0H%(0A0`I2E*4``I2@``4H``````!TP9/K`*=,$\V(E$^G7S(Y\3H/X]
M[94O3^WKTP\,JRNZ]3VS4[^2-6_S<A/^&-<!Y?=^IPW.D5#8E?>U.]5N'MM9
MDB@21@9]BA)13Y,`,7RW;)R4Z#A(Q3F*=-4ADSD,8ARF*80$$VG*<,L\^A]+
M*.W[]35E$5>2D&K6Y)PK6HM55]"+UQM3W#%T91L;SRN:DS9U9TLIW.7-<:-8
M1=92,;HM22%PO(:GR^?SZW[W*BAI[5;:1L4LWU[44)2W.6[NSR"4&P([G5FT
MV-E3"37*B"CI`]B,I..6JIA:O)9=U(.T5W3MRJK87'O/K<:G:[MCT]+%QP5.
MJ=5=3K^N5R%@GEFDEYFQ.XN.:L5YB3<N'3UR_D54$TS.7"[U](/UE%1'S'\A
M(OC]7;]XLL#;<2\8*%8-F5F"[T4W`RSTG4/31XE43*</P6=]?3I]!`0.4AEE
MB#]4<TJ6^BY(0?8-GV6;[T4%@AV1NH>GCS&*N8@_@L]'HN8>@B!@1].F<!Z&
M2'.BH2Z@C])PN@NFZ1642<HK$<).$SF(LFNF<%$UB*%$#E4(H`'*<!`P&`#`
M/4.N:!Z7-,7PFS=5T6\]Q#.)^OLUI+R^@)DFF@&CYU(@!\`1&8:/DB!T`>T@
M=0`?@/#4M-37#^VWV.]+E)^?<D[,E&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@
M#`&`8CW:*X2:+F+#<MBK\?M3SEJG8RXSDS<)RG4Z0E;!$6]+83*81]X?L%1?
M*7Y`EV<^VID-,W`3V&03?32ZKM1#>%(=7+\V8(H<^/!PX\1K2L4N^4%M&P<Y
M$6&*K.MJ)L2U032<KC=^V@9".&)KCZI(J0I9%TM$=KY)NQ?"VDF14W[)FZ;:
MTU<>AEUKF?,QWG?%X\+B&IZ&O:-$\D:=5F<\2PII:&C9G4#AR_2B_8T$G,I7
M]D4:8=Q+:'281;*%>+FBF,;#5Z/9LF[*OP[=C=#Z#_(NK\$_4RH\/_Q(M3;S
MU3L"0A%]T6&IT/>-^U]3)_9S&)=;">UEJSKEL9L;8^)=+`>4<55U<'M+A9MU
M+R$Q/U.MU^<LC@]FD)GI%0W-U9M>[&JJDM/_`)4JJWO?U,^VO*/5+@0!9U.L
M0'ZF=0RIP+^\?1+/#?ZBCC15W]]8,ZZ2]8O>&IY<2E:W>'1,;H`!)BZAN@C^
M!C2[=D0/RZ]W3\A'&FI;?GT*JD]R2F,C'RB`.8U^SD6QNG:X8ND':`]?D.BK
M<ZB8]0^0Z&S)3N8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`TG
M>/GLU:C<#753:N!2<;?VK1*.X23-VJJ1,0,KL5Z?X$#>G!Y28MJXZ#T,#PB)
MP$BI@'='U=E_1BO'B>(#.IR&`,`8`P!@#`.!T3S6SA+IW>8@J3I^?>F8O3^W
MKTP597='M<I_\DJM_FY"?\,:X#R^[]2X\$.%=P@U2.NY62;H)%[E%EU")))E
M#^<=102D*'[S"`8!%5@V[!QW>A#IGF70=2^:41;QY#?3J*YRBJOT'YZ(I>4<
M/V7!?KFU0WFWK[]P"$)^\6.QB8CY^9)H;K_>#+N;,^@_S3D*85'`!^`N5%A#
M\!#.BI2V!:.4#`&`;K/#GM)Y73UAK*R@G5J=R="V)UZ@E%SS%H_0(`?AW2:4
MRI\=`$3_`$Z@81\OQE%2?*^ZMZ0=:'9K@V"9Q-C`&`,`8`P!@#`&`,`8`P!@
M#`&`,`8!$^X=ZZ=X_55:[;IV14M;5I+S"I2%HEF[%2172("AV4)'=5)2?DNP
M0,2+A&4A(JE^4VIPPDW@3&30)R4_A$VN:ZH_@.+&J)'8KY(544-@;/.[JM0\
MP@F\MW&TZ.4^ULXQ5#M$`EI*C/4Q[@,U$.T1Z*CFW3W_`&<W7Q?K_1HSWEXJ
M_._?JCQ"R[ZL]/K[L5"A4]4'#6L(DV5$1.Q5<5@6ECF&9@$2F3L4_,F.3]6=
M0Q/NYI4I;>+,NIO?R-?#U\]DG;A_(O'4@^=JG7=O7KA5T[=+J#U.LX<KG466
M5./R=10YCF'Y$1'-&3JX`P#?KX*I>WC3MT/_`*I=E&_VJAK0W_OF5_+_`)?A
M'3XG\/\`]=/Y-P>:.8P#O1\G)1+@KN*D'T:Z)T[7,>[79N"]!ZAVK-U$U`Z#
M\AT,'S@$WU?DEL^NBFF[DV]F9$Z`+:?0!=?M_G"22;&;2`J"'[)W*[HA1^12
M-\@.70GT[?HTJVNOODRBI?**BV$46EB2<U"04[2][PWK88YQZ!T+)()D4;@(
M]1$SYFV03#H!G)AZCF'0UBYM5K>WW,D6CMH_;(O&+IN]:."`HW=-%DW#9=,W
M[*B*Z)CI*D'\#$,8H_@.8-G8P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@
M#`/,S_"1Y20-2.*%7:(.7#>4M6V9]RFW256*5:OQ-$CFIU`3*;M'LM#LJ8FZ
M=>J@%_G9T^&L]/0Y_$VX]_V>3\S!\3]MFZ)]1^\W6+\!]1^2!]/Q_+.L/A\'
M,X#)J$_;(<OX?>*8OU^GU`/KD!\8`P!@#`&`,`]I4/)QL'4*ZM*/6[%!.!B"
M`9PJ4@F$D<W`2)D_C%E/C]A(ISC^!1PELD5Y?=D<V#<K=/O0KC$7)_DH/Y`I
MDT/R[D6A3%64#Z"4RZC<0$.AD3!G14<OR(0K,V*:GU?-EI!P[Z&$Q$3&`C9+
MK_\`DMDP(@G\?`F*F!S!^T8P_.;22P"BY0,`8`P!@&TCPS9$Y)7;L2)A%-Q'
MTZ1*4?H4[)S86QS!^0F*_(!OS["?EGG^.OI?=>ATHRU[M_LVT9YSH,`8`P!@
M#`&`,`8`P!@#`&`,`8!1K%8Z_4(*5M%KG(BM5N"8KR<W/S\BTB(:(CFI!4<O
MY.3?K-V3%H@F`G5<.5DTDRAU,<,`\U7.+Q_(6OK3&NN%,2TLTHB*[![O*WQR
MIJVS6*)DE%:#3WA$5Y\Z9A[FT_:2-(@%D1%&M3\>NB]'I31N_+]G-U[+S]Y]
MY/,1M?<FU-Z6]]?=P7^T;%MT@)@6FK3*N9)=!`3F4(QCD%#`SB(M`QS`TB(I
MNRC&1.B31HBF`$#HDE@PVWDC3!!@#`&`,`W]^"V7MXV;<#\^3^PC?[=(U@;_
M`']>N9I_E_R?X]<FZ_X?\%ZLV^YHP,`8`P!@%^4G9=RU\Z!Q6Y=9NW,H!W,4
MXZNHAY].X'#!0WE@<P!VBX;B@[(7X2<)_7(TGDJ;6#/36'(JK7HS>)F@3K%E
M4[$R-G*X#%R2P]"@$<^4[`(LH;]A@[[%A,<B399Z<#&#DZ&NJ.JJ3Z,R(S)H
M8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8!Y[_'E9J'C^+\@`"*2#S<3-0WX
M`H[1UDLB'7\S%9+B'[B#T^@YZ/@?R\/R<_B;>)YU\]!S&`<1D$#_`+:*1_\`
M*3(;_P`P'`.N:-CC_ML&1_\`*:H&_P#-,<D+A>0.N:"@S_MPT4?\/O1S0W_F
MB.(7"!US5>LG_;KL&;Z_(Q+`1^?@?GT_7$+A>0.N:FU,_P!:Y#!_DQ[8G_H3
M+B%PO)`ZYJ)3S_6O1P?7]E(2?7_(,7^S\OPZ9--/`-S=9L+FTUBM3CMVL[5?
MP$2N)UU3JBD)V2(J(%$YC=A4%.]($R]"$[.TH=`S41@%2=F=$:N3L46[E\1N
ML9FW=N5&35=T5,PMT7+Q%H_6:-U5@(19RDQ>J()F,J1HY,0$3@8R0G(QVWCU
MIG9%7@*A%I2.V8XH5FTVO8$NX/J'8)=;SKAM$M]75\SA)[.F(K'-T7)Y)=BY
M9&28+.SNVC+&JTM0I:RV[/3QR;=-TDV\9265*_D]BKGY3ZD;,WSR4>66!(Q4
MD&94[#4IV#-(2\-=8O74["Q2TDT;,W[Z"NDY"04NNBZ&*9JR:3P\D,:VD7K)
MKIWE=TU-XMS=KSZ.)HJQ;S7&I/Q4M;VP73'[^U'*1E8EF5UB56EK4*FR`5RD
M=1O?$SDN56QLS"#JNM3)UV38$>2Z35HK,%:Q2*RCU\S26NJFUU?WX>/Y#IJ6
MWNV.<K$\EEDY<:.44D$2V5X5Q&PS697;KPT@U7[7"U5;*1QTG22)F4C'N[M6
MVLH23]`TCEG;\'3Q-.NV52'CKI6_7T])4\>#AHJX]W_3QGQ4]I[R>U[##:S6
M1I9JXA6[G!T9DM*0YT`LT[.ZXC-H)-88#*%*#AG6'KMV^;/E&JB1(TXD%51Z
MP0<76KYLTN[:FT]!H;B+RFWT2JTR_'@[T%R%J5QO%/JM*1D+!$6AK,NAN!8J
M89UP?;JO"VI%O$RKF/38RCL["P1?K&P.$5&QUUVZ8+O(N9;1K4FTE>=]L3XY
M]W&EI-NT;;YCPQ[L;M?#10.:V;3<@`^6E7:\@8?P`[B2?J)@/[Q*V4Z?U#G+
MX^*>[+1E]C;UGF.HP!@#`&`,`8`P!@#`&`,`8`P#&CE3RUTKPYUB]VANBR%B
MV(BNTK5:CP1>6V\3B:/FIP-4ASK(F?/#`*8NW:ZK:)B&ZA7LQ(,&GZ[*DW@C
M:63P_<\/$MWSSGL:[2Q/EJ+IF.?BXJ>G*_(+FA&X(J#Z.6M[TI&RERLY"`4P
M2$@W1CHU050K\1$%<.Q==52EWY.3J;[<&N?-&1@#`&`,`8`P#T`^#&7MXW[:
M#\^3-Y-_MT#59O\`WR+?O^%[1NO%'_!>M1MWRF!@#`&`,`8`P">:)S&0U>\A
MJGLAR]FH%X<B*4FD4SR8K++Y3([=EZF7DHI-0"I@V`#R**)5CLA<D;)1ZF7\
M-U2Z5C;9]C:KC-_7^S99#3,38HIA.04BSEX>4;)O(Z2CUTW+-XU6#N36072,
M8ARC\@/0>I3`8AP*<IBAQ::<.S1US=%3P!@#`&`,`8`P!@#`&`,`8`P!@#`&
M`,`8!I7\<*GJ2W''6]Q02%0]/VTU8NC`7KZ>,M-9GDEES&Z?=(,G$0[?Y$.I
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MN)45?5\N^Z^:+6><G8-,;A3DE'`'<+1X34T8L<%0Z",9$[63J\<T]:4XK"E,
MT1PK8U'?9YZAVC668J(11'K1[9K];:<Q5"\U<)41?,*\\T2WQ:JT=7G:GQ]J
MV[-K*-$&<S"-G4XW,21DZ@X-(QL:M3KW*.(Y1%W#Q,8`M+'!U>.,Y0^T#0AI
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MBCYGF*F`0(4PAAM++CN$F\*>Q8KK3>MI-JFT<0AG#9M(7E^0A)B8+Y;[8MR0
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M%D6K&:%TT5`\576K]BG6I.K$3;5^]VINM5;!3]>LZ)"+("SGQ7AYP=9.XROR
M9CBF[G*XM'FERO2K).%(J:<<1NYE*%CI;JLE=56^\[*Z=4O:ZU>3P75$::H4
M';RWF.931)]-5\Y2]1;K8^B47LK$1D'+225??33F#+*2T=#QQ)*3]O%\\<HK
M2"RYI!_).GC2IG\OQ<=?>XU.(V[+UB?`WD>&C`G0K&T[.8@^7*3U>@45!#X[
MX*/?R#@A1_JL;43@'Y)]?H&</CN]*X3?G_HU\/?P-G6<#H,`8`P!@#`&`,`8
M`P!@#`&`8=<VN:NJ.#NH'FR]BN/<YV1%U&:ZUZP=)(6"_69-`%"Q[(3D6&/A
MH\%$'-DL2S=9G",5$^B3V5>Q$3)5)MD;A?@\$7*7E3N'E_M:7VSN.P'DY5V*
MC2`@&8K(5BDUX%CJLJS5(LZJI8^+:`?JJJ<ZTA*.Q6DY=X^DG+ATIV224(XM
MMY,<<I!@'4D'J$:P>R+H3`VCVCEZX$A1.<$&J)UUA(0/DQ@33,)2A\F'H'XX
M*E+266X\RA-;C`K(**O'J,*=)_[8JVFUVD>L5\+1H_*W()W!F[DQV3]FX*+1
M=<H%7*0QBK$43))7/OVRNAIQFTRI:C'%KIJ_!4DY^"67<M49J)5<LUTFSMNG
M(LSKM7*SL(]%NX2*L*B*ZK\Q62:2A2J'=F*V*45A`@V5R32^'>ZL[VGTOV.9
M&7BG#H&3>3CUWHIJ+`T1>ME7(I(KJM55?((H97RTG*"[=0_9VD7152,(*)G*
M5/OWV8AQ,..8MYE0P08!Z!_!J+V\<ML!_P#4G<3?[6N-3&_]\BW[_A&Z\4?\
M%ZU&UBPV*`J4+(6.T3477H")0]3)S,T^;1L8Q0$Y$BJ.GKM1)NB!UE$T4^\X
M"JLHFBF!E5"%-3$39792UKY34*2^V0:R1*E$C:_(VI[:6SHCR(0KT0S<2$G*
MBY:>>!V[%HT<JN`2*=5,4%4Q3\T@D`6',1>8CJ7;@@P!@#`+:M5F9U:)5D7/
M118>J3)H!NAW;H0$2)A^)4R?MKJ=!!-,!Z`8YB$/4FV##N3DWDP_<R3]85G3
MI05%3C\`'X%33+U$"))$`J:28?!"%*4/IG?%D#*;C#RDL&B9I.(E3NYO6DHZ
M`TQ!`?S7$.JL8`4FZ\"AP(B[)^V]8=R;:52*)%!1=E;O$>?Q/AJM2K5+[]&:
MIJCL;X:[8H2VP<79*W)-9B#F6B3Z-D69_,0<ME0^#%Z@!TU"&`R2Z"I2+MUR
M*(+IIK)J$+XVFG#LT=LW16L`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`,0N>FJ5
M=S<1MX4IFV%W,$IZ]KKZ*9.]RM.49RVN$>S:?`B#F4/"FB"=.@')('3,($.8
M<W\.K36GMA]G8S4I3/$)GM.)9L[?JM6G;IE-2(L7#-K%/E@.V<&)Z.75F4T'
M*9TTS%61:IUZ8=R9DQ,,8Q9'>/`2041.IEU)9Z?>?2+FE355=+G[1ZRHY9;T
M3N2CSJK)O$/'S]Z_=2;1%BA&N1=@K$QT++.P.02@7J#"QP;@J29U'`%?F!1%
M,T?+`PFNGK-[1Q'[7GWBNBI3,6WGJU^'Y=IIL9O:@O6U95?O'4$ZLU>BK&FQ
ME6JB2D:RF6C]Y'ED52`=),SM&+?G;G3,HD9)-LJJ9$LC'>J+XE+C*E)]IQZ%
M_P`=5XO#:[Q"MYG;:[2&1AKU,Q=9FGA:D:/!E&N&$I'RDLG(0<7-$7-'J1B\
MBB@FE)`J?T+"4>&:HJ`@Q<2)#1N-=JFD[0XNG==F31#I3J2F9>4H;73M^3CC
MMPP;A1=%VV.IY$'5I<LE6SN+-`R+BW6&8K41#PLDDP8.G[]64B3-C$6C&0)+
M'<D<`@6-?J(E6N-DY5TYF(PWCCG9,.A\[M0[-:4FV\K#G..Z/J6W#7D*_99:
M%0DI5W7*M8["\;*Q<FS:1SFOHV,JD1/OU&@I0ST\E59F-527`QVZ[0.\H>LC
M?6G6H;4N$WC$39^*:]H*ARD]ZDE?,M?3SE/VR1H.:C[%%M9F*447C7P**,71
MT%4"/6I53IHOVI5B$.LP>D(#J/>%+Y#]DJ@]:G5:N$53Z3E3MMUZF6H</._3
MIWY,X>*<MW-K=!'-_%+QLLW)U^OGIKLW9@#_`!?3,@$?Q[@Z_0,I"2]]4NS7
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M%9`\K,QF9TU-.F]E$MN'\B6)?\KST:YGIJI6FJTS+2I4IZV\Y^FR75/9,DVU
M:CWK*/9U:"F9:-CY=O+I4QF.W;>R<ZWL#Z@:9A:S:YA9H=P-[9U.>JE]</H*
M2=/F\RXE#.5FLD%NG'<=734\6M"N[.*8?6&G_<F4Z5&\9^576JKG#AJ_%K1?
MGL.E]R>FL[J'MEH</[');*E'+8-I6PK4ZZN\?M?J=BW9O9%-O"UMAKM16L6F
M%J3RIKN899Q#H2*CA%B[(=-4.&YE_P`G_P!TK?BS5K#53:RMI_BO^V*IM+<W
M3:=T>M3@Y1)*A<9=:M9Y%LA9+'%$N%A*S5>+M#2$\FBHW,U7D>LBNW]H0C"I
M+/Q%ZJ0H'<_K1,&>;XCFM]/EWVSGK)JG'=MF6V8-#`&`,`8`P!@#`&`,`8`P
M")=Y;IH_'O5UKVSL)^+.O5:/.X],@9$9*<E%0%.*KL(@LJB1U,S3T4F3%(ZJ
M2!#J&=/%VS!NZ=(U)U.%D-PI/Y[?-'E5MKE_O2R[3VP=>.7\U2)J%((NJI#Z
M_J#==52*K<.4Y4RK=I%!>2DN"*2L]*N'4JH1,CA%NAV5.FW!P;ERS$W*08`P
M#H2L>G+1<E%JJ'22DF#R/453`!433>-U&YU"`8!*)R%4$Q0,`AU`.H=,.]BI
MPT^&GY$>%U>S30=(H2BC3W%I,1C]-E&Q[5B,7/,X1E)(,(]-/R6+I4D"S7!Z
M(N#F=*NU7"3@JB*;?.G]><3;P-_Y+J5,0U=S*;:ONKNW:.M6<T-JJ1#R)!RV
M6:/)A^V5!%%4"NI6ZQ5X**J9@#SD6LC$(-`3[R'69*+`94BPE5+8_/W:?X(J
M^5,PG?BET9ZISW.:&II8:0;/TY5TL**#]-R4$4FQI-1^_>R'=)"W$C9RFT6?
M+G8I^D*JT4.H*#@B"R[91%YZ1WX]]157JFRVC>(25N\7Y\B]LI@8!Z#?!Q+V
M\=MKA^?(VTF_V]8ZA/\`\W_^_7(LOO\`A&ZL4?\`#_[5&R;;%1&]:_L-6+7X
MBT*298TR$--VNPT1FJYCYB/DVKU"Z5*+F;/5)B'<,DIFOV"!CEI6)GF$:]9*
M-%T2/$#NN3*<-.8ZQ/V=F8#W7B3R/OS=HWLFPJ+(.PU?LZB/;&O(N1L#UC>=
M4;LH\+4++)HZO0G[K$5R=OU`E7EH&RU2-L*E*6L\EJ<UR4922<:J>_/W3Z7[
MV['55TK9KYDX2M9TMOZK3#47A0DTI+VF.*FR[9LVYV*S35*"DVVWP$A,P$/(
MR$>G;:O7=PQ-RC65GBHRD0SQY(AKQH]ILRG9KK?64ZX?2+1HI6J7+GJL>AWQ
M>/%)[^%B+XB5*23E*$^+1:[WAV2QN[DP:#UI<*=?-U2%D=R"E296D]3TRQ?*
MN!!"@O7LCM*;D4T57*Q42$N^QYG6\44$T2A2]3TPR)`(<RBU2N_MZ^MNR1FN
MJ52K3$U1SCT2?=LRGRF#IR$@TBV3F0?+%0:-$C*K*F_`H?`%*`?)U#F$")IE
M`3**&*0H"8P!C-D##VWVEW:Y91\MW)-4NY&/:";J5LV[NH=W0>T5UA`%'"@=
M>X_0A1\I-,I>U*A==P6KF@,`S9X?<G7.G+$G3K:]55UE9'I0<&5,90*C+.!*
MF6<:E'J)8U<>PDZU('\44LD@4SAJJ@^Y?$^'J4KZE]UQ^O(U35#Z>[F]-)5)
M=)-=!1-9%9,BJ*R1RJ)*I*%`Z:B:A!$ATSD$#$.41*8H@8HB`@.>0[')@#`&
M`,`8`P!@#`&`,`8`P!@#`&`,`_!`#`)3``@("`@(=0$!^!`0'X$!#X$!^N`>
M(3G3Q_7XV\F]D:^09&:59[)GN&OS`02-UJ1:%EW\0W;&$`\PD$OZZL+J]I0.
M]@W1BAV"41]OPZM5*>^'W7[SXG"I0VC!F<I%7LDG'2\Y$I2+Z*CYN+9G65<`
MB5C8F7MTLBNU36(U=^H8F6:)J.D5E&B#M\1H=`'KKSM.E.[7*\&H?O\`;"J:
M4)PI3\5@MV4J="@8V&5L<LY9Q$#,LI./6LUTERL"RS55BO$BY7EI?R7BC)>*
M:+1Z+HZHE53<G`JAG\D+O+II24N$G-WO,J9-*JIMPE+6U-XO..9OX<*.6,UA
M28Y!F$>V?^A1@6U?*@:Q3CI@_K[5)^G',)!%:250E&C%I*.VK(SP%S$8G0:F
M44;M&9$&BG.T<N(COQ_8UU;Q,S]*E/=JUFXN=J$I=4BF<Y"PSR6`[]2.5F%B
MV^P/)Q$[>/9M(H?=%9=:6CREC6#1-!-)R@DY;IF%0BY%W`K5)*4FWC>^+$=5
M3AM*TI?*HZVB,YMDZH:GI)$SIILI-(546J:RR5BL";I=RRM#^ZLY9=T63!PK
M--K3+2LP26.H9\9>3?I*K*-7)T!:*>OFYLY3GF6W/5C75ZVA1=)-=H24=`&J
M*45%\W(RE$V\K#2,%,MTK'8DT)QG+#.'?K3:190"2TDX6LLXZ/*OP7D3/'XO
M!<BZ:,%6K0L7NFG=WF;OEW=_TH:ZNF4U96B,6LK*W3N7C"PD;7F!8N(;BTCT
MEW:[=H"RZJ+3UCI5VJW9E744](Q2664*S8-_+9,&_EM&*#=HBBBG4DE"(VVY
M>3)/C;+>W;)19&-T).0\G'=!'[HJ(D3E4Q_+NZ1QR%'Z_K!*'R;H-(;"\`8!
M!6U[?9(&U:Q@ZA98Q&>L=JATG-*>131V$S2V\_#%V)8I"45>(NX-C6JFY?>Q
MNVQ$4GEXD*O!N32`S*$:KEMRDM]HVW<[0L=86YJE)JIO"69WAPHWE_:60CJ?
MD3<9:L[5L=O%A(KP.O(C8U%ATV[&//<64LPV;+L)&H*QZ[E=:E6J.HZ8U&(L
MZ+3:D8>+M#FXPC1FK!'6RJFU4\VE8O\`5B^\8<-0Y-.E2DMWI?":A7ZIN[7R
MPU#F2W5.0VSHJO,+*41FR5N6?Q]\8RK.ELTI"7D]?T_8<*TKZE)G+:K]CV=1
ME+%95W<:YL-K@FL<+JR)2,'''?RS55X3#5LPG9INT2\=Y&E3G.,XEJ7,7E)1
M9.=C,W6]C&U4N&EE7;A\_)[C"S;EU&MXA8]DK,L_K5G(,:T=R#1HFA88B300
M2:2,DU\A),[:3D4#$>K[3E+[VBZL[=S#4/[^#NOLS(O2FMWFVMGU"B-2J^1,
M2B1IAPD`]6,`RZO)MYW_`+)#I1R#@&W>8I57AV[<#`=8@#*ZM-+?EW"4M(]*
MK1JV8M6S)FBFV:,VZ+5JW2*!$D&S=,J*"*1`^"II)$*0A0^"E*`!],\)W.Q@
M#`&`,`8`P!@#`&`,`8!^"(%`3&$```$1$1Z``!\B(B/P``'R(C],`\A/B?\`
M,];DSMQ6C4N5,KI;5<B\CJ[Z58?17&T)>8RFKNJ!#>6Z:B(+156.852I0I5Y
M%N*"E@?(%]?PJ-*EY?IQ^SC4Y?18-2%KIL5;&OENR>G?)%$&DDD0HKH#\B!%
M`^[ZAN)A$3(',`!U,9(Z2@]^=&DT9,5;'696L/19R:'0INX6SM/J9J[3*/3O
M04$`^0ZAYB1P*JEW%[R`!BB;BTU[]^YX!;^0#`.)?M\E;O\`-`OE*=PH>;YP
M%[!Z^3Y("MYO3KY?E`*O?T\L.[I@$(G;6UQ!5]&,9S)VT7;S/'2;UY*QTNX0
M)?&[F-(Z&41]8^AR5MPNL\%557O.#<'!NL>Z;JY4Q;GK/U=>GO)V;IU5-NF]
M,*R:^B'BR>K&_F7E-^:^GZX=N6R-"K$G8]VLV;3!6K1)=J\9-G:Q$DSQB2PO
M@37:NW)?.(AY#@3D:F[AK\?#;\>^YFFU-4P_I:NIRF\WQ:Q2ZBA8HZ7;M7[1
MXYCE63H6+Q<KM`&#-S(RCPQ5$%E7)$'*BB,<7T+ER=ZA'NXMJFFF,1*G<E[\
M<V]QA;S:]+3::F5*YLE:RQ>\1,\HE7*<A@'H3\'@O;QYVJ'Y\A[";_:U3IT1
M_P!XCD67W_"-58H_X_\`VJ-E.SY<8'7MPF`M["A#'03YR%QDRQ)FE?$B?P_'
MWXP0A7!1'RV)Y9-U')O5&ZCR/D4"G8.3LF^A*5+2B;X-?%/Y.72TO],R".W(
MER^G:EQ.>HT./;Z_78[<9;-<3C#>]W,N2%6L)"Z];1EAEETZ3,0,+47>OY(E
MC9N63Q=BGE/%]E;F<O&W3$=XZNA+5\N'6IO\L1I6=^JERH)?V!:=C6#9,BOI
MK?BC>E0^H$=M6P\J&I5M6Q4):%FC&@!7;F76,W/-@L=>KNS;T-FE;!<(B"7B
M*V\?P$I5;`WCBV\V=HEXCI'W>Z,I)+YJ?Y0LRXS;4L66/N5?B[NVV[`F++2M
ME*3!=A5BL45>38C$0<;!)(&I]7DW%A,BW]%;8^>O3FUHV9>,M58I[*,CEFE3
M@8(9:EW60>5>_>=\._0?$I5,-1#;YG+MQ:(LV]WE&9@B!0$QA```!$1$>@``
M?(B(C\``!\B(_3*<S%G9-W&Q/1C(Y4?96*H]#E'H$@Z)U*+D?S03ZF(U+_.`
M3+C\J$*GVIIC.??O\@B[-`8`P!@&X'@/R%/88O\`0I;7PJ3,"S4<T9ZY4ZJR
M,`V+W.J^)SCW*.8(G]\1Q0,8QX;S4"$20AP%3S?&HAZEAY[\^/KW.E%6S\/T
M;+\X'08`P!@#`&`,`8`P!@#`&`,`8`P!@#`-3GBS\3%]]:32V?38PSS9FE6\
MA+IMFB(J/K)05BE<6B$3(F7S'3V)].G9(=$14/T:3,>Q0.\FB@/7X5>FJ-JK
M=GL_V8K4J>/;/)5GK.1'5NAIM6S52TQ$6QL!(*-M44YA'S\L</FV/V(S:;9.
M%FCML+N/3AG<4JFJ5`XQ=@DSHKG,063S-2<II3$II]8OQ:/N:I:BI-Q,.>VW
MY[H@^*UG?RKA5C+OVD7%Q,1%J23>UV:/K2#!U3)IC,0$%7DB-F3]B23D8YJQ
MDRIH.V23`KTP,)",8-W?/15CA93:2E.4EWM.3IJISN]H4N*E#;OLG;PEJ2N%
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M:_EO8KO5)4QNQ-I/1HN#=>G1HJY30>?/[VJJP?/Q\_/Q@&UC`&`6_*U.K3KV
M/DYRM5^9D8DY5(N0E8:.D7L:H18C@AX]V[;++LSD7337*9NHF)5B$4`0.4I@
M0N!+Y/R/J54B555XNL5Z-77E%9Q=:/A8UFJM-+MG+->854;MDSJ2BS-X[:JR
M!Q%VHV=.4#K"DNJ4TA+"2\!/Z/N-JM7AFZ#2(K<#%-&IGQFK6-AX]BW;&DQ`
M9(R"+5NDFB:0$`%\*92B[$`%?S!`,0N$"HQT;'0[%M&1+!E%QK)($6<?'-4&
M3%HB41$J39HV32002`1$0323(0!$1`/G*#=EP%T8K2:<ZVK8F8HV.^-$D8%!
M=/M7C::50CA)?H8`,12QN4T7XE$#`,:TB52&*+A=,/+\:O4U2L+/?^ORSK0K
M3SZ&PO.)L8`P!@#`&`,`8`P!@#`&`:I?%FY5J:&T/^CBIR0M-D[M2D:\T6:J
MB1[`45%--*WSI#)CYC9R_1=(5J*5'R5.^3D9!BL#F%-V]?A4:JI>*;]WLC-;
MA=['DASUG$8!39:(CIMDK'R;9-TV5#Y*<.ADS@`@55%0.AT5B=1[%$Q*8.HA
MU$IC`,:34,&+MTU](U90[MOWOX4Q_P!6[*7]:U[C=")/B%#H0>H@0C@H`BJ/
M3X24."(<JJ6NJ]S[X!'>9`P!@#`&`,`8!Z&O!^+TX[[-'^ER`GS?_P!6ZA+_
M`,N19??\(U5BC_B__>HVO=.OP/R&4R?/83N*;L+W$`Q2F[0[BE.)1.4H].H`
M<2%$P!T`PE*(]>@=`/PR:9R'3.F0Z:A!34(8I3$.0Q1*)#E$!*8@E$2B40$!
M*(@(=,`^NT`$3```80`!-T#J(%Z]`$?J(!U'IU^G4>GUP""MJ7CR2JU>)6_6
MG+VS#E,W\6F8/_AY#`/[:@?+L0_93$&X]1.L4G2BG=^"_(,?<Z`8`P!@#`*_
M5K-,TRQPEKKSL[&;K\DUE(UT3J($<M%2J%*J3J`*MU@`R+E`_5-PW4505`R:
MABC&DTT\,'I+U+L>)VSKVL7V'[4T)V/(H\9@<%#QDLW,9M+1:H_!A,Q?I+H$
M.8I?4(%1<E+Y:Y!'PU4NEM/;[]3NG*DD;(48`P!@#`&`,`8`P!@#`&`,`8`P
M!@`0Z_`_(#\"`_C@'E(\4K@8ZT)<WV\=7PQC:5O,J9::CHY`10UI;I)83K1Z
MB*1>QI4YYT<RU><%`C2,?*JULY6I`@@D?5\+XFKY7E*W5+\_[.55,76/0T\K
MF$B"QP530$J2A@76+W(HB4@B"JI?,2[DT^G><OFI]2@(>83]H.S\NIA>?0Q.
MG-KWB+A/<8V683,>JYN<S#S9(ED@Y>4JKQ=5,>VS3`[E-N:HL9V6E0>EKX*6
MZ:K2]7DJQ&OCN)!<>+K:4ISF'"PDKOL_%IJQVIHI;AJ(2E3:6W9=8B-DTTW@
MDJV[%=Q5WBH9L9P$`BA6U9%[&)03P[N2LUS4IC:.<!)RC5V1E'/T2)2R<"PD
M99%61;G.9H+4C.6U55%26T*;*[=41,^<)M&::4Z6XEWC-DJ9FR=WM,)[%-H>
MQ+*^LC.KV\4DGI!>QIUF+1LJVD[`#>1>+M@=M5E6J#"("L6IFV69BZ.Z<-31
M\RK%R\2LWEU-3;A]<1E;>$,M5-,33W6;*WW>JG.UU*<D_9T.0P``B`@(#T$/
MD!#X$!#Z"`X!MIJLK[[6:_,]W<:4A8Q\H/Y*N6:*JQ1_QB*F.0P?@8HA@%?P
M!@#`&`9I</\`C,ZW+9TK7:62B>LJR](=\*I3$):I5`2JI5YH8>G>S)U35G7"
M8CY;4Q&*9B.'I5FW+XOQ-*A?4_LN?UYFJ:9?3W8WMIIIHIIHHID222(5-)),
MI2)IID*!2)ID*`%(0A0`I2E`"E*`````9Y#L?>`,`8`P!@#`&`,`8`P!@'R<
MY$R&44,4B9"F.<YS`4A"%`3&,8QA`I2E*`B8PB```"(CTP#Q%\[>1"_)GDO?
M[^V>'<U"->C3==I]YC((TFM+N&L:[;D-U%(+`[/(6A=,1$4G4VLD`]B9`+[?
MATZ:4M\ON_U@XU.7]C#W-F1@#`/A1--9,Z2J9%4E"F(HFH4ITU"'`2F(<A@$
MIBF*(@8I@$!`1`0$,`Q\O&K#M_.EJPD95#[RCF(+U.JC^)E&'7J95(/D1:B(
MJD_P`J%$$D^55&Z\O>00<("`B`@("`]!`?@0$/J`A^`AF`?F`,`8`P!@'H@\
M(,O3CIL4?Z>^K";^OIK75!?^7ID6_?\`"-58H_XO_P!ZC:QE,C`&`1UL.ZDJ
M\?Z5F<IIM^F8&I/@WI$1$2'?*E'J'W1`Q&Q#!T46`3"!TT52YNFF;O`,3U%#
MJG.JJ<RBBAS***',)CG.<1,<YS&$3&,8PB8QA$1$1$1'KG4'Q@#`&`,`8`P#
M9=X=6V3Q5HG]0RCD0C[.BM8ZR10_W4K!&-RA+,T"B/[4G"HE>&_FE]B'H'>N
M;KP^-395;JS[<^=O$W0[QSZFX+/,=1@#`&`,`8`P!@#`&`,`8`P!@#`&`,`H
M5GK%>NE>F:G;(:/L-:L4<ZB9N$E6R;N.DXYZD9%RT=-U0$BB:B9A#\#D,!5$
MS$4*4P$VG*LT,V9Y._$"\-"V<;'TQL763"1NN@)!599P;RU)*:UL1T<0&)M9
M`*HH^K@=_D1MJ,0R78)(^P>F?"U>3/J^'\15?+5]7VJ_OE>7"Y54Q=8]#4,G
M3ZDDBDV2J]=3;H/"R*""<)&$11D"$*F1\DD5L!$WA2$(0KHA07*0I2@<`*`!
MUA<+R1G55R_-G?/"PRCAHZ/$QAW3!P[=L7)V#4SAFZ?G,H^<M%A2%1NX>G,8
M[M9$Q%'!S&,L8XB(XA<+D2^7QG;@Y"1<8FLU<)QS`B[%-=%DN1FW*LS2="4S
MI)JJ5,#MTW)BE,N1(Q"K"4HJ`80#+"XQ@2^7?/6,'?P08`P#8YQ\EO=-80Z1
MC=ZL0ZDHE4>O40\IT=VW*/Y=C-ZV(`?T2@/XX!-F`,`8!F-QEXDV;=K]K8[$
MF\KFL6RX&<RYB>2_L@HGZ*QU;(J00.03%,B[F3D.R9CYB:`/'B2C9/E\3XBI
ME*]7IU?Z-4TM]N3>?6ZW!5""BZS68QK#04,T391L:S)V(-D$^H]`ZB8ZJJIS
M'6<.%CJ.'3A15PX557544-Y&VW+NV=L616\`8`P!@#`&`,`8`P!@#`&`8%^)
M5NX^C.(>RY>/>"SLUY;HZOJJA#^6L62N:;EK*N6R@#WI.HVIM['*-%DP$Z;M
MDW$!(/ZPN_ATZJTME=^']F:G%+\O,\7>>TXC`&`,`8`P"*[OK5G8`5DHD$F,
MST$ZA>@$:R)NG406`H=$7)A^CDH=#F'HX*;J"J>:J9NL^H,9GS%Y&NEF3]NJ
MU=(&[%4%B]IRC]0'\C%,'0Q#E$Q#E$#D,8H@(\<68.I@#`&`,`]$WA#E[>.-
M]'^GO2QF_P!6O-7D_P"7'/OR*\4]O_M5@VI8(,`MZSV-E5XI:2>"!SA^K:-0
M,!5';HP"*:)/KT+\"=53H()I%,;H8W:0U2;8,.I:5>S<@YDY!4573I03G'Y`
MA"A\)HI%$1[$42`5-,G4>A2AU$1ZB/9*%`*;E`P!@#`&`,`8!=E$MTC0;G5[
MI$F$']8G(Z80(!A(5P#)R159FJ(?X!ZW!5HX+]#H+J$'X,.1J4URF@K7/3C"
M3#"PPT1/Q:P.(R<C&$O'+ATZ+L9)JD\:*AT$0#S&ZR9^@"/U^HYX':QZ%>Y4
M\`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`.%PW;O&Z[1V@BZ:ND56[ELX2(NW<-
MUR&260715*9-9%9,QDU4E"F(H0QB'*)1$,`T?\P?!SIVP5Y2_<8WD7KJV.#+
M/7^M9,5$-?S+@W553[..D$UW%,>+F$_EQX(/*T=0R"#9"N-$U%C=J/C-6JNN
M=_'GU,.B<6//%MO1^VM$V-2J;<H-BHTR4RH-R3#(0CY1-$P%4=0<TV,O#3S$
MIA`OKH9^^:=W4@K`<#%#TJI5*4Y]_8YM-9(JRD&`,`8!F=Q3ENYE;H(YNGD.
MHZ60)U_:]4DNS=F`/P[/1L@,/X]Y?RP#+K`+RI.O;ML>7)!T:LRUEDC"3S$H
MUL91%H0XB4J\@]/Y;&-;=P=!=/W+9N`_`J@/0,CJ5*EN/?W"3>#:?H?P_8>`
M496;=+EI9)1,4W#>DQJASUYHH'0Y`G'PE25FU2#V@HP;D;Q0'(=-=:7:J=N>
M>OXS=J;+G?PX]>QTIHW?E^S90V;-F3=!FS;H-&C5%-NV:MDDT&[9NB0$T4$$
M$BD21123*4B:292D(0H%*4"@`9P.ASX`P!@#`&`,`8`P!@#`&`,`8!YNO'1V
MF=Y<]*:7:.1!O`UZ8V1.-R&[B+/;&_/7*]YX`(@5>/:5Z?.D7X.",R)S!V*)
M"/H^`OJJ\/R_P<ZW=+W[_9H,ST',8`P!@#`&`,`M*UTV*MC7RW9/(>I%$&DB
MD4/4(#\B!#_3SVXF'J9`X]/DQDC)*#WY&DT#%6QUB5J[T6<DCT*83"V=I]3-
M7:91_;14$`^\`"'F)'`JJ0B'>4`,4QN+3606]D`P!@'HL\(PO3C;=1_I;NLA
MO_L36Q?^7)SWOY+\%>%V_+-IF4AU7KUK'-'#YZL1NU:I&675./0I"%#\OJ8Q
MAZ%(0H"<YQ*0@"8P`(&'URM;JV2IW:G<DR0[DHYH(_"#?K^V<`$2BX7Z`=<P
M=?GM2*84TB9WI4+U!:64#`&`,`8`P!@#`&`;\>#5U-<./E<:KK"L^I<A*4YT
M8QNI_)8J)R,27M$>I4T(65CFB8_LB#8>GR`@'C^*HK?6_P"_NF=J/I[?[_)E
M_G,T,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`6M<:/3-AP3NKWVJ5VYUQ\'1
MW!VB&CYV*7$`,4JAV,DW<M_.3`QA17*0%D3#WI'(<`,!-K#CL#5SM_P:.*VP
M%74C07%PTU+KB=0J%<D@L54\Y3J)U%:_9Q>/TR=X]4VL38HAFB7JFD@1/L*3
MJOC5K,/O_1AT+L:]KQX&>\XQ58^O=OZQN#0@F%,MF9V6CR2Q/YH$:L6-T8`J
M/Q\*RJ2?U_6A\!G1?'6]+7:'^C.A\HQ]D_!_YOL%#$:TBGS12B(`M&;$JZ29
MP#\2A,/(E8`'\.](H_F`9K_-1U\AHJZ'S&^$#S@?*%(YHM1ARB(`*TEL2J*I
ME#^D8(A_*K=`_'M2,/Q\`/QU?YJ.OD315Q]T9E<=/!ZWY2K(O-[!V1K"#C'\
M4M'.&-;4LEJE4S'<M'*2JB+N%K$;WI&;&)T2E5BB54W0X".9?QZ=DWWM^RZ'
MR;0Z'X?.EZP=!W:W5@V`]2$IC(R3H(6#,<OR4Y8R',D],'=\F1=S+Q!0.A%$
MC%[@-S?QJWCY>W]FE0M[_8S2KM8KE1C$86K04178EO\`Q4="Q[6-9E,(`!E!
M0:))$,J?H`J+'`RJIOO*',81'.;;=VVWUN;B,%=R`8`P!@#`&`,`8`P!@#`&
M`,`8`P#QA>)[>CWSFYNQP5856-7DX6BQZ?=W%;$J5>BXN31*/X`:PIS+DQ0Z
M=JC@Y?D0$1]GPE%"ZR_?A!QJ<U/I;WXF`F=#(P!@#`&`,`8`P"FRL3'S;)6/
MDVR;IJJ'R0X=#$.`"!545`Z'16)U'L43,4P=1#KT$0&-)J&#%VZZ]D*L<[MO
MYC^%,;[CL"]56G</0J3XA0Z%'J(%(X*`(JCT`024.5+.55+7;G]@CO,@8!Z,
MO"1+TXU6P?Z6Z+,;_P"S->E_Y<%>%V_+-HPB``(B/0`^1$?@``/J(C@AB[LN
M\#/NQB(U4?9F*H]ZA!^[(NR"("MU#]ILB/4K<OR50W<X'NZH^7UIIB[SZ`BG
M-@8`P!@#`&`,`8`P!@&U+PT+*8'&TZ>JIU(=&NV5BCU^"F2/(1<HH!?_`-0%
MH<HB'T\L`'KU#IY_CKZ7W7I_9THRU[M_LVO9YSH,`8`P!@#`&`,`8`P!@#`&
M`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`/!!ONQ
M'M^\]S6M13S367:VPYX3]>O<$M;9=^7H/]$"K@!0^@%``#X#/=3:FE<4KT/.
MR)LT!@#`&`,`8`P!@#`/A1--5,Z2I"*I*%,11-0I3IJ$,`E,0Y#`)3%,`B!B
MF`0$!$!#I@&/MXU8=OYTM6$C*(?>4<Q!>IE4?J)E&'7J95/ZB+41%4GT0\PH
ME23YU4;KR_0(-$!`1`0$!`1`0$.@@(?`@(#\@(#]0SF#T;^$J7IQGL@_TMQ6
M@W]?_52B%_Y>G]F"O;M^69H;3O'I$U:S$K?WRL3MEG*9OEN@<.OH2&#Y!9<H
M]7`@(>6B()?)E3^5THIF[\"&.^=`,`8`P!@#`&`,`8`P!@&=7AYRQH_?CACW
M="3M%L,<)/P,=N\AI@@]/Z12QBG0?P*8X?B.<?C+Y.S7Y1JCZN_^_P`&\;/*
M=A@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`
M&`,`8`P!@#`&`,`_!$``1'Z``B/]0?(X!_/3?NCOGSUZJ(BH\=N72@C\B)W"
MQU3B/7YZB8XY]`\YU,`8`P!@#`&`,`8`P!@#`(LN^M6=A!62B@38S703G#IV
M-)$WU$'`%#]4X-^#HH??'X<%/U!5/%5,XSZ@VR>'18UZ#Q<L,:LB9O9'.V[8
M1!HN4.YJ7[.4Q,S]4H]2F1*!?[U$!.FY4[1(*B)51+A4MN]DL@GM551=1199
M0ZJJIS**JJ&$YU%#F$QSG,81,8QC")C&$1$1$1'YSL#CP!@#`&`,`8`P!@#`
M&`,`RWX-+F1Y,T%,H]`=-+B@?]Y2TN?<@`_Z;8H_/Y?GG/XO_3?AZHU1]2\?
M1F_G/&=A@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8
M`P!@#`&`,`8`P!@#`&`,`_!`!`0'Y`0Z#_4.`?SUI-F>.DI"/5`048OG;-0!
M^H';+J(G`>OSU`Q!`>N?0/.='`&`,`8!9UMO=?I)6ZD\=^1)=G+21U&,6^DP
M:1<$BW<2\D\*P075191Z+I%5=3RS&`AA,0AP(?MRZE3GJ_!9?A)JFEU8CQ<9
MP5%Q;:JU]S]59J^V]D!$TSZB9CD?:`<_]W&3\QR7T`./\"+KR@5_F=V74N5;
M-T335:SOBSOV*##;-I<V9X+:>BD$&]C=U1HZ>3$(DE,S;!0J#QG$IDDU7:RJ
M+DP-RHN&S5PY'L<LT'#%PV=+Q54O?=J[5VLP5T5+9NTV3LGS;WC)6%;I3D53
M(K6RLI+$?FBSI*SL6FJ63*+<IHXR9G0&*_*9VU*9F(`X`7+<!3ZK)]UU+E>:
M)I?#YPSE;VVJ.S19&MFKSD\YYX0I&\U&K&E_2G42=>UE3<F&0],HDJFOZ0%O
M).FH13M,0P`E<KS0TU*?E=LV=NYQ%NE.,R5DBVRLFCD'B<<N_+.Q8LD9!8A5
M46"KH'7D)O%4SD43:G4!<Y#E.4@E,`BE<KS0TO$.8G#QSV*JSF(B0=/V+"4C
MGSV*4(C*,V;YLY=1JJG?Y:3]NBJ=5FHIY2G81P1,Q_+/V@/8;I9$-0VG#QU[
M%1P0SIXL/?-I]@CQ'J+2QBY`/Q*1]&LDRA_4)V2@A^\38!D_@#`&`6Q;;K3Z
M#$C/7BTU^GP95@;FF+-+L(2,*N9!=R")GTDNV;%4%NU<K]@J`;R6ZRG3L3.(
M1M*[:2ZV*DW9)M\)3Z'9KUIK=L:*OZQ.Q-@8H+)-U7D._;2+4BR[%G)HIBX:
MJ*I"96/D&+PG0X]S=T@H'W3@.$TYAS&2--94=RO90,`8!UVKIJ^:MGS%RW>,
MGC=%TS>-5DW#5TU<)E6;N6SA$QTEVZZ1R*HK)',FJF8IR&,4P"('493,7(OI
MB-9/4'+Z`=-F,RU3,(JQSMY'-)9J@X`0`"J+QK]F\(`"8!1<)CU`1$`?@%3P
M!@&7'!I`RW)FA*`'4&K.XKG_`'%-3)YJ`C_I.2A_6(9S^-]#ZQZR:H^I>/HS
M?QGC.PP!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8
M`P!@#`&`,`8`P!@#`&`,`\%'(:N&I^_=W50Z8IC7-N;&A"DZ=`\N,M\PS1,7
M\TSI)$.F8/@R9BF*(@(#GNI<TTOHO0\[LVN"'LT!@#`&`659J)"VZ6@9"=1(
M_9PC:;;C$.$Q48R`3(1I3@^3\TJ;AND6/[3LG*3AHZ*N8%TA`A>N72JFF]IM
MLYC/D:534QEQ?@LEOIEBE)NGJTKZM`UL4M<>1VA*NGC!1Y?FFQ).,*=Y874*
M1BYFF:)$!BZ]$N$4&[-1TM(.FYG"\T7F<-O'-6J,\\(UKLK?QC:'\NE.U*>.
M6[GU+:?)(E>HHV`S9O,I7J.FR+1*;M56$OMG)9I%O#K>N;C#RK-5,&C26,20
M1$G8Y7BU'+9DHV:,WS,^+FW$>[A?$Q*QIB'%Z5%\S]NYR/\`342_C%(M20[4
ME(7:$.)QC6Q_G9UJB[2^>=AE.T5H]:,]*4/_`,:1RHLL=,P=ACH4)<)K'+3_
M`!]Q_D<S&]+_`/BFOO,GX[U&JXFVTBG:WR$8E:V]M5@RMW1&AW[:TEM!2IE:
M2[-DKZA8H,W*DQ'3/EII(N8HD4[,]5>M%YG=.(X<C7:--XB>D1Q;P:ZR=5CI
MDL*-7<0=@2:OJM7ZK7FAGT"B_CG*%=KMDK3ATXCDI%B/K)%E8U54U4W9?1+-
M4TU`?LG#IHK-$1#Q"Q.T/S]R/\C<IJS;>6HEIQV4?Z=RKUK5#"`?R3I:4D'R
M3B0?OHXZ$I:XR49)R4](6)Q'NWK:UG8O(\'\@IT9LX>(:N2)D4E$))T)G`U4
M1OSRG=MY3C?A$=;>RZVI:Q&],S;+;Z02SFS!EYQ1>]KNZ1PC_&MX1ZF7K]/3
MJ2*"H@'^-ZE$!'_%+@&9F`,`8!'VV*D_ONL-@TB*<,VDG;:;8ZXP<R!EB,6[
MR8B73!NL\.V0<N"-DU5RF6,BW75!,#"1)0W0HRI2FN4UYHM+BI/AI^3(!V?Q
M\NE^DMFNT+,S;(6-IL1S1R&G[/'*5NS3VH]14RD3*GM:!0:+5>YT6Q6A!=D=
MTK%+R4;.129YT5@99=$ZNLQT<4I>34FU4EIMATSC"JJ;\U4EX1@HS_C7="7F
M*?Q%E!#7\/;G\U`U=A;G$&YJ39W*T>;&1B5I/7UZ,ZDG3^%LJ4A',7U645CY
M9S'DM!65EGFR<T.;.VU[K[/[0_N%6H:W:AN)FS5[KF9O=*UD7=?]&[)L4^V7
M@-NS3:*E*U),K5*3!VC>Q)V*OM+8MJB2@&-0@ZU`)HP5DNB\Y8%SHL7\FG3*
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MGLRX(G'`3S)`RKAP\D%7CQQJE-3,*8LFVK*-XS[EF*FG$39-727\F]K89D+F
MC(P#.OP\HDTAOMR^[>I(*B6"0$XA\%.Y>PT.0H#^!C%DE!`/J)2G_`!SC\9_
M(NM2]&;H^KP-XN>4ZC`&`,`8`P!@&M_D%XDE2XT<A=8Z4V=QVY+,*-M7<FLN
M/E:Y,-JA4#Z+=;?V]$MI:EUEB\7O*%[EV)@75BYVR1E(<0L/.1TO$E<O741)
ME:#2IE-IJR;B\PO"/OBY;-#\5W2M^Y!U[2S+5V[8FCW[;^W^/FK.2DM!TX-)
M[,W9HJ/EY'8U&K9X^[/]A(%;!7Y^.K-DFJ)&5ZXS$'*Q]??NS-R*K`Z&DW*L
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MK'8&PZTZD*]-/8]E:*K(R4;8H8[]!7T+INB_69`Z84RFL2ISPY291=B^(]5Z
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M2:3>J-W!&1XZ-<`\.V<E;"J+=8"!#S#CDIM=Y3\8[?L5+4%3Y%:+M&V%PLXH
MZRKNV:'-7]7[%2DI!W$J=/C9YS8#'JDS!S<58R!'B>%D8:79R16SB,>IH!#S
M#CF.<>9:Z/-[ABYIUTV&VY:\:7%!UQ/-*ML"ZH;SUDM5*39I`7`1U>M5@3LY
MHJ!G)$S-V2.BI-VV?/SM7)&B"QT%0(&EV4.7BSOV+#M7B.<**AL+C?K>1Y%Z
MI>2G*]G8Y#2D]"WVG2U*LK"O"9LB^/;6D\>';-+7/).:?1G`+K)7"ZLGU3A#
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ML8R0M-+J<*%O?%B,-V^*GQITK?\`A/KP[+8.QY+G:\U\KJJ5UO$5^4@ZM4-I
M6K7U+HNQ-D.IJSP#F#I]BL6RH!E&.(AG8))YZ2<]/&J*QH(N05+<_P#CGPNX
M[1[E$XZGYF:EO[>Q(W.S:WU'98>_;^JD54;'O+3%DF[)6N.L^M#[!V`R)2[M
M.(L8BO-4TY2ZP\HHUL&M4U@:WQA"+@45!(??&SM*LOUSL=7E%S$J?'[0M*W7
M38R+W>MM[86C-8:*K]5N,>RA=LVGD#=:Y5*(I!WIA'6B+"O.(R>6N(SS".F6
MSNNQ3A>.3=F7;=XJ4N,0FWTA28I["\834&L+[R`A;7QXY4&U%Q=VK&:@WMR8
MKM-UW9]/ZYL<I%5>9++V".A]I.-NEJ#!A;H9>5L,?K"02CR+B==N!2G$HJH;
MB],M2J9N_M'W-@+ODUQP8;,K&EWV_M+LMPW6+9SE/U4[V?2FVQK5#R#4[Z/E
M*]2EILEDF&,@Q26>L',?&N$GK1!=RV,J@@L<@S#B8<+>+>94JCR!T/L#8=TU
M'0]U:GNNUM<%.?86M*GL2HV*_48B;M)@J:WU"(EWE@KA47ZZ#%<9>/9^0\70
M:J]BZR:9@AI3#AX<69A+,^)G#R.SMIT717$WE?RAJFAKZ]U=NO;VDJMK9U0J
MAL2&*U&UTJNMKQL^EW#9]FHIW:*-UBM>UB>5AW!B-&QI)ZJFU,+IQ+2E2DYN
MO!./&#+J7Y7<7:_8[=3Y[DAH:%ME`CIZ8OE9EMNT".GJ1%55*ON+-)6^)=V!
M%_6F-?0ME77FG4T@R0C$;%"*O#HDDV9EA(>8</#CWP_(ID?S(XBRVN6.X(SE
M+QV?:GD[%(4^.V:VW3KA6@/;;$P4C:)2K-;>6R#`+62-K,/+6)_!DD#2C2"C
M)"7<-4X]FX<)AIJF(<\0Y\B*[;XD_!^FVSC?5)+DGJ-\'*US:F^F;7![!IDQ
M0YU.I,I!5X_>7)I/F@XZ-E)J,<TFNOE'1T)W8`HTI@92P*@RP735=P_EST]Y
M[%3Y3\V*GQGMNH]3Q>KMK<@-^;V/;5M7Z0TO'U1Q:Y6"H3%G(7.Y6&<O=LI%
M)IE-KR4E&MG,W8[*S,]D9%LPB&<BL1[Z,%3,N4DLM]<8EOP1:^D?$EXP[9UQ
M:K[=[8AQ?E-=[5MVCMGZ[Y0SU'U1<:#MBC5M6YV.I2*CRVOZM-^526[F[1TQ
M5;).1,C46C^:3=)IQ4PE'`Z6G&;3*NHQ/GR?%Y\1?C_3=K\9ZDWN>N[!I_DC
MJOD3MQAR78;5II-.U*K\>$J$>:?/[3ZA>MR,7+KW<[,TTG9&+*#=0CI!YZA5
M4Q&P:7#Y32B+RY_17^7/.?6/%37;W82KNH[$)3Y71\YM6IPFQH%E=:%H;<VT
MHC5A-]DK2#6<E)NIP,E*JR;8JC:&B;(SA9Y)C:&BT8O@)3]X<6;2F/>#-[!D
M8`P#QD^*)1CT7F]N=(J(I,;4\K]YCCB7M!P2T5N*>RBP!]!`+$6:0[@$>X4!
M,/0PB4/9\)S0NDKWX0<:OJ9K]SH9&`,`8!;-Q>34=7)&3K[<[V3C/2R81Z38
MSQS*,8]ZV>2\2Q;D^^I)2L0B^CXP2=3$D7+50"G[.PTJE)M95^9Y7D6F&TGA
MVXCA^9"1;1N9622*NS;PR2]:4F4DG58L\LV26DH6P2A6+K[/UF4(:7K,D$+#
MF8*6**=2:4<\*C%R3Z>BU$,37V[TO=-[)W7?I=N_6/AQN_FC-*W2W:L[O#CE
M0RGFLFUDRR,LU0MYEG57IR#*)DZXX5:(N$-C6&$NTZDK'4LKI*4;U,\7/P[%
MS7FTG*,'+-TI3G:K!S"M9-:G.%%I_DTW9?\`;?";G%H$463BS<M-3>E.E?5&
M;.[2:=U)VT)794K8Z0TFPEB(-9N">*EB*A84864BCL;.#V6FIR0A8A2(D6K@
MD4T<PSUM$E\P3NDX91K(L'#"S4VIV:_BU.;W2CKZ"*$JHX:O4I3M9)-RGS?O
M*OP68;HRLMK]@=WEPW<2M>EW$ZTAKB92N1K&YT=I,UF*A91K(U6V-'U>4L$P
MQ>TZ+]P;M(V1C9)N_<2HN7\>J7&K*<P[+4K).4[2UIX:BX3IA2J=U$TW>EPV
MU%5-X7S.+I['?<V_:1'4H"+&=,V3?2C>4$*-('&N1:&R:_"0DE5S`P_ZWO)/
M7#NP6I\W:!8!:2D:V*>.8]X5UVFN^?\`XNRU*&N9I;;43*)IIMC%OF6=#;3O
M:*DDKJ4]\E>H3VY?;VWH2S>:-5)12.E8&8>P+Y@>6?)T37;21]P;O$&YJRD@
MNDX48QY6J1)&77LK=<6+N"%F[M,ZG,P[IPU/RTYG'VESQ!*M.E1$JS4S'S58
MBS_49F2<LZ',R/XP/?3W^0:"/W7]:?)@7\UF[Z-<$']_:D1?_:$?PP#/G`&`
M,`POWAMVZ:^OTTTA;9'O2N=;V%:DTB)=TZ0<,KW!4;8-R6?[+JSJ(5V']FY%
MA!1ZE>G:C/(QQ9-D6*GX5NS=FEGW.IM/.4X5LI-RU$QU3Z1N=*:4TI7\E+<X
M;2L\6F\KK.Q29;EQ)P(2:GLM)MH046_.O&5>VN#V"QG8:$>;N&Z5Q@$8^(IK
MMPZ:AKT)81<BG8"R"Y'*R\>2$>M;O9.)P\Q3JE6P_I[A43&5+65:]6F'_P"4
M?-''F7!5M[SS_>D52G4G3)VMVNA4MXULM4L'NU`96$MAWRB^BH&519*.G]TM
MK&IQ!6\,_<-XMNQI5K53DQE6+**G2J>I*S3I5T[3-6.6X^S[,Z?EF\INS5XB
MG/"4YZKFU!E=TVJ/M<@Y2OZ#BSQNX[!25^/WI:D42Z]AF<FHE:E0"&-L-N\<
MUEFTV@%B/.C6!BWJ<02',59!<3J<YNJFM-L*;\WB9EJ-@J4[1"=,JJ^>,QFV
M)MDHD1RKN-K-2'#`=9,(6:E$&LU,0EH7L,:LI8-.2VQHBH0LVZBFK)._0SR.
M4;/H]TP<D>$7@7`1Z))-W'M9K;O\L='S3JC&5^K;#0E.6]I4?R5,M2W'EOW.
MRCRYGVL(\=IURN3;R+J,P\]A=6P4+TF_KNL86^!:;A&QU:39PU-LSN42A&DO
M'QH)I+R=:D&K-8EB"&A[KZ2^)OB9=K+_`'V:.N6MK7JTPG.5F.CO:7)D#R`G
M5M@U>@6B&JT4ZDK5=*9)/8J?6E5'<]7TG+Z'2B(0Z#6P-&,G#MUGR\S(1B\&
MW=,)**<2;)P6-5DZJG*32RUGT6<?[1'39M/"3OP_M*?GQ>V56;,#`-JGAHUD
MPJ[3N*J?0A4Z[66*O3]HQS2$I*I]WX=@)PQA`/KY@"/T+GG^._I7=_K\G3X>
M[]^[&US/.=!@#`&`,`8`P#2=R+X]\\-K>(?K?<LSI[0NZN)?':3JTYQMH,_R
M)L>KG%6V=)1+%M>>0^P:<WT9L%#86RJ?[A/P>H892R0M?J+!J$VRZ6>><R[$
M;3I5+5U4\N$[<+YETFQ#FB_#;Y8TS<7'S6=U;Z=2XK\1N:/);F/K_:4+?[#(
M;1VF.XOTEOM<:VEM<+T-E'TQ]3IG:<RXO%E4N<\PF&<:S:0+`#]SI<5U4M-W
MU54JEK91IO,SM9>9]4C@)S2W6/B/:^Y$06L^-FO^>]\HNV%;QIK=BV]+/47=
M%C]151[IV5I=MT?K>$N-*V35J58T;?8'DM%)C#RJ]/7I\LSE74HD&JE:6I;I
ME722RW-FVFF_S*,P/#4X9<AN)<_S:=[XW+%[8C]^\EW.U*&>)JE2JAE8I37U
M/JTC=IN/J<#!M:[8[7[&P@W=(BQ=5>MQU'B9*"43>V2;`PS54GIA1%,?=F,G
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M4:#\13<//+^ZS@[O,OM^[BA=@.=E2<+J2>H"FN8]6)F)!QL!A";'GI#9DG`O
M*]4(E.):R*S)JDX%U*'F72J8V41=.>F(W+3X^^#!=M?UO@9'7S7''&3E-"<9
M>>.M=UNDV<=+_:'9O(298+ZIG&CAY2DUK02+BW%@;2L]*E;2,"E(O&T>D\2>
MJ@<6JN=<-W=+7A/]&%4WX?W+D=B%X>UW1_'O:FPP\"W0?$JY[#VO9Y^)J.HY
MZ:VCN>LR>P-6V\FK[:-GE:29)I+C6&R-3FW(-ZY,,7Y0B0C7XJJ43+7_`.5U
M0LM6<-2LXG8S74\(K>\!R:F7LVB7?FB[_;.#UQ<7#^Z7D-)6&C3?$RB:XI"D
MI;*(&BMF2NPWD;(4)6[:\;UK8E.34/,/JM.OHE.1?S^#.M1NG%2Q*^:>JZ+#
MQX%^T3PI-MU"TZ/O`571YK=3?$LYI\I=ASJ4FLPF;1I/?L!N"%I=??65A4#3
MLE).VUIIL;9(-8ZC:*CF@E:N7_M3=$P.NS5_IHI71TM-[]"/=>\`/$GU;I"Q
MZUU@I0*%K&!WKQ\F-2:!F-X53:VRJ!HZE5S9K'<E*UIRGN_%I=Q5&\Q9;72U
M=2'M5%MMJI5*A;U%-[+#2%N,BXGOUZ>_4ZJ6Y<MM.7B6XAM)[+*32G;FIZ!\
M+[E7H=MX<5M>TC0NR[?Q7Y%\VY_:%4E]F/T6)M9<K;38'E5L]7O+G3YC6*8U
M>G*#;QK[FD58TO.K"A%A7'+MR_CJ'52W7E:E2DX4V2Z[Q&=RFT;PR^8NB%]`
M[+@=9\;>25CUS&>(3KVQZ0VKLF4K%*BXKEOR+F-LTC:%7L;C5]V9.Y=M6%&E
M7V57UZ]&/W<"\<0L/*O1456;"NJESE3I<I7>FF(SS=.2BQO@F;?@]66+7DVO
MIK:LS&^"C(\$J!;[0==PK#<F9+9NWMA%DX`TS6'LA7-?P?VYK\77[@W]/8",
MX9L92OL5&Q422',[1'C(UK5*E+7JCHOM+-F/(SAOL[<>@O#SU8@%.E)/C;R1
MX>[0W(A8)5R:(F*7I6O/XC8[6%44B79I]_(G>&)&,)!M'H2R"BOJW+/J)1IE
M50ZG>ZJ2\<&L+3G@O<F-=FK+JUWRC7Y]I?G7PY'C\[E+%*G>4SPZ>(^[K?MF
MNU0SE6`[D=B28["E4W]7)ZB-66JM=1&S*%(5<!IUKAWIJGK74DF\XMWN[%*Y
M$>#1RNWWI60TBTF-/T4S;EMXBG+**V>C8YYY:'I-].KBUTYHTP,(1BXCM=;;
MC;HLVY(%%=VFG7(5C"Q[&?65,)`5:3F_TTTQVRU?*A:?P;"?$;J.QAXL<'MJ
MS&OH^*FN*W,G@WO_`'-K;5Z;RT0M:K%2LK:C[*845%C&M7TU6Z`G>G4Y%K)1
M#11.N5KW-PR9)-5RH'?[?9R8IRU.55$\Q*WWQW9C3M;@+X@%O?>)3H2AQ7&R
MN:'\0_>"MRF=^6S9UUE+[KO64]KS7VO[C#PVCXC5Q8ZPW1S$U24"#=2.U(.'
M;/)%$[HP$;%<'&E53\K>INE)19)M-M7GKP4IIX3.WJIS%L<ZM`EVSQRLW)7C
M#R%J-L'DZ]U9/ZQ5X^U37E5BFEOUHEH2[R>R9^E)45=2@E@-G4^&FHB3"`FG
M=52>23M,-:T\514L6:J;;W49X;^YF-X9'%;D3Q$:3&E=L:GX].J51Y/?,G5>
M5=1N<C,;QW:?<.\5=H12-RIS[6D,O42-(1\HROJKS9%I"6GZS2DX=HO&QAI%
M$2IIW3<N)3PH49F_*LH3->O(/PMN=!ZCOOC?HV+U!9-;[0Y3WWD[H+DJ[Y*;
MBT5M#C6_W+?Z[>=I5.[:VHU*G(C<;0GMLU7:K**6`YT8J9&4=1Z$F1-FV>_M
M[]>A56K.\I*EJ$TTE"=\;29<V#P_.0]?KGBJWC4$?H>*Y)<K]^05]X_[#M,1
M7;$_::QB:QIIA(U:Q2MJUY;FE<EW"]5V$%11>0%NKU;MDK"6]RQ7,BJ"8:DW
M1,Q2H?>][.>.'G!C%K;PFN3+Q]!/MNPNL96'?>++I3G):*G<-EH;;=*:EI7&
MJ>UK86-@F4]/Z\K=JV*6Z2$8J=@SI,-!.B-573:4<)LVKQ\+K6T_]/3B(>J>
M<07?3O#`Y&ZCO'&G9=4UWQ^OIM$>(ESMW:&LY>XKU&#+QYY8)7""HBD),$UK
M9FD=,:P;S[.X#0T8`&/N;1)C#RK9SUD6XFI--7O32IA.],=5F,F=7,+CGR6#
MEQQLYR\5*]K':%ST[K3;>D=B:2VI?9?5C2[Z]V<\K<['R]*V)&4N_M:[::O9
MZZDX>MYNL.V$U#.E&R+IDZ;D!T)2UI=+E)M--7AKE2I4>V855_PK=_6Z\:PW
MAOAGHV?V#>_$\2YQ<A=;1<E)676]#UM`Z&MNIM>Z\J#VSU)HILBUU=PK6927
MG9&OU=G(3#AVZCD$D85H[?BZ\I;4Z4\-_,FV^)4G7TEX1NSH:W:-KVVX[63O
M1=4-XN-3V%5:Y/.C"367.F\UU[K&"JT2:MLV"94:FSETY]F0S)M6G9VZ3$)'
MN$Q`=:BTS_\`COUH3EY\OP:Y]5\<]Z3WA`<PI>_)S>T-_P#,N^\?.`7'^03J
MD^U=3FB./=ZIG&K3UK6BY1K[U!Q#[T&UMRV>;FBL6SY@H%F>JI`Z0$HU*UTQ
MBF:G?=W?.+*%-SV:LVP,F;1F5118K1L@V*JL;O65!!(J0**F_G*'`O<<WXF$
M1_'!Q.S@#`/-YXZ6K3M+AI+<[1L(H3E?FM;3;DA1`B+NNOSV2NE6,`=IEG[:
MPV(J1AZG%*($HCV)I@'H^`_J79_O\'.M8?@:"L]!S&`,`8`P"DS\TRK<%-6*
M2%0(Z!B9&:?BB3S%@91;-9\Z%)/J7S%`004["=Q>XW0O4.O7(W";>$I\BI2T
MEEN/,CDNSW,0^3C+K6S0L@_8Q+^$;5U^\N"DC[J^4C2QRQ$8.)69RC1[Z4CD
M"HNXDJ3LCDLP9!N[.AG7&5F(TO5GP7Y[FM$X>)F5$1Y_A]#Y:[CKT@[.DS;/
M4X](U8,>9E4'D9'F1L9'A_+)U8N'"4C&BR<(O&+]%@1-P@Z1<.VQFQQ%K7%K
M7OOX97`=#7>]K;;YPYS]CF5W/2T6Q5U"V,%#IINDF'V7FQDE8Q:(?S[>7*Q!
MGYY8QQ$Q<DZ2<*E3-YK!S''3)*I^A%_D7#YB+Q$S`_QU=+9OAS$=TX\T7C7[
M?"6AS,MH9=5U[&Z09O7`H'2;BY70!P":)E.U0XE2,101,FF4Z2R#A`5FRZ2Q
M])IS&QETM1._OW][ESY2#`)AT(]]%M2L]1Z$=#*,E/W^HB'P)!__`""HX!LG
MP!@#`./RDA4\[RT_.!,4@5["^8"0F`XI]_3N\L3`!A)U[1,`"(=0`<`^2-VZ
M0E,F@BF8B0($,1(A!(@`]P(E$I0$J0&`!!,.A`$.H!UP")W>T6+"T35(9T&X
MR%BAX,+%%1D:A34@L\(UFH^$>O()60ML<VCR1;Z715!&VJ5=:3:E>NZVE-)M
MEQ+G5>(;>=N8W?C>)6)-:;)RLQO;O;TF-X*$]W/3WVNJQ>UJI9';'8[]S48>
M"4^R+"<D/,2L2AR*R<C;8^JEB7L?7Y.3CI%*V'82C%9@XB5W:DBT(HU*)V=O
M=QI>IJ5\MV[].$WE\2M\'Y`;:URRFOT5P\++LY2LOZG5XZO%91[@YEI!FY,8
MK,4Y9V?R:E%Q$H^L,A(G;=T?%.WL*M/E4:G=E4IB_'OM^!I;6KF6^G?:[<+K
MP3OY"'<8WDI=QTRHG-Y9.XZ).[L2,/3J9,G>?M(/4I>XW0`[AZZ,G[Y*/F%5
M\I/S2=X%4["^87S>WS.T_3N#S.PG?T$._L+W=>T.@')@#`-^G!VDFIW'RM.5
MT?)?7-])W)V42]#"E(J)L8D_<(`)B+0<9&.B?@'J!Z=>HB/C^*YK?2WE_9VH
M^GO_`*_!EYG,T,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8!C?OC9=]JUG
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MD<Y658B[<F0%=09=G!*V`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@&!/B6Z34WA
MQ!V9%1[07EEHC=#:563(055C2%+3<N99NV2*'F*NI"HN;)&-$4_OJ.WK<I2J
M#T3-T^'5IK76S\?[,U*5VN>+W/8<1@#`&`,`Z[MHV?M'3%Z@DZ9O6ZS1VU7(
M51!RV<IF17063,`E4262.=-0A@$IB&$H@(#AWL\,*UUE$-2FOM=HK-H8;(ZB
MY=L:$FS>X7B9>60E=J2[QVU;L7<G/GF8J%:*+.5%W;-5-$3`JH_,Y$#"&'33
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M_;U%)-`B>E2E=9:2F=O?N#+J;L\)MQ&_OW)=6:,C`+TUP]]OOU,=B/:5.RPQ
M%#=>G1%=^@@L/]B2I_Z_I@&U3`&`,`8`P"!Y'1J$C;[Q=B7&7AYZWTBS41"1
MKL/68.2C(^S*0RH2KZ28Q)'=IL%4""9MJ))6$SO[-,7$H@5!ZK*OG"V=-VYR
MFK0L]8O&TXN:U62BR:=Y>)ZV3F\9+@L6K22E:2IT+--Z]5&4+7X"(KAZE4['
M"Q$;",YF,42:LK#%OBJB]C7\6V3(\.X;,!KD>+=L+=[--9,U*CM%D\=PJH<Y
M<MMRTW/5/GU[1'<SQ;ILM'P+`LW/,QJT!7:E7WY/;W$HRK<#5'=4.59\Y:*+
M/+$^*Y:3_P!IU1*]8V6JT25:HE-5$$GDT+G$)6V2B_/[2X&MWZW:VS...G#J
M6YDYFS(P!@%WT"G2&P;M5J3%`;UMGG(^(34`HG!LF[<$(Z>J%#Y\A@U\YZX'
M^:@@H;\,E3TIOA2#TWPT2Q@8B*@HM$&\9"QK&)CFX?1!C'-4F;1$/@/A)NBF
M0/@/@OT#/`>A*%!4L`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P")-WP6
MEIC74U(;^K](G];4\@W.4-?8-A/P\&O!MW)DIYHU?,WJB,RS0<.6\<XBT1F%
M#O%&,?YBSWR%A5.V2'(W^Y`?Z_@]LP6LJL^K&OT8[6L`VK^@[&[NM+#7E^8O
MXK7C'5,10E-E5YY0=AU]C-,:<2FM'U1F(PL^A&QP)'?8%\3USRN<71;K"Z\"
MK+,1%PBV6GIR90@6=\K5HCM?IR#B5C]QSU9O+=>K3;6MJEL\_=K3R!IMO6K4
M$YE+0O8=UU>>=1"4GL6)=3`OS8OQ^+^6_#X,SX>(BJ]$Q<!!1K&&@X..91$-
M$1;5%C&Q45&MDF4=&QS)L1-NS8L6B*+5HU;IIHMVZ2:*1"ID*4!DJ.`,`8`P
M!@#`&`,`8`P!@#`&`,`8`P!@'PHFFJF=)4A%$E"&3434*!TU$S@)3D.0P"4Y
M#E$2F*8!`P"("`@.`>(3G-QZ7XS\E=A:[0:*-ZH[?FMVO51*8$G%'LJSAW$(
M('-\K>Q+E?5=TL(%\U]!NE"E`AB"/M^'5JI3WP^Z_>?$X5*&UY=C$7-D&`,`
M8`P"+;%6[!+;!I4RV123A*S(NI-THN_9BT7%U6+'`**I1B<065//$]Z(T;K+
M37LR40=ZJ9N9\*:!\-/4FEC-[8:QF;PMH^VTTJ:ENU'7*>9C3*XF3IMJC+$J
MDU&RL0VDI.Z+S<]:A83?MBB$B[58(1$/'.Q8'!8L3`-6,&UDC@T():^U562Z
MOU%$&EPU&9;NEQ"5O#PR74M2:=E"4J9Y;OS>.N"RI/5UQFV,:\DG2:U@;)R0
MO5UI)NX%[#M)^;6J57<$+&-HIZ^:URR2K.6E7<:,;(+![7+,I^/DGCY'+H;S
MF^^VIM+R=]MBZZ5;:UHB^E2^BE*%G=-."?H(LL2$AR3ZC=:=)%L"S*K0`!JK
M*E:I!(*-@!-$/(.[!8R71%(.P2]$DP^X7HIA3F+]SFXEQB7';8JN4@P#M,G)
MV3UH\3Z][1TW<DZ?`]Z"I%2]!_/J0,`V]IG*JF14@]Q%"%.0P?0Q3@!BB']8
M"`X!]X`P!@#`&`,`8`P!@#`-FOAT:F/)6*P[@E&P^AKJ2U9JYU"?=5G)%`AI
MI\@80`0-&Q"R;#N#J10)M<O7O;FZ>?X]5E3XO\&Z%>>/4V]YYSJ,`8`P!@#`
M&`,`8`P!@#`&`,`8`P!@#`&`,`8`P"'-_P"K7>YM26W7<;.-ZU,RWL4I7YUY
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MRC=N!6Z!W:I3N#HH%!%(R@D2`"%*&#)W<`8`P!@#`&`,`8`P!@#`&`,`8`P!
M@#`&`:E_%PXK*;QT63:E3C1=;$T@C(S8HMDN]Y/:]<$(M;(HI4R@HX<0H-D;
M/'$.8XIHL9MHS1.ZEP`W7X5>FJ'BJW9[/]F:U*ZH\E^>LXC`&`,`8`P!@#`&
M`,`8`P#;%2GON-.JC_KW"\KD(Y./^.K&MCJ`/[RG$P#^\!P"YL`8`P!@#`&`
M,`8`P"XJE59J[V:#J-=:&>S=ADFT7'-PZ@45W*@%\U8X`;R6K9/O<NW!@[&[
M5)9=0033,(1M)-O"&;(])NJ]=P^J:!6:%"`!VD!')H+N_+!-22DEC&<RDHN4
M.O160D%7#H2"8P(D4(@0?+2(`>&INIMO?W]CNE"2)!R%&`,`8`P!@#`&`,`8
M`P!@#`&`,`8`P!@#`&`:UN4GBQ\,>*B\C`6788[%V''&517USJ9)I;YYD\2$
M2':3TJ#YE4ZTY05["NX^;L#2:13,*J,2Y[1(.E2WMYF74EN:'=X?PB?D%:%G
MD?H;4M`U3#G$Z;>:MZS[8]P["]02=H`'V;JL>JH'ZQ1D[@;"FB(@D5XN!164
MVJ%NY^QEU\+S-:=]\4?Q`]CK+*SW*G:48"PFZHT.29:Q03*81Z)I)ZY85;L*
M4/N@/45!`.ISG,(F&Z:5M^?4SJJY_'H0E"\GN3$YL+599?D1O.5]9NK2C=Y[
MEMN_/O5M'.V::B];.?56!7ST';4ZS=RBKW)KHJJ)*E,F<P":7"RMNJ-?#;U*
M^U7_`*L]C+:_WIF8#-;I;&Y@_%&Q2Z?]@@5X`"'Y@("`_B&6%PO)&)?+\R^8
M?D#MJ',7LMCB12+T[D)AJRDBJ`'X&77;B]#]XINDQ'\1R::7M[]"ZJEO[]2<
M*OR]7`R:-SJR:A!Z`I(5Q8R9RA]!'VN154*H(A\B)91$`$![4^@@!<NCA^?O
M\&E7RO+W^3*:F[,I-\2`U:G6KMR!.]6,6$6DJ@`!U.*D>Y!-P8A!^#+H%6;=
M?V5C!T$<--9-IIX+\R%&`,`8`P!@#`&`,`8`P!@#`&`,`8!\G(10ADU"E.F<
MIB'(<H&(<A@$IBF*8!*8IBB(&*("`@(@(=,`\>WB9<,W'%W<2UFJ,8=/2^T7
MKZ7IRC=(19U6:,874W0USE#M0+'G4,^K95.WU-?63;)*.W4-*JD]GPJ]:A_4
ML]>O[ZG&I0^C]P:TLZ&1@#`&`,`8`P!@#`&`,`V::2>^OU;4%NO44F+AD/YA
M[?(O&)0'^HK<O3]W3I\=,`E3`&`,`8`P!@#`&`,`W%\">/1ZO#?IGMK$4Y^R
M,C-Z6S<I]%8JMN0#SYH2'#JD\L!``C,P%*=.$`5"*'2F%$T_-\:N7I6%GJ^/
M#U.E%.[\#9+G`Z#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@&.W)GE3I'B+KE
MWLS=]O;5R'**S:#AVY2/K5<9=-+S2051@2JIN9B34`2>:;N0C8Q%0'TU(1D:
M19XG4F\$;2R>-SG'XR?([E<XF*;0'\AHG2#@R[,E2JDHJE;[7'&$R???+DS]
M,^<)/41.#FLP1HVN@@N+&33L)VY))7K32EU?O!R=3>+(T]YHR,`8!<%+*!]C
M:D`?PW5I4W]I-K4\X?[RY'CQ7JC?P_J7:K_U9[6,I@8`P#F;.7#-=%TT76:N
MFZA54'+94Z"Z*I!ZD4162,51-0H_)3D,4Q1^0$,`RVU?RAE8H[:&V'YLQ&=2
MI)V%$@&EV1?@I3/TB`!91`@=!.L0"2)2]ZAA?J"5/,54;KR]X-TU[/S]Y,[(
MJ5C9R/:RL0^;2,<]2!9J\:*E5063'J'4IRC\&*8!(HF;M424*9-0I3E,4.6+
M,ZYNBH8`P!@#`&`,`8`P!@#`&`,`8`P!@$-[\T91>1NK+/J;8;'U,'8FO][/
MD"I^YUZ;;`8\19(5=0I@;RL2Z$%D3"`HND#.(YZFXCGKQLM::G2TUE$:E0>*
M7DEQVV#Q?VK.ZLV$S$KN/.+N!GFZ*I(BW5M=54D99(513KWM'I$CIN&XG.O&
M2*+R+>=KMFL4/;34JE*_T^#BU#@@7-$&`,`8`P!@#`&`,`8!L'XTO?5:U!#N
MZ^VSTJSZ=?V04(TD.G[NHOA'^T<`R!P!@#`&`,`8`P!@&<7#KC"OMZP(WBXL
M5":SKKTIO)7(8I;A+M3E.6(0`P!YD0U.!33CDO4JH=L4@(K+NEF'+XOQ-*A?
M4_LOWP:IIGLO?^S>6FF1(A$DB$333(5---,H$(F0@`4A"$*`%*0I0`I2E``*
M`````!GD.Q]X`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`PLYS<X-6<&-0.=B7
MM0LU:ICU<9K37+)VFWF[W9$42G%%,YB+&C:[$^<W<V:Q*MUF\2T50111?3$C
M#Q4C4FV1M+\'@GY0<I]O\M-G3.W-UVA27EG`+)1,4@95K5J37B*'7;5RJ1*B
MRJ43#,2B)CB*BSZ1<^=)S#V0E'+IZMV224(XMMLQIC)>+FD#.8F0:2*!%/*4
M5:+D6*FJ*2:X)J=@B*9S(+(KE(<"F,BLDJ4!34(8UR&FK-05'!!@#`+GH90-
MLK4P"'7_`+8]/F_M+LVJ&`?[!`!_LP_UZFZ/J7:K_P!6>U'!@L]IL"D/[A)Z
M_96J#=W6%:$>R]8;2""TO&-U&\<\+ZYHF<QVJWH9F'?F:K=CHD?+Q3\Z)6<B
MR67="PXF+<E60L4*YL4I4T)!%2Q0D+`6*5BBE5!=G"VA]9(V`D%#"F"(HR3Z
MH61NB5-4ZI3Q+@5DTR'0,J)UV_4?M%:P!@$O:GV].ZPE`%(RLA6WBQ1EX(ZG
MZLX#VE,]CQ./8UD4R`'0X=J3HA2H.@$I454,U4SW-*IKMP;/JY8X>V0K&?@G
MA'L9((@J@L7X,40'M5073'[R+ENH!DG"!^ATE2F*(?'4>.+,[3."N8`P!@#`
M&`,`8`P!@#`&`,`8`P!@&)W+[B+KOE]K1:F6XA8BSQ(.7U!O;5L1:5J,VJF4
MIA[1,D:0@9/RD$)Z#4631?MTT5T56DHQC9!GJBIT.5XKE>\$:E?D\;V^-";,
MXW[$EM9[2@5(><CC"LQ>I>8M"62'444(RL%<DC)I)R4.^!,WEJE(FX:KD7CY
M)LRDVCMFA[*:E4I7]KN<6H<$,YH@P!@#`&`,`8`P!@&;7%-[YD';8[K_`-UE
MH][V_EZ]FJAU_M]MZ?Z.`978`P!@#`&`,`8!E]Q=XK3V\Y=*>G$W<+K&,=`$
ME+@4474^L@?];"U\QRB!SB(>7(28%.WC2"8@>:][&^<_B?$5"A7J?VZLU33/
M8WMP,##5>&C*]7HYK$0D.S181L:R3!)LT:H%[2)IE#J(B/R=14YCJK*F.LL=
M150YS>-MMR[MG;%D5?`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@$6[LW'0^/V
MJKQN39DL6&I5`@G,Y,N@`AW+CRQ(@PB8Q`YT@>3,Y)+LX>%8@H0SZ5?-&I3E
M%7N!FR&+L_GF<RN6VQN:&\K+N/8#A1JW=*'BZ/4$G2CB*H=*:+K'AJU&]P)D
M453(J=Y-2144#S,XZ?R:B*!7";5OW2A0<&V[LQ)?MS.V+QJ0Q2G<M'#<IC=>
MTIED3IE,;H`CV@)@$>@"/3Z!E"LT^I#C?7$XBQ%%0T2[*H4"'B9"7F))F5V6
MOM85*="6=QYI!5XT,S2481IFI&S!,R@,7K9<2+$SIMZR^BWY46<>!U_R+KW2
M2;6J=,3$/=[[IWFJFU_*I"HZ;R;=:2-Z\RSUPJZ36DA]QKLC%HOE$TU3)HD-
M#.R*]A5BLS23A5JBL9PZ*JBV;\XWGWQLB+XBPTXM&+1,QCG/2"HQ%6G&DU&2
MSM2,,9-:PJR0E<JO>U"7F+%*LV,6F[B4UFJK099DDXDT'[(K]NV5:.XE<B4:
MLQ)/U^[;X[=_!$=5.EI3_&-L))MI/I;.<J\R1FCF7=KHHFV=J@`^?^US51O[
M"[#K1A_U`'7#_7J:H^I>/HSVE8,F%>S=#[4L=[V#/T%>BU6!N\0@A;(V6LD[
M9(G;;Y!O18EHYMFN[!1IVATBS0]8K<E6F&P8QM>U9>-2J[*Y4NSP<*V@6V8<
MV]7TO&+(Z4U4I4S+CM;,PTTX;<Q:',-.Y!L]PMW,_P!?OJHSM>NW3V5IM:IJ
MYY@$'/LK2LV'E;-0#FO/W^K)N'BU:H7>&OF\+[+1(!=)E49N-K#F@A[%(H(?
M.T<<^43;RL:_R4ZIAQGKBB?Y?^+W>;S<O:^<7[PC`NG=7E>NR]@;B(QNERAW
M,B,HMI.^UQUK^\1LC,/'#-ZS^QE<F)S8%,;M#*,V>QXJ%<-4`7G9I9S7^5Y?
MC?&]^2*M3=?*J92A?4G*\\/I/!L,112;HI(()D2003(BBDF4"II))%`B:9"A
MT`I"$*!2E#X````RG(^Q$``1$0``#J(C\``!]1$?P`,`N?3?+&(U9>V5<=K*
M/J+./DVME?D4$S2#<J=$$)M@0`,+@&I_+++&1Z$6CB&%$KMPV:E(J^&ZJ6]U
MA<^]NO<U35#Z;FXY)5)=))=!5-9!9,BJ*R1RJ)*I*%`Z:J2A!$BB:A!`Q#E$
M2F*(&*(@(#GG.QR8`P!@#`&`,`8`P!@#`&`,`8`P!@&.?)?BYJ?E705J-L^&
M\U1MZAQ5[9&@BA:*=*K)E(,C!2"B2O:FMY:(2,6Z(O%RJ221'K50Z#59OJFI
MT.5XKDC4J#R0<N>#FY.(=D.A;8X]CU[(/#H5;9\(T7&NRY3"8[=E*DZK'K5B
M%$HF6A))406,DY4AWLNR0.]SUT?$IKZ/=?KE>V<72U^##+-D&`,`8`P!@#`&
M`96<5'OES]LCNO\`WJ'8O>W\_0/3H=?]'W+I_I8!FY@#`&`,`8``!$0``ZB/
MP`!\B(C]``,`V+<:>#DU=3Q]UV\U>UZG]4G<?5#^:SL%E3^#IFD`_5N(*'6#
MIU[O+EWR(F].1@BHW?J</B?%B53GG9=N?0W31-WCU-Q43$QD#&,8:%CV<5$Q
MC9)G'QS!NFU9LVJ!0(D@W;HE(FDF0H``%*4`^HCU$1'/,=2H8`P!@#`&`,`8
M`P!@#`&`,`8`P!@#`&`,`8!Y!/']YG.+WM"%X@4F6-]CM4G8VC:1F:P^3.;*
ME&'GPL$Y,F82.&E*KS]-RHD!Q3&P6!ZW>MRO:ZU.GTH6[\/?7WDYUO9>/OI[
MP><K.AS.)<Y$T%E%%@;ID24.=P(D*"!"D$QEA,J!DB@D4!.(J%,0`+U.`EZA
M@$,-[BI[&WF279JO'N+U#-(Y=XI72OWE?=O8-F[:R@-VC5NT.<B\K+)IHM&<
MHTBW$:+T[99!TF;,VF=UQBV?N]G'B=M%W3H<Z',:H523=KN=EF)3@N>P6-`L
M_6HV*M+=N^>28HN(PR\,:.78L7QV4J1T9PW-(&D3.@&(CV4>^0=&E1`3-E&[
M*1,G6\7W_P!^/3DS32]-3=-HL[SRHVC=N,;E)J]EFPFV,)87AGRJQ7K5J[9$
M9>CD72"3E5Z[.J+:+<*,F"L0]8M3LHTI4W#D4WXK)'B9%Y$WOV3YM+?;M]\E
MJI6EU)1BSF4ME$N[E-R\*5NE+>:.1>VL2]^TM5!^6U-9F_V+S`''_6!>F/Z-
M4?4O'T9[0L&3`+?6^[5KK8FXH"J[+KSZ7B.-LK=ZWKMT-1!:H6>,E622MH=H
ME9.[4_%E7GCZW2;:34=0H5^-;K(0:22#Y_)9;O">S\':']SI32FJ96:H;O?\
M=#F'?AG/%G;-@0W''5V_4FN[%=QNP7UFUE<49,*S+.(R,M51E4J11Z9:*U+3
M8MZ;"3#K7C-H6RF5A7,;+R;$2OTV?3JOUX8R72M=*BS=*:AJ)V<MM.+Y^Q8>
MP^0FSJ>]875&_P`;:-13U(I%EE'%'4I3^3J%?GG&OH5K+D>3,1!5=E.W&W1F
MSH*!?3.Q7$,^CIAW)1<"C*ZO+#6XVU>;=(G:^(SZ]"JE.5$--I3-VI<1=M)0
MW"[N';8T>?C$(5">>+&CX]PS;/"B_24:N2$=(E7205:J%!<CSM.!#-.P5RJ@
M9+L[RB&:2;P<3'"Z[)?V(58^-\R/A1ZD,4#=KI^7KTZNCE']6B8/HU3,)1ZC
MYQU?NE3ZTTI7R_0$7YL&ZW@)NQ2[T5WK*>=BM8M>H(C$*+*=R\A35C@@T*'<
M(F.:ONC$C#F^"),',,D4#&*H;/+\:B*M2Q5Z[^>?,ZT.5&Z]#8'G$V,`8`P!
M@#`&`,`8`P!@#`&`,`8`P"A6:L5RYP,I5K=!1-FK<VT48S$%.L&TI$R3-7IW
MMWK!XFLW<)B(%,`*)F[#E(H3M.0I@3%U9@T"<M_!?\Y23N_$V232[Q6=N=.V
MF2[$P,/4PH4FW2*H@0##T*A#VUP"9!%10+00@(,2^BCXVU7FL^*.;HX\C0?>
M]?7G6%D?4_8E2L%+L\:;M=PEDBW<4_(03&*FX32=)I^I9K]ACM7S85F;M+HL
MU762,4X]TTU*<KH<RS\H&`,`8`P!@$_\:WOI=EIH=>GN4%*LNG7]KR_32/3]
M_3T'=_9UP#83@#`&`,`F34^@]H[G?%;TFMN%HTJP)/;+)`>/K4=T$`/ZB553
M,1=9,!`QF,<F^D1+]XC,Q0$0S5733EWX6?+]V*DWC^C<#H3A?KS4!F5AG_*O
M=\0[%DY:1:E+#0CD.A@&`B%!5(5=$_3RY9^9P^`Z95V98SO.CGFK^*ZK*U/'
M/=_@ZTTI9N_3WR9EYR-#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`(AW]MZ
M#T#I/:>Z;&!%(G6=&L-N5:&4\HTFZBH]9:+A45!^"NIR4]%#L^O0!=OD2B(=
M>H5*6D&X4G\U>]72Q['NMMV#;Y!26M=XLLW;;))K"/F/YRPR3F5E'0@(F[06
M>.ECE3`>U,HE3+T*4`SN><M7`&`,`8`Z?[O@,`8!?FJB@?:NJP'\-G:]-_:2
MXPIP_P!Y0P:I^I'L\P9&``#I\!\`'P`!^&`6A:KC#U-N*CLQ5WZQ.K:.1$OJ
M5^G<!#JCT-Y#<#=0%90!#]L$2*G`294F_P!@Q9LEIEK2\]3)+?JB";TK)+J5
MJT(;\$DQ$>XXAT\Q903*J=``3=A2$+V22P"W,H&`35QZV8KJ7;U-N(KF1BT9
M).+L90$0(K7)<08RWF$#X5](@J$DW(;H7UC%L<1`2`(9KIU4M;[=T5.&F>D4
MIBF*!BB!BF`#%,40$IBB'4!`0^!`0^0$/@0^0SPG<_<`8`P!@#`&`,`8`P!@
M#`&`,`8`P!@#`(IVUH[4>]J^-8VYK^MWJ(`%/2EFF)32$6HL4"J.(2:;&;S,
M$[.4`*9Y#OV+H2?<%42B)1JJ=.&UV(TGE&EG>_@=UZ14>S/'39Z]=6.*BJ-)
MV8FM*0Q3FZF*@QN,,U-,,&J?0"))24!871^[N6D_NB)NU/QW_)3U7Z_T8='#
M\_?O[&H_;GA]\O-+G=*VG2UIEX9L)S#9:(W+>X(S8G7J\77K`R+R*;#T'YG6
M,4J7X\Q(G<7N[+XE%6*O.WK^##I:V,.%T%FRRK=RBJW<(*&26073.DLBJ01*
M=-5)0"G34(8!*8AR@8H@("`"&;(<6`,`8!*6E7OH-HT];KT!2069#\_7W%@[
M8``_GU,Y#H'Y].GSTP#9M@%8A*[/V5X2.KD',3\@?H!&,+&/95X?N'H':V8H
MKK#U'X#H3Y'(VEEI=P99:_X*[YNAD%Y:'84&*4[3&>6QX5-\*0]._P`F"C@>
MRA5RA^RC)(QA##\"N0.HAS?QJ%ASV_;C[2:5%3Z=_<F?^K>`VH*09M(W`[S9
M<VB)3])E,L?6DU2]![DJ\U65]47KW%.E,2,HU4+T$6I#!G&KXU3Q\JZ9\_U!
MM4+>_H9NL6+&,9MX^-9M8]@S2*@T8L6Z+1FU0('0B+=L@1-%!(@?!4TB%(4/
M@`#.1L[6`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8!HE_A!.WUJ-PRK^
MM(]T*+[=>TH&'DD"G$@N*E2F[FYR@_`]QP3LK"ED.3IV&(N;O'Z%/NA7GCW^
MS%;M'/X/%3G4Y#`&`,`8`P!@$B:A+W;:U:'3K_VCT<0#]X6>+$/]X?'X_E\X
M+3E=T>S3!!@$/W;:+6(\Z,@#)/90.J:SS[JK)B;Z&`OR)73HG]`.J"1OA4RA
MBG0S=-$W>/O[\@8X.WCI^Y6>/7"KITN<3K+K'$ZAS#^(F'\`#H4I0Z%(4`*4
M`*``'7%D#K8`P!@#`/1SQDN1[YH?6E@75%9Y]G$(604,;N54D*TLM7G:ZW4>
MH*NE8P79NO3N!P!RAVF+GBK6FMKKZW.U+E+R)WS!H8`P!@#`&`,`8`P!@#`&
M`,`8`P!@#`&`,`8!&-[TKI[:)#%V1JS7M[$Q.P%K93J_/.DR@'0HH/))@X=-
MSD#]A1!9-0G\PQ<J;6&UV;1&D\HQ'M7A:<&K4=1=72;>!=J"(^IJMNN\"0G7
MY'RXUI8O92``_0`C.A?H'0OQFU\6M?R\X?K<CII>T=O<$*R?@L<.GYS&:OMQ
M0H&^B<9=H=4A/GZ%&8J,L<>GT^^<P]/J(C\Y?\U?3R)H77WX%&3\$3B00X&-
M<=]K!U_BU+?1@(/[A%+6:2G3\/@X#^_+_GKXI\G^QH77[?HD6H^$#PWJ,K&S
M!8K8D\]BGK5^T--WMT1,'+18BZ)E$X%C!`<H*$+W)B($.7J4P"41#)_FKY2\
M%^2Z*3,&`XI\=ZT8AX[5%8<'3Z"4TZF]L_W@^0,);(\E2"/7Y^2]`'Z`&9==
M;S4_3T&FGC\^I.,7#Q$&U(QA(J-AV)/V&<6Q:Q[4GQT^XW:)(HE^`Z?!`^/C
M,&BI8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`\EG\)(N"SO9O
M%^@@J/D0%$V!<#(`;H45K=8(*%(J<H?!A*2DG(D8W7L`RP%Z=Y^O2C#?NW^S
MG\38\T6=#F,`8`P!@#`&`27I<HGW%J<@?4^RZ(4/ZS6B*`/_`#P597=>I[)'
MCQK'MEGCUPDU:H$$ZRZQP(F0H?F(_41'H4I0ZF.80*0!,(`(AC==MH.ICSHR
M!,JQBQ[DUG7RF\?E^A@#H(&:M3A_@P$%E2#T6$A3'0SK33%WGT!$.;`P!@#`
M&`,`W:>'1-'?Z2G(I4XF-`W^600+UZ]C.0B(*0(`!^'<\6?F_+J/7ZB.>7XR
M^?NE^4=:,/N9^9Q-C`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@
M#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`>-/^$8G5'F#J
M!,>[R"\:Z^=,/YOFGVAM4%NG^-V)H=W[@+G6C'C^$<Z\H\_>;.8P!@#`&`,`
MJ;"%EY00".C'[[YZ"9LU66(7_+4(04R!^8G,4`_$<0V":]4T6R0.P:':I=JB
MPC:W<JO8'I5G*9W)V4/-L9%R5!%KZD?/,BV."9%?*`3B`&$H?.:5#?3N#T5V
M6[R5S42=++D+&"!5X]DU4[V94E"]R2W>'PZ5.F8!]2;Z@8?)*DF;LSHJ52"U
MLT!@#`&`,`8`P#<)X:9C#1MED$1["VR),4/P[CPY@.(?AU$"$Z_U!^[/-\?-
M/9^IT^'OX?DV69P.@P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8
M`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@'D7_`(2'5EFF
MZ>-=V%,00L&K[=5DUNW[IUJ?:V\LLF!OH(IDO"!A+^`*@/\`.SI1AKW?_1S^
M)L_?NYYM\Z',`'7X#Y$?@`#\<`N./J%GE>T6,'(*D-T[55$#-D!Z_DX=>2@/
M[_UGQ^.5)O"]]P7U'Z;L;GM,_=Q\:0>G4OF'>."_G^K1*5`>G[G7U_=\YI4/
ML"^8_3,`W[32+^0D#ATZE3\IDW-^8"0@++@'^2Y*.:5"WO[]_P!@OJ/I55B^
MT6<$P`Y?V57"7K5BC^95G@KJE']Y3!_JS226$"YP`"@!2@!2@````````'T`
M`#X``_``R@_<`V#<=;K]I*;[$[5[Y2J&28_>-U.M$*@8T8K\_(@@5-9@(%`0
M(FU0,8>Y4,`KG(9.<)I/:$K6)FQ0=FK5#N5FKCRKNCMY,T]"5:8>P[?RR(N/
M7MU)`C<QXXR*A'BB:29B&_9'-<Z7#::3:CE)FJ(U*4FFTG/#:((NVRMK:V>;
M&AJ4S+8D:9%VRPM7UZ;6JU.IMI2M2U"Z)0K->/F8@K9_9)B5?P9)!$CI)JL4
M'GM$J\;.&3S+;4Q>)S+Q2GLUGU9I).)M,*T+-37V]$?<YOG<==MC&DO*_37+
MU&U3L*YM*L:XK=6M`L6VK)>*K\*-BV"V6A)V0B]@2[5)RW=WQ\_>U1V]B:<[
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M:"0B'[:$;`00`</S+ZAXY3_RDS9P^._F2XI]6S5&'W-AF<38P!@#`&`,`8`P
M!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&
M`,`8`P!@#`&`,`8`P!@&B'Q\M"AM/CEJS8*"QF[G5&SE&KYR1J#DR%;V!#*1
M[\_454@2!2PP-2;]QA,43+EZE$Q2AG3X5ZHF)7I_4F*\+O[]]3RJQVHZFS[3
M.B/I0X?(^J="DEU_Q4V96QNW_%.HIU_$1#XSTJA=_?0Y%\Q\!"173VZ)CV9@
M_P`(@U1*L/[S+]HK'']YCB.:22P@1U#[DK4D[DF;MG+1*C(Y@9@HBVEEID@3
M<[`D+'1U==3$N9X=U79-R5@XCD'1XY$[Y$BJ#21%CE5IS9K[S>,*\OB,&W\-
MJ-^<J+3EPHNKR<\QMVL-/0(02JEG?R,M6HI!.,:3"\<B:T,FTO'.7DO'0\HV
M;I*P3I&61*4BJJR"S41(DBN+A(ZU:+MQSO?9/9R14/>V7=K:SB6MRK);1HBP
M)"C/%5,X>1[)DDE'2RB\DI+(2CF*<1+<K`5Y>-DV\),+QTO&)NXIZE%R!VSU
M4K1<2753SF(S>9B/)^0T5+;[JT1,WME6?)\Q^U*%*/FL<PL":[IX+;TQ?;Y5
M)%4CXKH6"WJEF";4C6158OV<:[.L5M(R4?(1;)5>18NVJ)5TNR>>X=%24M67
M5>DSWXS@+[3HC5N=R[G#,R)+/D'"3N)FVKQF:,91LG(JOV#B-3?,&C**F(R7
M<OGC=!DC#O498[@(X1=`U+G[/93Z.1HJXXW47F+ST:C,VR=QSL.HM3/"*R:Q
MS,I%2(.#:)FGOJI1`'XO&$4+..7":=1H14H,NC#B^/#A&O\`W0&GHW'EM=//
M3?*"HJ<6S?*5N;NV5G,J">]+WYO5;=!SZ+Q):OS**31^Y05*JU<0TH"2B+]-
M4@F(JBW/Z61343$WF(I&*F(@K\Z,F:5PWO6Z7<9JHR<1-+C7->.-F3,BS4A3
MG&N-T;(JJ>!KRLLC:K8HT4K2C25-6X21;Q#N;KA'RR:3]TO'9=23CHV[K"G"
MR\7\#2I;2=KO2LYMO$+,W>S*@COG51A:%=VCV8743[PH:P0\[`M8Q$*V[N)V
M$Y(RL8TC(.>3J3![:#5V5>M)TU<:K3R<>I$%!Z+73S&][1:;\6O?:^!IJXGL
MT]XM#NIM*M-LGQ#[OI<U<TJ:@J^:.I"#KLM!C*Q<S#R<RYGI*^LE8Q&M2\6Q
MGVAXIK0)&6>O7C)%F6+<HOC*)M`*X6:E,=OO.V=ONAI<3U:?2(WQ>?.Q3G6]
MX=I.K-EJM9@IS6]DUFZV+W5_[.H7,YTV0,S1XS86<\62PJI4]273@S)$M!_3
M>0,2169(U7Q:8GKVST[[1<:>JF-4;QGMB\<=;!GR-U3*O:BQ@I>7GUKM.$@8
M12*JEH6;@LYJKZY1LH_66B$`95N9@6"[R%LQRF@Y1`CAZS?*QL;,/8YJ3B',
MXSQ/@NHTN_12[KF/.7@YF7(C4JT4C*2%L8Q"05-*W2*SI)\I$1K/[&-=@O8]
M2RH,CUYU-QM,=I6AW!,Y):;)6Q+/^W!$G*Z%J6[C_6I^2N--4PE-X7.8QG-I
MQ-LERP6W*!97\7%0DRZ?2DLI,))1Q:]947T>:!7*VDAL;1S#HKU,A'"B2#56
MT)PZ<DJNV)&G=F<H`I54GA_9^UXDAY_6_'/@>F#A[4CT_COKIHND*;R9CG-J
M==0[3'"ROG$JP,8!`!`2Q"\<D/7Y_5]?QZ!Y/BN:ZNEO*S^\G6FU*]^[&3.<
MS0P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@
M#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@$%<F]/M]^:"VMJ)8$?472H2+*&5
M<=`0:6=CY<O4WRPC]$6-ECXIVKT$HBDB<`.01[@U2]-2?#_W]B-2FCPDR4<_
MAY%_$RC1=A)Q;UU'2+%TF9%RR?LEU&SMHY2.`&27;.$E$5DS`!B*$,40Z@.>
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MH\]O:M4E3I(AV)`"14D""*;=-)+HF&DDL&6V\O\`KL9LT&HP.]:_!+W2P620
M&AD>Q05--6`0ATW<C5;!44+*1^2`&XI/7E6L<G&+(I6I.'=.VIW3F)56*8ZD
M=,Y;[=8:GG#YCH$X3A*^]YRG&8RD\3U+U?<7Z3,M'\78K)>;!"3+50;!"/W]
M>:,)Z=4UFIJ`;8_4@ZQ$22$X77YF\,1O$OXVME7CV$U]G_?4/<CS0HAMN<__
M`!T\<?LUK?"E8=[?-JC,9\=I+F9:-@4KI";&DK5<K!L&`C8Z$;VZ2<UMI)NH
M!D^L[U>`D&E>K,'"KPLQ]J%T9>/)%(H.E8:M3")6]C@64T2Z5*=Y4*>BFS\[
M]D\HFJT0DLQ>SM>[;FW.[6'!PR.B:\]EI*1"PVE.%?V=Q??L&=W#C227U9IY
M1+0*80@6@RA)("6'V8;3]FOM(4)T(0)+HN#2IF^=4;3SSX3$W@:G'6(F\QQF
M,6QBQ;%#XVP]0BZ(M*7:W3-NI?V+,:RK+UQ/U#2H42=H#6J$9A64VA:B>)M=
MG`@K-SVXSB7.^6M2D@DBY3*F(NY47GA1':[\7.0ZIFR2<V4[M.<YLNG0XT^*
M&NDX0:N,S=5*J2'7CVE<4DX86#"7=:I#2SJWM'):\28"PN=?F=QBB"\FO6"O
M)&0ET:XE)N`<D:%$7B_W4-]X]2ZWFTS,_P#]:HXS?$[3!.FLN*D'M'?.OBQ\
MC84I>2V2ZLPHMB5T4FSF9BV,99'ONAJXI;&<.UK\.#U_#1=C81DN#`B<XUE6
MQ$VY95%*=3VO%L^OA)%4W\MKPM^;=+<Q]SUGL636-9,XYBB1LRCVK=DS;IAT
M30:M42(-T4P_`B2*9"%#\"E#/$=CM8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`
M,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P
M!@#`/)_XO_&!;4.^?TRUR.%*@[Q5<RSL[=+HUB-DM2%/:6*PD`2I#8R&2M;4
MZQRG>OGEB(W3\F,.(>KX-4TZ7FG[K^L>1RK4.>?7W^34/G8P0C>6&W%IF<1I
MCT6\0M7'4W$OU%HHYT;4A#2L`G52,WBB)_2/%GD/:V+I?HP3EXAVVD7B#1V"
M*W.I5R].(E7B\1'Y6TYZ]*71"U*\P^TS/'*YC!:;VO;:=QK>,]79WR4C"W2-
M<>M7A*[[*,G&RQ85RL_CKU99&2>-'GHV;8CH)8PMW31][G$N6$B5Y&JVH^9I
MRMD[IP_J?2S^V#4T)S90Z<2YAJ<TI=W;LSY-$;L!23/%N[!&I(5=9*LL9`:O
M)=RPT(&R+":E5;BX10L"5\,M)HR05R;:F;(QC->:]J<R;9DBO:5:V(QAP[--
MVSMU$_#>8<U?,U*WREIQ%G#7:8*FC295[1KW&3,)<5!GKTPGXMBX>T>9LRK2
M.;4\[!63+)2ZM4DV:+^#.B_C)1^NN_B$%$5O4/5R+*6'I::?U2L-Y33<N,JY
M-255+3IM3#M4E=U3$+5AYY*1&5S9T<8%UH:<9HR"5&-.1%-FJ_&L&D5'UEY&
M2,%3V+^P%:U]XSGFT(Z?)-G9&7L/N+2&GG[LR0*1*OB,3$*V\*;/'2)+JH>6
MG&J'4JFY;LVXEJ)^TH_'%>W%+0+Z-FB2SJQ'+1%X215?5A:HM4HQ>FR$F6PQ
M;25C)!]8VD\QL$C(.(QJDQ>L2MVD3)I$5(S*BMIIS.UU&V;IS,WA6@)T)IJ(
M^:4M4MM58;4)72OC,$_U(LLG6H9.>3>)3:;%).6!^\92#@\BGU(\7]9')MV2
MZ#E<#N6AF[1@4&BJ!#1L8<IF#;I3,*<[S>YRJB7&-HG'C?OUW9D+HVZ_8Z],
M0=+>7$3_`&0TGW&Z)I"X4+Z!X;K]TOI7GE@HJ;^+:+.AZ_(Y2&R7`,0)#7,L
MMO"]7$-5/GE.F-96JM3B"3;6<&[NLRYG**XBV\>[BKFSD+>VFV<3/*/U-KDB
M"P#5)**AG+9G8;!'O><?,W%FFME-UP[S?,?>_2?E2U7E-?5\JA]+;1I]4BC.
M:U>U^+=$U;)\?WEKM<5K76U1?0]I7T_/PD%-MX=Y4Y^?!G)["+$SKNF-8@;&
MS8IR+%*>+8:W&LIIDZ4M*M40]"6F6J:5>&N&\WC,;XG,)6MO7";;E:DXS%E*
MF8Z0W>TVM/Z0V%6IIK:]75N:F#)0NOUI6M[%EJE)K3U@JE01855K,*Q4_`FE
M&].F:O6'\\ZE;G.()V266L-(!=C7'T%;6EIRD]E>-E;=3#B;Y;C$-J3M5R[J
M<-WA--*4W$)64/IL!SH<S;%X=NF5&Z$SNN<:"47J;FM4D%B?)FQ50"PS2/<'
MT471)"M%R"!@!":1,`D4*(^?XU6*5M=_A?GQ1TH6_D;3L\YT&`,`8`P!@#`&
M`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`
MP!@#`&`,`8`P!@#`&`,`8`P"!.3/'ZI<G--6[45O`J",XU!S`S94"KNZO:F`
M'5@;$R*(D,91@[-Y;QN15$9&*<2,4HLF@^5'-4U.EIK8C4J#Q$[<U3==(;%M
M6KMA12D1:ZC)JQT@@/>9LZ2Z`JQE8Q<Q$_61$NR40DHMZ4A2NF+E%7M(8QB%
M]M+5236YPQ9D<901Q9[#9"6-&LUE6OL'*=7DK2\D+(T?/FBJ31ZUCVL:V082
MD0=`%55EEI*74<NB1:1&92Q;XS[N;9;<PHPVYZ<77G-C=*IB:I^I*%]WA^6Y
M';GD"F6K/;"VI4V)T:^9^S!R\B$F+F?#5C';0P1S@^&30(WKCM8KB17BT4?5
ML%VR)%%EFI5L?Y+-Z>TM95.IJ,V1K_%=)U+*FSPZG3..8\^A<4AN!"$=V=M(
MP4JZ5K*4C+S+=BE%(G@:[!U2BV&;<.7#B?43G'3,]R3!$(M)N=V5NY:HLS&9
MMWTQ=<-IK%WT25+??.W^YHE)IYLIF[;J26+?3X3Y?;K<K%K[L)ZK9128.9]!
MFX($2LA)(U6[)T2Q2?\`>TDX7C(F(DUV[YV\E&[44X<7#\4@(U5+EUQ_%[]K
M5:7VO'F%\-N(:VM>5-.I+JVIB."7FKE)XU;.T#$.BZ;HN43IJHKIG273*JF8
MBS=15!8AB&`2JH*J(J`('34.02F'9S.Q@#`-F6F;K]MJ-&NW"OF2T6`0\QW&
MZJ'=-$R`D[/U^1%\U,@Y.?H!!<'<)EZ^4/0"5L`8`P"<./\`I.<WIL"/JL<5
M=K"-3)2%MG2)]4H:#(J`+&*<Q13-)/A`6D4V,!A6='%8Y`9M7BR.*ZU13.^R
MY94I<'HHKT!$56"B*W`,DHZ%@X]K%QC%$!!-NS9I%113ZB(F.?M*!E55!,JL
MJ)U53G4.8P^)MMR[MG?%D5C`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,
M`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!
M@&N3Q".!D#R]I2<[6@80.\:;'KDI]@<`"#.QQQ3*.3TJS."%$WMSEP=5:&DC
ME4/`2:ZJQ`%@_E$''3X=>AW^EY_9FJF>_NQY"+G3+5KRTSE)N\#)5BUUM^M&
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M<W7/'N'@N7,;6470MED(DBJ%>A.'$_TOPE;>`O\`([IOBSZO;.6^T]2J-F6N
M;4'HD(V'D3"WEWRK4\8=)PT3EK&X5F_6I+-T7$:YDK3&/C/VCP&SMW*QLD"J
M"BS%Z"5^5V[O?=Y\6G]R?/3NUA9X2CO":A]2_4446R*3=NDDW;MTDT4$$4R)
M(HHI$`B2221`*1-),A2D33(4I"$*!2@```9HP<N`,`GGCW=?LO=DXIVKV15J
M!*,6[C=$TI(#F&)<#^'4RRBC$1^``K[O-\)AT`V'X`P"2-6:JN.X;:RJ%,CC
M.WJXE5?/E0.2,A(X#E*O*2SHI#@V:(=P```!UW2PIM6:*[I9)$^:JE0I?@N2
MI-N$>@;2&EJKHRE-:G7">I=JB1Y8I]=(B;^P2XI@11XX[1-Y+5$.J,:P*H=)
MBU`"]ZSE1TZ<^.JIUN7X+9'9))$Q9DHP!@#`&`,`8`P!@#`&`,`8`P!@#`&`
M,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P
M!@#`&`,`8`P#!CF9P+U/S!@`<3!"T_:<0R,VJVS(IFDL_12+WG1AK,R`[<+)
M7?..8Y&B[A!_&***K0\@R!R^1>[HK=#M=;KWAF:J55WY/)QRBXB[XXNRS^N;
M(JQF;9\#QK5KU'FD'M#LQ_*4\E2,L#$K-PW7[0!9Q%N1B[(P2$%U&"`&054]
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M#&DG3MT\D'CI32TYFVZ]\<Y%5:J41?9N,+PSSMCA$OYLYC`&`?1#G3.11,QB
M*)F*<AR")3D.40,4Q3!T$IBF`!*("`@(`(?.`;1-77(EYI<3-&.4S\B?M\P0
MO0!3E692$<F$H?!`=%%)\D0.O:BZ3*(]0'`,YM"\3]C;O<M9(K96JT/S"B[M
M\LU4!-TB4W11*NL3BBK-N1Z&)YR9THQ`Y3E<OR+%(W5YU_$IHME\+\\&E2WV
MY-WVJ-04;3-92K%(BRM$!\M63DW`D7F9UZ0G:+Z7?`0AG"P]3>2BF1)FS(<R
M+)LW1'R\\M53J<M_I=CJDE@D[,E&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`
M&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8
M`P!@#`&`,`8!;]IJ=7O$!)56YUV%M=:F$!;2D#88QG+Q$@@(@/ENV#]%=LL!
M3`4Y!.F)DU"E43$IRE,"8NK,-)Y-,?(?P4]3W19]8./]N>:FF5Q47"GSY7=H
MH:ZQNH@BQ>'7&T5Q,YS"=10SBS-DB@5%G%-D@`"]J?C5*U2U=</^_=S#H6S-
M.NV_#1YE:A5<J/\`4,M>89N)^RP:M.%[9.4T^O>N6)BD_M8T0*4.\RDI7(\`
M)U,/P4_;V7Q:'O'>W]?<PZ:EMY&$,Q!S5>?*Q<_$2D')H#T7CIB/=QCY$>HA
MT5:/4D'"8]0$.ATP^0$/J&=$T\.>QDI>`,`NZHT"][`?!&4.E6VZR1CE3"/J
M5<F+&]$Y^G:3TL.S>+=QNH=`[.H]>N1M++2[N`;"M.>$GS`VDJT=6"JQ6H*\
MN)#J2NQI1)M)^1\"J#>IPP2MB*[*4?U;>99PB*I_NF>)`!CEYOXU"Q\W;]LT
MJ&^G?]&]/BGX8>F.-[-5W89:4W#:7BC1T[<65DUCZ<T>M"J%(M$4U%1Z3N.5
M42+C/2T\58$FYTTFQT2=.-7Q:JK+Y5TSY_Z-JA+-V;*DDDT4TT44R)(I$(DD
MDD0J::::90*1-,A0`I"$*`%(0H`4I0````#.1L^\`8`P!@#`&`,`8`P!@#`&
M`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8`
MP!@#`&`,`8`P!@#`&`,`8`P!@#`&`,`8!A=S<_\`EB'];O\`]">;HSX?E$>5
MW_#/(5O#^4SS_P`0?_U9ZJ<4]JO5'`FKB?\`RDC_`/Q"/_K',UY\/RS2_C_R
J_P#\GL&TG_\`+2L?^#_]\\AV)6P!@#`&`,`8`P!@#`&`,`8`P!@#`/_9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g913905img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g913905img1.jpg
M_]C_X``02D9)1@`!`0$"6`)8``#_X@Q824-#7U!23T9)3$4``0$```Q(3&EN
M;P(0``!M;G1R4D="(%A96B`'S@`"``D`!@`Q``!A8W-P35-&5`````!)14,@
M<U)'0@``````````````````]M8``0````#3+4A0("``````````````````
M`````````````````````````````````````````````!%C<')T```!4```
M`#-D97-C```!A````&QW='!T```!\````!1B:W!T```"!````!1R6%E:```"
M&````!1G6%E:```"+````!1B6%E:```"0````!1D;6YD```"5````'!D;61D
M```"Q````(AV=65D```#3````(9V:65W```#U````"1L=6UI```#^````!1M
M96%S```$#````"1T96-H```$,`````QR5%)#```$/```"`QG5%)#```$/```
M"`QB5%)#```$/```"`QT97AT`````$-O<'ER:6=H="`H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0``9&5S8P`````````2<U)'0B!)14,V,3DV
M-BTR+C$``````````````!)S4D="($E%0S8Q.38V+3(N,0``````````````
M````````````````````````````````````````````````````6%E:(```
M`````/-1``$````!%LQ865H@`````````````````````%A96B````````!O
MH@``./4```.06%E:(````````&*9``"WA0``&-I865H@````````)*````^$
M``"VSV1E<V,`````````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````
M````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````````````````````
M``````````````````````````````````!D97-C`````````"Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M('-21T(`````````
M`````"Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M
M('-21T(`````````````````````````````9&5S8P`````````L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0``````````
M````+%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$``````````````````````````````````'9I97<``````!.D_@`47RX`
M$,\4``/MS``$$PL``UR>`````5A96B```````$P)5@!0````5Q_G;65A<P``
M```````!`````````````````````````H\````"<VEG(`````!#4E0@8W5R
M=@````````0`````!0`*``\`%``9`!X`(P`H`"T`,@`W`#L`0`!%`$H`3P!4
M`%D`7@!C`&@`;0!R`'<`?`"!`(8`BP"0`)4`F@"?`*0`J0"N`+(`MP"\`,$`
MQ@#+`-``U0#;`.``Y0#K`/``]@#[`0$!!P$-`1,!&0$?`24!*P$R`3@!/@%%
M`4P!4@%9`6`!9P%N`74!?`&#`8L!D@&:`:$!J0&Q`;D!P0')`=$!V0'A`>D!
M\@'Z`@,"#`(4`AT")@(O`C@"00)+`E0"70)G`G$">@*$`HX"F`*B`JP"M@+!
M`LL"U0+@`NL"]0,``PL#%@,A`RT#.`-#`T\#6@-F`W(#?@.*`Y8#H@.N`[H#
MQP/3`^`#[`/Y!`8$$P0@!"T$.P1(!%4$8P1Q!'X$C`2:!*@$M@3$!-,$X03P
M!/X%#04<!2L%.@5)!5@%9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&)P8W!D@&
M609J!GL&C`:=!J\&P`;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E
M!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)
MN@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X`+F`NP
M"\@+X0OY#!(,*@Q##%P,=0R.#*<,P`S9#/,-#0TF#4`-6@UT#8X-J0W##=X-
M^`X3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[!`)$"800Q!A
M$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3
M(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/`5$A4T%585>!6;%;T5X!8#
M%B86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$`891B*&*\8U1CZ&2`9
M11EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H<`APJ'%(<>QRC
M',P<]1T>'4<=<!V9'<,=[!X6'D`>:AZ4'KX>Z1\3'SX?:1^4'[\?ZB`5($$@
M;""8(,0@\"$<(4@A=2&A(<XA^R(G(E4B@B*O(MTC"B,X(V8CE"/"(_`D'R1-
M)'PDJR3:)0DE."5H)9<EQR7W)B<F5R:')K<FZ"<8)TDG>B>K)]PH#2@_*'$H
MHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K`BLV*VDKG2O1+`4L.2QN+*(LURT,
M+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<O_C`U,&PPI##;,1(Q2C&",;HQ
M\C(J,F,RFS+4,PTS1C-_,[@S\30K-&4TGC38-1,U336'-<(U_38W-G(VKC;I
M-R0W8#><-]<X%#A0.(PXR#D%.4(Y?SF\.?DZ-CIT.K(Z[SLM.VL[JCOH/"<\
M93RD/.,](CUA/:$]X#X@/F`^H#[@/R$_83^B/^)`(T!D0*9`YT$I06I!K$'N
M0C!"<D*U0O=#.D-]0\!$`T1'1(I$SD42155%FD7>1B)&9T:K1O!'-4=[1\!(
M!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I-`DU*39--W$XE
M3FY.MT\`3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4
MVU4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N5
M6^5<-5R&7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB
M\&-#8Y=CZV1`9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(
M:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R
M2W*F<P%S77.X=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&
M>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$>`J($*@6N!S8(P@I*"
M](-7@[J$'82`A..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6
MB_R,8XS*C3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4
M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY`
MGJZ?'9^+G_J@::#8H4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H
M4JC$J3>IJ:H<JH^K`JMUJ^FL7*S0K42MN*XMKJ&O%J^+L`"P=;#JL6"QUK)+
MLL*S.+.NM"6TG+43M8JV`;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]
M%;V/O@J^A+[_OWJ_]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&QL/'0<>_
MR#W(O,DZR;G*.,JWRS;+MLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1OM(_TL'3
M1-/&U$G4R]5.U='65=;8UUS7X-ADV.C9;-GQVG;:^]N`W`7<BMT0W9;>'-ZB
MWRG?K^`VX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJ
MY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50]=[V;?;[
M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____VP!#``(!`0(!`0("
M`@("`@("`P4#`P,#`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,
M!PD.#PT,#@L,#`S_VP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"``>`(H#
M`2(``A$!`Q$!_\0`'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`
MM1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*Q
MP152T?`D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA9
M6F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*S
MM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ
M_\0`'P$``P$!`0$!`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#
M!`<%!`0``0)W``$"`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1
M"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI
M:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZ
MPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1
M`Q$`/P#Z/_X*'?\`!<7XK?LI_MB>*/`V@Z9X8N=$T.Y2.,W-NYF="J,?G#@`
M\GM7Z*?L5_M5Z+^V'^SKX>\<Z1)&%U*+9=0A]QMKA3M=#W'(R/8BOPZ_X*R>
M!7^*/_!6[Q/X:AD2WD\0ZS:Z>DI7(C9T0`D=^2.:]%_X)2?M1:W_`,$UOVV]
M1^$/CN9X/#NMZ@MC</-E4M)V0&&4*>`'!C&>G-`'[E^(+]M.T.\N8MN^&!Y5
M)Y&54D?7I7XI?$3_`(.&/CIX8^*>OZ#INB>$[N/3M0FM;=18R&215;"CAN6-
M?M#XEN8[CP1?21$&*2RE9"IR"/+;'/XU_.+^S_\`%WP]\`?^"GUMXN\7&6/P
M_HGBR6>]9(#*8U#'/R]#0!]$'_@X=_:./W?"/ATCVTR4_P#LU>Z?LK_\%DOC
M-\8/@1\9/$_B'1-#T^_\`Z9;7NEH+"6..=W\_?ORW(&Q#CWKV-?^"]?[*;`9
MOKHD]/\`B0]1D_X5!^U5^UW\-OVR?^"9?Q2\3?#8M)I]I:36=P[60M9#((F(
M!'<`-G\:`*7_``18_P""G_Q`_P""@GBWQE9>-+'0[6'0+&VN;5[&$Q[R[NIR
M"3V6NC_X*O\`_!7S2/V$]'B\.^%X[#Q!X_O@3]FEES!IT7>20#J?1>]?D[_P
M3E_X*"G]@/P7\2;W3+5+SQ1XHTVVL=.S\L5L49\R'WPPQ]*]+_X)$?LHZ-_P
M49_:OUSQ!\3/$K7][I6W59=-D(,E^YDZ[B<[!GH*`.NM/^#A_P#:(GBC:#PM
MX;F21`4D&FR'S5QD,,-W!Z567_@Y!^/K7YM1X?\`"AN@YB$7]GR;V<'!0#=U
MK]N]-\`:)HVD0VEMHVEQ6UK$(8XQ;)M1%&`HXZ`5_/QX&MHI/^"Z3QO!`]NO
MQ,NXQ"(5,>SS)<+M/&*`/I/]F#_@NC\>OC)^T9X,\+:UX:T"STK7-4CM+J:.
MP='B1CSR6./K70_\%$_^"]'C_P#9[_:M\2^"/`6F^';G1_"TGV6>YN8S*9YM
MH<X8''0D5^AO[7_Q/T3]F3]G#Q7XR>PTJ&31K1VLU,,<?F3D850<<,3G&*_#
M3]A;]C"Y_;SLOC1XZU?SS/HVG76JV3F+>;B[=R_D%L#)`/'TH`_;S_@GE^U:
MW[:7[*7A?QW/%:6NIZE"XO;:`Y%M,KLA&.<9VY^A%?'7_!6W_@KU\3/V&OVE
M;?PGX2L?#ESIDEA'-NOK=I)=[`$\AAQR*\G_`.#:_P#:1G\)?$7Q7\(M6<P"
MZ#W]HDC8Q<HV)(E!]%5F_"O+_P#@XOD63]NO32P"H=/MMQ<[=@VIR:`.LM_^
M"Z_[5>H644\7PYTV:WG7?')'I$I5U_O`YQBNK_9F_P"#D+Q3:?$VST#XN^%-
M.L[&^O([62^LR;>33U<X\QHCG<!UZBOM;]D3]L/X+>'OV7/`ECJWQ#^']EJ%
MOHEO'<Q3ZE;I)&X7D,"<@_6ORB_X+1_$+PC^U;^WO8VOPLBM_$4MQIUGIDLN
MF1>9'>W'F2<((_O8WH=PR3N]J`/U-\5_M!?'G1;ZZO-`\.:9XJT::\N(K6=+
M1K<^08HVAE)!(8[V8?1:^I?#%_J5[X:TZ:]1HKR:VC>=`HPDA0%A^!S7*_LI
M>"]1^'?[/7A'1-5FEN-1T_3HXIVD/.['(/N.E>C=*`/P#_X*`D?\/T%SDG_A
M+=-P!VPT7-?7?_!>_P#X)^R?%CX36/QC\+VP;Q#X8LXH]2CCBR]S;`_ZP;>2
MZ;MVX]`@JQ^TY_P1D\=?&[_@HF/B]8>,_"ECHHU^SU$6$]O.;H(C("NY1MW?
M*<=N:_26[\,6^L^#Y-(OHX[BUN+8VEPA&5E0KM88]",_G0!\%?\`!%S_`(*%
MQ?M9?LM:AX,\0W;2^,?!NGRP.7?+7]H(_DEZ9^4$)GN17Y@?LR_"+0/CG_P5
M7L?"GBG3AJ6BZWXKFMKVU;*AU+'.2/YU][>'O^"(_P`1OV:OVU;KXB?#'Q]X
M5T[P[)>DQZ7?07(EDMYE(DMY"@VE!N;:/IZ5Y=XW_P"#=WXOZM\6M9\3:1\4
M?!FC7%W>R7<#P)>I-;;FR,,HR",]:`/NN/\`X(<?LRE<K\-K-/FX'G.,<_6N
M8_;?_9+\!_LA?\$U/B7H/@#18=!TS4+>:XFB5RP:0Q,-V3[*/RKX_P#^'#G[
M271?V@[+`XYO]4)/OUKU7X!_\$</C+X'^$_Q1T'Q5\6M*\2-XRTE-/LGFFO9
MTLG(E!<K+G&0XY7GB@#XN_X(G_\`!/[P]^W3\:-9_P"$JN7.@>$K2&\FLE7F
M^\QV&UC_``XV_J:S?VL?@CXQ_P""/O[==EJOAN::&Q^TM>Z)=IE4GMMQ)A?G
M#8!V[3SWK]+_`/@CC_P2M\9?\$[O&/B^]\3^)_#/B"+Q#8V\$":9%.K0%'<[
MF,@&<YZ5[?\`\%*?V"=)_;X^`\OAVXGM]-UFQD-QI>HO'N^S3E2N6P,E<'H*
M`.Q_8T_:Y\/?MF?L^Z-XVT*6)?[2M4-Y:J^YK&XVY>)NXP<X)ZBOP\\"%E_X
M+KS$'*?\++O1N'W3^\EP<^E??O\`P2V_X)A_&G_@GA\5[R>\\>>!]>\(^((]
MNIZ;;P7:2!Q@K-%N&T.`&&#Q\U<KX;_X(@>/=,_X*4M\8V\:>#Y=&;Q=/X@6
MP,%S]J^SR/(PC)QL\P;NO3B@"A_P<N?M1C2/`?ACX66%U'YVIW2ZKJ4(.'"Q
MC,7/8$L?RKY6_86_;[^.?["OP;E\+^$/@L^L:5J<K7TEY?:3>,]UO7C#H,,,
M=/K7U]^UE_P15^(O[7W[=-[\0M<\=>$_^$5DU1?(L##<_;(K)&^6$G&PM^E?
MIEX:\.V_ACPKI^FVZ*+72[>.VB7&,+&H4?RH`_FF^#7QQ\3_`+.W[=^@?$O5
MM"NO"NI2:X][<VDUO);JD5R2DQ"OR559&(^E>^_\'`?BBR^('[7'A_5[*;S=
M.UC0[*XBD4?ZR*2.,AOR-?>__!7W_@D?JG[??B7PUKOA;7]!\.Z_I,;6L\VH
MV\CI<0X+$?NQG.2.O:OG;XQ_\$&_C!\;M$\$_P!H_$3P`+SPKIZ6#S?9KP^?
M'&P$0''&U`%_"@#HO@/_`,&XOPA^+WP3\,^*+_Q1XPMK[Q#IT5Y/%";?8&=<
MD#*$X_&OCK]IKX4ZY_P13_X*`Z6OA'54UB"S2WU6SFN+90989'(:&08P"`C?
M,F#R*_>_]G?X<7GPI^"'A7PU?W%K=W>B:=%:2S0!O+E*C!*AN0#[U\4_\%>?
M^"2?BC]OGXK^'?$_AKQ/X;T!M.L_LTZ:E!-(TNQF(P4'3YJ`/NKX2^,!\0?A
M_HVN)LV:K9QW.5'0LN2#^)KI:\]_9<^'FL_"SX$^&?#^O7EC?:GI%HL$T]D'
,6&8C/(#<UZ%0!__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g913905img2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g913905img2.jpg
M_]C_X``02D9)1@`!`0$"6`)8``#_X@Q824-#7U!23T9)3$4``0$```Q(3&EN
M;P(0``!M;G1R4D="(%A96B`'S@`"``D`!@`Q``!A8W-P35-&5`````!)14,@
M<U)'0@``````````````````]M8``0````#3+4A0("``````````````````
M`````````````````````````````````````````````!%C<')T```!4```
M`#-D97-C```!A````&QW='!T```!\````!1B:W!T```"!````!1R6%E:```"
M&````!1G6%E:```"+````!1B6%E:```"0````!1D;6YD```"5````'!D;61D
M```"Q````(AV=65D```#3````(9V:65W```#U````"1L=6UI```#^````!1M
M96%S```$#````"1T96-H```$,`````QR5%)#```$/```"`QG5%)#```$/```
M"`QB5%)#```$/```"`QT97AT`````$-O<'ER:6=H="`H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0``9&5S8P`````````2<U)'0B!)14,V,3DV
M-BTR+C$``````````````!)S4D="($E%0S8Q.38V+3(N,0``````````````
M````````````````````````````````````````````````````6%E:(```
M`````/-1``$````!%LQ865H@`````````````````````%A96B````````!O
MH@``./4```.06%E:(````````&*9``"WA0``&-I865H@````````)*````^$
M``"VSV1E<V,`````````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````
M````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````````````````````
M``````````````````````````````````!D97-C`````````"Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M('-21T(`````````
M`````"Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M
M('-21T(`````````````````````````````9&5S8P`````````L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0``````````
M````+%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$``````````````````````````````````'9I97<``````!.D_@`47RX`
M$,\4``/MS``$$PL``UR>`````5A96B```````$P)5@!0````5Q_G;65A<P``
M```````!`````````````````````````H\````"<VEG(`````!#4E0@8W5R
M=@````````0`````!0`*``\`%``9`!X`(P`H`"T`,@`W`#L`0`!%`$H`3P!4
M`%D`7@!C`&@`;0!R`'<`?`"!`(8`BP"0`)4`F@"?`*0`J0"N`+(`MP"\`,$`
MQ@#+`-``U0#;`.``Y0#K`/``]@#[`0$!!P$-`1,!&0$?`24!*P$R`3@!/@%%
M`4P!4@%9`6`!9P%N`74!?`&#`8L!D@&:`:$!J0&Q`;D!P0')`=$!V0'A`>D!
M\@'Z`@,"#`(4`AT")@(O`C@"00)+`E0"70)G`G$">@*$`HX"F`*B`JP"M@+!
M`LL"U0+@`NL"]0,``PL#%@,A`RT#.`-#`T\#6@-F`W(#?@.*`Y8#H@.N`[H#
MQP/3`^`#[`/Y!`8$$P0@!"T$.P1(!%4$8P1Q!'X$C`2:!*@$M@3$!-,$X03P
M!/X%#04<!2L%.@5)!5@%9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&)P8W!D@&
M609J!GL&C`:=!J\&P`;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E
M!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)
MN@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X`+F`NP
M"\@+X0OY#!(,*@Q##%P,=0R.#*<,P`S9#/,-#0TF#4`-6@UT#8X-J0W##=X-
M^`X3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[!`)$"800Q!A
M$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3
M(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/`5$A4T%585>!6;%;T5X!8#
M%B86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$`891B*&*\8U1CZ&2`9
M11EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H<`APJ'%(<>QRC
M',P<]1T>'4<=<!V9'<,=[!X6'D`>:AZ4'KX>Z1\3'SX?:1^4'[\?ZB`5($$@
M;""8(,0@\"$<(4@A=2&A(<XA^R(G(E4B@B*O(MTC"B,X(V8CE"/"(_`D'R1-
M)'PDJR3:)0DE."5H)9<EQR7W)B<F5R:')K<FZ"<8)TDG>B>K)]PH#2@_*'$H
MHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K`BLV*VDKG2O1+`4L.2QN+*(LURT,
M+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<O_C`U,&PPI##;,1(Q2C&",;HQ
M\C(J,F,RFS+4,PTS1C-_,[@S\30K-&4TGC38-1,U336'-<(U_38W-G(VKC;I
M-R0W8#><-]<X%#A0.(PXR#D%.4(Y?SF\.?DZ-CIT.K(Z[SLM.VL[JCOH/"<\
M93RD/.,](CUA/:$]X#X@/F`^H#[@/R$_83^B/^)`(T!D0*9`YT$I06I!K$'N
M0C!"<D*U0O=#.D-]0\!$`T1'1(I$SD42155%FD7>1B)&9T:K1O!'-4=[1\!(
M!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I-`DU*39--W$XE
M3FY.MT\`3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4
MVU4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N5
M6^5<-5R&7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB
M\&-#8Y=CZV1`9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(
M:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R
M2W*F<P%S77.X=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&
M>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$>`J($*@6N!S8(P@I*"
M](-7@[J$'82`A..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6
MB_R,8XS*C3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4
M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY`
MGJZ?'9^+G_J@::#8H4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H
M4JC$J3>IJ:H<JH^K`JMUJ^FL7*S0K42MN*XMKJ&O%J^+L`"P=;#JL6"QUK)+
MLL*S.+.NM"6TG+43M8JV`;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]
M%;V/O@J^A+[_OWJ_]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&QL/'0<>_
MR#W(O,DZR;G*.,JWRS;+MLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1OM(_TL'3
M1-/&U$G4R]5.U='65=;8UUS7X-ADV.C9;-GQVG;:^]N`W`7<BMT0W9;>'-ZB
MWRG?K^`VX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJ
MY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50]=[V;?;[
M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____VP!#``(!`0(!`0("
M`@("`@("`P4#`P,#`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,
M!PD.#PT,#@L,#`S_VP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`"%``L#
M`2(``A$!`Q$!_\0`'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`
MM1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*Q
MP152T?`D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA9
M6F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*S
MM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ
M_\0`'P$``P$!`0$!`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#
M!`<%!`0``0)W``$"`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1
M"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI
M:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZ
MPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1
M`Q$`/P#]%OVF/$4OAKQEXKO]2OD\13:GJMY;:#K-MX[UG2V\.>1%&)(GL+*&
M0*EHY#R3*&5MZ[RK-MK[.^'IG/@'0S=:I#KER=/@\W4H0!'J#^6NZ=0.-KG+
M#'&&KY4^,7P;;QS^T)XCU#0/`?QZTZ;3)Y;6_G\.^)-,TG2]?%U;VYGDC2YN
M`^R410*[Q>63);9X==Q^LO!^C6WAWPEI>GV=B=,M+&SBMX+,L&-HB(%6+()!
MV@!<@GIU/6@#YS^,_P`2=1\`^+=<U36?VAHO"^@7VJR6>CZ=8>&;6\ET\06\
M9N8Y2T4LC")]SO*=J(LBAL8!/TEH,ZW6AV4J7B:BDD",MVFW;=`J#Y@V_+AN
MOR\<\5\X>,M8^#'PB^,OB_6)M=\2_P#"0RV]W;:G$DNK7FC:6]VD#3[S#');
MVC,(8'=OE90-Q`!Y^@?ASI-IH/P]T&QL%MEL;+3K>"V%O<&XA$:Q*JA)#@R+
M@##$988/>@#YK^-*_#/PYXP\:VT'Q"^)WAZ.[F>?Q'IWAR*\DT:*YDB!E,]U
M%9S_`&-G3:TACEC*[MY`8[C]+?#ZQL],\!:';:='90Z?;Z?!%:QV<QFMDB6-
M0@C<@%T"@;6(Y&#7B_Q0^!_@5O$?B0Q?$K7?"+Z](]SJNA6'BR/3K2]G=`'9
M@5:6W,H`WM"4)R6QN))]L\$Z5;Z%X,TBQM+:UL[6SLH8(8+64RP0(L:JJ(Y`
M+(```2!D`'%`'P[\:/VD/AEX)_:6\7Z-/\+/@_)KVOZO-;7&K^(]0A@<75M9
MP[KR_1K9S'"\7EI$8B[RF(`A,[E^YO"TB3>&=.>,V9C>UB*FT&VW(V#'ECLG
MI[8J_10!@ZO\4_#&@7\EI?\`B/0;*ZA.)(;C4(HY$.,\JS`CBMR&9+F%)(W6
M2.10RLIR&!Z$'N*X*[_93^&6H^*];UV[\`>#[W5_$=PMWJ5W=:3!/+>2K$D0
M=BZGYO+C1<]PHS6I\%?%5QXQ\`)=W-I;V30W]_8QPP1F.-(K>\GMX\*>F8XE
M/ISQQB@#Y8\>>.]`^&?Q)\;3Z7\0?B1I?CRZUZ\GABT32;W6].U%(XXVDA-G
M,C6\WV6(+YQMFC=-P&_<<'[!\(:S'XC\)Z7J,-Y!J$5_:17"74$9CBN5=`PD
M52255@<@$D@'J:^,_C/\"?$GQ%^+7B[6M)^&6C6EH^HZ@@U6YUW6=/NH1!;1
M">8+;2*H74%_=$VX&5C!E\UOE7Z^^%5[;ZC\+_#=Q::8VB6D^EVLD.G,NTV"
M&%2L)&!@H"%Z#[M`'Y\?M<3:%%\>/'DE[XYT/78K'64M=2T2[M?$$RM-=PP1
M6<5X;2.2*/[$T@EM_+4E_-))1QO/Z&_#FQETOX>Z#;3ZC/J\]OIUO%)?3JR2
MWK+$H,S!OF#.1N(/.3S7S1\?+_Q+JWB[7/&^H_#:XN/#W@351%#/H5W>1>([
MI+(Q744\UO&@6_L6G53Y"%W51N0.^Y%^D?A5XIO/'/PO\-ZWJ%G_`&??ZQI5
MK?7-KAA]FEEA5WCPV&&UF(Y&>.:`/B;]HRU\_P"+WC]QX9/Q$E6^<0^+MNO$
M>"2(D)MO]#A=#]F/[S_1I$?GY]LFYC]O?#8Y^'6@'^U_[?SIMO\`\33`']I?
MNE_TCC(_>?>Z_P`5?$?[1\MNWQ6^(B2ZPO@,M>.#X5+^(E/C<>0@^T!;&XCB
M;[0/W?\`H\4C_+^\W/E!]N_#AMWP\T$C2/\`A'P=.MS_`&7@#^S?W2_Z/P`/
MW?W>!_#0!^>W[:_Q:L?A/^TQXL\,:SX;M?&6O:_-#<Z-X@O-1N[>?P['<(JQ
M0QI%(/EA8%E,30DYR3ORY_1#P;I-SH'A#2K"]OYM5O+*SA@GO95VR7DBH%:5
-ADX+$%B,]3110!__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g913905img3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g913905img3.jpg
M_]C_X``02D9)1@`!`0$"6`)8``#_X@Q824-#7U!23T9)3$4``0$```Q(3&EN
M;P(0``!M;G1R4D="(%A96B`'S@`"``D`!@`Q``!A8W-P35-&5`````!)14,@
M<U)'0@``````````````````]M8``0````#3+4A0("``````````````````
M`````````````````````````````````````````````!%C<')T```!4```
M`#-D97-C```!A````&QW='!T```!\````!1B:W!T```"!````!1R6%E:```"
M&````!1G6%E:```"+````!1B6%E:```"0````!1D;6YD```"5````'!D;61D
M```"Q````(AV=65D```#3````(9V:65W```#U````"1L=6UI```#^````!1M
M96%S```$#````"1T96-H```$,`````QR5%)#```$/```"`QG5%)#```$/```
M"`QB5%)#```$/```"`QT97AT`````$-O<'ER:6=H="`H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0``9&5S8P`````````2<U)'0B!)14,V,3DV
M-BTR+C$``````````````!)S4D="($E%0S8Q.38V+3(N,0``````````````
M````````````````````````````````````````````````````6%E:(```
M`````/-1``$````!%LQ865H@`````````````````````%A96B````````!O
MH@``./4```.06%E:(````````&*9``"WA0``&-I865H@````````)*````^$
M``"VSV1E<V,`````````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````
M````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````````````````````
M``````````````````````````````````!D97-C`````````"Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M('-21T(`````````
M`````"Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M
M('-21T(`````````````````````````````9&5S8P`````````L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0``````````
M````+%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$``````````````````````````````````'9I97<``````!.D_@`47RX`
M$,\4``/MS``$$PL``UR>`````5A96B```````$P)5@!0````5Q_G;65A<P``
M```````!`````````````````````````H\````"<VEG(`````!#4E0@8W5R
M=@````````0`````!0`*``\`%``9`!X`(P`H`"T`,@`W`#L`0`!%`$H`3P!4
M`%D`7@!C`&@`;0!R`'<`?`"!`(8`BP"0`)4`F@"?`*0`J0"N`+(`MP"\`,$`
MQ@#+`-``U0#;`.``Y0#K`/``]@#[`0$!!P$-`1,!&0$?`24!*P$R`3@!/@%%
M`4P!4@%9`6`!9P%N`74!?`&#`8L!D@&:`:$!J0&Q`;D!P0')`=$!V0'A`>D!
M\@'Z`@,"#`(4`AT")@(O`C@"00)+`E0"70)G`G$">@*$`HX"F`*B`JP"M@+!
M`LL"U0+@`NL"]0,``PL#%@,A`RT#.`-#`T\#6@-F`W(#?@.*`Y8#H@.N`[H#
MQP/3`^`#[`/Y!`8$$P0@!"T$.P1(!%4$8P1Q!'X$C`2:!*@$M@3$!-,$X03P
M!/X%#04<!2L%.@5)!5@%9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&)P8W!D@&
M609J!GL&C`:=!J\&P`;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E
M!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)
MN@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X`+F`NP
M"\@+X0OY#!(,*@Q##%P,=0R.#*<,P`S9#/,-#0TF#4`-6@UT#8X-J0W##=X-
M^`X3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[!`)$"800Q!A
M$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3
M(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/`5$A4T%585>!6;%;T5X!8#
M%B86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$`891B*&*\8U1CZ&2`9
M11EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H<`APJ'%(<>QRC
M',P<]1T>'4<=<!V9'<,=[!X6'D`>:AZ4'KX>Z1\3'SX?:1^4'[\?ZB`5($$@
M;""8(,0@\"$<(4@A=2&A(<XA^R(G(E4B@B*O(MTC"B,X(V8CE"/"(_`D'R1-
M)'PDJR3:)0DE."5H)9<EQR7W)B<F5R:')K<FZ"<8)TDG>B>K)]PH#2@_*'$H
MHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K`BLV*VDKG2O1+`4L.2QN+*(LURT,
M+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<O_C`U,&PPI##;,1(Q2C&",;HQ
M\C(J,F,RFS+4,PTS1C-_,[@S\30K-&4TGC38-1,U336'-<(U_38W-G(VKC;I
M-R0W8#><-]<X%#A0.(PXR#D%.4(Y?SF\.?DZ-CIT.K(Z[SLM.VL[JCOH/"<\
M93RD/.,](CUA/:$]X#X@/F`^H#[@/R$_83^B/^)`(T!D0*9`YT$I06I!K$'N
M0C!"<D*U0O=#.D-]0\!$`T1'1(I$SD42155%FD7>1B)&9T:K1O!'-4=[1\!(
M!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I-`DU*39--W$XE
M3FY.MT\`3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4
MVU4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N5
M6^5<-5R&7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB
M\&-#8Y=CZV1`9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(
M:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R
M2W*F<P%S77.X=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&
M>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$>`J($*@6N!S8(P@I*"
M](-7@[J$'82`A..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6
MB_R,8XS*C3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4
M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY`
MGJZ?'9^+G_J@::#8H4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H
M4JC$J3>IJ:H<JH^K`JMUJ^FL7*S0K42MN*XMKJ&O%J^+L`"P=;#JL6"QUK)+
MLL*S.+.NM"6TG+43M8JV`;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]
M%;V/O@J^A+[_OWJ_]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&QL/'0<>_
MR#W(O,DZR;G*.,JWRS;+MLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1OM(_TL'3
M1-/&U$G4R]5.U='65=;8UUS7X-ADV.C9;-GQVG;:^]N`W`7<BMT0W9;>'-ZB
MWRG?K^`VX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJ
MY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50]=[V;?;[
M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____VP!#``(!`0(!`0("
M`@("`@("`P4#`P,#`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,
M!PD.#PT,#@L,#`S_VP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`"&``L#
M`2(``A$!`Q$!_\0`'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`
MM1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*Q
MP152T?`D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA9
M6F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*S
MM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ
M_\0`'P$``P$!`0$!`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#
M!`<%!`0``0)W``$"`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1
M"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI
M:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZ
MPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1
M`Q$`/P#])OVE?$G_``BWQ.\3ZKKF?&UG=:S]@T5['Q_J^BSZ))':0O)9"QL8
MG):/YIVGC5VVRC=MV@5]2?L[RWD_P&\'/J'B&T\67KZ-:M-K-J_F0ZFQB4F9
M&/+*W4,0"<Y(!-?.GQQ^%L'C#]I?5M2\/>$/V@])UGP]<I/<ZEX5U+2K#3-7
M>XM$C>6(7L_S!HHTBD:-4.^V7/S(K5]-?"#PM9>"/A9X>TC3M*O-#L=.T^&"
M'3[N837%FJH!Y<CAW#N/XF#MDY.XYS0!XC\;_'GB#P/XO\0:SJ/QZT+PAX3?
M48M-TK3[;PW#?7=M<+;"2>"0MO>1P`TV54;8V^8`+N/O7P_U!=6\"Z-=)K-O
MXC2YLH95U6!46+4@R`B=0F4"N#N&WC!XXKP/QKJ?P7^"7[3MWXGU?QAKEOXJ
MMGEO+C34NKR]TW39;BWCA>:2&-'CMW>&-#ERO&6Z,2?9O@-H.F^&/@OX7L-'
M^R?V7;:;"MH;6_\`M\#1E`59)]J^:I!R'V@$'.!0!X;\9-8\`_"[XJ>)X+7X
MP^-?`E]KDJ7_`(@TW0K*+4+>"=H43SW=[*X-I(\21D_.@PJOM'+'W'X":%I?
MAGX)^%-/T1;9=(M-*MX[/[/J!U")HA&-K+<$#S@1@^9CYLY[UQWBK]FZVC\7
MZ_J6A_$?QEX&_P"$HG%YJECI5S8^1<7'E)$9T^TV\KQ2,D:`F-E!V@XSDGNO
M@UX.M?A]\)_#NAV5B--M=)T^&UBMOMAO/)5$`P9B`93ZN>6//>@#XX^/OQG^
M"O@S]J7Q9;:S\)?A[XB\2:_J<6D27^O:WI44MSJ$&GK.))XKOYK6T%LNSSUW
M%WB51$Q9"WV;\*VMV^&F@&TM]"M+4Z?"88-%F$VFPIL&%MW"H&B`X5@J@C!P
M.E7-1\%:-J]V\]WI&F74\@`>2:U1W<#IDD9-:%M;1V5ND,,:111*%1$4*J`=
M``.`*`,>/XE^')O'4GA=/$&B-XFA@%S)I`OHC?)$>DAAW;PA_O8Q6CHNMV7B
M32;>_P!.N[:_L;M!+!<6\JRQ3(>C*RDA@?4&O./$G['W@GQ7_P`)%+=V4_\`
M:.OZN->34XI!%J.DWRP10I/:7"@21,JPH1R1RRD%&*5XIX!_:5E_9B\(V?PY
MTW2X]5L/`H;08+V]NP+F\2V<Q"60(BH';9N.T`9)P`.*`)OB+\3HOAI\6?'=
MU_PO*Y\/>*(=61[7P]<6DOB'39K9K>`1VZV*()Q-G=(R6<JNJ.)'!#9KZ*^&
M3Z=X_P#AWH>NRQ^&]3EUBQAO7O--BWV=T9$#F2(N-Q1LY&[G!YYKY0^+7P[U
M+QY^TEK5YX,\&^,Q?VOB>6VL=7MO&']F6ND:NNE1M<WYMWLYTBCFM&^S"1EF
M#NV!%'YAEKZ=_97O-'U#]F[P/-X?L[S3]&DT6V-I;7<_GSPIY8^623)$C9SE
MP<,>>]`'R/\`M=?$35O`WQS\57.L_%+P]%X5L-0BEU/04^*":#>75@UI&L-A
M'!\K6<T=RPN'F65#/$P0DAMJ_8?[.=OJ-I\!/!L>KZO9:]J::/:BYU&TN!<P
M7K^4N9$E``D4_P!\`;OO8&<5\U_M(V&@_$'XD>,=0N/`_B+P]X?T?4+;1O$_
MC/0I+::>Z$26]RWVW3VC9I;-$D1/M(#31C<RA(U+U]*?L[_%JT^//P*\)>-+
M"T6PL?%&EP:E;VZRK,L4<J!E`=0%88(P0,$4`?*?[4?QF;X??'CQ;8>*-=\9
M7\A:*71(_"OC>/1K;1K8P)MCO80Z>7+Y@DD,LHE#(RD`*-E?6/P"&JCX(>$C
MKFHZ5J^KMI-LUY?::R/9W<AC4M)$R*J,C'D,JJI!R%4'`^6_BAXEU[3?C;\3
M8_A[XQM/`MC9:BDWB6UU;Q3IVFO>W1LH"UU;1W.G73P(T(C7S6D5&:,D(-I9
MOI/]E6;1;G]FKP'+X<L[_3]!ET*T>PM[V3S;F*$Q*5$CY.]L<E@<-G(X-`'Q
ME^W3\3_"?@?]I/7K7XI6GBK7-3C2&Z\(OH%Y#;0:;9M&H5)`Z`B;[0LK%SYP
M(9<``;*^X_@B-?'P=\+_`/"57EKJ'B0Z7;G4KFW&(IYS&N]E^5."<\A%![*O
&0%%`'__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
